| 2024 (n=226) |
| 2725 | Haanen TJ et.al. (2024). Mutant PP2A Induces IGFBP2 Secretion to Promote Development of High-Grade Uterine Cancer. Cancer Res :. |
| 2724 | Demir S et.al. (2024). Drug prioritization identifies panobinostat as a tailored treatment element for patients with metastatic hepatoblastoma. J Exp Clin Cancer Res 43:299. |
| 2723 | Liu Y et.al. (2024). Targeting CLK2 and serine/arginine-rich splicing factors inhibits multiple myeloma through downregulating RAE1 by nonsense-mediated mRNA decay mechanism. Cancer Sci :. |
| 2722 | Pasello M et.al. (2024). CD99 contributes to the EWS::FLI1 transcriptome by specifically affecting FOXM1-targets involved in the G2/M cell cycle phase, thus influencing the Ewing sarcoma genetic landscape. J Cell Commun Signal 18:e12047. |
| 2721 | Poghosyan S et.al. (2024). VEGF-C propagates onward colorectal cancer metastasis from liver to lung. Br J Cancer :. |
| 2720 | Bocker M et.al. (2024). Ecto-NOX Disulfide-Thiol Exchanger 2 (ENOX2/tNOX) Is a Potential Prognostic Marker in Primary Malignant Melanoma and May Serve as a Therapeutic Target. Int J Mol Sci 25:. |
| 2719 | Yoo D et.al. (2024). STK33 as the functional substrate of miR-454-3p for suppression and apoptosis in neuroblastoma. Mol Cells :100145. |
| 2718 | Wang X et.al. (2024). Spatial and Single Cell Analyses Reveal Heterogeneity of DNAM-1 Receptor-Ligand Interactions that Instructs Intratumoral gammadeltaT-Cell Activity. Cancer Res :. |
| 2717 | Rohena-Rivera K et.al. (2024). Targeting ketone body metabolism in mitigating gemcitabine resistance. JCI Insight :. |
| 2716 | Villalard B et.al. (2024). Neuroblastoma plasticity during metastatic progression stems from the dynamics of an early sympathetic transcriptomic trajectory. Nat Commun 15:9570. |
| 2715 | Nkosi D et.al. (2024). SATB2 is an Emergent Biomarker of Anaplastic Thyroid Carcinoma: A Series with Comprehensive Biomarker and Molecular Studies. Endocr Pathol :. |
| 2714 | Dupuy M et.al. (2024). Chimeric protein EWS::FLI1 drives cell proliferation in Ewing Sarcoma via aberrant expression of KCNN1/SK1 and dysregulation of calcium signaling. Oncogene :. |
| 2713 | Tu Z et.al. (2024). Tumor-suppressive activities for pogo transposable element derived with KRAB domain via ribosome biogenesis restriction. Mol Cell :. |
| 2712 | Huang M et.al. (2024). Celastrol attenuates the invasion and migration and augments the anticancer effects of olaparib in prostate cancer. Cancer Cell Int 24:352. |
| 2711 | Chilamakuri R et.al. (2024). Repurposing of c-MET Inhibitor Tivantinib Inhibits Pediatric Neuroblastoma Cellular Growth. Pharmaceuticals (Basel) 17:. |
| 2710 | Cardus DF et.al. (2024). Systematic Analysis of miR-506-3p Target Genes Identified Key Mediators of Its Differentiation-Inducing Function. Genes (Basel) 15:. |
| 2709 | Hamilton AK et.al. (2024). A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma. Cancer Cell :. |
| 2708 | Reissland M et.al. (2024). USP10 drives cancer stemness and enables super-competitor signalling in colorectal cancer. Oncogene :. |
| 2707 | Zhao C et.al. (2024). Adipocyte-derived glutathione promotes obesity-related breast cancer by regulating the SCARB2-ARF1-mTORC1 complex. Cell Metab :. |
| 2706 | Wang Y et.al. (2024). Unconventional microRNA role: Enhancing the human leukocyte antigen class I antigen processing pathway via interacting with a silencer. Clin Transl Med 14:e70010. |
| 2705 | Giang LH et.al. (2024). RRM2 inhibition alters cell cycle through ATM/Rb/E2F1 pathway in atypical teratoid rhabdoid tumor. Neoplasia 58:101075. |
| 2704 | Serra R et.al. (2024). Neurosurgical application of olaparib from a thermo-responsive paste potentiates DNA damage to prolong survival in malignant glioma. Br J Cancer :. |
| 2703 | Killingsworth ZK et.al. (2024). Subcellular expression of CYP2E1 in HepG2 cells impacts response to free oleic and palmitic acid. Curr Res Toxicol 7:100195. |
| 2702 | Katoh H et.al. (2024). CD163(+) Tumor-Associated Macrophage Recruitment Predicts Papillary Thyroid Cancer Recurrence. J Surg Res 303:532-544. |
| 2701 | Nazam N et.al. (2024). PP2A activation overcomes leptomeningeal dissemination in Group 3 medulloblastoma. J Biol Chem :107892. |
| 2700 | Cornelissen FMG et.al. (2024). The translatome of glioblastoma. Mol Oncol :. |
| 2699 | Fang Y et.al. (2024). Zinc Finger Protein 536 is a Potential Prognostic Biomarker that Promotes Neuroblastoma Progression via VEGFR2-PI3K-AKT Pathway. Curr Cancer Drug Targets :. |
| 2698 | Ruhl S et.al. (2024). Inhibition of BAK-mediated apoptosis by the BH3-only protein BNIP5. Cell Death Differ :. |
| 2697 | Tu R et.al. (2024). USP7 depletion potentiates HIF2alpha degradation and inhibits clear cell renal cell carcinoma progression. Cell Death Dis 15:749. |
| 2696 | Cheung BB et.al. (2024). Golgi-localized Ring Finger Protein 121 is necessary for MYCN-driven neuroblastoma tumorigenesis. Commun Biol 7:1322. |
| 2695 | Camilo LP et.al. (2024). Evaluation of epithelial-to-mesenchymal transition and Ki-67 index in aggressive papillary thyroid cancer. Braz J Otorhinolaryngol 91:101510. |
| 2694 | Izutsu R et.al. (2024). AMIGO2 enhances the invasive potential of colorectal cancer by inducing EMT. Cancer Gene Ther :. |
| 2693 | Toyoda H et.al. (2024). MHC class I polypeptide-related sequence B shedding modulates pancreatic tumor immunity via the activation of NKG2D(Low) T cells. Sci Rep 14:23401. |
| 2692 | Yang L et.al. (2024). The DHODH inhibitor teriflunomide impedes cell proliferation and enhances chemosensitivity to daunorubicin (DNR) in T-cell acute lymphoblastic leukemia. Ann Hematol :. |
| 2691 | Adiamah M et.al. (2024). MYC-dependent upregulation of the de novo serine and glycine synthesis pathway is a targetable metabolic vulnerability in group 3 medulloblastoma. Neuro Oncol :. |
| 2690 | Bonine N et.al. (2024). NBAtlas: A harmonized single-cell transcriptomic reference atlas of human neuroblastoma tumors. Cell Rep 43:114804. |
| 2689 | Wang D et.al. (2024). Fam3a-mediated prohormone convertase switch in alpha-cells regulates pancreatic GLP-1 production in an Nr4a2-Foxa2-dependent manner. Metabolism :156042. |
| 2688 | Deutschmeyer VE et.al. (2024). SIAH3 is frequently epigenetically silenced in cancer and regulates mitochondrial metabolism. Int J Cancer :. |
| 2687 | Peng C et.al. (2024). Apigenin inhibits lipid metabolism of hepatocellular carcinoma cells by targeting the histone demethylase KDM1A. Phytomedicine 135:156024. |
| 2686 | Huang G et.al. (2024). SNPs Give LACTB Oncogene-Like Functions and Prompt Tumor Progression via Dual-Regulating p53. Adv Sci (Weinh) :e2405907. |
| 2685 | Bojko J et.al. (2024). Spliceosomal vulnerability of MYCN-amplified neuroblastoma is contingent on PRMT5-mediated regulation of epitranscriptomic and metabolomic pathways. Cancer Lett :217263. |
| 2684 | Cutilli A et.al. (2024). IFNgamma induces epithelial reprogramming driving CXCL11-mediated T cell migration. J Leukoc Biol :. |
| 2683 | Li M et.al. (2024). SUV39H1 epigenetically modulates the MCPIP1-AURKA signaling axis to enhance neuroblastoma tumorigenesis. Oncogene :. |
| 2682 | Alifano E et.al. (2024). Glucose metabolism transcriptome clustering identifies subsets of resectable lung adenocarcinoma with different prognoses. JTCVS Open 20:194-201. |
| 2681 | Lin M et.al. (2024). FTO diversely influences sensitivity of neuroblastoma cells to various chemotherapeutic drugs. Front Pharmacol 15:1384141. |
| 2680 | Markovska A et.al. (2024). Targeted inhibition of glycogen synthase kinase-3 using 9-ING-41 (elraglusib) enhances CD8 T-cell-reactivity against neuroblastoma cells. Sci Rep 14:21710. |
| 2679 | Liu N et.al. (2024). RBM39 enhances cholangiocarcinoma growth through EZH2-mediated WNT7B/beta-catenin pathway. Cell Mol Gastroenterol Hepatol :101404. |
| 2678 | Hartl L et.al. (2024). Hypoxia Abrogates Tumor-Suppressive Activities of C/EBPdelta in Pancreatic Cancer. Int J Mol Sci 25:. |
| 2677 | Ma Y et.al. (2024). CAMK2G Promotes Neuronal Differentiation and Inhibits Migration in Neuroblastoma. J Pediatr Surg :161679. |
| 2676 | Yan H et.al. (2024). Eupafolin hinders cross-talk between gastric cancer cells and cancer-associated fibroblasts by abrogating the IL18/IL18RAP signaling axis. Phytomedicine 134:155984. |
| 2675 | Guo Q et.al. (2024). The SIX2/PFN2 feedback loop promotes the stemness of gastric cancer cells. J Transl Med 22:832. |
| 2674 | Huser L et.al. (2024). Aged fibroblast-derived extracellular vesicles promote angiogenesis in melanoma. Cell Rep 43:114721. |
| 2673 | Nagarajan D et.al. (2024). Epigenetic regulation of cell state by H2AFY governs immunogenicity in high-risk neuroblastoma. J Clin Invest :. |
| 2672 | Ding J et.al. (2024). MYC Drives mRNA Pseudouridylation to Mitigate Proliferation-Induced Cellular Stress during Cancer Development. Cancer Res :. |
| 2671 | Altun Z et.al. (2024). Low Expression of CASP8 Could be a Prognostic Biomarker in Neuroblastoma Patients. J Child Neurol :8830738241273431. |
| 2670 | Cheng J et.al. (2024). Proteomic analysis of serum small extracellular vesicles identifies diagnostic biomarkers for neuroblastoma. Front Oncol 14:1367159. |
| 2669 | Wang Y et.al. (2024). FOSL1 promotes stem cell‑like characteristics and anoikis resistance to facilitate tumorigenesis and metastasis in osteosarcoma by targeting SOX2. Int J Mol Med 54:. |
| 2668 | Suman M et.al. (2024). Altered methylation of imprinted genes in neuroblastoma: implications for prognostic refinement. J Transl Med 22:808. |
| 2667 | Zhang Y et.al. (2024). Synergistic induction of ferroptosis by targeting HERC1-NCOA4 axis to enhance the photodynamic sensitivity of osteosarcoma. Redox Biol 76:103328. |
| 2666 | Zeng L et.al. (2024). The deubiquitinase USP44 enhances cisplatin chemosensitivity through stabilizing STUB1 to promote LRPPRC degradation in neuroblastoma. Neuro Oncol :. |
| 2665 | Zhong WJ et.al. (2024). Identification of DNA methylation-regulated WEE1 with potential implications in prognosis and immunotherapy for low-grade glioma. Cancer Biomark 40:297-317. |
| 2664 | Vivarelli S et.al. (2024). Computational Analyses Reveal Deregulated Clock Genes Associated with Breast Cancer Development in Night Shift Workers. Int J Mol Sci 25:. |
| 2663 | Ashbaugh AM et.al. (2024). Unexpected Expression and Function of FcepsilonRI in Immortalized Breast Cancer Cells: A Cautionary Null Study. Cells 13:. |
| 2662 | Tirelli M et.al. (2024). Integrative genomic analyses identify neuroblastoma risk genes involved in neuronal differentiation. Hum Genet :. |
| 2661 | Okada R et.al. (2024). L3MBTL2 maintains MYCN-amplified neuroblastoma cell proliferation through silencing NRIP3 and BRME1 genes. Genes Cells :. |
| 2660 | Zhang G et.al. (2024). TRIP13 regulates progression of gastric cancer through stabilising the expression of DDX21. Cell Death Dis 15:622. |
| 2659 | Zhang L et.al. (2024). CRISPR-Cas9 screening develops an epigenetic and transcriptional gene signature for risk stratification and target prediction in neuroblastoma. Front Cell Dev Biol 12:1433008. |
| 2658 | Xu M et.al. (2024). Targeting SWI/SNF ATPases reduces neuroblastoma cell plasticity. EMBO J :. |
| 2657 | Nagata H et.al. (2024). ACTN4 is associated with the malignant potential of thymic epithelial tumors through the beta-catenin/Slug pathway. Cancer Sci :. |
| 2656 | Hsu TW et.al. (2024). Nrf2-mediated adenylosuccinate lyase promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma cells through ferroptosis escape. J Cell Physiol :e31416. |
| 2655 | Lansbergen MF et.al. (2024). Transcriptome-based classification to predict FOLFIRINOX response in a real-world metastatic pancreatic cancer cohort. Transl Res :. |
| 2654 | Cui Y et.al. (2024). SLC7A11 protects luminal A breast cancer cells against ferroptosis induced by CDK4/6 inhibitors. Redox Biol 76:103304. |
| 2653 | Stroes CI et.al. (2024). Tumor immune microenvironmental characteristics in Human Epidermal Growth Factor-2 (HER2) positive esophageal adenocarcinoma: A comparative analysis and biomarker study. Transl Oncol 49:102079. |
| 2652 | Samarzija I et.al. (2024). The extracellular matrix component perlecan/HSPG2 regulates radioresistance in prostate cancer cells. Front Cell Dev Biol 12:1452463. |
| 2651 | Silva GND et.al. (2024). Combined expression of JHDM1D/KDM7A gene and long non-coding RNA RP11-363E7.4 as a biomarker for urothelial cancer prognosis. Genet Mol Biol 47:e20230265. |
| 2650 | Zhou J et.al. (2024). Comprehensive analysis identifies ubiquitin ligase FBXO42 as a tumor-promoting factor in neuroblastoma. Sci Rep 14:18697. |
| 2649 | Sundaramoorthy S et.al. (2024). Preclinical spheroid models identify BMX as a therapeutic target for metastatic MYCN nonamplified neuroblastoma. JCI Insight 9:. |
| 2648 | Tang K et.al. (2024). USP7 deubiquitinates epigenetic reader ZMYND8 to promote breast cancer cell migration and invasion. J Biol Chem :107672. |
| 2647 | Yang G et.al. (2024). NDRG1 enhances the sensitivity to Cetuximab by promoting Stat1 ubiquitylation in colorectal cancer. J Adv Res :. |
| 2646 | Sun W et.al. (2024). Targeting MCL1 with Sanggenon C overcomes MCL1-driven adaptive chemoresistance via dysregulation of autophagy and endoplasmic reticulum stress in cervical cancer. Phytomedicine 133:155935. |
| 2645 | Yao W et.al. (2024). Atractyloside inhibits gefitinib‑resistant non‑small‑cell lung cancer cell proliferation. Oncol Lett 28:466. |
| 2644 | Cassandri M et.al. (2024). HDAC3 genetic and pharmacologic inhibition radiosensitizes fusion positive rhabdomyosarcoma by promoting DNA double-strand breaks. Cell Death Discov 10:351. |
| 2643 | Miranda-Carboni GA et.al. (2024). Targeting WNT5B and WNT10B in osteosarcoma. Oncotarget 15:535-540. |
| 2642 | Lizardo MM et.al. (2024). Pharmacologic inhibition of eIF4A blocks NRF2 synthesis to prevent osteosarcoma metastasis. Clin Cancer Res :. |
| 2641 | Guo X et.al. (2024). Rabenosyn-5 suppresses non-small cell lung cancer metastasis via inhibiting CDC42 activity. Cancer Gene Ther :. |
| 2640 | Maciejewski K et.al. (2024). The Epigenetic Modifiers HDAC2 and HDAC7 Inversely Associate with Cancer Stemness and Immunity in Solid Tumors. Int J Mol Sci 25:. |
| 2639 | Hohmann T et.al. (2024). Analyzing the Impact of the Highest Expressed Epstein-Barr Virus-Encoded microRNAs on the Host Cell Transcriptome. Int J Mol Sci 25:. |
| 2638 | Utjes D et.al. (2024). Transcriptomic Profile of Breast Tissue of Premenopausal Women Following Treatment with Progesterone Receptor Modulator: Secondary Outcomes of a Randomized Controlled Trial. Int J Mol Sci 25:. |
| 2637 | Vriend J et.al. (2024). Survival-Related Genes on Chromosomes 6 and 17 in Medulloblastoma. Int J Mol Sci 25:. |
| 2636 | Liu D et.al. (2024). Predictive Biomarkers for Response to TGF Pharmacol Res :107315. |
| 2635 | Santos VS et.al. (2024). Atypical phosphatase DUSP11 inhibition promotes nc886 expression and potentiates gemcitabine-mediated cell death through NF-kB modulation. Cancer Gene Ther :. |
| 2634 | Contenti J et.al. (2024). HIF-1 inactivation empowers HIF-2 to drive hypoxia adaptation in aggressive forms of medulloblastoma. Cell Death Discov 10:338. |
| 2633 | Djos A et.al. (2024). Loss of Chromosome Y in Neuroblastoma Is Associated With High-Risk Disease, 11q-Deletion, and Telomere Maintenance. Genes Chromosomes Cancer 63:e23260. |
| 2632 | Bate-Eya LT et.al. (2024). Sustained cancer-relevant alternative RNA splicing events driven by PRMT5 in high-risk neuroblastoma. Mol Oncol :. |
| 2631 | Boer JM et.al. (2024). Oncogenic and immunological targets for matched therapy of pediatric blood cancer patients: Dutch iTHER study experience. Hemasphere 8:e122. |
| 2630 | Yang H et.al. (2024). Identification and characterization of TM4SF1(+) tumor self-seeded cells. Cell Rep 43:114512. |
| 2629 | Lishman-Walker E et.al. (2024). Casein Kinase 1alpha-A Target for Prostate Cancer Therapy? Cancers (Basel) 16:. |
| 2628 | Luo W et.al. (2024). Combinatorial macrophage induced innate immunotherapy against Ewing sarcoma: Turning Two Keys simultaneously. J Exp Clin Cancer Res 43:193. |
| 2627 | Murray JE et.al. (2024). The transcriptional co-repressor Runx1t1 is essential for MYCN-driven neuroblastoma tumorigenesis. Nat Commun 15:5585. |
| 2626 | Stefani MA et.al. (2024). ENTPD1 (CD39) and NT5E (CD73) expression in human medulloblastoma: an in silico analysis. Purinergic Signal :. |
| 2625 | Choi SH et.al. (2024). Oral transforming growth factor-beta receptor 1 inhibitor vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti-tumor immunity. Cancer Commun (Lond) :. |
| 2624 | Wang Y et.al. (2024). Identification of RNA-binding protein hnRNP C targeting the 3UTR of the TAP-associated glycoprotein tapasin in melanoma. Oncoimmunology 13:2370928. |
| 2623 | Nagata Y et.al. (2024). Melatonin Inhibits Chemical Carcinogen-mediated Malignant Transformation of Urothelial Cells: In Vitro Evidence. Cancer Genomics Proteomics 21:388-394. |
| 2622 | Seiboldt T et.al. (2024). Synergy of retinoic acid and BH3 mimetics in MYC(N)-driven embryonal nervous system tumours. Br J Cancer :. |
| 2621 | Singh V et.al. (2024). UBR7 E3 Ligase Suppresses Interferon-beta Mediated Immune Signaling by Targeting Sp110 in Hepatitis B Virus-Induced Hepatocellular Carcinoma. ACS Infect Dis :. |
| 2620 | Ognibene M et.al. (2024). Overexpression of H2AFX gene in neuroblastoma is associated with worse prognosis. Pediatr Blood Cancer :e31146. |
| 2619 | Chen W et.al. (2024). Estrogen-related receptor alpha promotes thyroid tumor cell survival via a tumor subtype-specific regulation of target gene networks. Oncogene :. |
| 2618 | Medeiros M et.al. (2024). Amicis Omnia Sunt Communia: NF-kappaB Inhibition as an Alternative to Overcome Osteosarcoma Heterogeneity. Pharmaceuticals (Basel) 17:. |
| 2617 | Qiao S et.al. (2024). KLF7 promotes neuroblastoma differentiation through the GTPase signaling pathway by upregulating neuroblast differentiation-associated protein AHNAKs and glycerophosphodiesterase GDPD5. FEBS J :. |
| 2616 | Chagas PS et.al. (2024). Network-Based Transcriptome Analysis Reveals FAM3C as a Novel Potential Biomarker for Glioblastoma. J Cell Biochem :e30612. |
| 2615 | Adhikari S et.al. (2024). UBR7 in concert with EZH2 inhibits the TGF-beta signaling leading to extracellular matrix remodeling. Cell Rep 43:114394. |
| 2614 | Iqbal S et.al. (2024). Multiomics Analysis of the PHLDA Gene Family in Different Cancers and Their Clinical Prognostic Value. Curr Issues Mol Biol 46:5488-5510. |
| 2613 | Tang XX et.al. (2024). A Perspective on the CD47-SIRPA Axis in High-Risk Neuroblastoma. Curr Oncol 31:3212-3226. |
| 2612 | Wang N et.al. (2024). RUNX3 exerts tumor-suppressive role through inhibiting EXOSC4 expression. Funct Integr Genomics 24:103. |
| 2611 | Fredlund E et.al. (2024). MOXD1 is a lineage-specific gene and a tumor suppressor in neuroblastoma. Sci Adv 10:eado1583. |
| 2610 | Verhagen MP et.al. (2024). Non-stem cell lineages as an alternative origin of intestinal tumorigenesis in the context of inflammation. Nat Genet :. |
| 2609 | Kang JY et.al. (2024). The novel prognostic marker SPOCK2 regulates tumour progression in melanoma. Exp Dermatol 33:e15092. |
| 2608 | Ma Y et.al. (2024). CLK3 positively promoted colorectal cancer proliferation by activating IL-6/STAT3 signaling. Exp Cell Res :114132. |
| 2607 | Jacobson JC et.al. (2024). Migration, invasion, and metastasis are mediated by P-Rex1 in neuroblastoma. Front Oncol 14:1336031. |
| 2606 | Jansen SA et.al. (2024). Chemotherapy-induced intestinal epithelial damage directly promotes galectin-9-driven modulation of T cell behavior. iScience 27:110072. |
| 2605 | Van Camp L et.al. (2024). Acute myeloid leukemia stem cell signature gene EMP1 is not an eligible therapeutic target. Pediatr Res :. |
| 2604 | Singh A et.al. (2024). REST-dependent downregulation of von Hippel-Lindau tumor suppressor promotes autophagy in SHH-medulloblastoma. Sci Rep 14:13596. |
| 2603 | Pascual-Pasto G et.al. (2024). Targeting GPC2 on intraocular and CNS metastatic retinoblastomas with local and systemic delivery of CAR T-cells. Clin Cancer Res :. |
| 2602 | Chai X et.al. (2024). [Clinicopathological characteristics of the CD8(+) T lymphocytes infiltration and its mechanism in distinct molecular subtype of medulloblastoma]. Beijing Da Xue Xue Bao Yi Xue Ban 56:512-518. |
| 2601 | Zhang Y et.al. (2024). [Role and mechanism of cysteine and glycine-rich protein 2 in the malignant progression of neuroblastoma]. Beijing Da Xue Xue Bao Yi Xue Ban 56:495-504. |
| 2600 | Dong H et.al. (2024). DAB2IP inhibits glucose uptake by modulating HIF-1alpha ubiquitination under hypoxia in breast cancer. Oncogenesis 13:20. |
| 2599 | Bakhit M et.al. (2024). Bioinformatic Analysis of Gene Expression Related to Sialic Acid Biosynthesis in Patients With Medulloblastoma. Cureus 16:e59997. |
| 2598 | Okonechnikov K et.al. (2024). Clinically unfavorable transcriptome subtypes of non-WNT/non-SHH medulloblastomas are associated with a predominance in proliferating and progenitor-like cell subpopulations. Acta Neuropathol 147:95. |
| 2597 | Brichkina A et.al. (2024). DYRK1B blockade promotes tumoricidal macrophage activity in pancreatic cancer. Gut :. |
| 2596 | Shiraishi R et.al. (2024). Cancer-specific epigenome identifies oncogenic hijacking by nuclear factor I family proteins for medulloblastoma progression. Dev Cell :. |
| 2595 | Shi Y et.al. (2024). NEDD4L mediates ITGB4 ubiquitination and degradation to suppress esophageal carcinoma progression. Cell Commun Signal 22:302. |
| 2594 | Jeremiasse B et.al. (2024). A multispectral 3D live organoid imaging platform to screen probes for fluorescence guided surgery. EMBO Mol Med :. |
| 2593 | Giugliano FP et.al. (2024). Pro-inflammatory T cells-derived cytokines enhance the maturation of the human fetal intestinal epithelial barrier. iScience 27:109909. |
| 2592 | Abdoul-Azize S et.al. (2024). Glucocorticoids paradoxically promote steroid resistance in B cell acute lymphoblastic leukemia through CXCR4/PLC signaling. Nat Commun 15:4557. |
| 2591 | Murphy C et.al. (2024). In vivo cisplatin-resistant neuroblastoma metastatic model reveals tumour necrosis factor receptor superfamily member 4 (TNFRSF4) as an independent prognostic factor of survival in neuroblastoma. PLoS One 19:e0303643. |
| 2590 | Suarez-Martinez E et.al. (2024). Protein homeostasis maintained by HOOK1 levels promotes the tumorigenic and stemness properties of ovarian cancer cells through reticulum stress and autophagy. J Exp Clin Cancer Res 43:150. |
| 2589 | Guha D et.al. (2024). ZMYND8 Is a Regulator of Sonic Hedgehog Signaling in ATRA-Mediated Differentiation of Neuroblastoma Cells. Biochemistry :. |
| 2588 | Jian C et.al. (2024). A GAD1 inhibitor suppresses osteosarcoma growth through the Wnt/beta-catenin signaling pathway. Heliyon 10:e31444. |
| 2587 | Yu P et.al. (2024). Exosomes derived from pulmonary metastatic sites enhance osteosarcoma lung metastasis by transferring the miR-194/215 cluster targeting MARCKS. Acta Pharm Sin B 14:2039-2056. |
| 2586 | Polychronopoulos PA et.al. (2024). The Neuroblastoma Microenvironment, Heterogeneity and Immunotherapeutic Approaches. Cancers (Basel) 16:. |
| 2585 | van der Haar Avila I et.al. (2024). Limited impact of cancer-derived gangliosides on anti-tumor immunity in colorectal cancer. Glycobiology :. |
| 2584 | de Back TR et.al. (2024). A consensus molecular subtypes classification strategy for clinical colorectal cancer tissues. Life Sci Alliance 7:. |
| 2583 | Sui Y et.al. (2024). Targeting Super-Enhancer-Driven Transcriptional Dependencies Suppresses Aberrant Hedgehog Pathway Activation and Overcomes Smoothened Inhibitor Resistance. Cancer Res :. |
| 2582 | Ekstrom TL et.al. (2024). USP44 overexpression drives a MYC-like gene expression program in neuroblastoma through epigenetic reprogramming. Mol Cancer Res :. |
| 2581 | Burov A et.al. (2024). Multikinase inhibitors modulate non-constitutive proteasome expression in colorectal cancer cells. Front Mol Biosci 11:1351641. |
| 2580 | van der Zalm AP et.al. (2024). The pluripotency factor NANOG contributes to mesenchymal plasticity and is predictive for outcome in esophageal adenocarcinoma. Commun Med (Lond) 4:89. |
| 2579 | Knoll L et.al. (2024). Expression of gemcitabine metabolizing enzymes and stromal components reveal complexities of preclinical pancreatic cancer models for therapeutic testing. Neoplasia 53:101002. |
| 2578 | Hu M et.al. (2024). Genomic landscape defines peritoneal metastatic pattern and related target of peritoneal metastasis in colorectal cancer. Int J Cancer :. |
| 2577 | Jin T et.al. (2024). CTLA4 expression profiles and their association with clinical outcomes of breast cancer: a systemic review. Ann Surg Treat Res 106:263-273. |
| 2576 | Zhu J et.al. (2024). HDAC Inhibition Increases CXCL12 Secretion to Recruit Natural Killer Cells in Peripheral T Cell Lymphoma. Cancer Res :. |
| 2575 | Zhong P et.al. (2024). Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer cells. J Exp Clin Cancer Res 43:138. |
| 2574 | Wu X et.al. (2024). Dual roles of HK3 in regulating the network between tumor cells and tumor-associated macrophages in neuroblastoma. Cancer Immunol Immunother 73:122. |
| 2573 | Vermonden P et.al. (2024). Phospholipase PLA2G7 is complementary to GPX4 in mitigating punicic-acid-induced ferroptosis in prostate cancer cells. iScience 27:109774. |
| 2572 | Hou Y et.al. (2024). WDR61 ablation triggers R-loop accumulation and suppresses breast cancer progression. FEBS J :. |
| 2571 | Saldana-Guerrero IM et.al. (2024). A human neural crest model reveals the developmental impact of neuroblastoma-associated chromosomal aberrations. Nat Commun 15:3745. |
| 2570 | Pomaville M et.al. (2024). Small-molecule inhibition of the METTL3/METTL14 complex suppresses neuroblastoma tumor growth and promotes differentiation. Cell Rep 43:114165. |
| 2569 | Perkins RS et.al. (2024). WNT5B drives osteosarcoma stemness, chemoresistance and metastasis. Clin Transl Med 14:e1670. |
| 2568 | Do AD et.al. (2024). LOXL1-AS1 contributes to metastasis in sonic-hedgehog medulloblastoma by promoting cancer stem-like phenotypes. J Exp Clin Cancer Res 43:130. |
| 2567 | Liao Q et.al. (2024). FTO elicits tumor neovascularization in cancer-associated fibroblasts through eliminating m(6)A modifications of multiple pro-angiogenic factors. Cancer Lett :216911. |
| 2566 | Roessner PM et.al. (2024). T-bet suppresses proliferation of malignant B cells in chronic lymphocytic leukemia. Blood :. |
| 2565 | Ampudia-Mesias E et.al. (2024). The OTX2 Gene Induces Tumor Growth and Triggers Leptomeningeal Metastasis by Regulating the mTORC2 Signaling Pathway in Group 3 Medulloblastomas. Int J Mol Sci 25:. |
| 2564 | Sheeter DA et.al. (2024). Unsaturated Fatty Acid Synthesis Is Associated with Worse Survival and Is Differentially Regulated by MYCN and Tumor Suppressor microRNAs in Neuroblastoma. Cancers (Basel) 16:. |
| 2563 | Mosca N et.al. (2024). A Novel ceRNET Relying on the lncRNA JPX, miR-378a-3p, and Its mRNA Targets in Lung Cancer. Cancers (Basel) 16:. |
| 2562 | Rozen EJ et.al. (2024). Blockade of Discoidin Domain Receptor Signaling with Sitravatinib Reveals DDR2 as a Mediator of Neuroblastoma Pathogenesis and Metastasis. Mol Cancer Ther :. |
| 2561 | Bootsma S et.al. (2024). Exploiting a subtype-specific mitochondrial vulnerability for successful treatment of colorectal peritoneal metastases. Cell Rep Med :101523. |
| 2560 | Volegova MP et.al. (2024). The MYCN 5 UTR as a therapeutic target in neuroblastoma. Cell Rep 43:114134. |
| 2559 | Stamatiou K et.al. (2024). Ki-67 is necessary during DNA replication for fork protection and genome stability. Genome Biol 25:105. |
| 2558 | Wang J et.al. (2024). METTL14 promotes neuroblastoma formation by inhibiting YWHAH via an m6A-YTHDF1-dependent mechanism. Cell Death Discov 10:186. |
| 2557 | Khan T et.al. (2024). STAT1 mediated downregulation of the tumor suppressor gene PDCD4, is driven by the atypical cadherin FAT1, in glioblastoma. Cell Signal :111178. |
| 2556 | Mogal MR et.al. (2024). Integrated bioinformatics analysis reveals upregulated extracellular matrix hub genes in pancreatic cancer: Implications for diagnosis, prognosis, immune infiltration, and therapeutic strategies. Cancer Rep (Hoboken) 7:e2059. |
| 2555 | Politiek FA et.al. (2024). Molecular and cellular consequences of mevalonate kinase deficiency. Biochim Biophys Acta Mol Basis Dis 1870:167177. |
| 2554 | Frohlich LM et.al. (2024). PARP1 expression predicts PARP inhibitor sensitivity and correlates with metastatic potential and overall survival in melanoma. Int J Cancer :. |
| 2553 | Wang L et.al. (2024). Gut Microbiome and Transcriptomic Changes in Cigarette Smoke-Exposed Mice Compared to COPD and CD Patient Datasets. Int J Mol Sci 25:. |
| 2552 | Bibbo F et.al. (2024). Targeting Group 3 Medulloblastoma by the Anti-PRUNE-1 and Anti-LSD1/KDM1A Epigenetic Molecules. Int J Mol Sci 25:. |
| 2551 | Chen MS et.al. (2024). Lidocaine attenuates TMZ resistance and inhibits cell migration by modulating the MET pathway in glioblastoma cells. Oncol Rep 51:. |
| 2550 | Guo Y et.al. (2024). IGSF3 is a homophilic cell adhesion molecule that drives lung metastasis of melanoma by promoting adhesion to vascular endothelium. Cancer Sci :. |
| 2549 | Slapak EJ et.al. (2024). CAPN2-responsive mesoporous silica nanoparticles: A promising nanocarrier for targeted therapy of pancreatic cancer. Cancer Lett :216845. |
| 2548 | Ebegboni VJ et.al. (2024). ETS1, a target gene of the EWSR1::FLI1 fusion oncoprotein, regulates the expression of the focal adhesion protein TENSIN3. Mol Cancer Res :. |
| 2547 | Gallo-Oller G et.al. (2024). TRIB3 silencing promotes the downregulation of Akt pathway and PAX3-FOXO1 in high-risk rhabdomyosarcoma. Exp Hematol Oncol 13:38. |
| 2546 | Julson JR et.al. (2024). PIM Kinase Inhibition Sensitizes Neuroblastoma to Doxorubicin. J Pediatr Surg :. |
| 2545 | Valenzuela Alvarez MJP et.al. (2024). Osteosarcoma cells exhibit functional interactions with stromal cells, fostering a lung microenvironment conducive to the establishment of metastatic tumor cells. Mol Biol Rep 51:467. |
| 2544 | Kim Y et.al. (2024). ELAVL2 loss promotes aggressive mesenchymal transition in glioblastoma. NPJ Precis Oncol 8:79. |
| 2543 | Trampert DC et.al. (2024). Laminin 511-E8, an autoantigen in IgG4-related cholangitis, contributes to cholangiocyte protection. JHEP Rep 6:101015. |
| 2542 | Abu-Zaid A et.al. (2024). Histone lysine demethylase 4 family proteins maintain the transcriptional program and adrenergic cellular state of MYCN-amplified neuroblastoma. Cell Rep Med 5:101468. |
| 2541 | Bugara B et.al. (2024). Silencing of the PHLDA1 leads to global proteome changes and differentiation pathways of human neuroblastoma cells. Front Pharmacol 15:1351536. |
| 2540 | Zhong X et.al. (2024). Moracin D suppresses cell growth and induces apoptosis via targeting the XIAP/PARP1 axis in pancreatic cancer. Phytomedicine 128:155527. |
| 2539 | Qin X et.al. (2024). CKLF instigates a cold microenvironment to promote MYCN-mediated tumor aggressiveness. Sci Adv 10:eadh9547. |
| 2538 | Jablonowski CM et.al. (2024). Metabolic reprogramming of cancer cells by JMJD6-mediated pre-mRNA splicing associated with therapeutic response to splicing inhibitor. Elife 12:. |
| 2537 | Kim D et.al. (2024). N-cadherin dynamically regulates pediatric glioma cell migration in complex environments. J Cell Biol 223:. |
| 2536 | Bark SA et.al. (2024). Gene Expression of CSF3R/CD114 Is Associated with Poorer Patient Survival in Glioma. Int J Mol Sci 25:. |
| 2535 | Villasante A et.al. (2024). Identification of GB3 as a Novel Biomarker of Tumor-Derived Vasculature in Neuroblastoma Using a Stiffness-Based Model. Cancers (Basel) 16:. |
| 2534 | Danielli SG et.al. (2024). Evaluation of the role of AXL in fusion-positive pediatric rhabdomyosarcoma identifies the small-molecule inhibitor bemcentinib (BGB324) as potent chemosensitizer. Mol Cancer Ther :. |
| 2533 | Wang Q et.al. (2024). Enzyme-Mediated Bioorthogonal Cascade Catalytic Reaction for Metabolism Intervention and Enhanced Ferroptosis on Neuroblastoma. J Am Chem Soc :. |
| 2532 | Yuan F et.al. (2024). Heparanase interacting BCLAF1 to promote the development and drug resistance of ICC through the PERK/eIF2alpha pathway. Cancer Gene Ther :. |
| 2531 | Huang M et.al. (2024). ALK upregulates POSTN and WNT signaling to drive neuroblastoma. Cell Rep 43:113927. |
| 2530 | Chen KC et.al. (2024). Nicotinamide phosphoribosyltransferase modulates PD-L1 in bladder cancer and enhances immunotherapeutic sensitivity. Biochim Biophys Acta Mol Basis Dis :167106. |
| 2529 | Blumel L et.al. (2024). Proteogenomic profiling uncovers differential therapeutic vulnerabilities between TCF3::PBX1 and TCF3::HLF translocated B-cell acute lymphoblastic leukemia. Haematologica :. |
| 2528 | Kinoshita H et.al. (2024). Thioredoxin Reductase Inhibitor Suppresses the Local Progression of Rhabdomyosarcoma With PDX Models. Cancer Genomics Proteomics 21:178-185. |
| 2527 | Miele E et.al. (2024). Clinicopathological and molecular landscape of 5-year IDH-wild-type glioblastoma survivors: A multicentric retrospective study. Cancer Lett :216711. |
| 2526 | Munoz-Galvan S et.al. (2024). Essential role of PLD2 in hypoxia-induced stemness and therapy resistance in ovarian tumors. J Exp Clin Cancer Res 43:57. |
| 2525 | Lee WG et.al. (2024). Precision Oncology in Pediatric Cancer Surgery. Surg Oncol Clin N Am 33:409-446. |
| 2524 | Rosemann J et.al. (2024). NANOS1 restricts oral cancer cell motility and TGF-ss signaling. Eur J Cell Biol 103:151400. |
| 2523 | Arroyo Villora S et.al. (2024). Biomarker RIPK3 Is Silenced by Hypermethylation in Melanoma and Epigenetic Editing Reestablishes Its Tumor Suppressor Function. Genes (Basel) 15:. |
| 2522 | Nakatani K et.al. (2024). Inhibition of OCT4 binding at the MYCN locus induces neuroblastoma cell death accompanied by downregulation of transcripts with high-open reading frame dominance. Front Oncol 14:1237378. |
| 2521 | Gose T et.al. (2024). Tumor-acquired somatic mutation affects conformation to abolish ABCG2-mediated drug resistance. Drug Resist Updat 73:101066. |
| 2520 | Wan X et.al. (2024). Super enhancer related gene ANP32B promotes the proliferation of acute myeloid leukemia by enhancing MYC through histone acetylation. Cancer Cell Int 24:81. |
| 2519 | Rinaldi L et.al. (2024). Downregulation of praja2 restrains endocytosis and boosts tyrosine kinase receptors in kidney cancer. Commun Biol 7:208. |
| 2518 | Wang Y et.al. (2024). Identifying squalene epoxidase as a metabolic vulnerability in high-risk osteosarcoma using an artificial intelligence-derived prognostic index. Clin Transl Med 14:e1586. |
| 2517 | Koelink PJ et.al. (2024). The phospholipid flippase ATP8B1 is involved in the pathogenesis of Ulcerative Colitis via establishment of intestinal barrier function. J Crohns Colitis :. |
| 2516 | Vernaza A et.al. (2024). Identification of CDKN3 as a Key Gene that Regulates Neuroblastoma Cell Differentiation. J Cancer 15:1153-1168. |
| 2515 | Chiang JY et.al. (2024). ABCC4 suppresses glioblastoma progression and recurrence by restraining cGMP-PKG signalling. Br J Cancer :. |
| 2514 | Logan A et.al. (2024). Targeted delivery of polo-like kinase 1 siRNA nanoparticles using an EGFR-PEG bispecific antibody inhibits proliferation of high-risk neuroblastoma. J Control Release 367:806-820. |
| 2513 | Mollick T et.al. (2024). Retinoblastoma vulnerability to combined de novo and salvage pyrimidine ribonucleotide synthesis pharmacologic blockage. Heliyon 10:e23831. |
| 2512 | Hu T et.al. (2024). HNRNPA2B1 and HNRNPR stabilize ASCL1 in an m6A-dependent manner to promote neuroblastoma progression. Biochim Biophys Acta Mol Basis Dis :167050. |
| 2511 | Randolph ME et.al. (2024). RNA helicase DDX3 regulates RAD51 localization and DNA damage repair in Ewing sarcoma. iScience 27:108925. |
| 2510 | Prasad H et.al. (2024). An endosomal acid-regulatory feedback system rewires cytosolic cAMP metabolism and drives tumour progression. Mol Cancer Res :. |
| 2509 | Schober SJ et.al. (2024). TCR-transgenic T cells and YB-1-based oncolytic virotherapy improve survival in a preclinical Ewing sarcoma xenograft mouse model. Front Immunol 15:1330868. |
| 2508 | Dai S et.al. (2024). The potential mechanism of Aidi injection against neuroblastoma-an investigation based on network pharmacology analysis. Front Pharmacol 15:1310009. |
| 2507 | Chennakesavalu M et.al. (2024). 5-Hydroxymethylcytosine Profiling of Cell-Free DNA Identifies Bivalent Genes That Are Prognostic of Survival in High-Risk Neuroblastoma. JCO Precis Oncol 8:e2300297. |
| 2506 | Chen H et.al. (2024). AURKA inhibition induces Ewings sarcoma apoptosis and ferroptosis through NPM1/YAP1 axis. Cell Death Dis 15:99. |
| 2505 | Demir S et.al. (2024). Targeting G9a/DNMT1 methyltransferase activity impedes IGF2-mediated survival in hepatoblastoma. Hepatol Commun 8:. |
| 2504 | Rozen EJ et.al. (2024). A Novel Druggable Dual-Specificity tYrosine-Regulated Kinase3/Calmodulin Kinase-like Vesicle-Associated Signaling Module with Therapeutic Implications in Neuroblastoma. Biomedicines 12:. |
| 2503 | Gabre JL et.al. (2024). Preclinical exploration of the DNA damage response pathway using the interactive neuroblastoma cell line explorer CLEAN. NAR Cancer 6:zcad062. |
| 2502 | Zhao K et.al. (2024). LncRNA ZNF674-AS1 drives cell growth and inhibits cisplatin-induced pyroptosis via up-regulating CA9 in neuroblastoma. Cell Death Dis 15:5. |
| 2501 | Landolina N et.al. (2024). The anti-inflammatory cytokine IL-37 improves the NK cell-mediated anti-tumor response. Oncoimmunology 13:2297504. |
| 2500 | Pusch FF et.al. (2024). Elimusertib has Antitumor Activity in Preclinical Patient-Derived Pediatric Solid Tumor Models. Mol Cancer Ther 23:507-519. |
| 2023 (n=309) |
| 2499 | Kersten R et.al. (2023). Galectin-3 and prohibitin 1 are autoantigens in IgG4-related cholangitis without clear-cut protective effects against toxic bile acids. Front Immunol 14:1251134. |
| 2498 | Kang JY et.al. (2023). Systematic Multiomic Analysis of PKHD1L1 Gene Expression and Its Role as a Predicting Biomarker for Immune Cell Infiltration in Skin Cutaneous Melanoma and Lung Adenocarcinoma. Int J Mol Sci 25:. |
| 2497 | Arabkari V et.al. (2023). miRNA-378 Is Downregulated by XBP1 and Inhibits Growth and Migration of Luminal Breast Cancer Cells. Int J Mol Sci 25:. |
| 2496 | Wienke J et.al. (2023). Integrative analysis of neuroblastoma by single-cell RNA sequencing identifies the NECTIN2-TIGIT axis as a target for immunotherapy. Cancer Cell :. |
| 2495 | Li Q et.al. (2023). AID-induced CXCL12 upregulation enhances castration-resistant prostate cancer cell metastasis by stabilizing beta-catenin expression. iScience 26:108523. |
| 2494 | Zapilko V et.al. (2023). Generation of a Zebrafish Knock-In Model Recapitulating Childhood ETV6::RUNX1-Positive B-Cell Precursor Acute Lymphoblastic Leukemia. Cancers (Basel) 15:. |
| 2493 | Djos A et.al. (2023). Telomere Maintenance Mechanisms in a Cohort of High-Risk Neuroblastoma Tumors and Its Relation to Genomic Variants in the TERT and ATRX Genes. Cancers (Basel) 15:. |
| 2492 | Palma M et.al. (2023). NUAK1 coordinates growth factor-dependent activation of mTORC2 and Akt signaling. Cell Biosci 13:232. |
| 2491 | Giang LH et.al. (2023). Targeting of RRM2 suppresses DNA damage response and activates apoptosis in atypical teratoid rhabdoid tumor. J Exp Clin Cancer Res 42:346. |
| 2490 | Savary C et.al. (2023). Fusion-negative rhabdomyosarcoma 3D organoids to predict effective drug combinations: A proof-of-concept on cell death inducers. Cell Rep Med 4:101339. |
| 2489 | Gu X et.al. (2023). Histone lactylation-boosted ALKBH3 potentiates tumor progression and diminished promyelocytic leukemia protein nuclear condensates by m1A demethylation of SP100A. Nucleic Acids Res :. |
| 2488 | Casillo SM et.al. (2023). An ERK5-PFKFB3 axis regulates glycolysis and represents a therapeutic vulnerability in pediatric diffuse midline glioma. Cell Rep 43:113557. |
| 2487 | Yu L et.al. (2023). Deoxyribonuclease 1-like 3 inhibits colorectal malignancy through antagonizing NEDD4-triggered CDKN1A ubiquitination. Cell Biol Int :. |
| 2486 | Liu B et.al. (2023). Periostin-TGF-beta feedforward loop contributes to tumour-stroma crosstalk in liver metastatic outgrowth of colorectal cancer. Br J Cancer :. |
| 2485 | Malawsky DS et.al. (2023). Chronic AMPK inactivation slows SHH medulloblastoma progression by inhibiting mTORC1 signaling and depleting tumor stem cells. iScience 26:108443. |
| 2484 | Wang Z et.al. (2023). Histone demethylase KDM4B accelerates the progression of glioblastoma via the epigenetic regulation of MYC stability. Clin Epigenetics 15:192. |
| 2483 | Valdivia V et.al. (2023). Biological evaluation of carbohydrate-based aprepitant analogs for neuroblastoma treatment. Eur J Med Chem 264:116021. |
| 2482 | Tobias GC et.al. (2023). Aerobic exercise training mitigates tumor growth and cancer-induced splenomegaly through modulation of non-platelet platelet factor 4 expression. Sci Rep 13:21970. |
| 2481 | Wang WH et.al. (2023). Multiomics Reveals Induction of Neuroblastoma SK-N-BE(2)C Cell Death by Mitochondrial Division Inhibitor 1 through Multiple Effects. J Proteome Res :. |
| 2480 | Lospinoso Severini L et.al. (2023). SALL4 is a CRL3(REN/KCTD11) substrate that drives Sonic Hedgehog-dependent medulloblastoma. Cell Death Differ :. |
| 2479 | Kallberg E et.al. (2023). AIRE is expressed in breast cancer TANs and TAMs to regulate the extrinsic apoptotic pathway and inflammation. J Leukoc Biol :. |
| 2478 | Somasundaram DB et.al. (2023). Mesenchymal stem cell-based TRAIL delivery inhibits the metastatic state of clinical therapy-resistant progressive neuroblastoma. World J Pediatr :. |
| 2477 | Zhang W et.al. (2023). Oncogenic and immunological values of RBM34 in osteosarcoma and its pan-cancer analysis. Am J Cancer Res 13:5094-5121. |
| 2476 | Xiang W et.al. (2023). Inhibition of ACLY overcomes cancer immunotherapy resistance via polyunsaturated fatty acids peroxidation and cGAS-STING activation. Sci Adv 9:eadi2465. |
| 2475 | Liang J et.al. (2023). Targeting CENP-E augments immunotherapy in non-small cell lung cancer via stabilizing PD-L1. Int Immunopharmacol 126:111294. |
| 2474 | Xu Q et.al. (2023). IRX2 regulates endometrial carcinoma oncogenesis by transcriptional repressing RUVBL1. Exp Cell Res :113866. |
| 2473 | Mukherjee S et.al. (2023). Breast cancer stem cells generate immune-suppressive T regulatory cells by secreting TGFbeta to evade immune-elimination. Discov Oncol 14:220. |
| 2472 | Almeida SFF et.al. (2023). Unveiling the role of osteosarcoma-derived secretome in premetastatic lung remodelling. J Exp Clin Cancer Res 42:328. |
| 2471 | Chaudhry KA et.al. (2023). Aryl hydrocarbon receptor is a tumor promoter in MYCN-amplified neuroblastoma cells through suppression of differentiation. iScience 26:108303. |
| 2470 | Branella GM et.al. (2023). Ligand-based targeting of c-kit using engineered gammadelta T cells as a strategy for treating acute myeloid leukemia. Front Immunol 14:1294555. |
| 2469 | Yang Y et.al. (2023). Immune microenvironment heterogeneity reveals distinct subtypes in neuroblastoma: insights into prognosis and therapeutic targets. Aging (Albany NY) 15:13345-13367. |
| 2468 | Lin L et.al. (2023). Functional TET2 gene polymorphisms increase the risk of neuroblastoma in Chinese children. IUBMB Life :. |
| 2467 | Galiger C et.al. (2023). The survivin-ran inhibitor LLP-3 decreases oxidative phosphorylation, glycolysis and growth of neuroblastoma cells. BMC Cancer 23:1148. |
| 2466 | Liu Y et.al. (2023). N6-methyladenosine-mediated overexpression of long noncoding RNA ADAMTS9-AS2 triggers neuroblastoma differentiation via regulating LIN28B/let-7/MYCN signaling. JCI Insight 8:. |
| 2465 | Pichavaram P et.al. (2023). Oncogenic cells of renal embryonic lineage sensitive to the small molecule inhibitor QC6352 display depletion of KDM4 levels and disruption of ribosome biogenesis. Mol Cancer Ther :. |
| 2464 | Qin N et.al. (2023). The long non-coding RNA OTX2-AS1 promotes tumor growth and predicts response to BCL-2 inhibition in medulloblastoma. J Neurooncol :. |
| 2463 | Chittavanich P et.al. (2023). Ceftriaxone exerts antitumor effects in MYCN-driven retinoblastoma and neuroblastoma by targeting DDX3X for translation repression. Mol Oncol :. |
| 2462 | Du X et.al. (2023). Unveiling the prognostic implications of RPLP1 upregulation in osteosarcoma. Am J Cancer Res 13:4822-4831. |
| 2461 | Lo HC et.al. (2023). GMI, a Ganoderma microsporum protein, abolishes focal adhesion network to reduce cell migration and metastasis of lung cancer. Life Sci :122255. |
| 2460 | Qin H et.al. (2023). Degradation of AZGP1 suppresses the progression of breast cancer cells via TRIM25. Environ Toxicol :. |
| 2459 | Li Q et.al. (2023). PLEK2 mediates metastasis and invasion via alpha5-nAChR activation in nicotine-induced lung adenocarcinoma. Mol Carcinog :. |
| 2458 | Julson JR et.al. (2023). CDK4/6 Inhibition With Lerociclib is a Potential Therapeutic Strategy for the Treatment of Pediatric Sarcomas. J Pediatr Surg :. |
| 2457 | Chen PD et.al. (2023). Decreased B4GALT1 promotes hepatocellular carcinoma cell invasiveness by regulating the laminin-integrin pathway. Oncogenesis 12:49. |
| 2456 | Ali W et.al. (2023). Survival and Enrichment Analysis of Epithelial-Mesenchymal Transition Genes in Bladder Urothelial Carcinoma. Genes (Basel) 14:. |
| 2455 | Souza BK et.al. (2023). Histone Methyltransferases G9a/Ehmt2 and GLP/Ehmt1 Are Associated with Cell Viability and Poorer Prognosis in Neuroblastoma and Ewing Sarcoma. Int J Mol Sci 24:. |
| 2454 | Rodrigues EM et.al. (2023). The Nervous System Development Regulator Neuropilin-1 as a Potential Prognostic Marker and Therapeutic Target in Brain Cancer. Cancers (Basel) 15:. |
| 2453 | Klonisch T et.al. (2023). DUBing Primary Tumors of the Central Nervous System: Regulatory Roles of Deubiquitinases. Biomolecules 13:. |
| 2452 | Babl N et.al. (2023). MCT4 blockade increases the efficacy of immune checkpoint blockade. J Immunother Cancer 11:. |
| 2451 | Sun H et.al. (2023). DUSP1 Signaling Pathway Regulates Cytarabine Sensitivity in Acute Myeloid Leukemia. Technol Cancer Res Treat 22:15330338231207765. |
| 2450 | Ferrena A et.al. (2023). SKP2 knockout in Rb1/p53 deficient mouse models of osteosarcoma induces immune infiltration and drives a transcriptional program with a favorable prognosis. Mol Cancer Ther :. |
| 2449 | OBrien E et.al. (2023). Pharmacological EZH2 inhibition combined with retinoic acid treatment promotes differentiation and apoptosis in rhabdomyosarcoma cells. Clin Epigenetics 15:167. |
| 2448 | Yang J et.al. (2023). EDARADD promotes colon cancer progression by suppressing E3 ligase Trim21-mediated ubiquitination and degradation of Snail. Cancer Lett :216427. |
| 2447 | Lai SW et.al. (2023). Dysregulated expression of slingshot protein phosphatase 1 (SSH1) disrupts circadian rhythm and WNT signaling associated to hepatocellular carcinoma pathogenesis. Aging (Albany NY) 15:. |
| 2446 | Martinez de Estibariz I et.al. (2023). The Role of the Dysregulation of Long Non-Coding and Circular RNA Expression in Medulloblastoma: A Systematic Review. Cancers (Basel) 15:. |
| 2445 | Zhang X et.al. (2023). miR-124 and VAMP3 Act Antagonistically in Human Neuroblastoma. Int J Mol Sci 24:. |
| 2444 | Scicchitano S et.al. (2023). Zinc Finger 521 Modulates the Nrf2-Notch Signaling Pathway in Human Ovarian Carcinoma. Int J Mol Sci 24:. |
| 2443 | Huang YC et.al. (2023). FGF2 drives osteosarcoma metastasis through activating FGFR1-4 receptor pathway-mediated ICAM-1 expression. Biochem Pharmacol :115853. |
| 2442 | Mamidi MK et.al. (2023). FCRL1 immunoregulation in B cell development and malignancy. Front Immunol 14:1251127. |
| 2441 | Mei X et.al. (2023). Radiosensitization by Hyperthermia Critically Depends on the Time Interval. Int J Radiat Oncol Biol Phys :. |
| 2440 | Liu N et.al. (2023). The RNA methyltransferase METTL16 enhances cholangiocarcinoma growth through PRDM15-mediated FGFR4 expression. J Exp Clin Cancer Res 42:263. |
| 2439 | Wang HY et.al. (2023). High LYRM4-AS1 predicts poor prognosis in patients with glioma and correlates with immune infiltration. PeerJ 11:e16104. |
| 2438 | Barman S et.al. (2023). Integrated virtual screening and MD simulation approaches toward discovering potential inhibitors for targeting BRPF1 bromodomain in hepatocellular carcinoma. J Mol Graph Model 126:108642. |
| 2437 | Quan J et.al. (2023). DNMT1-mediated regulating on FBXO32 promotes the progression of glioma cells through the regulation of SKP1 activity. Environ Toxicol :. |
| 2436 | Bahhar I et.al. (2023). The IL-25/ILC2 axis promotes lung cancer with a concomitant accumulation of immune-suppressive cells in tumors in humans and mice. Front Immunol 14:1244437. |
| 2435 | Le Clorennec C et.al. (2023). USP7 Inhibition Suppresses Neuroblastoma Growth via Induction of p53-Mediated Apoptosis and EZH2 and N-Myc Downregulation. Int J Mol Sci 24:. |
| 2434 | Elahi Najafi MA et.al. (2023). GABBR2 as a Downstream Effector of the Androgen Receptor Induces Cisplatin Resistance in Bladder Cancer. Int J Mol Sci 24:. |
| 2433 | Ogushi K et.al. (2023). High Tumoral STMN1 Expression Is Associated with Malignant Potential and Poor Prognosis in Patients with Neuroblastoma. Cancers (Basel) 15:. |
| 2432 | Li D et.al. (2023). Camel nanobody-based B7-H3 CAR-T cells show high efficacy against large solid tumours. Nat Commun 14:5920. |
| 2431 | Ferguson KM et.al. (2023). Palbociclib releases the latent differentiation capacity of neuroblastoma cells. Dev Cell :. |
| 2430 | Schafer H et.al. (2023). Correlation of the tumor escape phenotype with loss of PRELP expression in melanoma. J Transl Med 21:643. |
| 2429 | Tagay Y et.al. (2023). Dynein-Powered Cell Locomotion Guides Metastasis of Breast Cancer. Adv Sci (Weinh) :e2302229. |
| 2428 | Cai L et.al. (2023). Bioinformatical analysis of the key differentially expressed genes for screening potential biomarkers in Wilms tumor. Sci Rep 13:15404. |
| 2427 | Hao J et.al. (2023). A novel TOX3-WDR5-ABCG2 signaling axis regulates the progression of colorectal cancer by accelerating stem-like traits and chemoresistance. PLoS Biol 21:e3002256. |
| 2426 | Ning J et.al. (2023). The protein arginine methyltransferase family (PRMTs) regulates metastases in various tumors: From experimental study to clinical application. Biomed Pharmacother 167:115456. |
| 2425 | Griesinger AM et.al. (2023). Multi-omic approach identifies hypoxic tumor-associated myeloid cells that drive immunobiology of high-risk pediatric ependymoma. iScience 26:107585. |
| 2424 | Ortiz Rivera J et.al. (2023). Pyk2/FAK Signaling Is Upregulated in Recurrent Glioblastoma Tumors in a C57BL/6/GL261 Glioma Implantation Model. Int J Mol Sci 24:. |
| 2423 | Ye F et.al. (2023). Antileukemic effect of venetoclax and hypomethylating agents via caspase-3/GSDME-mediated pyroptosis. J Transl Med 21:606. |
| 2422 | Grand-Guillaume J et.al. (2023). CUDC-907, a dual PI3K/histone deacetylase inhibitor, increases meta-iodobenzylguanidine uptake ((123/131)I-mIBG) in vitro and in vivo: a promising candidate for advancing theranostics in neuroendocrine tumors. J Transl Med 21:604. |
| 2421 | Hsieh CH et.al. (2023). Homoharringtonine as a PHGDH inhibitor: Unraveling metabolic dependencies and developing a potent therapeutic strategy for high-risk neuroblastoma. Biomed Pharmacother 166:115429. |
| 2420 | Wang C et.al. (2023). ENO2-derived phosphoenolpyruvate functions as an endogenous inhibitor of HDAC1 and confers resistance to antiangiogenic therapy. Nat Metab :. |
| 2419 | Huang Q et.al. (2023). DAB2IP suppresses invadopodia formation through destabilizing ALK by interacting with USP10 in breast cancer. iScience 26:107606. |
| 2418 | Shinzawa K et.al. (2023). GREB1 isoform 4 is specifically transcribed by MITF and required for melanoma proliferation. Oncogene :. |
| 2417 | Picard D et.al. (2023). Integrative multi-omics reveals two biologically distinct groups of pilocytic astrocytoma. Acta Neuropathol :. |
| 2416 | Hounjet J et.al. (2023). Iron-responsive element of Divalent metal transporter 1 (Dmt1) controls Notch-mediated cell fates. FEBS J :. |
| 2415 | Spaan CN et.al. (2023). Grp78 is required for intestinal Kras-dependent glycolysis proliferation and adenomagenesis. Life Sci Alliance 6:. |
| 2414 | Wang Y et.al. (2023). Research Progress of CXCR4-Targeting Radioligands for Oncologic Imaging. Korean J Radiol 24:871-889. |
| 2413 | Zhang C et.al. (2023). Targeting PUF60 prevents tumor progression by retarding mRNA decay of oxidative phosphorylation in ovarian cancer. Cell Oncol (Dordr) :. |
| 2412 | Zhang Y et.al. (2023). MKRN1 promotes colorectal cancer metastasis by activating the TGF-beta signalling pathway through SNIP1 protein degradation. J Exp Clin Cancer Res 42:219. |
| 2411 | Wang Y et.al. (2023). Acute cigarette smoke exposure leads to higher viral infection in human bronchial epithelial cultures by altering interferon, glycolysis and GDF15-related pathways. Respir Res 24:207. |
| 2410 | Zhang HF et.al. (2023). A MYCN-independent mechanism mediating secretome reprogramming and metastasis in MYCN-amplified neuroblastoma. Sci Adv 9:eadg6693. |
| 2409 | Wu HW et.al. (2023). DoSurvive: A webtool for investigating the prognostic power of a single or combined cancer biomarker. iScience 26:107269. |
| 2408 | Malik N et.al. (2023). Protumorigenic role of the atypical cadherin FAT1 by the suppression of PDCD10 via RelA/miR221-3p/222-3p axis in glioblastoma. Mol Carcinog :. |
| 2407 | Kersten R et.al. (2023). IgG4-related cholangitis J Hepatol 79:1502-1523. |
| 2406 | Di Fiore A et.al. (2023). KCTD1 is a new modulator of the KCASH family of Hedgehog suppressors. Neoplasia 43:100926. |
| 2405 | Khan GH et.al. (2023). Levamisole suppresses activation and proliferation of human T cells by the induction of a p53-dependent DNA damage response. Eur J Immunol :e2350562. |
| 2404 | Steen E et.al. (2023). Targeting the RET tyrosine kinase in neuroblastoma: a review and application of a novel selective drug design strategy. Biochem Pharmacol :115751. |
| 2403 | Ariey-Bonnet J et.al. (2023). Combination drug screen targeting glioblastoma core vulnerabilities reveals pharmacological synergisms. EBioMedicine 95:104752. |
| 2402 | Lei FJ et.al. (2023). Cellular and exosomal GPx1 are essential for controlling hydrogen peroxide balance and alleviating oxidative stress in hypoxic glioblastoma. Redox Biol 65:102831. |
| 2401 | Pilgrim AA et.al. (2023). The yes-associated protein (YAP) is associated with resistance to anti-GD2 immunotherapy in neuroblastoma through downregulation of ST8SIA1. Oncoimmunology 12:2240678. |
| 2400 | Roy A et.al. (2023). Using evolutionary constraint to define novel candidate driver genes in medulloblastoma. Proc Natl Acad Sci U S A 120:e2300984120. |
| 2399 | Hartley R et.al. (2023). MYC promotes aggressive growth and metastasis of a WNT-medulloblastoma mouse model. Dev Neurosci :. |
| 2398 | Zhang X et.al. (2023). Deficiency of BAP1 inhibits neuroblastoma tumorigenesis through destabilization of MYCN. Cell Death Dis 14:504. |
| 2397 | Wang X et.al. (2023). Therapeutic targeting of FUBP3 phase separation by GATA2-AS1 inhibits malate-aspartate shuttle and neuroblastoma progression via modulating SUZ12 activity. Oncogene 42:2673-2687. |
| 2396 | Li Y et.al. (2023). Smurf1 and Smurf2 mediated polyubiquitination and degradation of RNF220 suppresses Shh-group medulloblastoma. Cell Death Dis 14:494. |
| 2395 | Thakur K et.al. (2023). Physical interaction between STAT3 and AP1 in cervical carcinogenesis: Implications in HPV transcription control. Biochim Biophys Acta Mol Basis Dis 1869:166817. |
| 2394 | Takahashi S et.al. (2023). ESS2 controls prostate cancer progression through recruitment of chromodomain helicase DNA binding protein 1. Sci Rep 13:12355. |
| 2393 | Hu J et.al. (2023). Integrative analysis of multi-omics data for discovery of ferroptosis-related gene signature predicting immune activity in neuroblastoma. Front Pharmacol 14:1162563. |
| 2392 | Zaghmi A et.al. (2023). High-content screening of drug combinations of an mPGES-1 inhibitor in multicellular tumor spheroids leads to mechanistic insights into neuroblastoma chemoresistance. Mol Oncol :. |
| 2391 | de Araujo MA et.al. (2023). Low Expression of the NRP1 Gene Is Associated with Shorter Overall Survival in Patients with Sonic Hedgehog and Group 3 Medulloblastoma. Int J Mol Sci 24:. |
| 2390 | Orozco CA et.al. (2023). Validation of an Ultraviolet Light Response Gene Signature for Predicting Prognosis in Patients with Uveal Melanoma. Biomolecules 13:. |
| 2389 | Sigaud R et.al. (2023). MAPK inhibitor sensitivity scores predict sensitivity driven by the immune infiltration in pediatric low-grade gliomas. Nat Commun 14:4533. |
| 2388 | Man YN et.al. (2023). TAF1D Functions as a Novel Biomarker in Osteosarcoma. J Cancer 14:2051-2065. |
| 2387 | Mallard HJ et.al. (2023). USP1 expression driven by EWS::FLI1 transcription factor stabilizes Survivin and mitigates replication stress in Ewing sarcoma. Mol Cancer Res :. |
| 2386 | Chakraborty S et.al. (2023). EHD1-dependent traffic of IGF-1 receptor to the cell surface is essential for Ewing sarcoma tumorigenesis and metastasis. Commun Biol 6:758. |
| 2385 | Wrenn ED et.al. (2023). Cancer-associated fibroblast-like tumor cells remodel the Ewing sarcoma tumor microenvironment. Clin Cancer Res :. |
| 2384 | Karakaya S et.al. (2023). Cytoplasmic HIF-2alpha as tissue biomarker to identify metastatic sympathetic paraganglioma. Sci Rep 13:11588. |
| 2383 | Zhou Y et.al. (2023). CCNB1IP1 prevents ubiquitination-mediated destabilization of MYCN and potentiates tumourigenesis of MYCN-amplificated neuroblastoma. Clin Transl Med 13:e1328. |
| 2382 | Chagas PS et.al. (2023). Musashi-1 regulates cell cycle and confers resistance to cisplatin treatment in Group 3/4 medulloblastomas cells. Hum Cell :. |
| 2381 | Huang CY et.al. (2023). Identification of Moesin (MSN) as a Potential Therapeutic Target for Colorectal Cancer via the beta-Catenin-RUNX2 Axis. Int J Mol Sci 24:. |
| 2380 | Slapak EJ et.al. (2023). Preclinical Assessment of ADAM9-Responsive Mesoporous Silica Nanoparticles for the Treatment of Pancreatic Cancer. Int J Mol Sci 24:. |
| 2379 | Khazan N et.al. (2023). Vitamin D Receptor Antagonist MeTC7 Inhibits PD-L1. Cancers (Basel) 15:. |
| 2378 | Liu J et.al. (2023). Transcriptome Profiling of Goose Ovarian Follicle Granulosa Cells Reveals Key Regulatory Networks for Follicle Selection. Animals (Basel) 13:. |
| 2377 | Agnello L et.al. (2023). Tissue Inhibitor of Metalloproteinases-1 Overexpression Mediates Chemoresistance in Triple-Negative Breast Cancer Cells. Cells 12:. |
| 2376 | Sun Y et.al. (2023). FAM60A promotes osteosarcoma development and progression. Cancer Med :. |
| 2375 | Ni F et.al. (2023). TRIP 13-dependent pathways promote the development of gastric cancer. Funct Integr Genomics 23:232. |
| 2374 | Hou J et.al. (2023). NCAPG promotes the progression of glioblastoma by facilitating PARP1-mediated E2F1 transactivation. Neuro Oncol :. |
| 2373 | Laub V et.al. (2023). Bioinformatics for wet-lab scientists: practical application in sequencing analysis. BMC Genomics 24:382. |
| 2372 | Bisaccia J et.al. (2023). The TLR3 L412F polymorphism prevents TLR3-mediated tumor cell death induction in pediatric sarcomas. Cell Death Discov 9:230. |
| 2371 | Fang M et.al. (2023). E3 ligase MG53 suppresses tumor growth by degrading cyclin D1. Signal Transduct Target Ther 8:263. |
| 2370 | Gunnarsdottir FB et.al. (2023). Breast cancer associated CD169(+) macrophages possess broad immunosuppressive functions but enhance antibody secretion by activated B cells. Front Immunol 14:1180209. |
| 2369 | Zhang B et.al. (2023). Truncated SCRIB isoform promotes breast cancer metastasis through HNRNP A1 mediated exon 16 skipping. Acta Pharmacol Sin :. |
| 2368 | Fuchs S et.al. (2023). Defining the landscape of circular RNAs in neuroblastoma unveils a global suppressive function of MYCN. Nat Commun 14:3936. |
| 2367 | Braganhol E et.al. (2023). ENTPD1 (CD39) and NT5E (CD73) expression in human glioblastoma: an in silico analysis. Purinergic Signal :. |
| 2366 | Pu J et.al. (2023). N(6) -methyladenosine-modified FAM111A-DT promotes hepatocellular carcinoma growth via epigenetically activating FAM111A. Cancer Sci :. |
| 2365 | Li Z et.al. (2023). False discovery rate control in cancer biomarker selection. Genes Dis 10:1141-1142. |
| 2364 | Wei PL et.al. (2023). PCTAIRE Protein Kinase 1 (PCTK1) Suppresses Proliferation, Stemness, and Chemoresistance in Colorectal Cancer through the BMPR1B-Smad1/5/8 Signaling Pathway. Int J Mol Sci 24:. |
| 2363 | Lin X et.al. (2023). Taxifolin Inhibits Breast Cancer Growth by Facilitating CD8+ T Cell Infiltration and Inducing a Novel Set of Genes including Potential Tumor Suppressor Genes in 1q21.3. Cancers (Basel) 15:. |
| 2362 | van Driel MS et.al. (2023). Caffeine Limits Expansion of Apc-Deficient Clones in the Intestine by NOTUM Inhibition. Cell Mol Gastroenterol Hepatol :. |
| 2361 | Zhang H et.al. (2023). Inhibition of TAZ impairs the migration ability of melanoma cells. Open Life Sci 18:20220633. |
| 2360 | Cifaldi L et.al. (2023). DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy. Front Immunol 14:1197053. |
| 2359 | Pan R et.al. (2023). PDE4DIP contributes to colorectal cancer growth and chemoresistance through modulation of the NF1/RAS signaling axis. Cell Death Dis 14:373. |
| 2358 | Chang J et.al. (2023). Functional polymorphisms of the TET1 gene increase the risk of neuroblastoma in Chinese children. J Cell Mol Med 27:2239-2248. |
| 2357 | Matsumoto S et.al. (2023). Wnt Signaling Stimulates Cooperation between GREB1 and HNF4alpha to Promote Proliferation in Hepatocellular Carcinoma. Cancer Res 83:2312-2327. |
| 2356 | Lee JY et.al. (2023). Identification and targeting of protein tyrosine kinase 7 (PTK7) as an immunotherapy candidate for neuroblastoma. Cell Rep Med 4:101091. |
| 2355 | Wu W et.al. (2023). Non-canonical role of UCKL1 on ferroptosis defence in colorectal cancer. EBioMedicine 93:104650. |
| 2354 | Shahab SW et.al. (2023). The LIN28B-let-7-PBK pathway is essential for group 3 medulloblastoma tumor growth and survival. Mol Oncol :. |
| 2353 | Fan C et.al. (2023). The lncRNA LETS1 promotes TGF-beta-induced EMT and cancer cell migration by transcriptionally activating a TbetaR1-stabilizing mechanism. Sci Signal 16:eadf1947. |
| 2352 | Di Matteo S et.al. (2023). The roles of different forms of IL-15 in human melanoma progression. Front Immunol 14:1183668. |
| 2351 | Litzler LC et.al. (2023). Protein arginine methyltransferase 1 regulates B cell fate after positive selection in the germinal center in mice. J Exp Med 220:. |
| 2350 | Di Pace AL et.al. (2023). MicroRNA analysis of Natural Killer cell-derived exosomes: the microRNA let-7b-5p is enriched in exosomes and participates in their anti-tumor effects against pancreatic cancer cells. Oncoimmunology 12:2221081. |
| 2349 | Fanlo L et.al. (2023). Neural crest-related NXPH1/alpha-NRXN signaling opposes neuroblastoma malignancy by inhibiting organotropic metastasis. Oncogene 42:2218-2233. |
| 2348 | Chen C et.al. (2023). Repurposing a plant alkaloid homoharringtonine targets insulinoma associated-1 in N-Myc-activated neuroblastoma. Cell Signal 109:110753. |
| 2347 | Saggioro M et.al. (2023). A perfusion-based three-dimensional cell culture system to model alveolar rhabdomyosarcoma pathological features. Sci Rep 13:9444. |
| 2346 | Broso F et.al. (2023). Alpha-1 Adrenergic Antagonists Sensitize Neuroblastoma to Therapeutic Differentiation. Cancer Res 83:2733-2749. |
| 2345 | Al-Jamaei AAH et.al. (2023). A narrative review of the role of Eph receptors in head and neck squamous cell carcinoma. Oral Dis :. |
| 2344 | Nirala BK et.al. (2023). MYC regulates CSF1 expression via microRNA 17/20a to modulate tumor-associated macrophages in osteosarcoma. JCI Insight 8:. |
| 2343 | Young IC et.al. (2023). Multi-cancer analysis reveals universal association of oncogenic LBH expression with DNA hypomethylation and WNT-Integrin signaling pathways. Cancer Gene Ther :. |
| 2342 | Hagemann S et.al. (2023). IGF2BP1 induces neuroblastoma via a druggable feedforward loop with MYCN promoting 17q oncogene expression. Mol Cancer 22:88. |
| 2341 | Nikolic A et.al. (2023). macroH2A2 antagonizes epigenetic programs of stemness in glioblastoma. Nat Commun 14:3062. |
| 2340 | DeMartino J et.al. (2023). Single-cell transcriptomics reveals immune suppression and cell states predictive of patient outcomes in rhabdomyosarcoma. Nat Commun 14:3074. |
| 2339 | Almutairi BO et.al. (2023). HSPB6 Is Depleted in Colon Cancer Patients and Its Expression Is Induced by 5-aza-2-Deoxycytidine In Vitro. Medicina (Kaunas) 59:. |
| 2338 | Li M et.al. (2023). FTO Promotes the Stemness of Gastric Cancer Cells. DNA Cell Biol 42:411-420. |
| 2337 | Tedjawirja VN et.al. (2023). Exploring the expression and potential function of follicle stimulating hormone receptor in extragonadal cells related to abdominal aortic aneurysm. PLoS One 18:e0285607. |
| 2336 | Mondal I et.al. (2023). PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING-Type I Interferon Signaling in Glioblastoma. Cancer Res 83:2527-2542. |
| 2335 | Goda C et.al. (2023). Epidermal growth factor-like 7 is a novel therapeutic target in mantle cell lymphoma. Exp Hematol 123:28-33.e3. |
| 2334 | Cuesta-Casanovas L et.al. (2023). Prolactin receptor signaling induces acquisition of chemoresistance and reduces clonogenicity in acute myeloid leukemia. Cancer Cell Int 23:97. |
| 2333 | Wang Z et.al. (2023). METTL1/WDR4-mediated tRNA m(7)G modification and mRNA translation control promote oncogenesis and doxorubicin resistance. Oncogene 42:1900-1912. |
| 2332 | Zhou Q et.al. (2023). Multi-Omics Analysis of the Prognostic and Immunological Role of Runt-Related Transcription Factor 3 in Pan-Cancer. Crit Rev Eukaryot Gene Expr 33:63-83. |
| 2331 | Valinciute G et.al. (2023). Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells. J Neurooncol 163:143-158. |
| 2330 | Anantha J et.al. (2023). A combined proteomics and bioinformatics analysis of ZNHIT1-interacting proteins reveals a significant enrichment in proteins associated with mitochondrial function. J Chem Neuroanat 131:102288. |
| 2329 | Agarwal P et.al. (2023). MYCN Amplification Is Associated with Reduced Expression of Genes Encoding gamma-Secretase Complex and NOTCH Signaling Components in Neuroblastoma. Int J Mol Sci 24:. |
| 2328 | Yang JT et.al. (2023). ADAM17 Confers Temozolomide Resistance in Human Glioblastoma Cells and miR-145 Regulates Its Expression. Int J Mol Sci 24:. |
| 2327 | Bruss C et.al. (2023). Immune Checkpoint Profiling in Humanized Breast Cancer Mice Revealed Cell-Specific LAG-3/PD-1/TIM-3 Co-Expression and Elevated PD-1/TIM-3 Secretion. Cancers (Basel) 15:. |
| 2326 | Jackson HK et.al. (2023). Extracellular Vesicles Potentiate Medulloblastoma Metastasis in an EMMPRIN and MMP-2 Dependent Manner. Cancers (Basel) 15:. |
| 2325 | Alcantara JH et.al. (2023). Global trends, gaps, and future agenda in medulloblastoma research: a bibliometric analysis. Childs Nerv Syst :. |
| 2324 | Karapurkar JK et.al. (2023). CRISPR/Cas9-based genome-wide screening of the deubiquitinase subfamily identifies USP3 as a protein stabilizer of REST blocking neuronal differentiation and promotes neuroblastoma tumorigenesis. J Exp Clin Cancer Res 42:121. |
| 2323 | Ribeiro ML et.al. (2023). G protein-coupled receptor 183 mediates the sensitization of Burkitt lymphoma tumors to CD47 immune checkpoint blockade by anti-CD20/PI3Kdeltai dual therapy. Front Immunol 14:1130052. |
| 2322 | Tong W et.al. (2023). CircREOS suppresses lipid synthesis and osteosarcoma progression through inhibiting HuR-mediated MYC activation. J Cancer 14:916-926. |
| 2321 | Choi JH et.al. (2023). SEC22B inhibition attenuates colorectal cancer aggressiveness and autophagic flux under unfavorable environment. Biochem Biophys Res Commun 665:10-18. |
| 2320 | Guo P et.al. (2023). A rationally designed ICAM1 antibody drug conjugate eradicates late-stage and refractory triple-negative breast tumors in vivo. Sci Adv 9:eabq7866. |
| 2319 | Martell E et.al. (2023). Metabolism-based targeting of MYC via MPC-SOD2 axis-mediated oxidation promotes cellular differentiation in group 3 medulloblastoma. Nat Commun 14:2502. |
| 2318 | Power EA et.al. (2023). Overcoming translational barriers in H3K27-altered diffuse midline glioma: Increasing the drug-tumor residence time. Neurooncol Adv 5:vdad033. |
| 2317 | Koufaris C et.al. (2023). miR-22-enriched breast cancer cells display repressed glycolytic metabolism, increased glycogen synthesis, and reduced survival in low glucose conditions. Mol Biol Rep 50:5185-5193. |
| 2316 | Shishido K et.al. (2023). Targeting B7‑H3 through EZH2 inhibition in MYC‑positive Group 3 medulloblastoma. Oncol Rep 49:. |
| 2315 | Lee M et.al. (2023). Alterations and Co-Occurrence of C-MYC, N-MYC, and L-MYC Expression are Related to Clinical Outcomes in Various Cancers. Int J Stem Cells 16:215-233. |
| 2314 | Ortega-Campos SM et.al. (2023). Interactions of circadian clock genes with the hallmarks of cancer. Biochim Biophys Acta Rev Cancer 1878:188900. |
| 2313 | Kavazovic I et.al. (2023). Vaccination provides superior in vivo recall capacity of SARS-CoV-2-specific memory CD8 T cells. Cell Rep 42:112395. |
| 2312 | Zhang X et.al. (2023). TAF1D promotes proliferation by transcriptionally activating G2/M phase-related genes in MYCN-amplified neuroblastoma. Cancer Sci 114:2860-2870. |
| 2311 | Korshunov A et.al. (2023). Transcriptome analysis stratifies second-generation non-WNT/non-SHH medulloblastoma subgroups into clinically tractable subtypes. Acta Neuropathol 145:829-842. |
| 2310 | Okonechnikov K et.al. (2023). 3D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymoma. Nat Commun 14:2300. |
| 2309 | Qiao R et.al. (2023). Critical Role of 6-Phosphogluconate Dehydrogenase in TAp73-Mediated Cancer Cell Proliferation. Mol Cancer Res 21:825-835. |
| 2308 | Zhang C et.al. (2023). Mapping the Response of Human Osteocytes in Native Matrix to Mechanical Loading Using RNA Sequencing. JBMR Plus 7:e10721. |
| 2307 | Alamoudi AA et.al. (2023). SOX9 Expression Is Increased in Alzheimers Disease (AD) and Is Associated With Disease Progression and APOE4 Genotype: A Computational Approach. Cureus 15:e36129. |
| 2306 | Lin Z et.al. (2023). Metabolic Reprogramming Driven by IGF2BP3 Promotes Acquired Resistance to EGFR Inhibitors in Non-Small Cell Lung Cancer. Cancer Res 83:2187-2207. |
| 2305 | Tran GB et.al. (2023). Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma. Cancer Res 83:2248-2261. |
| 2304 | Zhou J et.al. (2023). RNA cytosine methyltransferase NSUN5 promotes protein synthesis and tumorigenic phenotypes in glioblastoma. Mol Oncol :. |
| 2303 | Nagoya A et.al. (2023). CKAP4 is a potential exosomal biomarker and therapeutic target for lung cancer. Transl Lung Cancer Res 12:408-426. |
| 2302 | Langlois S et.al. (2023). Inhibition of PANX1 Channels Reduces the Malignant Properties of Human High-Risk Neuroblastoma. J Cancer 14:689-706. |
| 2301 | Schoenmaker T et.al. (2023). Transcriptomic Differences Underlying the Activin-A Induced Large Osteoclast Formation in Both Healthy Control and Fibrodysplasia Ossificans Progressiva Osteoclasts. Int J Mol Sci 24:. |
| 2300 | Luca S et.al. (2023). PATZ1 in Non-Small Cell Lung Cancer: A New Biomarker That Negatively Correlates with PD-L1 Expression and Suppresses the Malignant Phenotype. Cancers (Basel) 15:. |
| 2299 | Ognibene M et.al. (2023). Multiple Genes with Potential Tumor Suppressive Activity Are Present on Chromosome 10q Loss in Neuroblastoma and Are Associated with Poor Prognosis. Cancers (Basel) 15:. |
| 2298 | de Sousa GR et.al. (2023). Identification of HDAC4 as a potential therapeutic target and prognostic biomarker for ZFTA-fused ependymomas. Cancer Gene Ther 30:1105-1113. |
| 2297 | Bhavsar SP et.al. (2023). Hsa-miR-323a-3p functions as a tumor suppressor and targets STAT3 in neuroblastoma cells. Front Pediatr 11:1098999. |
| 2296 | Xu C et.al. (2023). Macrophages facilitate tumor cell PD-L1 expression via an IL-1beta-centered loop to attenuate immune checkpoint blockade. MedComm (2020) 4:e242. |
| 2295 | Lansbergen MF et.al. (2023). Poor-prognosis molecular subtypes in adenocarcinomas of pancreato-biliary and gynecological origin: A systematic review. Crit Rev Oncol Hematol 185:103982. |
| 2294 | Chornyi S et.al. (2023). The origin of long-chain fatty acids required for de novo ether lipid/plasmalogen synthesis. J Lipid Res 64:100364. |
| 2293 | Kaess C et.al. (2023). Evaluating the RIST Molecular-Targeted Regimen in a Three-Dimensional Neuroblastoma Spheroid Cell Culture Model. Cancers (Basel) 15:. |
| 2292 | Aschero R et.al. (2023). Prognostic value of xenograft engraftment in patients with metastatic high-risk neuroblastoma. Pediatr Blood Cancer 70:e30318. |
| 2291 | Dhamdhere MR et.al. (2023). IGF2BP1 regulates the cargo of extracellular vesicles and promotes neuroblastoma metastasis. Oncogene 42:1558-1571. |
| 2290 | Yuan L et.al. (2023). Arsenic resistance protein 2 and microRNA biogenesis: Biological implications in cancer development. Pharmacol Ther 244:108386. |
| 2289 | Kimman T et.al. (2023). Serpin B9 controls tumor cell killing by CAR T cells. J Immunother Cancer 11:. |
| 2288 | Lee CC et.al. (2023). In silico analysis to identify miR-1271-5p/PLCB4 (phospholipase C Beta 4) axis mediated oxaliplatin resistance in metastatic colorectal cancer. Sci Rep 13:4366. |
| 2287 | Jin Q et.al. (2023). MicroRNA-592 Inhibits the Growth of Ovarian Cancer Cells by Targeting ERBB3. Technol Cancer Res Treat 22:15330338231157156. |
| 2286 | Zhang S et.al. (2023). Nectin2 influences cell apoptosis by regulating ANXA2 expression in neuroblastoma. Acta Biochim Biophys Sin (Shanghai) 55:356-366. |
| 2285 | Pan G et.al. (2023). Aerobic glycolysis in colon cancer is repressed by naringin via the HIF1Alpha pathway. J Zhejiang Univ Sci B 24:221-231. |
| 2284 | Nasehi R et.al. (2023). 3D geometry orchestrates the transcriptional landscape of metastatic neuroblastoma cells in a multicellular in vitro bone model. Mater Today Bio 19:100596. |
| 2283 | Julson JR et.al. (2023). Inhibition of PIM Kinases Promotes Neuroblastoma Cell Differentiation to a Neuronal Phenotype. J Pediatr Surg 58:1155-1163. |
| 2282 | Veschi V et.al. (2023). Recapitulating thyroid cancer histotypes through engineering embryonic stem cells. Nat Commun 14:1351. |
| 2281 | Kucukkose E et.al. (2023). Lymphatic Invasion of Plakoglobin-Dependent Tumor Cell Clusters Drives Formation of Polyclonal Lung Metastases in Colon Cancer. Gastroenterology 165:429-444.e15. |
| 2280 | Citarella A et.al. (2023). Hedgehog-GLI and Notch Pathways Sustain Chemoresistance and Invasiveness in Colorectal Cancer and Their Inhibition Restores Chemotherapy Efficacy. Cancers (Basel) 15:. |
| 2279 | Carna M et.al. (2023). Missorting of plasma miRNAs in aging and Alzheimers disease. J Neurochem 165:149-161. |
| 2278 | Decaesteker B et.al. (2023). SOX11 regulates SWI/SNF complex components as member of the adrenergic neuroblastoma core regulatory circuitry. Nat Commun 14:1267. |
| 2277 | Tomolonis JA et.al. (2023). Interaction between tumor cell TNFR2 and monocyte membrane-bound TNF-alpha triggers tumorigenic inflammation in neuroblastoma. J Immunother Cancer 11:. |
| 2276 | Rapetti-Mauss R et.al. (2023). SK2 channels set a signalling hub bolstering CAF-triggered tumourigenic processes in pancreatic cancer. Gut 72:722-735. |
| 2275 | Liu Y et.al. (2023). Shc3 facilitates breast cancer drug resistance by interacting with ErbB2 to initiate ErbB2/COX2/MDR1 axis. Cancer Med 12:10768-10780. |
| 2274 | Chicco D et.al. (2023). Signature literature review reveals AHCY, DPYSL3, and NME1 as the most recurrent prognostic genes for neuroblastoma. BioData Min 16:7. |
| 2273 | Bruno G et.al. (2023). beta3-adrenergic receptor on tumor-infiltrating lymphocytes sustains IFN-gamma-dependent PD-L1 expression and impairs anti-tumor immunity in neuroblastoma. Cancer Gene Ther 30:890-904. |
| 2272 | Ge L et.al. (2023). MESP2 binds competitively to TCF4 to suppress gastric cancer progression by regulating the SKP2/p27 axis. Cell Death Discov 9:79. |
| 2271 | Zou H et.al. (2023). A neurodevelopmental epigenetic programme mediated by SMARCD3-DAB1-Reelin signalling is hijacked to promote medulloblastoma metastasis. Nat Cell Biol 25:493-507. |
| 2270 | Schultz CR et.al. (2023). New K50R mutant mouse models reveal impaired hypusination of eif5a2 with alterations in cell metabolite landscape. Biol Open 12:. |
| 2269 | Candido MF et.al. (2023). Drugging Hijacked Kinase Pathways in Pediatric Oncology: Opportunities and Current Scenario. Pharmaceutics 15:. |
| 2268 | Ognibene M et.al. (2023). A Simple, Test-Based Method to Control the Overestimation Bias in the Analysis of Potential Prognostic Tumour Markers. Cancers (Basel) 15:. |
| 2267 | Taylor L et.al. (2023). Drug Resistance in Medulloblastoma Is Driven by YB-1, ABCB1 and a Seven-Gene Drug Signature. Cancers (Basel) 15:. |
| 2266 | Marques RF et.al. (2023). Digital expression profile of immune checkpoint genes in medulloblastomas identifies CD24 and CD276 as putative immunotherapy targets. Front Immunol 14:1062856. |
| 2265 | Liu S et.al. (2023). Differential optineurin expression controls TGFbeta signaling and is a key determinant for metastasis of triple negative breast cancer. Int J Cancer 152:2594-2606. |
| 2264 | Ke S et.al. (2023). NKD2 Trigger NF-kappaB Signaling Pathway and Facilitates Thyroid Cancer Cell Proliferation. Mol Biotechnol :. |
| 2263 | Zhang J et.al. (2023). PDLIM3 supports hedgehog signaling in medulloblastoma by facilitating cilia formation. Cell Death Differ 30:1198-1210. |
| 2262 | Klonou A et.al. (2023). Histone H3K9 methyltransferase SETDB1 overexpression correlates with pediatric high-grade gliomas progression and prognosis. J Mol Med (Berl) 101:387-401. |
| 2261 | Seok J et.al. (2023). Anti-oncogenic effects of dutasteride, a dual 5-alpha reductase inhibitor and a drug for benign prostate hyperplasia, in bladder cancer. J Transl Med 21:129. |
| 2260 | Panosyan WS et.al. (2023). Anti-GD2 immunoliposomes loaded with oxamate for neuroblastoma. Pediatr Res 94:458-461. |
| 2259 | Biswas PK et.al. (2023). The Orphan GPR50 Receptor Regulates the Aggressiveness of Breast Cancer Stem-like Cells via Targeting the NF-kB Signaling Pathway. Int J Mol Sci 24:. |
| 2258 | Timpanaro A et.al. (2023). Surfaceome Profiling of Cell Lines and Patient-Derived Xenografts Confirm FGFR4, NCAM1, CD276, and Highlight AGRL2, JAM3, and L1CAM as Surface Targets for Rhabdomyosarcoma. Int J Mol Sci 24:. |
| 2257 | Perrone C et.al. (2023). Spermine oxidase induces DNA damage and sensitizes fusion negative rhabdomyosarcoma cells to irradiation. Front Cell Dev Biol 11:1061570. |
| 2256 | Koeniger A et.al. (2023). Tumor-suppressive disruption of cancer subtype-associated super enhancer circuits by small molecule treatment. NAR Cancer 5:zcad007. |
| 2255 | Danielli SG et.al. (2023). Single-cell profiling of alveolar rhabdomyosarcoma reveals RAS pathway inhibitors as cell-fate hijackers with therapeutic relevance. Sci Adv 9:eade9238. |
| 2254 | Lu Y et.al. (2023). High Expression of PKMYT1 Predicts Poor Prognosis and Aggravates the Progression of Osteosarcoma via the NF-kappaB Pathway in MG63 Cells. Curr Cancer Drug Targets 23:496-504. |
| 2253 | Cheng C et.al. (2023). P300 Interacted With N-Myc and Regulated Its Protein Stability via Altering Its Post-Translational Modifications in Neuroblastoma. Mol Cell Proteomics 22:100504. |
| 2252 | Wibowo BP et.al. (2023). The Effect of Salmonella AvrA Infection on Colon Cancer: An in-silico Study. Asian Pac J Cancer Prev 24:163-170. |
| 2251 | Qi D et.al. (2023). Transcriptomic analyses of patient peripheral blood with hemoglobin depletion reveal glioblastoma biomarkers. NPJ Genom Med 8:2. |
| 2250 | Stamatiou K et.al. (2023). CCDC86 is a novel Ki-67-interacting protein important for cell division. J Cell Sci 136:. |
| 2249 | Cai J et.al. (2023). AMPK attenuates SHH subgroup medulloblastoma growth and metastasis by inhibiting NF-kappaB activation. Cell Biosci 13:15. |
| 2248 | Mei W et.al. (2023). IQGAP3 is relevant to prostate cancer: A detailed presentation of potential pathomechanisms. J Adv Res :. |
| 2247 | Gomez-Munoz MA et.al. (2023). Analysis of Serial Neuroblastoma PDX Passages in Mice Allows the Identification of New Mediators of Neuroblastoma Aggressiveness. Int J Mol Sci 24:. |
| 2246 | Hartl L et.al. (2023). C/EBP-Family Redundancy Determines Patient Survival and Lymph Node Involvement in PDAC. Int J Mol Sci 24:. |
| 2245 | Arseni L et.al. (2023). Sphingosine-1-Phosphate Recruits Macrophages and Microglia and Induces a Pro-Tumorigenic Phenotype That Favors Glioma Progression. Cancers (Basel) 15:. |
| 2244 | Sinclair PB et.al. (2023). Disruption to the FOXO-PRDM1 axis resulting from deletions of chromosome 6 in acute lymphoblastic leukaemia. Leukemia 37:636-649. |
| 2243 | Bakr MN et.al. (2023). CHRNA1 and its correlated-myogenesis/cell cycle genes are prognosis-related markers of metastatic melanoma. Biochem Biophys Rep 33:101425. |
| 2242 | Lak NSM et.al. (2023). Cell-Free DNA as a Diagnostic and Prognostic Biomarker in Pediatric Rhabdomyosarcoma. JCO Precis Oncol 7:e2200113. |
| 2241 | Maklad A et.al. (2023). LIN28 expression and function in medulloblastoma. J Cell Physiol 238:533-548. |
| 2240 | Wetzel TJ et.al. (2023). The emerging role of the branched chain aminotransferases, BCATc and BCATm, for anti-tumor T-cell immunity. Immunometabolism (Cobham) 5:e00014. |
| 2239 | Wang F et.al. (2023). Claudin18.2 as a potential therapeutic target for primary ovarian mucinous carcinomas and metastatic ovarian mucinous carcinomas from upper gastrointestinal primary tumours. BMC Cancer 23:44. |
| 2238 | Okonechnikov K et.al. (2023). Comparison of transcriptome profiles between medulloblastoma primary and recurrent tumors uncovers novel variance effects in relapses. Acta Neuropathol Commun 11:7. |
| 2237 | Linke F et.al. (2023). Identifying new biomarkers of aggressive Group 3 and SHH medulloblastoma using 3D hydrogel models, single cell RNA sequencing and 3D OrbiSIMS imaging. Acta Neuropathol Commun 11:6. |
| 2236 | Stehle D et.al. (2023). Heterogeneity of cGMP signalling in tumour cells and the tumour microenvironment: Challenges and chances for cancer pharmacology and therapeutics. Pharmacol Ther 242:108337. |
| 2235 | Lin Y et.al. (2023). PLAGL2 promotes the stemness and is upregulated by transcription factor E2F1 in human lung cancer. Environ Toxicol 38:941-949. |
| 2234 | Trinidad EM et.al. (2023). Liquidhope: methylome and genomic profiling from very limited quantities of plasma-derived DNA. Brief Bioinform 24:. |
| 2233 | Wang R et.al. (2023). ZBTB18 restricts chromatin accessibility and prevents transcriptional adaptations that drive metastasis. Sci Adv 9:eabq3951. |
| 2232 | He Z et.al. (2023). Integrative Analysis Identified CD38 As a Key Node That Correlates Highly with Immunophenotype, Chemoradiotherapy Resistance, And Prognosis of Head and Neck Cancer. J Cancer 14:72-87. |
| 2231 | Martinez-Monleon A et.al. (2023). Identification of recurrent 3q13.31 chromosomal rearrangement indicates LSAMP as a tumor suppressor gene in neuroblastoma. Int J Oncol 62:. |
| 2230 | Chen KS et.al. (2023). Bifunctional cancer cell-based vaccine concomitantly drives direct tumor killing and antitumor immunity. Sci Transl Med 15:eabo4778. |
| 2229 | van Wouw SAE et.al. (2023). Sterol-regulated transmembrane protein TMEM86a couples LXR signaling to regulation of lysoplasmalogens in macrophages. J Lipid Res 64:100325. |
| 2228 | Sanders K et.al. (2023). Transcriptome sequencing reveals two subtypes of cortisol-secreting adrenocortical tumours in dogs and identifies CYP26B1 as a potential new therapeutic target. Vet Comp Oncol 21:100-110. |
| 2227 | Blomberg E et.al. (2023). Differential roles of type I interferon signaling in tumor versus host cells in experimental glioma models. Transl Oncol 28:101607. |
| 2226 | Palombo R et.al. (2023). Inhibition of the PI3K/AKT/mTOR signaling promotes an M1 macrophage switch by repressing the ATF3-CXCL8 axis in Ewing sarcoma. Cancer Lett 555:216042. |
| 2225 | Contadini C et.al. (2023). Caspase-8 as a novel mediator linking Src kinase signaling to enhanced glioblastoma malignancy. Cell Death Differ 30:417-428. |
| 2224 | Xu G et.al. (2023). C-Fos-activated circRPPH1 contributes to glioma stemness. Clin Transl Oncol 25:1277-1286. |
| 2223 | Ali W et.al. (2023). Associations of selenoprotein expression and gene methylation with the outcome of clear cell renal carcinoma. Arch Biochem Biophys 733:109470. |
| 2222 | Keck MK et.al. (2023). Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification. Acta Neuropathol 145:49-69. |
| 2221 | Shen Y et.al. (2023). Identification of eIF6 as a prognostic factor that drives tumor progression and predicts arsenic trioxide efficacy in lung adenocarcinoma. Mol Biol Rep 50:1167-1180. |
| 2220 | Tippett VL et.al. (2023). The strategy and clinical relevance of in vitro models of MAP resistance in osteosarcoma: a systematic review. Oncogene 42:259-277. |
| 2219 | Formicola D et.al. (2023). CFDP1 is a neuroblastoma susceptibility gene that regulates transcription factors of the noradrenergic cell identity. HGG Adv 4:100158. |
| 2218 | Zhang S et.al. (2023). NONO enhances mRNA processing of super-enhancer-associated GATA2 and HAND2 genes in neuroblastoma. EMBO Rep 24:e54977. |
| 2217 | Evans RJ et.al. (2023). Endo180 (MRC2) Antibody-Drug Conjugate for the Treatment of Sarcoma. Mol Cancer Ther 22:240-253. |
| 2216 | Pettitt GA et.al. (2023). Development of resistance to FGFR inhibition in urothelial carcinoma via multiple pathways in vitro. J Pathol 259:220-232. |
| 2215 | Mo J et.al. (2023). Therapeutic targeting the oncogenic driver EWSR1::FLI1 in Ewing sarcoma through inhibition of the FACT complex. Oncogene 42:11-25. |
| 2214 | Lee CJ et.al. (2023). Machine learning with in silico analysis markedly improves survival prediction modeling in colon cancer patients. Cancer Med 12:7603-7615. |
| 2213 | Pulido R et.al. (2023). Hopes on immunotherapy targeting B7-H3 in neuroblastoma. Transl Oncol 27:101580. |
| 2212 | Ouahoud S et.al. (2023). Loss of bone morphogenetic protein signaling in fibroblasts results in CXCL12-driven serrated polyp development. J Gastroenterol 58:25-43. |
| 2211 | Bloedjes TA et.al. (2023). AKT supports the metabolic fitness of multiple myeloma cells by restricting FOXO activity. Blood Adv 7:1697-1712. |
| 2210 | Jiang H et.al. (2023). Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma. Cancer Res 83:181-194. |
| 2209 | Lin Z et.al. (2023). N6-methyladenosine demethylase FTO enhances chemo-resistance in colorectal cancer through SIVA1-mediated apoptosis. Mol Ther 31:517-534. |
| 2208 | Nakata S et.al. (2023). Epigenetic upregulation of Schlafen11 renders
WNT Neuro Oncol 25:899-912. |
| 2207 | Tsujimoto A et.al. (2023). Use of DNA-alkylating pyrrole-imidazole polyamides for anti-cancer drug sensitivity screening in pancreatic ductal adenocarcinoma. Cancer Med 12:5821-5832. |
| 2206 | Chang G et.al. (2023). USP36 promotes tumorigenesis and drug sensitivity of glioblastoma by deubiquitinating and stabilizing ALKBH5. Neuro Oncol 25:841-853. |
| 2205 | Thus YJ et.al. (2023). Inhibition of casein kinase 2 sensitizes mantle cell lymphoma to venetoclax through MCL-1 downregulation. Haematologica 108:797-810. |
| 2204 | Korovina I et.al. (2023). Targeting integrin alpha2 as potential strategy for radiochemosensitization of glioblastoma. Neuro Oncol 25:648-661. |
| 2203 | Yang R et.al. (2023). Homeobox A3 and KDM6A cooperate in transcriptional control of aerobic glycolysis and glioblastoma progression. Neuro Oncol 25:635-647. |
| 2202 | Subramanian C et.al. (2023). Multi-genomic analysis of 260 adrenocortical cancer patient tumors identifies novel network BIRC5-hsa-miR-335-5p-PAX8-AS1 strongly associated with poor survival. Surgery 173:43-51. |
| 2201 | Liu J et.al. (2023). CircRPPH1 promotes the stemness of gastric cancer cells by targeting miR-375/SLC7A11 axis. Environ Toxicol 38:115-125. |
| 2200 | Rosch L et.al. (2023). ERBB and P-glycoprotein inhibitors break resistance in relapsed neuroblastoma models through P-glycoprotein. Mol Oncol 17:37-58. |
| 2199 | Li J et.al. (2023). ZIM3 activation of CCL25 expression in pulmonary metastatic nodules of osteosarcoma recruits M2 macrophages to promote metastatic growth. Cancer Immunol Immunother 72:903-916. |
| 2198 | Wei ST et.al. (2023). Hypoxia-induced CXC chemokine ligand 14 expression drives protumorigenic effects through activation of insulin-like growth factor-1 receptor signaling in glioblastoma. Cancer Sci 114:174-186. |
| 2197 | Al-Jamaei AAH et.al. (2023). Radiation modulates expression and related activities of c-Met protein in oral tongue squamous cell carcinoma cell lines. J Cancer Res Clin Oncol 149:4173-4184. |
| 2196 | Vriend J et.al. (2023). Genes of the Ubiquitin Proteasome System Qualify as Differential Markers in Malignant Glioma of Astrocytic and Oligodendroglial Origin. Cell Mol Neurobiol 43:1425-1452. |
| 2195 | Wang W et.al. (2023). N(6) -methyladenosine RNA demethylase FTO regulates extracellular matrix-related genes and promotes pancreatic cancer cell migration and invasion. Cancer Med 12:3731-3743. |
| 2194 | Chen L et.al. (2023). DRR1 promotes neuroblastoma cell differentiation by regulating CREB expression. Pediatr Res 93:852-861. |
| 2193 | Fratini L et.al. (2023). ZEB1 is a Subgroup-Specific Marker of Prognosis and Potential Drug Target in Medulloblastoma. Neuromolecular Med 25:64-74. |
| 2192 | Martins-da-Silva A et.al. (2023). Clinical Prognostic Implications of Wnt Hub Genes Expression in Medulloblastoma. Cell Mol Neurobiol 43:813-826. |
| 2191 | Jain D et.al. (2023). Prognostic significance of NT5E/CD73 in neuroblastoma and its function in CSC stemness maintenance. Cell Biol Toxicol 39:967-989. |
| 2022 (n=331) |
| 2190 | Wu Y et.al. (2022). Study on differentially expressed genes between stage M and stage MS neuroblastoma. Front Oncol 12:1083570. |
| 2189 | Yang J et.al. (2022). Remarkable Synergy When Combining EZH2 Inhibitors with YM155 Is H3K27me3-Independent. Cancers (Basel) 15:. |
| 2188 | Alannan M et.al. (2022). Rewiring Lipid Metabolism by Targeting PCSK9 and HMGCR to Treat Liver Cancer. Cancers (Basel) 15:. |
| 2187 | Alannan M et.al. (2022). Targeting PCSK9 in Liver Cancer Cells Triggers Metabolic Exhaustion and Cell Death by Ferroptosis. Cells 12:. |
| 2186 | Guo Y et.al. (2022). Inhibition of PI3 kinase isoform p110alpha suppresses neuroblastoma growth and induces the reduction of Anaplastic Lymphoma Kinase. Cell Biosci 12:210. |
| 2185 | Zeng W et.al. (2022). CCT6A knockdown suppresses osteosarcoma cell growth and Akt pathway activation in vitro. PLoS One 17:e0279851. |
| 2184 | Sugino RP et.al. (2022). Comparative epigenomics by machine learning approach for neuroblastoma. BMC Genomics 23:852. |
| 2183 | Santo SGE et.al. (2022). The Implications of Connexin 43 Deficiency during the Early Stages of Chemically Induced Mouse Colon Carcinogenesis. Antioxidants (Basel) 11:. |
| 2182 | Kucukkose E et.al. (2022). Modeling resistance of colorectal peritoneal metastases to immune checkpoint blockade in humanized mice. J Immunother Cancer 10:. |
| 2181 | Tan K et.al. (2022). SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma. J Exp Clin Cancer Res 41:352. |
| 2180 | Muhlethaler-Mottet A et.al. (2022). Low number of neurosecretory vesicles in neuroblastoma impairs massive catecholamine release and prevents hypertension. Front Endocrinol (Lausanne) 13:1027856. |
| 2179 | Kurupi R et.al. (2022). Pharmacologic Inhibition of SHP2 Blocks Both PI3K and MEK Signaling in Low-epiregulin HNSCC via GAB1. Cancer Res Commun 2:1061-1074. |
| 2178 | Penco-Campillo M et.al. (2022). Targeting of the ELR+CXCL/CXCR1/2 Pathway Is a Relevant Strategy for the Treatment of Paediatric Medulloblastomas. Cells 11:. |
| 2177 | Orth MF et.al. (2022). Systematic multi-omics cell line profiling uncovers principles of Ewing sarcoma fusion oncogene-mediated gene regulation. Cell Rep 41:111761. |
| 2176 | Laoukili J et.al. (2022). BRAF(V600E) in colorectal cancer reduces sensitivity to oxidative stress and promotes site-specific metastasis by stimulating glutathione synthesis. Cell Rep 41:111728. |
| 2175 | Bao L et.al. (2022). The human ion channel TRPM2 modulates migration and invasion in neuroblastoma through regulation of integrin expression. Sci Rep 12:20544. |
| 2174 | Wang PL et.al. (2022). The N-Myc-responsive lncRNA MILIP promotes DNA double-strand break repair through non-homologous end joining. Proc Natl Acad Sci U S A 119:e2208904119. |
| 2173 | Zhang J et.al. (2022). Identification of Key Genes Associated with Risk and Prognosis of Neuroblastoma. J Mol Neurosci 72:2398-2412. |
| 2172 | Hurkmans EGE et.al. (2022). SLC7A8 coding for LAT2 is associated with early disease progression in osteosarcoma and transports doxorubicin. Front Pharmacol 13:1042989. |
| 2171 | Tian Y et.al. (2022). Immunosuppressants Tacrolimus and Sirolimus revert the cardiac antifibrotic properties of p38-MAPK inhibition in 3D-multicellular human iPSC-heart organoids. Front Cell Dev Biol 10:1001453. |
| 2170 | Jia SQ et.al. (2022). The BRD4 Inhibitor dBET57 Exerts Anticancer Effects by Targeting Superenhancer-Related Genes in Neuroblastoma. J Immunol Res 2022:7945884. |
| 2169 | London WB et.al. (2022). WANTED: Better neuroblastoma biomarkers and better stratification. EBioMedicine 86:104358. |
| 2168 | Zapata-Garcia JA et.al. (2022). Comparative Genomic Hybridization and Transcriptome Sequencing Reveal Genes with Gain in Acute Lymphoblastic Leukemia: JUP Expression Emerges as a Survival-Related Gene. Diagnostics (Basel) 12:. |
| 2167 | Zhang D et.al. (2022). SOX4 Mediates ATRA-Induced Differentiation in Neuroblastoma Cells. Cancers (Basel) 14:. |
| 2166 | Yu Y et.al. (2022). ERK Inhibitor Ulixertinib Inhibits High-Risk Neuroblastoma Growth In Vitro and In Vivo. Cancers (Basel) 14:. |
| 2165 | Huang P et.al. (2022). The polymerase delta-interacting protein family and their emerging roles in diseases. Front Med (Lausanne) 9:1026931. |
| 2164 | Alkasalias T et.al. (2022). Proof-of-principle studies on a strategy to enhance nucleotide imbalance specifically in cancer cells. Cell Death Discov 8:464. |
| 2163 | Hou R et.al. (2022). Prostaglandin E2 in neuroblastoma: Targeting synthesis or signaling? Biomed Pharmacother 156:113966. |
| 2162 | Jurcevic S et.al. (2022). Bioinformatics analysis of miRNAs in the neuroblastoma 11q-deleted region reveals a role of miR-548l in both 11q-deleted and MYCN amplified tumour cells. Sci Rep 12:19729. |
| 2161 | Johansson P et.al. (2022). Epigenome-wide analysis of T-cell large granular lymphocytic leukemia identifies BCL11B as a potential biomarker. Clin Epigenetics 14:148. |
| 2160 | Czerwinska P et.al. (2022). Mining Transcriptomic Data to Uncover the Association between CBX Family Members and Cancer Stemness. Int J Mol Sci 23:. |
| 2159 | Bondarev N et.al. (2022). MGL S3 Chimeric Enzyme Drives Apoptotic Death of EGFR-Dependent Cancer Cells through ERK Downregulation. Int J Mol Sci 23:. |
| 2158 | Hartl L et.al. (2022). C/EBPdelta Suppresses Motility-Associated Gene Signatures and Reduces PDAC Cell Migration. Cells 11:. |
| 2157 | Pieraccioli M et.al. (2022). The transcriptional terminator XRN2 and the RNA-binding protein Sam68 link alternative polyadenylation to cell cycle progression in prostate cancer. Nat Struct Mol Biol 29:1101-1112. |
| 2156 | Li Y et.al. (2022). CircHIPK3 sponges miR-558 to suppress heparanase expression in bladder cancer cells. EMBO Rep 23:e56102. |
| 2155 | Dings MPG et.al. (2022). Estrogen-related receptor alpha drives mitochondrial biogenesis and resistance to neoadjuvant chemoradiation in esophageal cancer. Cell Rep Med 3:100802. |
| 2154 | Hu H et.al. (2022). The lncRNA THOR interacts with and stabilizes hnRNPD to promote cell proliferation and metastasis in breast cancer. Oncogene 41:5298-5314. |
| 2153 | van Neerven SM et.al. (2022). Intestinal Apc-inactivation induces HSP25 dependency. EMBO Mol Med 14:e16194. |
| 2152 | Marayati R et.al. (2022). PIM3 kinase promotes tumor metastasis in hepatoblastoma by upregulating cell surface expression of chemokine receptor cxcr4. Clin Exp Metastasis 39:899-912. |
| 2151 | Zhang L et.al. (2022). Delineation of a SMARCA4-specific competing endogenous RNA network and its function in hepatocellular carcinoma. World J Clin Cases 10:10501-10515. |
| 2150 | Manas A et.al. (2022). Clinically relevant treatment of PDX models reveals patterns of neuroblastoma chemoresistance. Sci Adv 8:eabq4617. |
| 2149 | Qin X et.al. (2022). Comprehensive analysis and validation reveal potential MYCN regulatory biomarkers associated with neuroblastoma prognosis. J Biomol Struct Dyn :1-16. |
| 2148 | Abancens M et.al. (2022). GPER Agonist G1 Prevents Wnt-Induced JUN Upregulation in HT29 Colorectal Cancer Cells. Int J Mol Sci 23:. |
| 2147 | Vriend J et.al. (2022). Ubiquitin Proteasome Gene Signatures in Ependymoma Molecular Subtypes. Int J Mol Sci 23:. |
| 2146 | Xiong Z et.al. (2022). Elevated ETV6 Expression in Glioma Promotes an Aggressive In Vitro Phenotype Associated with Shorter Patient Survival. Genes (Basel) 13:. |
| 2145 | Chen C et.al. (2022). Interplay: The Essential Role between INSM1 and N-Myc in Aggressive Neuroblastoma. Biology (Basel) 11:. |
| 2144 | Jiang X et.al. (2022). Targeting PI4KA sensitizes refractory leukemia to chemotherapy by modulating the ERK/AMPK/OXPHOS axis. Theranostics 12:6972-6988. |
| 2143 | Li M et.al. (2022). Dissecting super-enhancer driven transcriptional dependencies reveals novel therapeutic strategies and targets for group 3 subtype medulloblastoma. J Exp Clin Cancer Res 41:311. |
| 2142 | Tu Z et.al. (2022). Long noncoding RNA-mediated activation of PROTOR1/PRR5-AKT signaling shunt downstream of PI3K in triple-negative breast cancer. Proc Natl Acad Sci U S A 119:e2203180119. |
| 2141 | Brooks R et.al. (2022). Circadian lncRNA ADIRF-AS1 binds PBAF and regulates renal clear cell tumorigenesis. Cell Rep 41:111514. |
| 2140 | Filippova N et.al. (2022). Targeting the TREM1-positive myeloid microenvironment in glioblastoma. Neurooncol Adv 4:vdac149. |
| 2139 | Liu Z et.al. (2022). Loss of CASZ1 tumor suppressor linked to oncogenic subversion of neuroblastoma core regulatory circuitry. Cell Death Dis 13:871. |
| 2138 | Sconocchia G et.al. (2022). Direct CD32 T-cell cytotoxicity: implications for breast cancer prognosis and treatment. Life Sci Alliance 5:. |
| 2137 | Raza MT et.al. (2022). A systemic study on the vulnerability and fatality of prostate cancer patients towards COVID-19 through analysis of the TMPRSS2, CXCL10 and their co-expressed genes. Genomics Inform 20:e31. |
| 2136 | Gu X et.al. (2022). PRMT1 is an important factor for medulloblastoma cell proliferation and survival. Biochem Biophys Rep 32:101364. |
| 2135 | Xu J et.al. (2022). RAI14 Promotes Melanoma Progression by Regulating the FBXO32/c-MYC Pathway. Int J Mol Sci 23:. |
| 2134 | Yang C et.al. (2022). Targeting EZH2 Promotes Chemosensitivity of BCL-2 Inhibitor through Suppressing PI3K and c-KIT Signaling in Acute Myeloid Leukemia. Int J Mol Sci 23:. |
| 2133 | Recouvreux MS et.al. (2022). FOXC2 Promotes Vasculogenic Mimicry in Ovarian Cancer. Cancers (Basel) 14:. |
| 2132 | Ma L et.al. (2022). An inhibitor of BRD4, GNE987, inhibits the growth of glioblastoma cells by targeting C-Myc and S100A16. Cancer Chemother Pharmacol 90:431-444. |
| 2131 | Thakur K et.al. (2022). Investigation of molecular mechanisms underlying JAK/STAT signaling pathway in HPV-induced cervical carcinogenesis using omics approach. Med Oncol 39:255. |
| 2130 | Mills CM et.al. (2022). Synthesis and evaluation of small molecule inhibitors of LSD1 for use against MYCN-expressing neuroblastoma. Eur J Med Chem 244:114818. |
| 2129 | Li Y et.al. (2022). LARRPM restricts lung adenocarcinoma progression and M2 macrophage polarization through epigenetically regulating LINC00240 and CSF1. Cell Mol Biol Lett 27:91. |
| 2128 | Navarro N et.al. (2022). Integrin alpha9 emerges as a key therapeutic target to reduce metastasis in rhabdomyosarcoma and neuroblastoma. Cell Mol Life Sci 79:546. |
| 2127 | Borgenvik A et.al. (2022). Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma. Cancer Res 82:4586-4603. |
| 2126 | Pan R et.al. (2022). RSPO2 promotes progression of ovarian cancer through dual receptor-mediated FAK/Src signaling activation. iScience 25:105184. |
| 2125 | Zhang W et.al. (2022). The integration of single-cell sequencing, TCGA, and GEO data analysis revealed that PRRT3-AS1 is a biomarker and therapeutic target of SKCM. Front Immunol 13:919145. |
| 2124 | Yuan X et.al. (2022). Single-cell profiling of peripheral neuroblastic tumors identifies an aggressive transitional state that bridges an adrenergic-mesenchymal trajectory. Cell Rep 41:111455. |
| 2123 | Langenberg KPS et.al. (2022). Implementation of paediatric precision oncology into clinical practice: The Individualized Therapies for Children with cancer program iTHER. Eur J Cancer 175:311-325. |
| 2122 | Zhang HQ et.al. (2022). LncRNA THOR promotes endometrial cancer progression through the AKT and ERK signaling pathways. Med Oncol 39:207. |
| 2121 | Ma L et.al. (2022). BRD4 PROTAC degrader MZ1 exerts anticancer effects in acute myeloid leukemia by targeting c-Myc and ANP32B genes. Cancer Biol Ther 23:1-15. |
| 2120 | Pai P et.al. (2022). HOXA5-Mediated Stabilization of IkappaBalpha Inhibits the NF-kappaB Pathway and Suppresses Malignant Transformation of Breast Epithelial Cells. Cancer Res 82:3802-3814. |
| 2119 | Novak R et.al. (2022). RNF4~RGMb~BMP6 axis required for osteogenic differentiation and cancer cell survival. Cell Death Dis 13:820. |
| 2118 | Ren Y et.al. (2022). Tumorous expression of NAC1 restrains antitumor immunity through the LDHA-mediated immune evasion. J Immunother Cancer 10:. |
| 2117 | Peters NA et.al. (2022). Consensus molecular subtype 4 (CMS4)-targeted therapy in primary colon cancer: A proof-of-concept study. Front Oncol 12:969855. |
| 2116 | Gomez RL et.al. (2022). Super-enhancer associated core regulatory circuits mediate susceptibility to retinoic acid in neuroblastoma cells. Front Cell Dev Biol 10:943924. |
| 2115 | Nowak JK et.al. (2022). Unexpected Actors in Inflammatory Bowel Disease Revealed by Machine Learning from Whole-Blood Transcriptomic Data. Genes (Basel) 13:. |
| 2114 | Sengupta S et.al. (2022). Mesenchymal and adrenergic cell lineage states in neuroblastoma possess distinct immunogenic phenotypes. Nat Cancer 3:1228-1246. |
| 2113 | Krieg C et.al. (2022). Complement downregulation promotes an inflammatory signature that renders colorectal cancer susceptible to immunotherapy. J Immunother Cancer 10:. |
| 2112 | Chilamakuri R et.al. (2022). Direct Targeting of the Raf-MEK-ERK Signaling Cascade Inhibits Neuroblastoma Growth. Curr Oncol 29:6508-6522. |
| 2111 | Du X et.al. (2022). Cathepsin L promotes chemresistance to neuroblastoma by modulating serglycin. Front Pharmacol 13:920022. |
| 2110 | Blumel L et.al. (2022). Primary cilia contribute to the aggressiveness of atypical teratoid/rhabdoid tumors. Cell Death Dis 13:806. |
| 2109 | Li M et.al. (2022). IPO5 Mediates EMT and Promotes Esophageal Cancer Development through the RAS-ERK Pathway. Oxid Med Cell Longev 2022:6570879. |
| 2108 | Bosse KR et.al. (2022). Serial Profiling of Circulating Tumor DNA Identifies Dynamic Evolution of Clinically Actionable Genomic Alterations in High-Risk Neuroblastoma. Cancer Discov 12:2800-2819. |
| 2107 | Huang Y et.al. (2022). METTL1 promotes neuroblastoma development through m(7)G tRNA modification and selective oncogenic gene translation. Biomark Res 10:68. |
| 2106 | Jimenez C et.al. (2022). Structural disruption of BAF chromatin remodeller impairs neuroblastoma metastasis by reverting an invasiveness epigenomic program. Mol Cancer 21:175. |
| 2105 | Zhan F et.al. (2022). SAR1A regulates the RhoA/YAP and autophagy signaling pathways to influence osteosarcoma invasion and metastasis. Cancer Sci 113:4104-4119. |
| 2104 | Zhang T et.al. (2022). CDK7/GRP78 signaling axis contributes to tumor growth and metastasis in osteosarcoma. Oncogene 41:4524-4536. |
| 2103 | Zhong C et.al. (2022). S100A9 Derived from Chemoembolization-Induced Hypoxia Governs Mitochondrial Function in Hepatocellular Carcinoma Progression. Adv Sci (Weinh) 9:e2202206. |
| 2102 | Cheng C et.al. (2022). KHSRP modulated cell proliferation and cell cycle via regulating PPP2CA and p27 expression in Wilms tumor. Cell Signal 100:110447. |
| 2101 | Krebs N et.al. (2022). Axon guidance receptor ROBO3 modulates subtype identity and prognosis via AXL-associated inflammatory network in pancreatic cancer. JCI Insight 7:. |
| 2100 | Han W et.al. (2022). Targeting HOTAIRM1 ameliorates glioblastoma by disrupting mitochondrial oxidative phosphorylation and serine metabolism. iScience 25:104823. |
| 2099 | Ghiboub M et.al. (2022). Modulation of macrophage inflammatory function through selective inhibition of the epigenetic reader protein SP140. BMC Biol 20:182. |
| 2098 | Xu YL et.al. (2022). Glutathione peroxidase 8 expression on cancer cells and cancer-associated fibroblasts facilitates lung cancer metastasis. MedComm (2020) 3:e152. |
| 2097 | Hu X et.al. (2022). SMARCE1 promotes neuroblastoma tumorigenesis through assisting MYCN-mediated transcriptional activation. Oncogene 41:4295-4306. |
| 2096 | Zhang H et.al. (2022). Alterations of serine racemase expression determine proliferation and differentiation of neuroblastoma cells. FASEB J 36:e22473. |
| 2095 | Zhu P et.al. (2022). Alpha5 nicotinic acetylcholine receptor mediated immune escape of lung adenocarcinoma via STAT3/Jab1-PD-L1 signalling. Cell Commun Signal 20:121. |
| 2094 | Jin ML et.al. (2022). SETD1A-SOX2 axis is involved in tamoxifen resistance in estrogen receptor alpha-positive breast cancer cells. Theranostics 12:5761-5775. |
| 2093 | Sang X et.al. (2022). BRD4 Inhibitor GNE-987 Exerts Anticancer Effects by Targeting Super-Enhancer-Related Gene LYL1 in Acute Myeloid Leukemia. J Immunol Res 2022:7912484. |
| 2092 | Zalfa F et.al. (2022). Genome-Wide Identification and Validation of Gene Expression Biomarkers in the Diagnosis of Ovarian Serous Cystadenocarcinoma. Cancers (Basel) 14:. |
| 2091 | Fekry B et.al. (2022). Hepatic circadian and differentiation factors control liver susceptibility for fatty liver disease and tumorigenesis. FASEB J 36:e22482. |
| 2090 | Olsen TK et.al. (2022). DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma. JCI Insight 7:. |
| 2089 | Hains AE et.al. (2022). MYCN and HIF-1 directly regulate TET1 expression to control 5-hmC gains and enhance neuroblastoma cell migration in hypoxia. Epigenetics 17:2056-2074. |
| 2088 | Secchiari F et.al. (2022). The MICA-NKG2D axis in clear cell renal cell carcinoma bolsters MICA as target in immuno-oncology. Oncoimmunology 11:2104991. |
| 2087 | Takada I et.al. (2022). Transcriptional coregulator Ess2 controls survival of post-thymic CD4(+) T cells through the Myc and IL-7 signaling pathways. J Biol Chem 298:102342. |
| 2086 | Guo P et.al. (2022). BPTF inhibition antagonizes colorectal cancer progression by transcriptionally inactivating Cdc25A. Redox Biol 55:102418. |
| 2085 | Lenos KJ et.al. (2022). Molecular characterization of colorectal cancer related peritoneal metastatic disease. Nat Commun 13:4443. |
| 2084 | Jin Q et.al. (2022). BCL11A Facilitates Cell Proliferation and Metastasis in Neuroblastoma via Regulating the PI3K/Akt Signaling Pathway. Curr Cancer Drug Targets 22:919-930. |
| 2083 | Cai B et.al. (2022). A truncated derivative of FGFR1 kinase cooperates with FLT3 and KIT to transform hematopoietic stem cells in syndromic and de novo AML. Mol Cancer 21:156. |
| 2082 | Cai J et.al. (2022). High-risk neuroblastoma with NF1 loss of function is targetable using SHP2 inhibition. Cell Rep 40:111095. |
| 2081 | Woods ML et.al. (2022). Epigenetically silenced apoptosis-associated tyrosine kinase (AATK) facilitates a decreased expression of Cyclin D1 and WEE1, phosphorylates TP53 and reduces cell proliferation in a kinase-dependent manner. Cancer Gene Ther 29:1975-1987. |
| 2080 | Mustofa et.al. (2022). A Potent EGFR Inhibitor, N-Phenyl Pyrazoline Derivative Suppresses Aggressiveness and Cancer Stem Cell-Like Phenotype of Cervical Cancer Cells. Drug Des Devel Ther 16:2325-2339. |
| 2079 | Lebedev T et.al. (2022). Subtype of Neuroblastoma Cells with High KIT Expression Are Dependent on KIT and Its Knockdown Induces Compensatory Activation of Pro-Survival Signaling. Int J Mol Sci 23:. |
| 2078 | Treeck O et.al. (2022). DSCAM-AS1 Long Non-Coding RNA Exerts Oncogenic Functions in Endometrial Adenocarcinoma via Activation of a Tumor-Promoting Transcriptome Profile. Biomedicines 10:. |
| 2077 | Ortiz-Rivera J et.al. (2022). The Dynamics of Tumor-Infiltrating Myeloid Cell Activation and the Cytokine Expression Profile in a Glioma Resection Site during the Post-Surgical Period in Mice. Brain Sci 12:. |
| 2076 | Liu X et.al. (2022). Reduction of LPAR1 Expression in Neuroblastoma Promotes Tumor Cell Migration. Cancers (Basel) 14:. |
| 2075 | Shen X et.al. (2022). ETV1 Positively Correlated With Immune Infiltration and Poor Clinical Prognosis in Colorectal Cancer. Front Immunol 13:939806. |
| 2074 | Martinez-Monleon A et.al. (2022). Amplification of CDK4 and MDM2: a detailed study of a high-risk neuroblastoma subgroup. Sci Rep 12:12420. |
| 2073 | Swiderska-Syn M et.al. (2022). Noncanonical activation of GLI signaling in SOX2(+) cells drives medulloblastoma relapse. Sci Adv 8:eabj9138. |
| 2072 | Singh S et.al. (2022). Targeting KDM4 for treating PAX3-FOXO1-driven alveolar rhabdomyosarcoma. Sci Transl Med 14:eabq2096. |
| 2071 | Nunes C et.al. (2022). RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition. Sci Adv 8:eabn1382. |
| 2070 | Zhang Z et.al. (2022). FZD7 accelerates hepatic metastases in pancreatic cancer by strengthening EMT and stemness associated with TGF-beta/SMAD3 signaling. Mol Med 28:82. |
| 2069 | Marzouka NA et.al. (2022). The Lund Molecular Taxonomy Applied to Non-Muscle-Invasive Urothelial Carcinoma. J Mol Diagn 24:992-1008. |
| 2068 | Shen L et.al. (2022). DDX3 acts as a tumor suppressor in colorectal cancer as loss of DDX3 in advanced cancer promotes tumor progression by activating the MAPK pathway. Int J Biol Sci 18:3918-3933. |
| 2067 | Petroni M et.al. (2022). A gene dosage-dependent effect unveils NBS1 as both a haploinsufficient tumour suppressor and an essential gene for SHH-medulloblastoma. Neuropathol Appl Neurobiol 48:e12837. |
| 2066 | Zagozewski J et.al. (2022). Combined MEK and JAK/STAT3 pathway inhibition effectively decreases SHH medulloblastoma tumor progression. Commun Biol 5:697. |
| 2065 | Bartl J et.al. (2022). The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumors. Nat Commun 13:4061. |
| 2064 | Mabe NW et.al. (2022). Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1. Nat Cancer 3:976-993. |
| 2063 | Galiger C et.al. (2022). PPP2CA Is a Novel Therapeutic Target in Neuroblastoma Cells That Can Be Activated by the SET Inhibitor OP449. Front Oncol 12:744984. |
| 2062 | Poli E et.al. (2022). Immunoreactivity against fibroblast growth factor 8 in alveolar rhabdomyosarcoma patients and its involvement in tumor aggressiveness. Oncoimmunology 11:2096349. |
| 2061 | Huang L et.al. (2022). PRMT5 activates AKT via methylation to promote tumor metastasis. Nat Commun 13:3955. |
| 2060 | Habibe JJ et.al. (2022). Glucose-mediated insulin secretion is improved in FHL2-deficient mice and elevated FHL2 expression in humans is associated with type 2 diabetes. Diabetologia 65:1721-1733. |
| 2059 | Di Rocco A et.al. (2022). Anti‑oncogenic and pro‑myogenic action of the MKK6/p38/AKT axis induced by targeting MEK/ERK in embryonal rhabdomyosarcoma. Oncol Rep 48:. |
| 2058 | Stroes CI et.al. (2022). A phase Ib/II study of regorafenib and paclitaxel in patients with beyond first-line advanced esophagogastric carcinoma (REPEAT). Ther Adv Med Oncol 14:17588359221109196. |
| 2057 | Bishop E et.al. (2022). Characterisation of Expression the Arginine Pathway Enzymes in Childhood Brain Tumours to Determine Susceptibility to Therapeutic Arginine Depletion. Biomed Res Int 2022:9008685. |
| 2056 | Shen J et.al. (2022). YAP1 induces invadopodia formation by transcriptionally activating TIAM1 through enhancer in breast cancer. Oncogene 41:3830-3845. |
| 2055 | Tao L et.al. (2022). MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastoma. Nat Commun 13:3728. |
| 2054 | Li S et.al. (2022). Impaired oxygen-sensitive regulation of mitochondrial biogenesis within the von Hippel-Lindau syndrome. Nat Metab 4:739-758. |
| 2053 | Geng S et.al. (2022). ARIH2 regulates the proliferation, DNA damage and chemosensitivity of gastric cancer cells by reducing the stability of p21 via ubiquitination. Cell Death Dis 13:564. |
| 2052 | Sharpe BP et.al. (2022). Phosphodiesterase type 5 inhibitors enhance chemotherapy in preclinical models of esophageal adenocarcinoma by targeting cancer-associated fibroblasts. Cell Rep Med 3:100541. |
| 2051 | Hou R et.al. (2022). Targeting EP2 receptor with multifaceted mechanisms for high-risk neuroblastoma. Cell Rep 39:111000. |
| 2050 | Guo X et.al. (2022). Nuclear receptor estrogen-related receptor gamma suppresses colorectal cancer aggressiveness by regulating Wnt/beta-catenin signaling. Carcinogenesis 43:865-873. |
| 2049 | Gong B et.al. (2022). Complement C3a activates astrocytes to promote medulloblastoma progression through TNF-alpha. J Neuroinflammation 19:159. |
| 2048 | Isogai E et.al. (2022). Meis1 plays roles in cortical development through regulation of cellular proliferative capacity in the embryonic cerebrum. Biomed Res 43:91-97. |
| 2047 | Qin Q et.al. (2022). NELL1 Regulates the Matrisome to Promote Osteosarcoma Progression. Cancer Res 82:2734-2747. |
| 2046 | Yan X et.al. (2022). FSIP1 Is Associated with Poor Prognosis and Can Be Used to Construct a Prognostic Model in Gastric Cancer. Dis Markers 2022:2478551. |
| 2045 | Zhang K et.al. (2022). Identification of Hub Genes Associated With the Development of Stomach Adenocarcinoma by Integrated Bioinformatics Analysis. Front Oncol 12:844990. |
| 2044 | Nazim UM et.al. (2022). mTORC1-Inhibition Potentiating Metabolic Block by Tyrosine Kinase Inhibitor Ponatinib in Multiple Myeloma. Cancers (Basel) 14:. |
| 2043 | Wang Y et.al. (2022). Impact of AADAC gene expression on prognosis in patients with Borrmann type III advanced gastric cancer. BMC Cancer 22:635. |
| 2042 | Xu X et.al. (2022). A novel ALG10/TGF-beta positive regulatory loop contributes to the stemness of colorectal cancer. Aging (Albany NY) 14:4858-4873. |
| 2041 | Park SY et.al. (2022). Dysadherin awakens mechanical forces and promotes colorectal cancer progression. Theranostics 12:4399-4414. |
| 2040 | Al-Jamaei AH et.al. (2022). WEE1 kinase inhibitor MK-1775 sensitizes oral tongue squamous cell carcinoma cells to radiation irrespective of TP53 status. Oral Dis :. |
| 2039 | Schubert NA et.al. (2022). Target actionability review to evaluate CDK4/6 as a therapeutic target in paediatric solid and brain tumours. Eur J Cancer 170:196-208. |
| 2038 | Pathania AS et.al. (2022). miR-15a and miR-15b modulate natural killer and CD8(+)T-cell activation and anti-tumor immune response by targeting PD-L1 in neuroblastoma. Mol Ther Oncolytics 25:308-329. |
| 2037 | Jou E et.al. (2022). An innate IL-25-ILC2-MDSC axis creates a cancer-permissive microenvironment for Apc mutation-driven intestinal tumorigenesis. Sci Immunol 7:eabn0175. |
| 2036 | Apfelbaum AA et.al. (2022). EWS::FLI1 and HOXD13 Control Tumor Cell Plasticity in Ewing Sarcoma. Clin Cancer Res 28:4466-4478. |
| 2035 | Ognibene M et.al. (2022). E2F3 gene expression is a potential negative prognostic marker for localised and MYCN not-amplified neuroblastoma: Results of in silico analysis of 786 samples. Pediatr Blood Cancer 69:e29800. |
| 2034 | Zhang L et.al. (2022). Exosomal MiR-199a-5p Inhibits Tumorigenesis and Angiogenesis by Targeting VEGFA in Osteosarcoma. Front Oncol 12:884559. |
| 2033 | Iwatate Y et.al. (2022). Transcriptomic analysis reveals high ITGB1 expression as a predictor for poor prognosis of pancreatic cancer. PLoS One 17:e0268630. |
| 2032 | Metselaar DS et.al. (2022). AURKA and PLK1 inhibition selectively and synergistically block cell cycle progression in diffuse midline glioma. iScience 25:104398. |
| 2031 | Liu W et.al. (2022). TRIM22 inhibits osteosarcoma progression through destabilizing NRF2 and thus activation of ROS/AMPK/mTOR/autophagy signaling. Redox Biol 53:102344. |
| 2030 | Mosca N et.al. (2022). LIM Homeobox-2 Suppresses Hallmarks of Adult and Pediatric Liver Cancers by Inactivating MAPK/ERK and Wnt/Beta-Catenin Pathways. Liver Cancer 11:126-140. |
| 2029 | Thiruvalluvan M et.al. (2022). Antagonizing Glutamine Bioavailability Promotes Radiation Sensitivity in Prostate Cancer. Cancers (Basel) 14:. |
| 2028 | Lu Y et.al. (2022). EHD1 promotes the cancer stem cell (CSC)-like traits of glioma cells via interacting with CD44 and suppressing CD44 degradation. Environ Toxicol 37:2259-2268. |
| 2027 | Almutairi BO et.al. (2022). Cigarette Smoke Regulates the Expression of EYA4 via Alternation of DNA Methylation Status. Biomed Res Int 2022:5032172. |
| 2026 | Zhang M et.al. (2022). DAB2IP down-regulates HSP90AA1 to inhibit the malignant biological behaviors of colorectal cancer. BMC Cancer 22:561. |
| 2025 | Filipponi D et.al. (2022). Inhibiting ALK2/ALK3 Signaling to Differentiate and Chemo-Sensitize Medulloblastoma. Cancers (Basel) 14:. |
| 2024 | Dang TT et.al. (2022). XRN2 Is Required for Cell Motility and Invasion in Glioblastomas. Cells 11:. |
| 2023 | Le Boiteux E et.al. (2022). The Long Non-Coding RNA HOXA-AS2 Promotes Proliferation of Glioma Stem Cells and Modulates Their Inflammation Pathway Mainly through Post-Transcriptional Regulation. Int J Mol Sci 23:. |
| 2022 | Gul Mohammad A et.al. (2022). Integrated analyses of an RNA binding protein-based signature related to tumor immune microenvironment and candidate drugs in osteosarcoma. Am J Transl Res 14:2501-2526. |
| 2021 | Mogal MR et.al. (2022). A Computational Approach to Justifying Stratifin as a Candidate Diagnostic and Prognostic Biomarker for Pancreatic Cancer. Biomed Res Int 2022:1617989. |
| 2020 | Ben Amar D et.al. (2022). Environmental cues from neural crest derivatives act as metastatic triggers in an embryonic neuroblastoma model. Nat Commun 13:2549. |
| 2019 | Sezgin G et.al. (2022). Clinical Impact of KIR2DS3 and KIR2DL3 Genes in Neuroblastoma Patients. Med Princ Pract 31:532-539. |
| 2018 | Lee R et.al. (2022). Synthetic Essentiality of Tryptophan 2,3-Dioxygenase 2 in APC-Mutated Colorectal Cancer. Cancer Discov 12:1702-1717. |
| 2017 | Jasinski-Bergner S et.al. (2022). Novel approach to identify putative Epstein-Barr-virus microRNAs regulating host cell genes with relevance in tumor biology and immunology. Oncoimmunology 11:2070338. |
| 2016 | Piscazzi A et.al. (2022). Differential and divergent activity of insulin-like growth factor binding protein 6 in platinum-sensitive versus platinum-resistant high-grade serous ovarian carcinoma cell lines. Oncol Lett 23:185. |
| 2015 | Tang XX et.al. (2022). Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma. Genes Immun 23:129-140. |
| 2014 | Bononi G et.al. (2022). Reversible Monoacylglycerol Lipase Inhibitors: Discovery of a New Class of Benzylpiperidine Derivatives. J Med Chem 65:7118-7140. |
| 2013 | Tan K et.al. (2022). Identification and Characterization of a Glucometabolic Prognostic Gene Signature in Neuroblastoma based on N6-methyladenosine Eraser ALKBH5. J Cancer 13:2105-2125. |
| 2012 | Dai Y et.al. (2022). ISG15 enhances glioma cell stemness by promoting Oct4 protein stability. Environ Toxicol 37:2133-2142. |
| 2011 | Xiao W et.al. (2022). POU6F1 cooperates with RORA to suppress the proliferation of lung adenocarcinoma by downregulation HIF1A signaling pathway. Cell Death Dis 13:427. |
| 2010 | Federico A et.al. (2022). ATRT-SHH comprises three molecular subgroups with characteristic clinical and histopathological features and prognostic significance. Acta Neuropathol 143:697-711. |
| 2009 | Keane S et.al. (2022). Inflammation suppresses DLG2 expression decreasing inflammasome formation. J Cancer Res Clin Oncol 148:2295-2311. |
| 2008 | Yang Z et.al. (2022). ALKBH5 regulates STAT3 activity to affect the proliferation and tumorigenicity of osteosarcoma via an m6A-YTHDF2-dependent manner. EBioMedicine 80:104019. |
| 2007 | Cimmino F et.al. (2022). FGFR1 is a potential therapeutic target in neuroblastoma. Cancer Cell Int 22:174. |
| 2006 | Bishayee K et.al. (2022). Reversing the HDAC-inhibitor mediated metabolic escape in MYCN-amplified neuroblastoma. Biomed Pharmacother 150:113032. |
| 2005 | Chen Z et.al. (2022). Characterization of metabolic alterations of chronic lymphocytic leukemia in the lymph node microenvironment. Blood 140:630-643. |
| 2004 | Saifullah et.al. (2022). Integrated analysis of ALK higher expression in human cancer and downregulation in LUAD using RNA molecular scissors. Clin Transl Oncol 24:1785-1799. |
| 2003 | Alborzinia H et.al. (2022). MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosis. Nat Cancer 3:471-485. |
| 2002 | Ouyang S et.al. (2022). Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer. Redox Biol 52:102317. |
| 2001 | Fischer T et.al. (2022). PTEN mutant non-small cell lung cancer require ATM to suppress pro-apoptotic signalling and evade radiotherapy. Cell Biosci 12:50. |
| 2000 | Creemers A et.al. (2022). FOXO transcriptional activity is associated with response to chemoradiation in EAC. J Transl Med 20:183. |
| 1999 | Peng W et.al. (2022). CBX3 accelerates the malignant progression of glioblastoma multiforme by stabilizing EGFR expression. Oncogene 41:3051-3063. |
| 1998 | Shin HJ et.al. (2022). Association of Elevated Expression Levels of COL4A1 in Stromal Cells with an Immunosuppressive Tumor Microenvironment in Low-Grade Glioma, Pancreatic Adenocarcinoma, Skin Cutaneous Melanoma, and Stomach Adenocarcinoma. J Pers Med 12:. |
| 1997 | Ampudia-Mesias E et.al. (2022). SRPX Emerges as a Potential Tumor Marker in the Extracellular Vesicles of Glioblastoma. Cancers (Basel) 14:. |
| 1996 | Li J et.al. (2022). Ribosome assembly factor PNO1 is associated with progression and promotes tumorigenesis in triple‑negative breast cancer. Oncol Rep 47:. |
| 1995 | Timmerman DM et.al. (2022). Chromosome 3p25.3 Gain Is Associated With Cisplatin Resistance and Is an Independent Predictor of Poor Outcome in Male Malignant Germ Cell Tumors. J Clin Oncol 40:3077-3087. |
| 1994 | Bandaru S et.al. (2022). Filamin A increases aggressiveness of human neuroblastoma. Neurooncol Adv 4:vdac028. |
| 1993 | Huang M et.al. (2022). HSF1 facilitates the multistep process of lymphatic metastasis in bladder cancer via a novel PRMT5-WDR5-dependent transcriptional program. Cancer Commun (Lond) 42:447-470. |
| 1992 | Iwatate Y et.al. (2022). Machine learning with imaging features to predict the expression of ITGAV, which is a poor prognostic factor derived from transcriptome analysis in pancreatic cancer. Int J Oncol 60:. |
| 1991 | Zhang Y et.al. (2022). MicroRNA-18 facilitates the stemness of gastric cancer by downregulating HMGB3 though targeting Meis2. Bioengineered 13:9959-9972. |
| 1990 | Lin Y et.al. (2022). Multi-omics analysis based on 3D-bioprinted models innovates therapeutic target discovery of osteosarcoma. Bioact Mater 18:459-470. |
| 1989 | Chen S et.al. (2022). Enhanced pentose phosphate pathway activity promotes pancreatic ductal adenocarcinoma progression via activating YAP/MMP1 axis under chronic acidosis. Int J Biol Sci 18:2304-2316. |
| 1988 | Gringmuth M et.al. (2022). Enhanced Survival of High-Risk Medulloblastoma-Bearing Mice after Multimodal Treatment with Radiotherapy, Decitabine, and Abacavir. Int J Mol Sci 23:. |
| 1987 | Jin TY et.al. (2022). BRCA1/2 Serves as a Biomarker for Poor Prognosis in Breast Carcinoma. Int J Mol Sci 23:. |
| 1986 | Principi E et.al. (2022). Targeting of Ubiquitin E3 Ligase RNF5 as a Novel Therapeutic Strategy in Neuroectodermal Tumors. Cancers (Basel) 14:. |
| 1985 | Asuthkar S et.al. (2022). SMYD3 Promotes Cell Cycle Progression by Inducing Cyclin D3 Transcription and Stabilizing the Cyclin D1 Protein in Medulloblastoma. Cancers (Basel) 14:. |
| 1984 | Wang W et.al. (2022). m(6)A RNA demethylase FTO promotes the growth, migration and invasion of pancreatic cancer cells through inhibiting TFPI-2. Epigenetics 17:1738-1752. |
| 1983 | Khazan N et.al. (2022). Identification of a Vitamin-D Receptor Antagonist, MeTC7, which Inhibits the Growth of Xenograft and Transgenic Tumors In Vivo. J Med Chem 65:6039-6055. |
| 1982 | Zhang L et.al. (2022). Detection of Host Cell Gene/HPV DNA Methylation Markers: A Promising Triage Approach for Cervical Cancer. Front Oncol 12:831949. |
| 1981 | Zhang G et.al. (2022). HECTD3 promotes gastric cancer progression by mediating the polyubiquitination of c-MYC. Cell Death Discov 8:185. |
| 1980 | Shi P et.al. (2022). MOXD1 knockdown suppresses the proliferation and tumor growth of glioblastoma cells via ER stress-inducing apoptosis. Cell Death Discov 8:174. |
| 1979 | Choi J et.al. (2022). Co-treatment with vactosertib, a novel, orally bioavailable activin receptor-like kinase 5 inhibitor, suppresses radiotherapy-induced epithelial-to-mesenchymal transition, cancer cell stemness, and lung metastasis of breast cancer. Radiol Oncol 56:185-197. |
| 1978 | Voeltzke K et.al. (2022). EIF4EBP1 is transcriptionally upregulated by MYCN and associates with poor prognosis in neuroblastoma. Cell Death Discov 8:157. |
| 1977 | Fang T et.al. (2022). Evaluation of Immune Infiltration Based on Image Plus Helps Predict the Prognosis of Stage III Gastric Cancer Patients with Significantly Different Outcomes in Northeastern China. Dis Markers 2022:2893336. |
| 1976 | Tu R et.al. (2022). c-MYC-USP49-BAG2 axis promotes proliferation and chemoresistance of colorectal cancer cells in vitro. Biochem Biophys Res Commun 607:117-123. |
| 1975 | Wu CZ et.al. (2022). Urokinase plasminogen activator induces epithelial-mesenchymal and metastasis of pancreatic cancer through plasmin/MMP14/TGF-beta axis, which is inhibited by 4-acetyl-antroquinonol B treatment. Phytomedicine 100:154062. |
| 1974 | Sarnella A et.al. (2022). Inhibition of carbonic anhydrases IX/XII by SLC-0111 boosts cisplatin effects in hampering head and neck squamous carcinoma cell growth and invasion. J Exp Clin Cancer Res 41:122. |
| 1973 | Garcia-Dominguez DJ et.al. (2022). Selective histone methyltransferase G9a inhibition reduces metastatic development of Ewing sarcoma through the epigenetic regulation of NEU1. Oncogene 41:2638-2650. |
| 1972 | Madhavan K et.al. (2022). Venetoclax Cooperates with Ionizing Radiation to Attenuate Diffuse Midline Glioma Tumor Growth. Clin Cancer Res 28:2409-2424. |
| 1971 | Zhang B et.al. (2022). Characterizing cellular heterogeneity in chromatin state with scCUT&Tag-pro. Nat Biotechnol 40:1220-1230. |
| 1970 | Kaushik I et.al. (2022). GABA(A) receptor agonist suppresses pediatric medulloblastoma progression by inhibiting PKA-Gli1 signaling axis. Mol Ther 30:2584-2602. |
| 1969 | Wang J et.al. (2022). LINC01296 promotes neuroblastoma tumorigenesis via the NCL-SOX11 regulatory complex. Mol Ther Oncolytics 24:834-848. |
| 1968 | Cao M et.al. (2022). Therapy-resistant and -sensitive lncRNAs, SNHG1 and UBL7-AS1 promote glioblastoma cell proliferation. Oxid Med Cell Longev 2022:2623599. |
| 1967 | Chen YL et.al. (2022). BRD4 inhibitor GNE987 exerts anti-cancer effects by targeting super-enhancers in neuroblastoma. Cell Biosci 12:33. |
| 1966 | Lee J et.al. (2022). Hypoxic induction of apoptosis occurs through HIF-1alpha and accompanies mammalian sterile 20-like kinase 2 cleavage in human endometrial adenocarcinoma Ishikawa cells. Biochem Biophys Res Commun 604:104-108. |
| 1965 | Zhang X et.al. (2022). BRD4 inhibitor MZ1 exerts anti-cancer effects by targeting MYCN and MAPK signaling in neuroblastoma. Biochem Biophys Res Commun 604:63-69. |
| 1964 | Strating E et.al. (2022). Fibroblast activation protein identifies Consensus Molecular Subtype 4 in colorectal cancer and allows its detection by (68)Ga-FAPI-PET imaging. Br J Cancer 127:145-155. |
| 1963 | Capdeville C et.al. (2022). Spatial proteomics finds CD155 and Endophilin-A1 as mediators of growth and invasion in medulloblastoma. Life Sci Alliance 5:. |
| 1962 | Hurst CD et.al. (2022). Molecular profile of pure squamous cell carcinoma of the bladder identifies major roles for OSMR and YAP signalling. J Pathol Clin Res 8:279-293. |
| 1961 | Schoofs K et.al. (2022). Comprehensive RNA dataset of tissue and plasma from patients with esophageal cancer or precursor lesions. Sci Data 9:86. |
| 1960 | Bownes LV et.al. (2022). Serine-Threonine Kinase Receptor Associate Protein (STRAP) confers an aggressive phenotype in neuroblastoma via regulation of Focal Adhesion Kinase (FAK). J Pediatr Surg 57:1026-1032. |
| 1959 | Zhang H et.al. (2022). Lipoprotein-Inspired Nanoscavenger for the Three-Pronged Modulation of Microglia-Derived Neuroinflammation in Alzheimers Disease Therapy. Nano Lett 22:2450-2460. |
| 1958 | Sato N et.al. (2022). Yin Yang 1 regulates ITGAV and ITGB1, contributing to improved prognosis of colorectal cancer. Oncol Rep 47:. |
| 1957 | Chen J et.al. (2022). Reducing N6AMT1-mediated 6mA DNA modification promotes breast tumor progression via transcriptional repressing cell cycle inhibitors. Cell Death Dis 13:216. |
| 1956 | Sen A et.al. (2022). Allele-specific expression reveals genes with recurrent cis-regulatory alterations in high-risk neuroblastoma. Genome Biol 23:71. |
| 1955 | Qiu L et.al. (2022). CDC27-ODC1 Axis Promotes Metastasis, Accelerates Ferroptosis and Predicts Poor Prognosis in Neuroblastoma. Front Oncol 12:774458. |
| 1954 | Roca MS et.al. (2022). HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation. J Exp Clin Cancer Res 41:83. |
| 1953 | Nelson LJ et.al. (2022). Synthetic lethality of cyclin-dependent kinase inhibitor Dinaciclib with VHL-deficiency allows for selective targeting of clear cell renal cell carcinoma. Cell Cycle 21:1103-1119. |
| 1952 | Zhao M et.al. (2022). Malic enzyme 2 maintains protein stability of mutant p53 through 2-hydroxyglutarate. Nat Metab 4:225-238. |
| 1951 | Hauffe L et.al. (2022). Eukaryotic translation initiation factor 4E binding protein 1 (EIF4EBP1) expression in glioblastoma is driven by ETS1 Cell Death Discov 8:91. |
| 1950 | Sarkar T et.al. (2022). FOXP3/HAT1 Axis Controls Treg Infiltration in the Tumor Microenvironment by Inducing CCR4 Expression in Breast Cancer. Front Immunol 13:740588. |
| 1949 | Wang X et.al. (2022). Norepinephrine promotes glioma cell migration through up-regulating the expression of Twist1. BMC Cancer 22:213. |
| 1948 | Keane S et.al. (2022). DLG2 impairs dsDNA break repair and maintains genome integrity in neuroblastoma. DNA Repair (Amst) 112:103302. |
| 1947 | Nguyen R et.al. (2022). Combining selinexor with alisertib to target the p53 pathway in neuroblastoma. Neoplasia 26:100776. |
| 1946 | Liu X et.al. (2022). PCLAF promotes neuroblastoma G1/S cell cycle progression via the E2F1/PTTG1 axis. Cell Death Dis 13:178. |
| 1945 | Vierthaler M et.al. (2022). ADCK2 Knockdown Affects the Migration of Melanoma Cells via MYL6. Cancers (Basel) 14:. |
| 1944 | Chilamakuri R et.al. (2022). Dual Targeting of PI3K and HDAC by CUDC-907 Inhibits Pediatric Neuroblastoma Growth. Cancers (Basel) 14:. |
| 1943 | Shmakova AA et.al. (2022). Urokinase Receptor uPAR Downregulation in Neuroblastoma Leads to Dormancy, Chemoresistance and Metastasis. Cancers (Basel) 14:. |
| 1942 | Ben Arfi K et.al. (2022). Discoidin Domain Receptor 1 Expression in Colon Cancer: Roles and Prognosis Impact. Cancers (Basel) 14:. |
| 1941 | Vivarelli S et.al. (2022). Computational Analyses of YY1 and Its Target RKIP Reveal Their Diagnostic and Prognostic Roles in Lung Cancer. Cancers (Basel) 14:. |
| 1940 | Ziel-Swier LJYM et.al. (2022). The Role of the MYC/miR-150/MYB/ZDHHC11 Network in Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma. Genes (Basel) 13:. |
| 1939 | Martins Garcia T et.al. (2022). Altered Gut Structure and Anti-Bacterial Defense in Adult Mice Treated with Antibiotics during Early Life. Antibiotics (Basel) 11:. |
| 1938 | Spek CA et.al. (2022). Macrophage C/EBPdelta Drives Gemcitabine, but Not 5-FU or Paclitaxel, Resistance of Pancreatic Cancer Cells in a Deoxycytidine-Dependent Manner. Biomedicines 10:. |
| 1937 | Laoukili J et.al. (2022). Peritoneal metastases from colorectal cancer belong to Consensus Molecular Subtype 4 and are sensitised to oxaliplatin by inhibiting reducing capacity. Br J Cancer 126:1824-1833. |
| 1936 | Ladumor Y et.al. (2022). Vitamin D Receptor Activation Attenuates Hippo Pathway Effectors and Cell Survival in Metastatic Neuroblastoma. Mol Cancer Res 20:895-908. |
| 1935 | Paval DR et.al. (2022). The Emerging Role of Intelectin-1 in Cancer. Front Oncol 12:767859. |
| 1934 | Carpintero-Fernandez P et.al. (2022). Genome wide CRISPR/Cas9 screen identifies the coagulation factor IX (F9) as a regulator of senescence. Cell Death Dis 13:163. |
| 1933 | Hu Y et.al. (2022). A reciprocal feedback between N6-methyladenosine reader YTHDF3 and lncRNA DICER1-AS1 promotes glycolysis of pancreatic cancer through inhibiting maturation of miR-5586-5p. J Exp Clin Cancer Res 41:69. |
| 1932 | McCarthy E et.al. (2022). Gene Co-expression Analysis of the Human Substantia Nigra Identifies ZNHIT1 as an SNCA Co-expressed Gene that Protects Against alpha-Synuclein-Induced Impairments in Neurite Growth and Mitochondrial Dysfunction in SH-SY5Y Cells. Mol Neurobiol 59:2745-2757. |
| 1931 | Nakahata K et.al. (2022). K-Ras and p53 mouse model with molecular characteristics of human rhabdomyosarcoma and translational applications. Dis Model Mech 15:. |
| 1930 | Floros KV et.al. (2022). MYCN upregulates the transsulfuration pathway to suppress the ferroptotic vulnerability in MYCN-amplified neuroblastoma. Cell Stress 6:21-29. |
| 1929 | Ramesh P et.al. (2022). BCL-XL inhibition induces an FGFR4-mediated rescue response in colorectal cancer. Cell Rep 38:110374. |
| 1928 | Lin NY et.al. (2022). C1GALT1 expression predicts a favorable prognosis and suppresses malignant phenotypes via TrkA signaling in neuroblastoma. Oncogenesis 11:8. |
| 1927 | Kuo KT et.al. (2022). HNMT Upregulation Induces Cancer Stem Cell Formation and Confers Protection against Oxidative Stress through Interaction with HER2 in Non-Small-Cell Lung Cancer. Int J Mol Sci 23:. |
| 1926 | Quinn CH et.al. (2022). Targeting High-Risk Neuroblastoma Patient-Derived Xenografts with Oncolytic Virotherapy. Cancers (Basel) 14:. |
| 1925 | Poghosyan S et.al. (2022). Loss of Neuropilin-2 in Murine Mesenchymal-like Colon Cancer Organoids Causes Mesenchymal-to-Epithelial Transition and an Acquired Dependency on Insulin-Receptor Signaling and Autophagy. Cancers (Basel) 14:. |
| 1924 | Feng S et.al. (2022). DAB2IP suppresses tumor malignancy by inhibiting GRP75-driven p53 ubiquitination in colon cancer. Cancer Lett 532:215588. |
| 1923 | Schwarz FM et.al. (2022). Plasticity within Aldehyde Dehydrogenase-Positive Cells Determines Prostate Cancer Radiosensitivity. Mol Cancer Res 20:794-809. |
| 1922 | Somasundaram DB et.al. (2022). ALK expression, prognostic significance, and its association with MYCN expression in MYCN non-amplified neuroblastoma. World J Pediatr 18:285-293. |
| 1921 | Islam MR et.al. (2022). Identification of Potential Key Genes and Molecular Mechanisms of Medulloblastoma Based on Integrated Bioinformatics Approach. Biomed Res Int 2022:1776082. |
| 1920 | Wolpaw AJ et.al. (2022). Epigenetic state determines inflammatory sensing in neuroblastoma. Proc Natl Acad Sci U S A 119:. |
| 1919 | van Ouwerkerk AF et.al. (2022). Patient-Specific TBX5-G125R Variant Induces Profound Transcriptional Deregulation and Atrial Dysfunction. Circulation 145:606-619. |
| 1918 | Souza BK et.al. (2022). G9a/EHMT2 is a Potential Prognostic Biomarker and Molecular Target in SHH Medulloblastoma. Neuromolecular Med :. |
| 1917 | Xu Y et.al. (2022). The m(6)A reading protein YTHDF3 potentiates tumorigenicity of cancer stem-like cells in ocular melanoma through facilitating CTNNB1 translation. Oncogene 41:1281-1297. |
| 1916 | Junghof J et.al. (2022). CDH18 is a fetal epicardial biomarker regulating differentiation towards vascular smooth muscle cells. NPJ Regen Med 7:14. |
| 1915 | Lasorsa VA et.al. (2022). Somatic Mutations Enriched in Cis-Regulatory Elements Affect Genes Involved in Embryonic Development and Immune System Response in Neuroblastoma. Cancer Res 82:1193-1207. |
| 1914 | Kim HI et.al. (2022). Pharmacological targeting of polyamine and hypusine biosynthesis reduces tumour activity of endometrial cancer. J Drug Target 30:623-633. |
| 1913 | Verly IRN et.al. (2022). Urinary 3-Methoxytyramine Is a Biomarker for MYC Activity in Patients With Neuroblastoma. JCO Precis Oncol 6:e2000447. |
| 1912 | Bakht MK et.al. (2022). Identification of alternative protein targets of glutamate-ureido-lysine associated with PSMA tracer uptake in prostate cancer cells. Proc Natl Acad Sci U S A 119:. |
| 1911 | Monti M et.al. (2022). Clinical Significance and Regulation of ERK5 Expression and Function in Cancer. Cancers (Basel) 14:. |
| 1910 | Czerwinska P et.al. (2022). The association between bromodomain proteins and cancer stemness in different solid tumor types. Int J Cancer 150:1838-1849. |
| 1909 | Kavazovic I et.al. (2022). Hyperglycemia and Not Hyperinsulinemia Mediates Diabetes-Induced Memory CD8 T-Cell Dysfunction. Diabetes 71:706-721. |
| 1908 | Theruvath J et.al. (2022). Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication. Nat Med 28:333-344. |
| 1907 | Hou J et.al. (2022). ZC3H15 promotes glioblastoma progression through regulating EGFR stability. Cell Death Dis 13:55. |
| 1906 | Sepporta MV et.al. (2022). TWIST1 expression is associated with high-risk neuroblastoma and promotes primary and metastatic tumor growth. Commun Biol 5:42. |
| 1905 | Clark RA et.al. (2022). Induction of serine hydroxymethyltransferase 2 promotes tumorigenesis and metastasis in neuroblastoma. Oncotarget 13:32-45. |
| 1904 | Khurshid S et.al. (2022). Splice-switching of the insulin receptor pre-mRNA alleviates tumorigenic hallmarks in rhabdomyosarcoma. NPJ Precis Oncol 6:1. |
| 1903 | Pantelaiou-Prokaki G et.al. (2022). HDAC8 suppresses the epithelial phenotype and promotes EMT in chemotherapy-treated basal-like breast cancer. Clin Epigenetics 14:7. |
| 1902 | Wong JKL et.al. (2022). Association of mutation signature effectuating processes with mutation hotspots in driver genes and non-coding regions. Nat Commun 13:178. |
| 1901 | Bishayee K et.al. (2022). RNA binding protein HuD promotes autophagy and tumor stress survival by suppressing mTORC1 activity and augmenting ARL6IP1 levels. J Exp Clin Cancer Res 41:18. |
| 1900 | Eswaran S et.al. (2022). Comprehensive analysis of the exocytosis pathway genes in cervical cancer. Am J Med Sci 363:526-537. |
| 1899 | Sun Y et.al. (2022). Identification of proteins associated with treatment response of neoadjuvant chemoradiotherapy in rectal mucinous adenocarcinoma by co-expression network analysis based on proteomic analysis. J Proteomics 254:104472. |
| 1898 | Schmidt O et.al. (2022). Correction to: Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis. J Exp Clin Cancer Res 41:7. |
| 1897 | Dey A et.al. (2022). Preclinical Research Strategy Development for RNAi-Based Therapies in Oncology Using Patient-Centered Information from Public Databases of Human Protein Atlas and R2Genomics Platform. Methods Mol Biol 2423:181-185. |
| 1896 | Li Z et.al. (2022). IRF7 inhibits the Warburg effect via transcriptional suppression of PKM2 in osteosarcoma. Int J Biol Sci 18:30-42. |
| 1895 | Keller KM et.al. (2022). Target Actionability Review: a systematic evaluation of replication stress as a therapeutic target for paediatric solid malignancies. Eur J Cancer 162:107-117. |
| 1894 | Liu L et.al. (2022). Multi-omics of the expression and clinical outcomes of TMPRSS2 in human various cancers: A potential therapeutic target for COVID-19. J Cell Mol Med 26:709-724. |
| 1893 | Lu F et.al. (2022). MYCN Directly Targets NeuroD1 to Promote Cellular Proliferation in Neuroblastoma. Oncol Res 29:1-10. |
| 1892 | Zhao N et.al. (2022). SOX2 maintains the stemness of retinoblastoma stem-like cells through Hippo/YAP signaling pathway. Exp Eye Res 214:108887. |
| 1891 | Kawano Y et.al. (2022). A novel PDK1 inhibitor, JX06, inhibits glycolysis and induces apoptosis in multiple myeloma cells. Biochem Biophys Res Commun 587:153-159. |
| 1890 | Westerhout EM et.al. (2022). Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors. Cancer Res 82:484-496. |
| 1889 | Xiao X et.al. (2022). MEOX1 suppresses the progression of lung cancer cells by inhibiting the cell-cycle checkpoint gene CCNB1. Environ Toxicol 37:504-513. |
| 1888 | das Chagas PF et.al. (2022). Identification of ITPR1 as a Hub Gene of Group 3 Medulloblastoma and Coregulated Genes with Potential Prognostic Values. J Mol Neurosci 72:633-641. |
| 1887 | Liu W et.al. (2022). BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor Microenvironment. Cancer Res 82:264-277. |
| 1886 | Ando K et.al. (2022). FGFR2 loss sensitizes MYCN-amplified neuroblastoma CHP134 cells to CHK1 inhibitor-induced apoptosis. Cancer Sci 113:587-596. |
| 1885 | Oo JA et.al. (2022). Long non-coding RNAs: novel regulators of cellular physiology and function. Pflugers Arch 474:191-204. |
| 1884 | Laut AK et.al. (2022). CHD5 inhibits metastasis of neuroblastoma. Oncogene 41:622-633. |
| 1883 | Shi Z et.al. (2022). Loss of H2R Signaling Disrupts Neutrophil Homeostasis and Promotes Inflammation-Associated Colonic Tumorigenesis in Mice. Cell Mol Gastroenterol Hepatol 13:717-737. |
| 1882 | Durbin AD et.al. (2022). EP300 Selectively Controls the Enhancer Landscape of MYCN-Amplified Neuroblastoma. Cancer Discov 12:730-751. |
| 1881 | Willemsen M et.al. (2022). IFN-gamma-induced PD-L1 expression on human melanocytes is impaired in vitiligo. Exp Dermatol 31:556-566. |
| 1880 | Dash P et.al. (2022). High PGD(2) receptor 2 levels are associated with poor prognosis in colorectal cancer patients and induce VEGF expression in colon cancer cells and migration in a zebrafish xenograft model. Br J Cancer 126:586-597. |
| 1879 | Rozen EJ et.al. (2022). Systematic review of the receptor tyrosine kinase superfamily in neuroblastoma pathophysiology. Cancer Metastasis Rev 41:33-52. |
| 1878 | Peng Y et.al. (2022). Non-muscle myosin II isoforms orchestrate substrate stiffness sensing to promote cancer cell contractility and migration. Cancer Lett 524:245-258. |
| 1877 | Delaidelli A et.al. (2022). Clinically Tractable Outcome Prediction of Non-WNT/Non-SHH Medulloblastoma Based on TPD52 IHC in a Multicohort Study. Clin Cancer Res 28:116-128. |
| 1876 | Mugoni V et.al. (2022). Circulating RNAs in prostate cancer patients. Cancer Lett 524:57-69. |
| 1875 | Naeem A et.al. (2022). Regulation of Chemosensitivity in Human Medulloblastoma Cells by p53 and the PI3 Kinase Signaling Pathway. Mol Cancer Res 20:114-126. |
| 1874 | Anantha J et.al. (2022). NME1 Protects Against Neurotoxin-, alpha-Synuclein Mol Neurobiol 59:61-76. |
| 1873 | Prieto-Garcia C et.al. (2022). Inhibition of USP28 overcomes Cisplatin-resistance of squamous tumors by suppression of the Fanconi anemia pathway. Cell Death Differ 29:568-584. |
| 1872 | Baranowska-Kortylewicz J et.al. (2022). Multifarious Functions of Butyrylcholinesterase in Neuroblastoma: Impact of BCHE Deletion on the Neuroblastoma Growth In Vitro and In Vivo. J Pediatr Hematol Oncol 44:293-304. |
| 1871 | Truong DQ et.al. (2022). Collagen XI Alpha 1 (COL11A1) Expression in the Tumor Microenvironment Drives Neuroblastoma Dissemination. Pediatr Dev Pathol 25:91-98. |
| 1870 | Shi M et.al. (2022). HMGA1 promotes hepatocellular carcinoma proliferation, migration, and regulates cell cycle via miR-195-5p. Anticancer Drugs 33:e273-e285. |
| 1869 | Yang T et.al. (2022). Decoding DNA methylation in epigenetics of multiple myeloma. Blood Rev 51:100872. |
| 1868 | Subramanian C et.al. (2022). Identification of novel lipid metabolic biomarkers associated with poor adrenocortical carcinoma prognosis using integrated bioinformatics. Surgery 171:119-129. |
| 1867 | van Duijn A et.al. (2022). A secondary role for hypoxia and HIF1 in the regulation of (IFNgamma-induced) PD-L1 expression in melanoma. Cancer Immunol Immunother 71:529-540. |
| 1866 | Nie K et.al. (2022). SNAT2/SLC38A2 Confers the Stemness of Gastric Cancer Cells via Regulating Glutamine Level. Dig Dis Sci 67:2948-2956. |
| 1865 | Willemsen M et.al. (2022). Immunophenotypic Analysis Reveals Differences in Circulating Immune Cells in the Peripheral Blood of Patients with Segmental and Nonsegmental Vitiligo. J Invest Dermatol 142:876-883.e3. |
| 1864 | Jane EP et.al. (2022). Reversing tozasertib resistance in glioma through inhibition of pyruvate dehydrogenase kinases. Mol Oncol 16:219-249. |
| 1863 | Tas ML et.al. (2022). Refractory Stage M Ganglioneuroblastoma With Bone Metastases and a Favorable, Chronic Course of Disease: Description of a Patient Cohort. J Pediatr Hematol Oncol 44:e5-e13. |
| 1862 | Jacobs SM et.al. (2022). CXCR4 expression in glioblastoma tissue and the potential for PET imaging and treatment with [(68)Ga]Ga-Pentixafor /[(177)Lu]Lu-Pentixather. Eur J Nucl Med Mol Imaging 49:481-491. |
| 1861 | Jager N et.al. (2022). Bioinformatics workflows for clinical applications in precision oncology. Semin Cancer Biol 84:103-112. |
| 1860 | Buoso E et.al. (2022). Ribosomes as a nexus between translation and cancer progression: Focus on ribosomal Receptor for Activated C Kinase 1 (RACK1) in breast cancer. Br J Pharmacol 179:2813-2828. |
| 2021 (n=353) |
| 1859 | Parks SE et.al. (2021). PAK1 and PAK4 as therapeutic targets for Ewing sarcoma: a commentary. J Cancer Biol 2:94-97. |
| 1858 | Jin F et.al. (2021). Targeting epigenetic modifiers to reprogramme macrophages in non-resolving inflammation-driven atherosclerosis. Eur Heart J Open 1:oeab022. |
| 1857 | Tattersall L et.al. (2021). The P2RX7B splice variant modulates osteosarcoma cell behaviour and metastatic properties. J Bone Oncol 31:100398. |
| 1856 | Tu M et.al. (2021). TNF-alpha-producing macrophages determine subtype identity and prognosis via AP1 enhancer reprogramming in pancreatic cancer. Nat Cancer 2:1185-1203. |
| 1855 | Gartlgruber M et.al. (2021). Super enhancers define regulatory subtypes and cell identity in neuroblastoma. Nat Cancer 2:114-128. |
| 1854 | Li J et.al. (2021). Gain of GAS5 reveals worse prognosis in kidney renal clear cell carcinoma and liver hepatocellular carcinoma from the Cancer Genome Atlas dataset. Transl Cancer Res 10:223-232. |
| 1853 | Shen A et.al. (2021). Down-Regulating HAUS6 Suppresses Cell Proliferation by Activating the p53/p21 Pathway in Colorectal Cancer. Front Cell Dev Biol 9:772077. |
| 1852 | Hsieh CH et.al. (2021). BI-2536 Promotes Neuroblastoma Cell Death via Minichromosome Maintenance Complex Components 2 and 10. Pharmaceuticals (Basel) 15:. |
| 1851 | Alexander RP et.al. (2021). Open Problems in Extracellular RNA Data Analysis: Insights From an ERCC Online Workshop. Front Genet 12:778416. |
| 1850 | Hurst CD et.al. (2021). Stage-stratified molecular profiling of non-muscle-invasive bladder cancer enhances biological, clinical, and therapeutic insight. Cell Rep Med 2:100472. |
| 1849 | Li Q et.al. (2021). ZC3H15 Correlates with a Poor Prognosis and Tumor Progression in Melanoma. Biomed Res Int 2021:8305299. |
| 1848 | Jia G et.al. (2021). Decoding the Mechanism of Shen Qi Sha Bai Decoction in Treating Acute Myeloid Leukemia Based on Network Pharmacology and Molecular Docking. Front Cell Dev Biol 9:796757. |
| 1847 | Zhong X et.al. (2021). HMGB3 is Associated With an Unfavorable Prognosis of Neuroblastoma and Promotes Tumor Progression by Mediating TPX2. Front Cell Dev Biol 9:769547. |
| 1846 | Nunes-Xavier CE et.al. (2021). Protein Tyrosine Phosphatases in Neuroblastoma: Emerging Roles as Biomarkers and Therapeutic Targets. Front Cell Dev Biol 9:811297. |
| 1845 | Zhang Y et.al. (2021). Identification and preliminary validation of a four-gene signature to predict metastasis and survival in osteosarcoma. Am J Transl Res 13:12264-12284. |
| 1844 | Choi JH et.al. (2021). The Small-Molecule Wnt Inhibitor ICG-001 Efficiently Inhibits Colorectal Cancer Stemness and Metastasis by Suppressing MEIS1 Expression. Int J Mol Sci 22:. |
| 1843 | Nakkina SP et.al. (2021). Differential Expression of Polyamine Pathways in Human Pancreatic Tumor Progression and Effects of Polyamine Blockade on Tumor Microenvironment. Cancers (Basel) 13:. |
| 1842 | Dong Y et.al. (2021). Insights of RKIP-Derived Suppression of Prostate Cancer. Cancers (Basel) 13:. |
| 1841 | Alencastro Veiga Cruzeiro G et.al. (2021). YAP1 Is a Potential Predictive Molecular Biomarker for Response to SMO Inhibitor in Medulloblastoma Cells. Cancers (Basel) 13:. |
| 1840 | Galinski B et.al. (2021). Therapeutic Targeting of Exportin-1 in Childhood Cancer. Cancers (Basel) 13:. |
| 1839 | Vagapova E et.al. (2021). Selective Inhibition of HDAC Class I Sensitizes Leukemia and Neuroblastoma Cells to Anticancer Drugs. Biomedicines 9:. |
| 1838 | Naro C et.al. (2021). The oncogenic kinase NEK2 regulates an RBFOX2-dependent pro-mesenchymal splicing program in triple-negative breast cancer cells. J Exp Clin Cancer Res 40:397. |
| 1837 | Zhao X et.al. (2021). The ubiquitin hydrolase OTUB1 promotes glioma cell stemness via suppressing ferroptosis through stabilizing SLC7A11 protein. Bioengineered 12:12636-12645. |
| 1836 | Fu Y et.al. (2021). Exploration and Validation of a Novel Inflammatory Response-Associated Gene Signature to Predict Osteosarcoma Prognosis and Immune Infiltration. J Inflamm Res 14:6719-6734. |
| 1835 | DOto A et.al. (2021). KDM6B promotes activation of the oncogenic CDK4/6-pRB-E2F pathway by maintaining enhancer activity in MYCN-amplified neuroblastoma. Nat Commun 12:7204. |
| 1834 | Bleijs M et.al. (2021). EWSR1-WT1 Target Genes and Therapeutic Options Identified in a Novel DSRCT In Vitro Model. Cancers (Basel) 13:. |
| 1833 | Misiak D et.al. (2021). MiRNA Deregulation Distinguishes Anaplastic Thyroid Carcinoma (ATC) and Supports Upregulation of Oncogene Expression. Cancers (Basel) 13:. |
| 1832 | Giralt I et.al. (2021). Dickkopf-1 Inhibition Reactivates Wnt/beta-Catenin Signaling in Rhabdomyosarcoma, Induces Myogenic Markers In Vitro and Impairs Tumor Cell Survival In Vivo. Int J Mol Sci 22:. |
| 1831 | Xu J et.al. (2021). Characterization of the GATA Transcription Factor Family and Exploration of Their Relevance to Immune Infiltration and Tumor Microenvironment in Pancreatic Cancer. Int J Gen Med 14:9083-9101. |
| 1830 | Kinoshita H et.al. (2021). The Thioredoxin-1 Inhibitor, PX-12, Suppresses Local Osteosarcoma Progression. Anticancer Res 41:6013-6021. |
| 1829 | Tsakaneli A et.al. (2021). MYC regulates metabolism through vesicular transfer of glycolytic kinases. Open Biol 11:210276. |
| 1828 | Mieczkowska IK et.al. (2021). Decreased PRC2 activity supports the survival of basal-like breast cancer cells to cytotoxic treatments. Cell Death Dis 12:1118. |
| 1827 | Micheel J et.al. (2021). Advances in Non-Coding RNA Sequencing. Noncoding RNA 7:. |
| 1826 | Masi M et.al. (2021). Molecular Characterization of Membrane Steroid Receptors in Hormone-Sensitive Cancers. Cells 10:. |
| 1825 | Ramachandran S et.al. (2021). Pimavanserin: A Novel Autophagy Modulator for Pancreatic Cancer Treatment. Cancers (Basel) 13:. |
| 1824 | Darwich A et.al. (2021). Paralysis of the cytotoxic granule machinery is a new cancer immune evasion mechanism mediated by chitinase 3-like-1. J Immunother Cancer 9:. |
| 1823 | Ye L et.al. (2021). The mechanisms and therapeutic targets of ferroptosis in cancer. Expert Opin Ther Targets 25:965-986. |
| 1822 | Szydzik J et.al. (2021). ATR inhibition enables complete tumour regression in ALK-driven NB mouse models. Nat Commun 12:6813. |
| 1821 | Zhou Y et.al. (2021). Beta-Lapachone Attenuates BMSC-Mediated Neuroblastoma Malignant Transformation by Inhibiting Gal-3/Gal-3BP/IL6 Axis. Front Pharmacol 12:766909. |
| 1820 | Matas-Rico E et.al. (2021). Autotaxin impedes anti-tumor immunity by suppressing chemotaxis and tumor infiltration of CD8(+) T cells. Cell Rep 37:110013. |
| 1819 | Singh S et.al. (2021). Targeting the spliceosome through RBM39 degradation results in exceptional responses in high-risk neuroblastoma models. Sci Adv 7:eabj5405. |
| 1818 | Costa PAC et.al. (2021). Chemogenetic modulation of sensory neurons reveals their regulating role in melanoma progression. Acta Neuropathol Commun 9:183. |
| 1817 | Yang W et.al. (2021). Presenilin1 inhibits glioblastoma cell invasiveness via promoting Sortilin cleavage. Cell Commun Signal 19:112. |
| 1816 | Missios P et.al. (2021). LIN28B alters ribosomal dynamics to promote metastasis in MYCN-driven malignancy. J Clin Invest 131:. |
| 1815 | Sulejmani O et.al. (2021). Inhibiting Lysine Demethylase 1A Improves L1CAM-Specific CAR T Cell Therapy by Unleashing Antigen-Independent Killing via the FAS-FASL Axis. Cancers (Basel) 13:. |
| 1814 | Morice S et.al. (2021). Involvement of the TGF-beta Signaling Pathway in the Development of YAP-Driven Osteosarcoma Lung Metastasis. Front Oncol 11:765711. |
| 1813 | Zhang M et.al. (2021). DNA-methylation-induced silencing of DIO3OS drives non-small cell lung cancer progression via activating hnRNPK-MYC-CDC25A axis. Mol Ther Oncolytics 23:205-219. |
| 1812 | Kang W et.al. (2021). Identification of an Autophagy-Related Risk Signature Correlates With Immunophenotype and Predicts Immune Checkpoint Blockade Efficacy of Neuroblastoma. Front Cell Dev Biol 9:731380. |
| 1811 | Bibbo F et.al. (2021). Functional Genomics of PRUNE1 in Neurodevelopmental Disorders (NDDs) Tied to Medulloblastoma (MB) and Other Tumors. Front Oncol 11:758146. |
| 1810 | Wang J et.al. (2021). High-Risk HPV16 E6 Activates the cGMP/PKG Pathway Through Glycosyltransferase ST6GAL1 in Cervical Cancer Cells. Front Oncol 11:716246. |
| 1809 | Akter J et.al. (2021). Loss of p53 suppresses replication stress-induced DNA damage in ATRX-deficient neuroblastoma. Oncogenesis 10:73. |
| 1808 | Pu J et.al. (2021). ADORA2A-AS1 Restricts Hepatocellular Carcinoma Progression via Binding HuR and Repressing FSCN1/AKT Axis. Front Oncol 11:754835. |
| 1807 | Liao X et.al. (2021). ARV-825 Demonstrates Antitumor Activity in Gastric Cancer via MYC-Targets and G2M-Checkpoint Signaling Pathways. Front Oncol 11:753119. |
| 1806 | Chen YL et.al. (2021). MI-773, a breaker of the MDM2/p53 axis, exhibits anticancer effects in neuroblastoma via downregulation of INSM1. Oncol Lett 22:838. |
| 1805 | Jimenez Martin O et.al. (2021). MYCN and MAX alterations in Wilms tumor and identification of novel N-MYC interaction partners as biomarker candidates. Cancer Cell Int 21:555. |
| 1804 | Tsang YW et.al. (2021). Integrated Molecular Characterization to Reveal the Association between Kynurenine 3-Monooxygenase Expression and Tumorigenesis in Human Breast Cancers. J Pers Med 11:. |
| 1803 | Conti V et.al. (2021). mTORC1 promotes malignant large cell/anaplastic histology and is a targetable vulnerability in SHH-TP53 mutant medulloblastoma. JCI Insight 6:. |
| 1802 | Carloni S et.al. (2021). Identification of a choroid plexus vascular barrier closing during intestinal inflammation. Science 374:439-448. |
| 1801 | Kim J et.al. (2021). Single-cell RNA sequencing for the identification of early-stage lung cancer biomarkers from circulating blood. NPJ Genom Med 6:87. |
| 1800 | Schmidt O et.al. (2021). Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis. J Exp Clin Cancer Res 40:322. |
| 1799 | Li W et.al. (2021). TRIP4 transcriptionally activates DDIT4 and subsequent mTOR signaling to promote glioma progression. Free Radic Biol Med 177:31-47. |
| 1798 | Chuang HY et.al. (2021). The E3 Ubiquitin Ligase NEDD4-1 Mediates Temozolomide-Resistant Glioblastoma through PTEN Attenuation and Redox Imbalance in Nrf2-HO-1 Axis. Int J Mol Sci 22:. |
| 1797 | Jimenez C et.al. (2021). Neuronal Differentiation-Related Epigenetic Regulator ZRF1 Has Independent Prognostic Value in Neuroblastoma but Is Functionally Dispensable In Vitro. Cancers (Basel) 13:. |
| 1796 | De Wyn J et.al. (2021). MEIS2 Is an Adrenergic Core Regulatory Transcription Factor Involved in Early Initiation of TH-MYCN-Driven Neuroblastoma Formation. Cancers (Basel) 13:. |
| 1795 | Allen TA et.al. (2021). A Zebrafish Model of Metastatic Colonization Pinpoints Cellular Mechanisms of Circulating Tumor Cell Extravasation. Front Oncol 11:641187. |
| 1794 | Zhan F et.al. (2021). RhoA enhances osteosarcoma resistance to MPPa-PDT via the Hippo/YAP signaling pathway. Cell Biosci 11:179. |
| 1793 | Khan MT et.al. (2021). Identification of Gender-Specific Molecular Differences in Glioblastoma (GBM) and Low-Grade Glioma (LGG) by the Analysis of Large Transcriptomic and Epigenomic Datasets. Front Oncol 11:699594. |
| 1792 | Daub JT et.al. (2021). A systematic analysis of genetic interactions and their underlying biology in childhood cancer. Commun Biol 4:1139. |
| 1791 | Tu R et.al. (2021). USP29 coordinates MYC and HIF1alpha stabilization to promote tumor metabolism and progression. Oncogene 40:6417-6429. |
| 1790 | van der Meer JHM et.al. (2021). Epithelial argininosuccinate synthetase is dispensable for intestinal regeneration and tumorigenesis. Cell Death Dis 12:897. |
| 1789 | Kinoshita H et.al. (2021). The Thioredoxin Reductase Inhibitor Auranofin Suppresses Pulmonary Metastasis of Osteosarcoma, But Not Local Progression. Anticancer Res 41:4947-4955. |
| 1788 | Kisling SG et.al. (2021). Implications of prognosis-associated genes in pancreatic tumor metastasis: lessons from global studies in bioinformatics. Cancer Metastasis Rev 40:721-738. |
| 1787 | Harada A et.al. (2021). Localization of KRAS downstream target ARL4C to invasive pseudopods accelerates pancreatic cancer cell invasion. Elife 10:. |
| 1786 | Karachaliou N et.al. (2021). BRCA1 Expression and Outcome in Patients With EGFR-Mutant NSCLC Treated With Gefitinib Alone or in Combination With Olaparib. JTO Clin Res Rep 2:100113. |
| 1785 | Hupfer A et.al. (2021). Matrix stiffness drives stromal autophagy and promotes formation of a protumorigenic niche. Proc Natl Acad Sci U S A 118:. |
| 1784 | Veronez LC et.al. (2021). MSI2 expression in adrenocortical carcinoma: Association with unfavorable prognosis and correlation with steroid and immune-related pathways. J Cell Biochem 122:1925-1935. |
| 1783 | Maklad A et.al. (2021). Calcium Signalling in Medulloblastoma: An In Silico Analysis of the Expression of Calcium Regulating Genes in Patient Samples. Genes (Basel) 12:. |
| 1782 | Bamodu OA et.al. (2021). Concomitant High Apoptosis Inhibitor of Macrophage (AIM) and Low Prostate-Specific Antigen (PSA) Indicates Activated T Cell-Mediated Anticancer Immunity, Enhance Sensitivity to Pembrolizumab, and Elicit Good Prognosis in Prostate Cancer. Biomedicines 9:. |
| 1781 | Lavaud M et.al. (2021). Overexpression of the Ubiquitin Specific Proteases USP43, USP41, USP27x and USP6 in Osteosarcoma Cell Lines: Inhibition of Osteosarcoma Tumor Growth and Lung Metastasis Development by the USP Antagonist PR619. Cells 10:. |
| 1780 | Spek CA et.al. (2021). CEBPD Potentiates the Macrophage Inflammatory Response but CEBPD Knock-Out Macrophages Fail to Identify CEBPD-Dependent Pro-Inflammatory Transcriptional Programs. Cells 10:. |
| 1779 | Spirin P et.al. (2021). Cytotoxic Marine Alkaloid 3,10-Dibromofascaplysin Induces Apoptosis and Synergizes with Cytarabine Resulting in Leukemia Cell Death. Mar Drugs 19:. |
| 1778 | Gkikas D et.al. (2021). Nuclear receptor NR5A2 negatively regulates cell proliferation and tumor growth in nervous system malignancies. Proc Natl Acad Sci U S A 118:. |
| 1777 | Lebedev T et.al. (2021). Growth factor signaling predicts therapy resistance mechanisms and defines neuroblastoma subtypes. Oncogene 40:6258-6272. |
| 1776 | Li X et.al. (2021). ATF3 promotes the serine synthesis pathway and tumor growth under dietary serine restriction. Cell Rep 36:109706. |
| 1775 | Wang J et.al. (2021). Interplay between the EMT transcription factors ZEB1 and ZEB2 regulates hematopoietic stem and progenitor cell differentiation and hematopoietic lineage fidelity. PLoS Biol 19:e3001394. |
| 1774 | Magne N et.al. (2021). PAK3 is a key signature gene of the glioma proneural subtype and affects its proliferation, differentiation and growth. Cell Oncol (Dordr) 44:1257-1271. |
| 1773 | Kim JH et.al. (2021). SON drives oncogenic RNA splicing in glioblastoma by regulating PTBP1/PTBP2 switching and RBFOX2 activity. Nat Commun 12:5551. |
| 1772 | Deng MY et.al. (2021). Radiation-induced gliomas represent H3-/IDH-wild type pediatric gliomas with recurrent PDGFRA amplification and loss of CDKN2A/B. Nat Commun 12:5530. |
| 1771 | Xu YQ et.al. (2021). A Novel Microfluidic Chip for Fast, Sensitive Quantification of Plasma Extracellular Vesicles as Biomarkers in Patients With Osteosarcoma. Front Oncol 11:709255. |
| 1770 | Park SY et.al. (2021). Aberrant activation of the CD45-Wnt signaling axis promotes stemness and therapy resistance in colorectal cancer cells. Theranostics 11:8755-8770. |
| 1769 | Di Giulio S et.al. (2021). A combination of PARP and CHK1 inhibitors efficiently antagonizes MYCN-driven tumors. Oncogene 40:6143-6152. |
| 1768 | Muller M et.al. (2021). Combining APR-246 and HDAC-Inhibitors: A Novel Targeted Treatment Option for Neuroblastoma. Cancers (Basel) 13:. |
| 1767 | Langenberg KPS et.al. (2021). The Landscape of Pediatric Precision Oncology: Program Design, Actionable Alterations, and Clinical Trial Development. Cancers (Basel) 13:. |
| 1766 | Martinez-Sanz P et.al. (2021). CD47-SIRPalpha Checkpoint Inhibition Enhances Neutrophil-Mediated Killing of Dinutuximab-Opsonized Neuroblastoma Cells. Cancers (Basel) 13:. |
| 1765 | Roig-Carles D et.al. (2021). The Long Non-Coding RNA H19 Drives the Proliferation of Diffuse Intrinsic Pontine Glioma with H3K27 Mutation. Int J Mol Sci 22:. |
| 1764 | Bedoya-Reina OC et.al. (2021). Single-nuclei transcriptomes from human adrenal gland reveal distinct cellular identities of low and high-risk neuroblastoma tumors. Nat Commun 12:5309. |
| 1763 | Moriconi C et.al. (2021). Caveolin-1, a Key Mediator Across Multiple Pathways in Glioblastoma and an Independent Negative Biomarker of Patient Survival. Front Oncol 11:701933. |
| 1762 | Belpaire M et.al. (2021). HOXA1 Is an Antagonist of ERalpha in Breast Cancer. Front Oncol 11:609521. |
| 1761 | Feng H et.al. (2021). FOXK2 transcriptionally activating VEGFA induces apatinib resistance in anaplastic thyroid cancer through VEGFA/VEGFR1 pathway. Oncogene 40:6115-6129. |
| 1760 | Zhang Y et.al. (2021). Hypermethylation and Downregulation of UTP6 Are Associated With Stemness Properties, Chemoradiotherapy Resistance, and Prognosis in Rectal Cancer: A Co-expression Network Analysis. Front Cell Dev Biol 9:607782. |
| 1759 | van den Boogaard ML et.al. (2021). Defects in 8-oxo-guanine repair pathway cause high frequency of C > A substitutions in neuroblastoma. Proc Natl Acad Sci U S A 118:. |
| 1758 | Peng G et.al. (2021). LINC00152 acts as a potential marker in gliomas and promotes tumor proliferation and invasion through the LINC00152/miR-107/RAB10 axis. J Neurooncol 154:285-299. |
| 1757 | Pan LJ et.al. (2021). Exportin-T: A Novel Prognostic Predictor and Potential Therapeutic Target for Neuroblastoma. Technol Cancer Res Treat 20:15330338211039132. |
| 1756 | Yu Y et.al. (2021). Therapeutic targeting of both dihydroorotate dehydrogenase and nucleoside transport in MYCN-amplified neuroblastoma. Cell Death Dis 12:821. |
| 1755 | Vivarelli S et.al. (2021). YY1 Silencing Induces 5-Fluorouracil-Resistance and BCL2L15 Downregulation in Colorectal Cancer Cells: Diagnostic and Prognostic Relevance. Int J Mol Sci 22:. |
| 1754 | Aykul S et.al. (2021). Smad2/3 Activation Regulates Smad1/5/8 Signaling via a Negative Feedback Loop to Inhibit 3T3-L1 Adipogenesis. Int J Mol Sci 22:. |
| 1753 | Seok J et.al. (2021). Multi-Omics Analysis of SOX4, SOX11, and SOX12 Expression and the Associated Pathways in Human Cancers. J Pers Med 11:. |
| 1752 | Duitman J et.al. (2021). Non-Tumor CCAAT/Enhancer-Binding Protein Delta Potentiates Tumor Cell Extravasation and Pancreatic Cancer Metastasis Formation. Biomolecules 11:. |
| 1751 | Paumann-Page M et.al. (2021). Peroxidasin protein expression and enzymatic activity in metastatic melanoma cell lines are associated with invasive potential. Redox Biol 46:102090. |
| 1750 | Romiani A et.al. (2021). Neuroblastoma xenograft models demonstrate the therapeutic potential of (177)Lu-octreotate. BMC Cancer 21:950. |
| 1749 | Sales-Gil R et.al. (2021). Non-redundant functions of H2A.Z.1 and H2A.Z.2 in chromosome segregation and cell cycle progression. EMBO Rep 22:e52061. |
| 1748 | Alhalabi KT et.al. (2021). PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum. Acta Neuropathol 142:841-857. |
| 1747 | Jin TY et.al. (2021). LEP as a potential biomarker in prognosis of breast cancer: Systemic review and meta analyses (PRISMA). Medicine (Baltimore) 100:e26896. |
| 1746 | Di Franco S et.al. (2021). Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery. Nat Commun 12:5006. |
| 1745 | Smit WL et.al. (2021). Translation initiation factor eIF2Bepsilon promotes Wnt-mediated clonogenicity and global translation in intestinal epithelial cells. Stem Cell Res 55:102499. |
| 1744 | Gong C et.al. (2021). Over-expression of vitronectin correlates with impaired survival in gastric cancers. Medicine (Baltimore) 100:e26766. |
| 1743 | Li M et.al. (2021). Fat1 suppresses the tumor-initiating ability of nonsmall cell lung cancer cells by promoting Yes-associated protein 1 nuclear-cytoplasmic translocation. Environ Toxicol 36:2333-2341. |
| 1742 | Mori Y et.al. (2021). Deep learning-based gene selection in comprehensive gene analysis in pancreatic cancer. Sci Rep 11:16521. |
| 1741 | Yang G et.al. (2021). NDRG1 enhances the sensitivity of cetuximab by modulating EGFR trafficking in colorectal cancer. Oncogene 40:5993-6006. |
| 1740 | Shen A et.al. (2021). Targeting NUFIP1 Suppresses Growth and Induces Senescence of Colorectal Cancer Cells. Front Oncol 11:681425. |
| 1739 | Poli E et.al. (2021). Autoantibody profiling of alveolar rhabdomyosarcoma patients unveils tumor-associated antigens with diagnostic and prognostic significance. Oncoimmunology 10:1954765. |
| 1738 | Jimenez-Garcia MP et.al. (2021). Empty spiracles homeobox genes EMX1 and EMX2 regulate WNT pathway activation in sarcomagenesis. J Exp Clin Cancer Res 40:247. |
| 1737 | Meyer S et.al. (2021). Distinct Molecular Mechanisms of Altered HLA Class II Expression in Malignant Melanoma. Cancers (Basel) 13:. |
| 1736 | Rea J et.al. (2021). Identification and Functional Characterization of Novel MYC-Regulated Long Noncoding RNAs in Group 3 Medulloblastoma. Cancers (Basel) 13:. |
| 1735 | Bai X et.al. (2021). Kruppel-like factor 9 upregulates E-cadherin transcription and represses breast cancer invasion and metastasis. Am J Cancer Res 11:3660-3673. |
| 1734 | Li M et.al. (2021). TRAIP modulates the IGFBP3/AKT pathway to enhance the invasion and proliferation of osteosarcoma by promoting KANK1 degradation. Cell Death Dis 12:767. |
| 1733 | Xiong F et.al. (2021). Plastin-3 is a diagnostic and prognostic marker for pancreatic adenocarcinoma and distinguishes from diffuse large B-cell lymphoma. Cancer Cell Int 21:411. |
| 1732 | Raman S et.al. (2021). A GPC2 antibody-drug conjugate is efficacious against neuroblastoma and small-cell lung cancer via binding a conformational epitope. Cell Rep Med 2:100344. |
| 1731 | Suresh R et.al. (2021). Expression of cell type incongruent alpha-cardiac actin 1 subunit in medulloblastoma reveals a novel mechanism for cancer cell survival and control of migration. Neurooncol Adv 3:vdab064. |
| 1730 | Feng C et.al. (2021). A Deep-Learning Model With the Attention Mechanism Could Rigorously Predict Survivals in Neuroblastoma. Front Oncol 11:653863. |
| 1729 | Medeiros M et.al. (2021). The multifaceted NF-kB: are there still prospects of its inhibition for clinical intervention in pediatric central nervous system tumors? Cell Mol Life Sci 78:6161-6200. |
| 1728 | Rugolo F et.al. (2021). The expression of ELOVL4, repressed by MYCN, defines neuroblastoma patients with good outcome. Oncogene 40:5741-5751. |
| 1727 | Nowak JK et.al. (2021). Expression profiling of ileal mucosa in asthma reveals upregulation of innate immunity and genes characteristic of Paneth and goblet cells. Allergy Asthma Clin Immunol 17:82. |
| 1726 | Adolphe C et.al. (2021). SOX9 Defines Distinct Populations of Cells in SHH Medulloblastoma but Is Not Required for Math1-Driven Tumor Formation. Mol Cancer Res 19:1831-1839. |
| 1725 | Heisey DAR et.al. (2021). Pharmaceutical Interference of the EWS-FLI1-driven Transcriptome By Cotargeting H3K27ac and RNA Polymerase Activity in Ewing Sarcoma. Mol Cancer Ther 20:1868-1879. |
| 1724 | Chao CH et.al. (2021). Mutant p53 Attenuates Oxidative Phosphorylation and Facilitates Cancer Stemness through Downregulating miR-200c-PCK2 Axis in Basal-Like Breast Cancer. Mol Cancer Res 19:1900-1916. |
| 1723 | Miyamoto R et.al. (2021). HOXA9 promotes MYC-mediated leukemogenesis by maintaining gene expression for multiple anti-apoptotic pathways. Elife 10:. |
| 1722 | Nazio F et.al. (2021). Targeting cancer stem cells in medulloblastoma by inhibiting AMBRA1 dual function in autophagy and STAT3 signalling. Acta Neuropathol 142:537-564. |
| 1721 | Klonou A et.al. (2021). Histone Mark Profiling in Pediatric Astrocytomas Reveals Prognostic Significance of H3K9 Trimethylation and Histone Methyltransferase SUV39H1. Neurotherapeutics 18:2073-2090. |
| 1720 | Mulvey B et.al. (2021). Transcriptional-regulatory convergence across functional MDD risk variants identified by massively parallel reporter assays. Transl Psychiatry 11:403. |
| 1719 | Lak NSM et.al. (2021). Improving Risk Stratification for Pediatric Patients with Rhabdomyosarcoma by Molecular Detection of Disseminated Disease. Clin Cancer Res 27:5576-5585. |
| 1718 | Slapak EJ et.al. (2021). ADAM9-Responsive Mesoporous Silica Nanoparticles for Targeted Drug Delivery in Pancreatic Cancer. Cancers (Basel) 13:. |
| 1717 | Shi D et.al. (2021). Development of a Novel Immune Infiltration-Related ceRNA Network and Prognostic Model for Sarcoma. Front Cell Dev Biol 9:652300. |
| 1716 | Uckun E et.al. (2021). BioID-Screening Identifies PEAK1 and SHP2 as Components of the ALK Proximitome in Neuroblastoma Cells. J Mol Biol 433:167158. |
| 1715 | Yankaskas CL et.al. (2021). The fluid shear stress sensor TRPM7 regulates tumor cell intravasation. Sci Adv 7:. |
| 1714 | Anderson NM et.al. (2021). Metabolic Enzyme DLST Promotes Tumor Aggression and Reveals a Vulnerability to OXPHOS Inhibition in High-Risk Neuroblastoma. Cancer Res 81:4417-4430. |
| 1713 | Gu Y et.al. (2021). MCM6 indicates adverse tumor features and poor outcomes and promotes G1/S cell cycle progression in neuroblastoma. BMC Cancer 21:784. |
| 1712 | Eleveld TF et.al. (2021). Engineering large-scale chromosomal deletions by CRISPR-Cas9. Nucleic Acids Res 49:12007-12016. |
| 1711 | Villasante A et.al. (2021). Horizontal transfer of the stemness-related markers EZH2 and GLI1 by neuroblastoma-derived extracellular vesicles in stromal cells. Transl Res 237:82-97. |
| 1710 | Wang Q et.al. (2021). DNMT1-mediated methylation of BEX1 regulates stemness and tumorigenicity in liver cancer. J Hepatol 75:1142-1153. |
| 1709 | Dang TT et.al. (2021). Loss of CENP-I Impairs Homologous Recombination and Sensitizes Cells to PARP1 Inhibition. Cancers (Basel) 13:. |
| 1708 | Uva P et.al. (2021). Connectivity Map Analysis Indicates PI3K/Akt/mTOR Inhibitors as Potential Anti-Hypoxia Drugs in Neuroblastoma. Cancers (Basel) 13:. |
| 1707 | Martirosian V et.al. (2021). Medulloblastoma uses GABA transaminase to survive in the cerebrospinal fluid microenvironment and promote leptomeningeal dissemination. Cell Rep 35:109302. |
| 1706 | Novita Sari I et.al. (2021). Metabolism and function of polyamines in cancer progression. Cancer Lett 519:91-104. |
| 1705 | Frenkel N et.al. (2021). Long-Lived Human Lymphatic Endothelial Cells to Study Lymphatic Biology and Lymphatic Vessel/Tumor Coculture in a 3D Microfluidic Model. ACS Biomater Sci Eng 7:3030-3042. |
| 1704 | Burgess D et.al. (2021). A comprehensive view of human RNAs. Nat Rev Genet 22:481. |
| 1703 | Moreno-Smith M et.al. (2021). Restoration of the molecular clock is tumor suppressive in neuroblastoma. Nat Commun 12:4006. |
| 1702 | Burns JE et.al. (2021). The Warburg effect as a therapeutic target for bladder cancers and intratumoral heterogeneity in associated molecular targets. Cancer Sci 112:3822-3834. |
| 1701 | Kapoor A et.al. (2021). MUCIN 1 in Prostate Cancer. :. |
| 1700 | Chen Q et.al. (2021). ADHFE1 is a correlative factor of patient survival in cancer. Open Life Sci 16:571-582. |
| 1699 | Ivanova E et.al. (2021). DYRK3 contributes to differentiation and hypoxic control in neuroblastoma. Biochem Biophys Res Commun 567:215-221. |
| 1698 | Ballabio C et.al. (2021). Notch1 switches progenitor competence in inducing medulloblastoma. Sci Adv 7:. |
| 1697 | Tang Y et.al. (2021). Upregulation of HOXC9 generates interferon-gamma resistance in gastric cancer by inhibiting the DAPK1/RIG1/STAT1 axis. Cancer Sci 112:3455-3468. |
| 1696 | Genovesi LA et.al. (2021). Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma. Genome Med 13:103. |
| 1695 | Laine A et.al. (2021). CIP2A Interacts with TopBP1 and Drives Basal-Like Breast Cancer Tumorigenesis. Cancer Res 81:4319-4331. |
| 1694 | Luu K et.al. (2021). B7-H7 Is Inducible on T Cells to Regulate Their Immune Response and Serves as a Marker for Exhaustion. Front Immunol 12:682627. |
| 1693 | Lorenzi L et.al. (2021). The RNA Atlas expands the catalog of human non-coding RNAs. Nat Biotechnol 39:1453-1465. |
| 1692 | Li M et.al. (2021). ISL1 promoted tumorigenesis and EMT via Aurora kinase A-induced activation of PI3K/AKT signaling pathway in neuroblastoma. Cell Death Dis 12:620. |
| 1691 | Minderman M et.al. (2021). Immune evasion in primary testicular and central nervous system lymphomas: HLA loss rather than 9p24.1/PD-L1/PD-L2 alterations. Blood 138:1194-1197. |
| 1690 | Wang WH et.al. (2021). Proteomic Analysis Reveals That Metformin Suppresses PSMD2, STIP1, and CAP1 for Preventing Gastric Cancer AGS Cell Proliferation and Migration. ACS Omega 6:14208-14219. |
| 1689 | Mazzocchi M et.al. (2021). LMK235, a small molecule inhibitor of HDAC4/5, protects dopaminergic neurons against neurotoxin Mol Cell Neurosci 115:103642. |
| 1688 | Clemente-Olivo MP et.al. (2021). Four-and-a-half LIM domain protein 2 (FHL2) deficiency protects mice from diet-induced obesity and high FHL2 expression marks human obesity. Metabolism 121:154815. |
| 1687 | Radke K et.al. (2021). Anti-tumor effects of rigosertib in high-risk neuroblastoma. Transl Oncol 14:101149. |
| 1686 | Ramesh P et.al. (2021). BCL-XL is crucial for progression through the adenoma-to-carcinoma sequence of colorectal cancer. Cell Death Differ 28:3282-3296. |
| 1685 | Kimura H et.al. (2021). The Dickkopf1 and FOXM1 positive feedback loop promotes tumor growth in pancreatic and esophageal cancers. Oncogene 40:4486-4502. |
| 1684 | Mazor G et.al. (2021). TP73-AS1 is induced by YY1 during TMZ treatment and highly expressed in the aging brain. Aging (Albany NY) 13:14843-14861. |
| 1683 | Schmitt-Hoffner F et.al. (2021). FOXR2 Stabilizes MYCN Protein and Identifies Non-MYCN-Amplified Neuroblastoma Patients With Unfavorable Outcome. J Clin Oncol 39:3217-3228. |
| 1682 | Vassal G et.al. (2021). International Consensus on Minimum Preclinical Testing Requirements for the Development of Innovative Therapies For Children and Adolescents with Cancer. Mol Cancer Ther 20:1462-1468. |
| 1681 | Tirado-Gonzalez I et.al. (2021). AXL Inhibition in Macrophages Stimulates Host-versus-Leukemia Immunity and Eradicates Naive and Treatment-Resistant Leukemia. Cancer Discov 11:2924-2943. |
| 1680 | Garcia TM et.al. (2021). Early Life Antibiotics Influence In Vivo and In Vitro Mouse Intestinal Epithelium Maturation and Functioning. Cell Mol Gastroenterol Hepatol 12:943-981. |
| 1679 | Ni H et.al. (2021). MiR-375 reduces the stemness of gastric cancer cells through triggering ferroptosis. Stem Cell Res Ther 12:325. |
| 1678 | van Neerven SM et.al. (2021). Apc-mutant cells act as supercompetitors in intestinal tumour initiation. Nature 594:436-441. |
| 1677 | Vriend J et.al. (2021). Ubiquitin Proteasome Pathway Transcriptome in Epithelial Ovarian Cancer. Cancers (Basel) 13:. |
| 1676 | Pelosi A et.al. (2021). Pediatric Tumors-Mediated Inhibitory Effect on NK Cells: The Case of Neuroblastoma and Wilms Tumors. Cancers (Basel) 13:. |
| 1675 | Fairchild CK Jr et.al. (2021). Unmasking BCL-2 Addiction in Synovial Sarcoma by Overcoming Low NOXA. Cancers (Basel) 13:. |
| 1674 | Cantalupo S et.al. (2021). Regulatory Noncoding and Predicted Pathogenic Coding Variants of CCR5 Predispose to Severe COVID-19. Int J Mol Sci 22:. |
| 1673 | Bley N et.al. (2021). Musashi-1-A Stemness RBP for Cancer Therapy? Biology (Basel) 10:. |
| 1672 | Mehibel M et.al. (2021). Eliminating hypoxic tumor cells improves response to PARP inhibitors in homologous recombination-deficient cancer models. J Clin Invest 131:. |
| 1671 | Tu Z et.al. (2021). The LINC01119-SOCS5 axis as a critical theranostic in triple-negative breast cancer. NPJ Breast Cancer 7:69. |
| 1670 | Zhuang Q et.al. (2021). Prognostic and immunological roles of Fc fragment of IgG binding protein in colorectal cancer. Oncol Lett 22:526. |
| 1669 | Tabassum A et.al. (2021). Transporter associated with antigen processing 1 (TAP1) expression and prognostic analysis in breast, lung, liver, and ovarian cancer. J Mol Med (Berl) 99:1293-1309. |
| 1668 | Lotsch D et.al. (2021). Targeting fibroblast growth factor receptors to combat aggressive ependymoma. Acta Neuropathol 142:339-360. |
| 1667 | Sacchetti A et.al. (2021). Phenotypic plasticity underlies local invasion and distant metastasis in colon cancer. Elife 10:. |
| 1666 | Zong B et.al. (2021). HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage tolerance. Oncol Rep 46:. |
| 1665 | Misiak D et.al. (2021). The MicroRNA Landscape of MYCN-Amplified Neuroblastoma. Front Oncol 11:647737. |
| 1664 | Tan X et.al. (2021). Downregulation of fibronectin 1 attenuates ATRA-induced inhibition of cell migration and invasion in neuroblastoma cells. Mol Cell Biochem 476:3601-3612. |
| 1663 | Gutierrez LM et.al. (2021). Up-regulation of pro-angiogenic molecules and events does not relate with an angiogenic switch in metastatic osteosarcoma cells but to cell survival features. Apoptosis 26:447-459. |
| 1662 | Seier JA et.al. (2021). Druggable epigenetic suppression of interferon-induced chemokine expression linked to MYCN amplification in neuroblastoma. J Immunother Cancer 9:. |
| 1661 | Sun L et.al. (2021). eIF6 promotes the malignant progression of human hepatocellular carcinoma via the mTOR signaling pathway. J Transl Med 19:216. |
| 1660 | Susmi TF et.al. (2021). Prognostic and clinicopathological insights of phosphodiesterase 9A gene as novel biomarker in human colorectal cancer. BMC Cancer 21:577. |
| 1659 | Lu Y et.al. (2021). MYCN mediates TFRC-dependent ferroptosis and reveals vulnerabilities in neuroblastoma. Cell Death Dis 12:511. |
| 1658 | Bae WY et.al. (2021). beta-arrestin 2 stimulates degradation of HIF-1alpha and modulates tumor progression of glioblastoma. Cell Death Differ 28:3092-3104. |
| 1657 | Prokakis E et.al. (2021). USP22 promotes HER2-driven mammary carcinoma aggressiveness by suppressing the unfolded protein response. Oncogene 40:4004-4018. |
| 1656 | Schanzer A et.al. (2021). Mutations in HID1 Cause Syndromic Infantile Encephalopathy and Hypopituitarism. Ann Neurol 90:143-158. |
| 1655 | Hu Y et.al. (2021). Arginine methyltransferase PRMT3 promote tumorigenesis through regulating c-MYC stabilization in colorectal cancer. Gene 791:145718. |
| 1654 | Kempers L et.al. (2021). The endosomal RIN2/Rab5C machinery prevents VEGFR2 degradation to control gene expression and tip cell identity during angiogenesis. Angiogenesis 24:695-714. |
| 1653 | Galinski B et.al. (2021). XPO1 inhibition with selinexor synergizes with proteasome inhibition in neuroblastoma by targeting nuclear export of IkB. Transl Oncol 14:101114. |
| 1652 | Krstic A et.al. (2021). A Chemo-Genomic Approach Identifies Diverse Epigenetic Therapeutic Vulnerabilities in MYCN-Amplified Neuroblastoma. Front Cell Dev Biol 9:612518. |
| 1651 | Tang XX et.al. (2021). Clinical Relevance of CD4 Cytotoxic T Cells in High-Risk Neuroblastoma. Front Immunol 12:650427. |
| 1650 | Arnone CM et.al. (2021). Oncolytic adenovirus and gene therapy with EphA2-BiTE for the treatment of pediatric high-grade gliomas. J Immunother Cancer 9:. |
| 1649 | Tiago T et.al. (2021). Small heat-shock protein HSPB3 promotes myogenesis by regulating the lamin B receptor. Cell Death Dis 12:452. |
| 1648 | Yang M et.al. (2021). Identification of a novel glycolysis-related gene signature for predicting the prognosis of osteosarcoma patients. Aging (Albany NY) 13:12896-12918. |
| 1647 | Feng Y et.al. (2021). Predictive value of RAD51 on the survival and drug responsiveness of ovarian cancer. Cancer Cell Int 21:249. |
| 1646 | Song H et.al. (2021). APE1 and SSRP1 is overexpressed in muscle invasive bladder cancer and associated with poor survival. Heliyon 7:e06756. |
| 1645 | Choueiry F et.al. (2021). Integration of Metabolomics and Gene Expression Profiling Elucidates IL4I1 as Modulator of Ibrutinib Resistance in ABC-Diffuse Large B Cell Lymphoma. Cancers (Basel) 13:. |
| 1644 | Hulstaert E et.al. (2021). Messenger RNA capture sequencing of extracellular RNA from human biofluids using a comprehensive set of spike-in controls. STAR Protoc 2:100475. |
| 1643 | Zhang Z et.al. (2021). Fzd7/Wnt7b signaling contributes to stemness and chemoresistance in pancreatic cancer. Cancer Med 10:3332-3345. |
| 1642 | Tekin C et.al. (2021). Protease-activated receptor 1 drives and maintains ductal cell fates in the premalignant pancreas and ductal adenocarcinoma. Mol Oncol 15:3091-3108. |
| 1641 | Yang R et.al. (2021). POU2F2 regulates glycolytic reprogramming and glioblastoma progression via PDPK1-dependent activation of PI3K/AKT/mTOR pathway. Cell Death Dis 12:433. |
| 1640 | Korholz K et.al. (2021). Broad-Spectrum HDAC Inhibitors Promote Autophagy through FOXO Transcription Factors in Neuroblastoma. Cells 10:. |
| 1639 | Koeniger A et.al. (2021). Activation of Cilia-Independent Hedgehog/GLI1 Signaling as a Novel Concept for Neuroblastoma Therapy. Cancers (Basel) 13:. |
| 1638 | Nowak JK et.al. (2021). Ileal Lactase Expression Associates with Lactase Persistence Genotypes. Nutrients 13:. |
| 1637 | Gamble LD et.al. (2021). A G316A Polymorphism in the Ornithine Decarboxylase Gene Promoter Modulates MYCN-Driven Childhood Neuroblastoma. Cancers (Basel) 13:. |
| 1636 | Shin HJ et.al. (2021). Multiomic Analysis of Cereblon Expression and Its Prognostic Value in Kidney Renal Clear Cell Carcinoma, Lung Adenocarcinoma, and Skin Cutaneous Melanoma. J Pers Med 11:. |
| 1635 | Zhang Q et.al. (2021). Novel role of CAP1 in regulation RNA polymerase II-mediated transcription elongation depends on its actin-depolymerization activity in nucleoplasm. Oncogene 40:3492-3509. |
| 1634 | Portillo M et.al. (2021). SIRT6-CBP-dependent nuclear Tau accumulation and its role in protein synthesis. Cell Rep 35:109035. |
| 1633 | Nunez-Carpintero I et.al. (2021). The multilayer community structure of medulloblastoma. iScience 24:102365. |
| 1632 | Malone CF et.al. (2021). Selective Modulation of a Pan-Essential Protein as a Therapeutic Strategy in Cancer. Cancer Discov 11:2282-2299. |
| 1631 | Xiang S et.al. (2021). Targeting Cul3-scaffold E3 ligase complex via KLHL substrate adaptors for cancer therapy. Pharmacol Res 169:105616. |
| 1630 | Lee IN et.al. (2021). Elevated XRCC5 expression level can promote temozolomide resistance and predict poor prognosis in glioblastoma. Oncol Lett 21:443. |
| 1629 | Vernooij L et.al. (2021). High-Throughput Screening Identifies Idasanutlin as a Resensitizing Drug for Venetoclax-Resistant Neuroblastoma Cells. Mol Cancer Ther 20:1161-1172. |
| 1628 | Wood L et.al. (2021). Combining inhibitors of Brd4 and cyclin-dependent kinase can decrease tumor growth in neuroblastoma with MYCN amplification. J Pediatr Surg 56:1199-1202. |
| 1627 | Sun Q et.al. (2021). FOXD1 promotes dedifferentiation and targeted therapy resistance in melanoma by regulating the expression of connective tissue growth factor. Int J Cancer 149:657-674. |
| 1626 | Chen C et.al. (2021). miR-135a Reduces Osteosarcoma Pulmonary Metastasis by Targeting Both BMI1 and KLF4. Front Oncol 11:620295. |
| 1625 | Czerwinska P et.al. (2021). The Association between TIF1 Family Members and Cancer Stemness in Solid Tumors. Cancers (Basel) 13:. |
| 1624 | Ranjan N et.al. (2021). The Tumor Suppressor MTUS1/ATIP1 Modulates Tumor Promotion in Glioma: Association with Epigenetics and DNA Repair. Cancers (Basel) 13:. |
| 1623 | Megiorni F et.al. (2021). OTX015 Epi-Drug Exerts Antitumor Effects in Ovarian Cancer Cells by Blocking GNL3-Mediated Radioresistance Mechanisms: Cellular, Molecular and Computational Evidence. Cancers (Basel) 13:. |
| 1622 | Jasinski-Bergner S et.al. (2021). Relevance of 2-O-Methylation and Pseudouridylation for the Malignant Melanoma. Cancers (Basel) 13:. |
| 1621 | MacDonald TJ et.al. (2021). Liposome-Imipramine Blue Inhibits Sonic Hedgehog Medulloblastoma In Vivo. Cancers (Basel) 13:. |
| 1620 | Subbarayan K et.al. (2021). Immune Interaction Map of Human SARS-CoV-2 Target Genes: Implications for Therapeutic Avenues. Front Immunol 12:597399. |
| 1619 | Dondero A et.al. (2021). Multiparametric flow cytometry highlights B7-H3 as a novel diagnostic/therapeutic target in GD2neg/low neuroblastoma variants. J Immunother Cancer 9:. |
| 1618 | Yao B et.al. (2021). Hypoxia-induced cofilin 1 promotes hepatocellular carcinoma progression by regulating the PLD1/AKT pathway. Clin Transl Med 11:e366. |
| 1617 | Subbarayan K et.al. (2021). Identification of a novel miR-21-3p/TGF-beta signaling-driven immune escape via the MHC class I/biglycan axis in tumor cells. Clin Transl Med 11:e306. |
| 1616 | Ye M et.al. (2021). USP7 promotes hepatoblastoma progression through activation of PI3K/AKT signaling pathway. Cancer Biomark 31:107-117. |
| 1615 | Wirsik NM et.al. (2021). TGF-beta activates pericytes via induction of the epithelial-to-mesenchymal transition protein SLUG in glioblastoma. Neuropathol Appl Neurobiol 47:768-780. |
| 1614 | Cao H et.al. (2021). BMPR2 expression level is correlated with low immune infiltration and predicts metastasis and poor survival in osteosarcoma. Oncol Lett 21:391. |
| 1613 | Zhong X et.al. (2021). Prognostic Signature of Immune Genes and Immune-Related LncRNAs in Neuroblastoma: A Study Based on GEO and TARGET Datasets. Front Oncol 11:631546. |
| 1612 | Nagy Z et.al. (2021). An ALYREF-MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stability. Nat Commun 12:1881. |
| 1611 | Hupfer A et.al. (2021). The mammalian Hedgehog pathway is modulated by ANP32 proteins. Biochem Biophys Res Commun 553:78-84. |
| 1610 | Bhatt AB et.al. (2021). Diverse and converging roles of ERK1/2 and ERK5 pathways on mesenchymal to epithelial transition in breast cancer. Transl Oncol 14:101046. |
| 1609 | Su F et.al. (2021). Progression of prostate carcinoma is promoted by adipose stromal cell-secreted CXCL12 signaling in prostate epithelium. NPJ Precis Oncol 5:26. |
| 1608 | Caforio M et.al. (2021). GD2 redirected CAR T and activated NK-cell-mediated secretion of IFNgamma overcomes MYCN-dependent IDO1 inhibition, contributing to neuroblastoma cell immune escape. J Immunother Cancer 9:. |
| 1607 | Satriyo PB et.al. (2021). 4-Acetylantroquinonol B induced DNA damage response signaling and apoptosis via suppressing CDK2/CDK4 expression in triple negative breast cancer cells. Toxicol Appl Pharmacol 422:115493. |
| 1606 | Yu J et.al. (2021). Histone lactylation drives oncogenesis by facilitating m(6)A reader protein YTHDF2 expression in ocular melanoma. Genome Biol 22:85. |
| 1605 | Keane S et.al. (2021). The loss of DLG2 isoform 7/8, but not isoform 2, is critical in advanced staged neuroblastoma. Cancer Cell Int 21:170. |
| 1604 | Villanueva AA et.al. (2021). The Netrin-1-Neogenin-1 signaling axis controls neuroblastoma cell migration via integrin-beta1 and focal adhesion kinase activation. Cell Adh Migr 15:58-73. |
| 1603 | Wang C et.al. (2021). Autophagy mediated lipid catabolism facilitates glioma progression to overcome bioenergetic crisis. Br J Cancer 124:1711-1723. |
| 1602 | Huang Z et.al. (2021). CDK1 promotes the stemness of lung cancer cells through interacting with Sox2. Clin Transl Oncol 23:1743-1751. |
| 1601 | Rezaei O et.al. (2021). Non-Coding RNAs Participate in the Pathogenesis of Neuroblastoma. Front Oncol 11:617362. |
| 1600 | Weiss T et.al. (2021). Schwann cell plasticity regulates neuroblastic tumor cell differentiation via epidermal growth factor-like protein 8. Nat Commun 12:1624. |
| 1599 | Farkas C et.al. (2021). Characterization of SALL2 Gene Isoforms and Targets Across Cell Types Reveals Highly Conserved Networks. Front Genet 12:613808. |
| 1598 | Bownes LV et.al. (2021). EZH2 inhibition decreases neuroblastoma proliferation and in vivo tumor growth. PLoS One 16:e0246244. |
| 1597 | Buzzetti M et.al. (2021). Pre-therapeutic efficacy of the CDK inhibitor dinaciclib in medulloblastoma cells. Sci Rep 11:5374. |
| 1596 | Ishfaq M et.al. (2021). BTK Inhibition Reverses MDSC-Mediated Immunosuppression and Enhances Response to Anti-PDL1 Therapy in Neuroblastoma. Cancers (Basel) 13:. |
| 1595 | Liao YM et.al. (2021). Low Expression of IL-15 and NKT in Tumor Microenvironment Predicts Poor Outcome of MYCN-Non-Amplified Neuroblastoma. J Pers Med 11:. |
| 1594 | Qi C et.al. (2021). T cell immune regulator 1 is a prognostic marker associated with immune infiltration in glioblastoma multiforme. Oncol Lett 21:252. |
| 1593 | Ruiz-Perez MV et.al. (2021). Inhibition of fatty acid synthesis induces differentiation and reduces tumor burden in childhood neuroblastoma. iScience 24:102128. |
| 1592 | Slomp A et.al. (2021). Phosphatase PP2A enhances MCL-1 protein half-life in multiple myeloma cells. Cell Death Dis 12:229. |
| 1591 | Afanasyeva EA et.al. (2021). Kalirin-RAC controls nucleokinetic migration in ADRN-type neuroblastoma. Life Sci Alliance 4:. |
| 1590 | He J et.al. (2021). MIG-6 is essential for promoting glucose metabolic reprogramming and tumor growth in triple-negative breast cancer. EMBO Rep 22:e50781. |
| 1589 | Huo Z et.al. (2021). AQP1 Is Up-Regulated by Hypoxia and Leads to Increased Cell Water Permeability, Motility, and Migration in Neuroblastoma. Front Cell Dev Biol 9:605272. |
| 1588 | Zhu J et.al. (2021). Prognostic Role of EYA4 in Lower Grade Glioma with IDH1 Mutation and 1p19q Co-Deletion. World Neurosurg 149:e1174-e1179. |
| 1587 | Gao S et.al. (2021). BYSL contributes to tumor growth by cooperating with the mTORC2 complex in gliomas. Cancer Biol Med 18:88-104. |
| 1586 | Hartlieb SA et.al. (2021). Alternative lengthening of telomeres in childhood neuroblastoma from genome to proteome. Nat Commun 12:1269. |
| 1585 | Chen W et.al. (2021). MEF2A-mediated lncRNA HCP5 Inhibits Gastric Cancer Progression via MiR-106b-5p/p21 Axis. Int J Biol Sci 17:623-634. |
| 1584 | Chen J et.al. (2021). Elevated LINC01550 induces the apoptosis and cell cycle arrest of melanoma. Med Oncol 38:32. |
| 1583 | Roper SJ et.al. (2021). 3D spheroid models of paediatric SHH medulloblastoma mimic tumour biology, drug response and metastatic dissemination. Sci Rep 11:4259. |
| 1582 | Dong Z et.al. (2021). GAS7 Deficiency Promotes Metastasis in MYCN-Driven Neuroblastoma. Cancer Res 81:2995-3007. |
| 1581 | Filippova N et.al. (2021). Targeting the HuR Oncogenic Role with a New Class of Cytoplasmic Dimerization Inhibitors. Cancer Res 81:2220-2233. |
| 1580 | Korshunov A et.al. (2021). Integrated molecular analysis of adult sonic hedgehog (SHH)-activated medulloblastomas reveals two clinically relevant tumor subsets with VEGFA as potent prognostic indicator. Neuro Oncol 23:1576-1585. |
| 1579 | Van Damme H et.al. (2021). Therapeutic depletion of CCR8(+) tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy. J Immunother Cancer 9:. |
| 1578 | Mahmood TB et.al. (2021). Evaluation of the susceptibility and fatality of lung cancer patients towards the COVID-19 infection: A systemic approach through analyzing the ACE2, CXCL10 and their co-expressed genes. Curr Res Microb Sci 2:100022. |
| 1577 | Pan X et.al. (2021). ICT1 Promotes Osteosarcoma Cell Proliferation and Inhibits Apoptosis via STAT3/BCL-2 Pathway. Biomed Res Int 2021:8971728. |
| 1576 | Gu Y et.al. (2021). Differential Expression of a Panel of Ten CNTN1-Associated Genes during Prostate Cancer Progression and the Predictive Properties of the Panel Towards Prostate Cancer Relapse. Genes (Basel) 12:. |
| 1575 | Wirsching HG et.al. (2021). Negative allosteric modulators of metabotropic glutamate receptor 3 target the stem-like phenotype of glioblastoma. Mol Ther Oncolytics 20:166-174. |
| 1574 | Waissi W et.al. (2021). Radiosensitizing Pancreatic Cancer with PARP Inhibitor and Gemcitabine: An In Vivo and a Whole-Transcriptome Analysis after Proton or Photon Irradiation. Cancers (Basel) 13:. |
| 1573 | Szemes M et.al. (2021). Transcriptomic Analyses of MYCN-Regulated Genes in Anaplastic Wilms Tumour Cell Lines Reveals Oncogenic Pathways and Potential Therapeutic Vulnerabilities. Cancers (Basel) 13:. |
| 1572 | Wickenhauser C et.al. (2021). Tumor Microenvironment, HLA Class I and APM Expression in HPV-Negative Oral Squamous Cell Carcinoma. Cancers (Basel) 13:. |
| 1571 | Shi Y et.al. (2021). Aberrant splicing in neuroblastoma generates RNA-fusion transcripts and provides vulnerability to spliceosome inhibitors. Nucleic Acids Res 49:2509-2521. |
| 1570 | Xu H et.al. (2021). SMAR1 attenuates the stemness of osteosarcoma cells via through suppressing ABCG2 transcriptional activity. Environ Toxicol 36:1090-1098. |
| 1569 | Xiang T et.al. (2021). The novel ZEB1-upregulated protein PRTG induced by Helicobacter pylori infection promotes gastric carcinogenesis through the cGMP/PKG signaling pathway. Cell Death Dis 12:150. |
| 1568 | van den Ende T et.al. (2021). Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma: A Single-arm Phase II Feasibility Trial (PERFECT). Clin Cancer Res 27:3351-3359. |
| 1567 | Gu Y et.al. (2021). Effective Prediction of Prostate Cancer Recurrence through the IQGAP1 Network. Cancers (Basel) 13:. |
| 1566 | Putra V et.al. (2021). The RNA-helicase DDX21 upregulates CEP55 expression and promotes neuroblastoma. Mol Oncol 15:1162-1179. |
| 1565 | Zhang Y et.al. (2021). CSN6 promotes melanoma proliferation and metastasis by controlling the UBR5-mediated ubiquitination and degradation of CDK9. Cell Death Dis 12:118. |
| 1564 | Floros KV et.al. (2021). MYCN-Amplified Neuroblastoma Is Addicted to Iron and Vulnerable to Inhibition of the System Xc-/Glutathione Axis. Cancer Res 81:1896-1908. |
| 1563 | Berg TJ et.al. (2021). The Irradiated Brain Microenvironment Supports Glioma Stemness and Survival via Astrocyte-Derived Transglutaminase 2. Cancer Res 81:2101-2115. |
| 1562 | Westendorp F et.al. (2021). Epithelium-derived Indian Hedgehog restricts stromal expression of ErbB family members that drive colonic tumor cell proliferation. Oncogene 40:1628-1643. |
| 1561 | Heise T et.al. (2021). RNA-Binding Protein La Mediates TGFbeta-Induced Epithelial to Mesenchymal Transition and Cancer Stem Cell Properties. Cancers (Basel) 13:. |
| 1560 | Burghardt I et.al. (2021). Endoglin and TGF-beta signaling in glioblastoma. Cell Tissue Res 384:613-624. |
| 1559 | Milenova I et.al. (2021). Oncolytic Adenovirus ORCA-010 Activates Proinflammatory Myeloid Cells and Facilitates T Cell Recruitment and Activation by PD-1 Blockade in Melanoma. Hum Gene Ther 32:178-191. |
| 1558 | Shaik S et.al. (2021). REST promotes ETS1-dependent vascular growth in medulloblastoma. Mol Oncol 15:1486-1506. |
| 1557 | Kosti A et.al. (2021). Synergism of Proneurogenic miRNAs Provides a More Effective Strategy to Target Glioma Stem Cells. Cancers (Basel) 13:. |
| 1556 | Thompson EM et.al. (2021). A Review of DUSP26: Structure, Regulation and Relevance in Human Disease. Int J Mol Sci 22:. |
| 1555 | Abid K et.al. (2021). The noradrenergic profile of plasma metanephrine in neuroblastoma patients is reproduced in xenograft mice models and arise from PNMT downregulation. Oncotarget 12:49-60. |
| 1554 | Canzonetta C et.al. (2021). Identification of neuroblastoma cell lines with uncommon TAZ(+)/mesenchymal stromal cell phenotype with strong suppressive activity on natural killer cells. J Immunother Cancer 9:. |
| 1553 | Xu L et.al. (2021). EHMT2 inhibitor BIX-01294 induces endoplasmic reticulum stress mediated apoptosis and autophagy in diffuse large B-cell lymphoma cells. J Cancer 12:1011-1022. |
| 1552 | Ferrucci V et.al. (2021). Prune-1 drives polarization of tumor-associated macrophages (TAMs) within the lung metastatic niche in triple-negative breast cancer. iScience 24:101938. |
| 1551 | Xia Z et.al. (2021). GNA13 regulates BCL2 expression and the sensitivity of GCB-DLBCL cells to BCL2 inhibitors in a palmitoylation-dependent manner. Cell Death Dis 12:54. |
| 1550 | Fang R et.al. (2021). EGFR/SRC/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma. Nat Commun 12:177. |
| 1549 | Bierbaumer L et.al. (2021). YAP/TAZ inhibition reduces metastatic potential of Ewing sarcoma cells. Oncogenesis 10:2. |
| 1548 | Qasim SL et.al. (2021). p21-activated kinases as viable therapeutic targets for the treatment of high-risk Ewing sarcoma. Oncogene 40:1176-1190. |
| 1547 | Borenas M et.al. (2021). ALK ligand ALKAL2 potentiates MYCN-driven neuroblastoma in the absence of ALK mutation. EMBO J 40:e105784. |
| 1546 | Fu D et.al. (2021). iTRAQ-based proteomic analysis of the molecular mechanisms and downstream effects of fatty acid synthase in osteosarcoma cells. J Clin Lab Anal 35:e23653. |
| 1545 | Tornin J et.al. (2021). Osteosarcoma tissue-engineered model challenges oxidative stress therapy revealing promoted cancer stem cell properties. Free Radic Biol Med 164:107-118. |
| 1544 | Yi P et.al. (2021). LncRNA SNHG7 Serves as a Potential Biomarker on the Prognosis of Human Solid Tumors: A Meta-Analysis. Curr Pharm Biotechnol 22:1501-1510. |
| 1543 | Moon SJ et.al. (2021). Bruceantin targets HSP90 to overcome resistance to hormone therapy in castration-resistant prostate cancer. Theranostics 11:958-973. |
| 1542 | Carbo JM et.al. (2021). Pharmacologic Activation of LXR Alters the Expression Profile of Tumor-Associated Macrophages and the Abundance of Regulatory T Cells in the Tumor Microenvironment. Cancer Res 81:968-985. |
| 1541 | Bedekovics T et.al. (2021). USP24 Is a Cancer-Associated Ubiquitin Hydrolase, Novel Tumor Suppressor, and Chromosome Instability Gene Deleted in Neuroblastoma. Cancer Res 81:1321-1331. |
| 1540 | Chen KS et.al. (2021). NFIA and NFIB function as tumour suppressors in high-grade glioma in mice. Carcinogenesis 42:357-368. |
| 1539 | Lu W et.al. (2021). SUMOylation is essential for Sirt2 tumor-suppressor function in neuroblastoma. Neoplasia 23:129-139. |
| 1538 | Diao C et.al. (2021). SPT6 recruits SND1 to co-activate human telomerase reverse transcriptase to promote colon cancer progression. Mol Oncol 15:1180-1202. |
| 1537 | Subbarayan K et.al. (2021). Expression and Clinical Significance of SARS-CoV-2 Human Targets in Neoplastic and Non-Neoplastic Lung Tissues. Curr Cancer Drug Targets 21:428-442. |
| 1536 | Huang Y et.al. (2021). Combination of tumor necrosis factor-alpha and epidermal growth factor induces the adrenergic-to-mesenchymal transdifferentiation in SH-SY5Y neuroblastoma cells. Cancer Sci 112:715-724. |
| 1535 | Xu Y et.al. (2021). Carboxy terminus of HSP70-interacting protein (CHIP) attenuates the stemness of thyroid cancer cells through decreasing OCT4 protein stability. Environ Toxicol 36:686-693. |
| 1534 | Coronado E et.al. (2021). Intratumoral immunosuppression profiles in 11q-deleted neuroblastomas provide new potential therapeutic targets. Mol Oncol 15:364-380. |
| 1533 | Natsumeda M et.al. (2021). GLI3 Is Associated With Neuronal Differentiation in SHH-Activated and WNT-Activated Medulloblastoma. J Neuropathol Exp Neurol 80:129-136. |
| 1532 | Qi C et.al. (2021). Thrombospondin-1 is a prognostic biomarker and is correlated with tumor immune microenvironment in glioblastoma. Oncol Lett 21:22. |
| 1531 | Taylor L et.al. (2021). Y-Box Binding Protein-1: A Neglected Target in Pediatric Brain Tumors? Mol Cancer Res 19:375-387. |
| 1530 | Hu S et.al. (2021). Astragaloside IV inhibits cell proliferation and metastasis of breast cancer via promoting the long noncoding RNA TRHDE-AS1. J Nat Med 75:156-166. |
| 1529 | Linke F et.al. (2021). 3D hydrogels reveal medulloblastoma subgroup differences and identify extracellular matrix subtypes that predict patient outcome. J Pathol 253:326-338. |
| 1528 | Song X et.al. (2021). Synergistic targeting of CHK1 and mTOR in MYC-driven tumors. Carcinogenesis 42:448-460. |
| 1527 | Zhang Z et.al. (2021). Regulation of ABCG2 expression by Wnt5a through FZD7 in human pancreatic cancer cells. Mol Med Rep 23:. |
| 1526 | Lv H et.al. (2021). NAD(+) Metabolism Maintains Inducible PD-L1 Expression to Drive Tumor Immune Evasion. Cell Metab 33:110-127.e5. |
| 1525 | Dasgupta A et.al. (2021). Targeting PAK4 Inhibits Ras-Mediated Signaling and Multiple Oncogenic Pathways in High-Risk Rhabdomyosarcoma. Cancer Res 81:199-212. |
| 1524 | Story JY et.al. (2021). Bortezomib enhances cytotoxicity of ex vivo-expanded gamma delta T cells against acute myeloid leukemia and T-cell acute lymphoblastic leukemia. Cytotherapy 23:12-24. |
| 1523 | Panzeri V et.al. (2021). The RNA-binding protein MEX3A is a prognostic factor and regulator of resistance to gemcitabine in pancreatic ductal adenocarcinoma. Mol Oncol 15:579-595. |
| 1522 | Deng R et.al. (2021). BAP1 suppresses prostate cancer progression by deubiquitinating and stabilizing PTEN. Mol Oncol 15:279-298. |
| 1521 | Sievers P et.al. (2021). A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFR. Neuro Oncol 23:34-43. |
| 1520 | Chen B et.al. (2021). Integrated Microarray to Identify the Hub miRNAs and Constructed miRNA-mRNA Network in Neuroblastoma Via Bioinformatics Analysis. Neurochem Res 46:197-212. |
| 1519 | Lee TF et.al. (2021). TAZ negatively regulates the novel tumor suppressor ANKRD52 and promotes PAK1 dephosphorylation in lung adenocarcinomas. Biochim Biophys Acta Mol Cell Res 1868:118891. |
| 1518 | Salemme V et.al. (2021). The p140Cap adaptor protein as a molecular hub to block cancer aggressiveness. Cell Mol Life Sci 78:1355-1367. |
| 1517 | Fonseca LL et.al. (2021). RasGRP1 induces autophagy and transformation-associated changes in primary human keratinocytes. Transl Oncol 14:100880. |
| 1516 | Aravindan N et.al. (2021). Significance of hematopoietic surface antigen CD34 in neuroblastoma prognosis and the genetic landscape of CD34-expressing neuroblastoma CSCs. Cell Biol Toxicol 37:461-478. |
| 1515 | Xie R et.al. (2021). NONO Inhibits Lymphatic Metastasis of Bladder Cancer via Alternative Splicing of SETMAR. Mol Ther 29:291-307. |
| 1514 | Naveed A et.al. (2021). NEAT1 polyA-modulating antisense oligonucleotides reveal opposing functions for both long non-coding RNA isoforms in neuroblastoma. Cell Mol Life Sci 78:2213-2230. |
| 1513 | Pradhan S et.al. (2021). Evaluation of designs for renal drug studies based on the European Medicines Agency and Food and Drug Administration guidelines for drugs that are predominantly secreted. Br J Clin Pharmacol 87:1401-1410. |
| 1512 | Chen B et.al. (2021). Analysis and identification of novel biomarkers involved in neuroblastoma via integrated bioinformatics. Invest New Drugs 39:52-65. |
| 1511 | Haase J et.al. (2021). IGF2BP1 is the first positive marker for anaplastic thyroid carcinoma diagnosis. Mod Pathol 34:32-41. |
| 1510 | Velletri T et.al. (2021). Loss of p53 in mesenchymal stem cells promotes alteration of bone remodeling through negative regulation of osteoprotegerin. Cell Death Differ 28:156-169. |
| 1509 | Sommer G et.al. (2021). Role of the RNA-binding protein La in cancer pathobiology. RNA Biol 18:218-236. |
| 1508 | Wang D et.al. (2021). Loss of 4.1N in epithelial ovarian cancer results in EMT and matrix-detached cell death resistance. Protein Cell 12:107-127. |
| 1507 | Ding J et.al. (2021). Long Non-coding RNA LINC01503 Promotes Gastric Cancer Cell Proliferation and Invasion by Regulating Wnt Signaling. Dig Dis Sci 66:452-459. |
| 2020 (n=333) |
| 1506 | Brex D et.al. (2020). LINC00483 Has a Potential Tumor-Suppressor Role in Colorectal Cancer Through Multiple Molecular Axes. Front Oncol 10:614455. |
| 1505 | Wei M et.al. (2020). The Complex Roles and Therapeutic Implications of m(6)A Modifications in Breast Cancer. Front Cell Dev Biol 8:615071. |
| 1504 | Cui L et.al. (2020). TLRs as a Promise Target Along With Immune Checkpoint Against Gastric Cancer. Front Cell Dev Biol 8:611444. |
| 1503 | Huang J et.al. (2020). Rationally Designed Antibody Drug Conjugates Targeting the Breast Cancer-Associated Endothelium. ACS Biomater Sci Eng 6:2563-2569. |
| 1502 | Rotman J et.al. (2020). PD-L1 and PD-L2 Expression in Cervical Cancer: Regulation and Biomarker Potential. Front Immunol 11:596825. |
| 1501 | Hulstaert E et.al. (2020). Charting Extracellular Transcriptomes in The Human Biofluid RNA Atlas. Cell Rep 33:108552. |
| 1500 | Barbagallo C et.al. (2020). LncRNA LINC00518 Acts as an Oncogene in Uveal Melanoma by Regulating an RNA-Based Network. Cancers (Basel) 12:. |
| 1499 | Abancens M et.al. (2020). Sexual Dimorphism in Colon Cancer. Front Oncol 10:607909. |
| 1498 | Bruggeman JW et.al. (2020). Tumors Widely Express Hundreds of Embryonic Germline Genes. Cancers (Basel) 12:. |
| 1497 | Wang Z et.al. (2020). PIK3CA Is Regulated by CUX1, Promotes Cell Growth and Metastasis in Bladder Cancer via Activating Epithelial-Mesenchymal Transition. Front Oncol 10:536072. |
| 1496 | Huang J et.al. (2020). A Rationally Designed ICAM1 Antibody Drug Conjugate for Pancreatic Cancer. Adv Sci (Weinh) 7:2002852. |
| 1495 | Tirinato L et.al. (2020). ROS and Lipid Droplet accumulation induced by high glucose exposure in healthy colon and Colorectal Cancer Stem Cells. Genes Dis 7:620-635. |
| 1494 | Ke XX et.al. (2020). Deficiency of G9a Inhibits Cell Proliferation and Activates Autophagy via Transcriptionally Regulating c-Myc Expression in Glioblastoma. Front Cell Dev Biol 8:593964. |
| 1493 | Nolan JC et.al. (2020). A Context-Dependent Role for MiR-124-3p on Cell Phenotype, Viability and Chemosensitivity in Neuroblastoma in vitro. Front Cell Dev Biol 8:559553. |
| 1492 | Ognibene M et.al. (2020). Ezrin interacts with the tumor suppressor CHL1 and promotes neuronal differentiation of human neuroblastoma. PLoS One 15:e0244069. |
| 1491 | Li Z et.al. (2020). PROTAC Bromodomain Inhibitor ARV-825 Displays Anti-Tumor Activity in Neuroblastoma by Repressing Expression of MYCN or c-Myc. Front Oncol 10:574525. |
| 1490 | Ma M et.al. (2020). Role of FUT8 expression in clinicopathology and patient survival for various malignant tumor types: a systematic review and meta-analysis. Aging (Albany NY) 13:2212-2230. |
| 1489 | Yuan X et.al. (2020). Erythrocyte membrane protein band 4.1-like 3 inhibits osteosarcoma cell invasion through regulation of Snai1-induced epithelial-to-mesenchymal transition. Aging (Albany NY) 13:1947-1961. |
| 1488 | Masi M et.al. (2020). OXER1 and RACK1-associated pathway: a promising drug target for breast cancer progression. Oncogenesis 9:105. |
| 1487 | Zhao Y et.al. (2020). Effective Inhibition of MYC-Amplified Group 3 Medulloblastoma Through Targeting EIF4A1. Cancer Manag Res 12:12473-12485. |
| 1486 | Butera A et.al. (2020). The ZNF750-RAC1 axis as potential prognostic factor for breast cancer. Cell Death Discov 6:135. |
| 1485 | Pan J et.al. (2020). Knockdown of Forkhead box A1 suppresses the tumorigenesis and progression of human colon cancer cells through regulating the phosphatase and tensin homolog/Akt pathway. J Int Med Res 48:300060520971453. |
| 1484 | Tian C et.al. (2020). SKP1 promotes YAP-mediated colorectal cancer stemness via suppressing RASSF1. Cancer Cell Int 20:579. |
| 1483 | Domenichini A et.al. (2020). Rhenium N-heterocyclic carbene complexes block growth of aggressive cancers by inhibiting FGFR J Exp Clin Cancer Res 39:276. |
| 1482 | Hu XQ et.al. (2020). Gene expression profiles and protein-protein interaction networks in neuroblastoma with MEIS2 depletion. J BUON 25:2482-2489. |
| 1481 | Kwak HJ et.al. (2020). Expression of ATP/GTP Binding Protein 1 Has Prognostic Value for the Clinical Outcomes in Non-Small Cell Lung Carcinoma. J Pers Med 10:. |
| 1480 | Achiha T et.al. (2020). Activated leukocyte cell adhesion molecule expression correlates with the WNT subgroup in medulloblastoma and is involved in regulating tumor cell proliferation and invasion. PLoS One 15:e0243272. |
| 1479 | Wang J et.al. (2020). Effective inhibition of MYC-amplified group 3 medulloblastoma by FACT-targeted curaxin drug CBL0137. Cell Death Dis 11:1029. |
| 1478 | Kuster MM et.al. (2020). Epigenetic Inactivation of the Tumor Suppressor IRX1 Occurs Frequently in Lung Adenocarcinoma and Its Silencing Is Associated with Impaired Prognosis. Cancers (Basel) 12:. |
| 1477 | Li M et.al. (2020). Methylation of the Promoter Region of the Tight Junction Protein-1 by DNMT1 Induces EMT-like Features in Multiple Myeloma. Mol Ther Oncolytics 19:197-207. |
| 1476 | Melaiu O et.al. (2020). Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma. Nat Commun 11:5992. |
| 1475 | Colmenero-Repiso A et.al. (2020). Identification of VRK1 as a New Neuroblastoma Tumor Progression Marker Regulating Cell Proliferation. Cancers (Basel) 12:. |
| 1474 | Zhang L et.al. (2020). SNORA72 Activates the Notch1/c-Myc Pathway to Promote Stemness Transformation of Ovarian Cancer Cells. Front Cell Dev Biol 8:583087. |
| 1473 | Cai Y et.al. (2020). Prp19 Is an Independent Prognostic Marker and Promotes Neuroblastoma Metastasis by Regulating the Hippo-YAP Signaling Pathway. Front Oncol 10:575366. |
| 1472 | Chai P et.al. (2020). Generation of onco-enhancer enhances chromosomal remodeling and accelerates tumorigenesis. Nucleic Acids Res 48:12135-12150. |
| 1471 | McCann TS et.al. (2020). KDM5A and PHF2 positively control expression of pro-metastatic genes repressed by EWS/Fli1, and promote growth and metastatic properties in Ewing sarcoma. Oncotarget 11:3818-3831. |
| 1470 | Somarelli JA et.al. (2020). A Comparative Oncology Drug Discovery Pipeline to Identify and Validate New Treatments for Osteosarcoma. Cancers (Basel) 12:. |
| 1469 | Sarnella A et.al. (2020). A Novel Inhibitor of Carbonic Anhydrases Prevents Hypoxia-Induced TNBC Cell Plasticity. Int J Mol Sci 21:. |
| 1468 | Song J et.al. (2020). A signature of 29 immune-related genes pairs to predict prognosis in patients with neuroblastoma. Int Immunopharmacol 88:106994. |
| 1467 | Davis RS et.al. (2020). Roles for the FCRL6 Immunoreceptor in Tumor Immunology. Front Immunol 11:575175. |
| 1466 | Tang Q et.al. (2020). TM4SF1 promotes EMT and cancer stemness via the Wnt/beta-catenin/SOX2 pathway in colorectal cancer. J Exp Clin Cancer Res 39:232. |
| 1465 | Zhang S et.al. (2020). miR-766-3p Targeting BCL9L Suppressed Tumorigenesis, Epithelial-Mesenchymal Transition, and Metastasis Through the beta-Catenin Signaling Pathway in Osteosarcoma Cells. Front Cell Dev Biol 8:594135. |
| 1464 | Sun C et.al. (2020). MDM2-P53 Signaling Pathway-Mediated Upregulation of CDC20 Promotes Progression of Human Diffuse Large B-Cell Lymphoma. Onco Targets Ther 13:10475-10487. |
| 1463 | Garcia-Heredia JM et.al. (2020). Breast tumor cells promotes the horizontal propagation of EMT, stemness, and metastasis by transferring the MAP17 protein between subsets of neoplastic cells. Oncogenesis 9:96. |
| 1462 | Liu D et.al. (2020). Soluble Compounds Released by Hypoxic Stroma Confer Invasive Properties to Pancreatic Ductal Adenocarcinoma. Biomedicines 8:. |
| 1461 | Filippova N et.al. (2020). ELAVL1 Role in Cell Fusion and Tunneling Membrane Nanotube Formations with Implication to Treat Glioma Heterogeneity. Cancers (Basel) 12:. |
| 1460 | Hossain MM et.al. (2020). Differential expression, function and prognostic value of miR-17-92 cluster in ER-positive and triple-negative breast cancer. Cancer Treat Res Commun 25:100224. |
| 1459 | Zheng W et.al. (2020). RIG-I-Like Receptor LGP2 Is Required for Tumor Control by Radiotherapy. Cancer Res 80:5633-5641. |
| 1458 | Balakrishnan I et.al. (2020). Senescence Induced by BMI1 Inhibition Is a Therapeutic Vulnerability in H3K27M-Mutant DIPG. Cell Rep 33:108286. |
| 1457 | Bhattacharya A et.al. (2020). SMAR1 repression by pluripotency factors and consequent chemoresistance in breast cancer stem-like cells is reversed by aspirin. Sci Signal 13:. |
| 1456 | Cornet-Masana JM et.al. (2020). Histamine receptor 1 is expressed in leukaemic cells and affects differentiation sensitivity. J Cell Mol Med 24:13536-13541. |
| 1455 | Czerwinska P et.al. (2020). Melanoma Stem Cell-Like Phenotype and Significant Suppression of Immune Response within a Tumor Are Regulated by TRIM28 Protein. Cancers (Basel) 12:. |
| 1454 | Penco-Campillo M et.al. (2020). VEGFC negatively regulates the growth and aggressiveness of medulloblastoma cells. Commun Biol 3:579. |
| 1453 | Ye M et.al. (2020). Downregulation of MEG3 promotes neuroblastoma development through FOXO1-mediated autophagy and mTOR-mediated epithelial-mesenchymal transition. Int J Biol Sci 16:3050-3061. |
| 1452 | Yang G et.al. (2020). Upregulated mH2A1 serves as an unfavorable prognostic indicator and promotes the progress of hepatocellular carcinoma (HCC). Life Sci 263:118576. |
| 1451 | Hassan MK et.al. (2020). EEF1A2 triggers stronger ERK mediated metastatic program in ER negative breast cancer cells than in ER positive cells. Life Sci 262:118553. |
| 1450 | Ariey-Bonnet J et.al. (2020). In silico molecular target prediction unveils mebendazole as a potent MAPK14 inhibitor. Mol Oncol 14:3083-3099. |
| 1449 | Yamashita M et.al. (2020). The role of SCF(Skp2) and SCF(beta-TrCP1/2) in the cerebellar granule cell precursors. Genes Cells 25:796-810. |
| 1448 | Feng YC et.al. (2020). c-Myc inactivation of p53 through the pan-cancer lncRNA MILIP drives cancer pathogenesis. Nat Commun 11:4980. |
| 1447 | Ando K et.al. (2020). CEP131 Abrogates CHK1 Inhibitor-Induced Replication Defects and Is Associated with Unfavorable Outcome in Neuroblastoma. J Oncol 2020:2752417. |
| 1446 | Wang J et.al. (2020). Immunological and clinicopathological characteristics of C1RL in 2120 glioma patients. BMC Cancer 20:931. |
| 1445 | Smit WL et.al. (2020). Driver mutations of the adenoma-carcinoma sequence govern the intestinal epithelial global translational capacity. Proc Natl Acad Sci U S A 117:25560-25570. |
| 1444 | Zhang Y et.al. (2020). Prognostic Value of the FOXK Family Expression in Patients with Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy. Onco Targets Ther 13:9185-9201. |
| 1443 | Hansson K et.al. (2020). Therapeutic targeting of KSP in preclinical models of high-risk neuroblastoma. Sci Transl Med 12:. |
| 1442 | Siaw JT et.al. (2020). 11q Deletion or ALK Activity Curbs DLG2 Expression to Maintain an Undifferentiated State in Neuroblastoma. Cell Rep 32:108171. |
| 1441 | Perez M et.al. (2020). Sarcoma stratification by combined pH2AX and MAP17 (PDZK1IP1) levels for a better outcome on doxorubicin plus olaparib treatment. Signal Transduct Target Ther 5:195. |
| 1440 | Mehmeti-Ajradini M et.al. (2020). Human G-MDSCs are neutrophils at distinct maturation stages promoting tumor growth in breast cancer. Life Sci Alliance 3:. |
| 1439 | Chramiec A et.al. (2020). Integrated human organ-on-a-chip model for predictive studies of anti-tumor drug efficacy and cardiac safety. Lab Chip 20:4357-4372. |
| 1438 | Jemaa M et.al. (2020). Gene Expression Signature of Acquired Chemoresistance in Neuroblastoma Cells. Int J Mol Sci 21:. |
| 1437 | Dong R et.al. (2020). Single-Cell Characterization of Malignant Phenotypes and Developmental Trajectories of Adrenal Neuroblastoma. Cancer Cell 38:716-733.e6. |
| 1436 | Wu Y et.al. (2020). Systematic screening for potential therapeutic targets in osteosarcoma through a kinome-wide CRISPR-Cas9 library. Cancer Biol Med 17:782-794. |
| 1435 | Silveira VS et.al. (2020). SHOC2 scaffold protein modulates daunorubicin-induced cell death through p53 modulation in lymphoid leukemia cells. Sci Rep 10:15193. |
| 1434 | Blanas A et.al. (2020). FUT9-Driven Programming of Colon Cancer Cells towards a Stem Cell-Like State. Cancers (Basel) 12:. |
| 1433 | Lazaridou MF et.al. (2020). Identification of miR-200a-5p targeting the peptide transporter TAP1 and its association with the clinical outcome of melanoma patients. Oncoimmunology 9:1774323. |
| 1432 | Samad A et.al. (2020). Identification of angiotensin-converting enzyme 2 (ACE2) protein as the potential biomarker in SARS-CoV-2 infection-related lung cancer using computational analyses. Genomics 112:4912-4923. |
| 1431 | Hartl L et.al. (2020). CCAAT/Enhancer-Binding Protein Delta (C/EBPdelta): A Previously Unrecognized Tumor Suppressor that Limits the Oncogenic Potential of Pancreatic Ductal Adenocarcinoma Cells. Cancers (Basel) 12:. |
| 1430 | Thomaz A et.al. (2020). Neurotrophin Signaling in Medulloblastoma. Cancers (Basel) 12:. |
| 1429 | Shim J et.al. (2020). YAP-Mediated Repression of HRK Regulates Tumor Growth, Therapy Response, and Survival Under Tumor Environmental Stress in Neuroblastoma. Cancer Res 80:4741-4753. |
| 1428 | Vivarelli S et.al. (2020). Role of the Transcription Factor Yin Yang 1 and Its Selectively Identified Target Survivin in High-Grade B-Cells Non-Hodgkin Lymphomas: Potential Diagnostic and Therapeutic Targets. Int J Mol Sci 21:. |
| 1427 | Bloedjes TA et.al. (2020). AKT signaling restrains tumor suppressive functions of FOXO transcription factors and GSK3 kinase in multiple myeloma. Blood Adv 4:4151-4164. |
| 1426 | Coebergh van den Braak RRJ et.al. (2020). Interconnectivity between molecular subtypes and tumor stage in colorectal cancer. BMC Cancer 20:850. |
| 1425 | Lu Y et.al. (2020). Hypoxia Induces Resistance to EGFR Inhibitors in Lung Cancer Cells via Upregulation of FGFR1 and the MAPK Pathway. Cancer Res 80:4655-4667. |
| 1424 | Yu Z et.al. (2020). BRD8, which is negatively regulated by miR-876-3p, promotes the proliferation and apoptosis resistance of hepatocellular carcinoma cells via KAT5. Arch Biochem Biophys 693:108550. |
| 1423 | Wang F et.al. (2020). Integrated Genome-Wide Methylation and Expression Analyses Reveal Key Regulators in Osteosarcoma. Comput Math Methods Med 2020:7067649. |
| 1422 | Anantha J et.al. (2020). STRAP and NME1 Mediate the Neurite Growth-Promoting Effects of the Neurotrophic Factor GDF5. iScience 23:101457. |
| 1421 | Shi H et.al. (2020). ARID1A loss in neuroblastoma promotes the adrenergic-to-mesenchymal transition by regulating enhancer-mediated gene expression. Sci Adv 6:eaaz3440. |
| 1420 | Kanamori A et.al. (2020). Mint3 depletion restricts tumor malignancy of pancreatic cancer cells by decreasing SKP2 expression via HIF-1. Oncogene 39:6218-6230. |
| 1419 | Cangelosi D et.al. (2020). Hypoxia Predicts Poor Prognosis in Neuroblastoma Patients and Associates with Biological Mechanisms Involved in Telomerase Activation and Tumor Microenvironment Reprogramming. Cancers (Basel) 12:. |
| 1418 | Yang R et.al. (2020). E2F7-EZH2 axis regulates PTEN/AKT/mTOR signalling and glioblastoma progression. Br J Cancer 123:1445-1455. |
| 1417 | Po A et.al. (2020). Hedgehog-GLI signalling promotes chemoresistance through the regulation of ABC transporters in colorectal cancer cells. Sci Rep 10:13988. |
| 1416 | Tekin C et.al. (2020). Macrophage-secreted MMP9 induces mesenchymal transition in pancreatic cancer cells via PAR1 activation. Cell Oncol (Dordr) 43:1161-1174. |
| 1415 | Tombolan L et.al. (2020). Pediatric sarcomas display a variable EpCAM expression in a histology-dependent manner. Transl Oncol 13:100846. |
| 1414 | Kim JH et.al. (2020). A novel nucleolin-binding peptide for Cancer Theranostics. Theranostics 10:9153-9171. |
| 1413 | Zhang J et.al. (2020). Molecular markers associated with perineural invasion in pancreatic ductal adenocarcinoma. Oncol Lett 20:5. |
| 1412 | Paronetto MP et.al. (2020). Exercise-mediated downregulation of MALAT1 expression and implications in primary and secondary cancer prevention. Free Radic Biol Med 160:28-39. |
| 1411 | Hu Y et.al. (2020). Are Epithelial Ovarian Cancers of the Mesenchymal Subtype Actually Intraperitoneal Metastases to the Ovary? Front Cell Dev Biol 8:647. |
| 1410 | Kosti A et.al. (2020). The RNA-binding protein SERBP1 functions as a novel oncogenic factor in glioblastoma by bridging cancer metabolism and epigenetic regulation. Genome Biol 21:195. |
| 1409 | Ghalayini J et.al. (2020). Exploring the Therapeutic Potential of Protein Tyrosine Phosphatase 1B in hAPP-J20 Mouse Model of Alzheimers Disease. J Neurosci 40:6100-6102. |
| 1408 | Erarslan-Uysal B et.al. (2020). Chromatin accessibility landscape of pediatric T-lymphoblastic leukemia and human T-cell precursors. EMBO Mol Med 12:e12104. |
| 1407 | Nobre L et.al. (2020). Pattern of Relapse and Treatment Response in WNT-Activated Medulloblastoma. Cell Rep Med 1:. |
| 1406 | Ognibene M et.al. (2020). Roniciclib down-regulates stemness and inhibits cell growth by inducing nucleolar stress in neuroblastoma. Sci Rep 10:12902. |
| 1405 | Liszka L et.al. (2020). Pan-p63 but not DeltaNp63 (p40) expression in undifferentiated carcinoma of the pancreas. Pol J Pathol 71:155-172. |
| 1404 | de Sousa GR et.al. (2020). Should we keep rocking? Portraits from targeting Rho kinases in cancer. Pharmacol Res 160:105093. |
| 1403 | Park J et.al. (2020). STAT3 is a key molecule in the oncogenic behavior of diffuse intrinsic pontine glioma. Oncol Lett 20:1989-1998. |
| 1402 | Zhang Q et.al. (2020). Increased DEF6 expression is correlated with metastasis and poor prognosis in human osteosarcoma. Oncol Lett 20:1629-1640. |
| 1401 | Jian L et.al. (2020). AGR3 promotes estrogen receptor-positive breast cancer cell proliferation in an estrogen-dependent manner. Oncol Lett 20:1441-1451. |
| 1400 | Makino E et.al. (2020). Targeting Rad51 as a strategy for the treatment of melanoma cells resistant to MAPK pathway inhibition. Cell Death Dis 11:581. |
| 1399 | Jasinski-Bergner S et.al. (2020). The Role of the RNA-Binding Protein Family MEX-3 in Tumorigenesis. Int J Mol Sci 21:. |
| 1398 | Alshangiti AM et.al. (2020). Association of distinct type 1 bone morphogenetic protein receptors with different molecular pathways and survival outcomes in neuroblastoma. Neuronal Signal 4:NS20200006. |
| 1397 | Guo Q et.al. (2020). Transcriptional Factor Yin Yang 1 Promotes the Stemness of Breast Cancer Cells by Suppressing miR-873-5p Transcriptional Activity. Mol Ther Nucleic Acids 21:527-541. |
| 1396 | Bell JL et.al. (2020). Identification of RNA-Binding Proteins as Targetable Putative Oncogenes in Neuroblastoma. Int J Mol Sci 21:. |
| 1395 | Pikatan NW et.al. (2020). Aberrantly expressed Brutons tyrosine kinase preferentially drives metastatic and stem cell-like phenotypes in neuroblastoma cells. Cell Oncol (Dordr) 43:1067-1084. |
| 1394 | Illendula A et.al. (2020). Retinoic acid induces differentiation in neuroblastoma via ROR1 by modulating retinoic acid response elements. Oncol Rep 44:1013-1024. |
| 1393 | Hingorani P et.al. (2020). Transcriptome analysis of desmoplastic small round cell tumors identifies actionable therapeutic targets: a report from the Childrens Oncology Group. Sci Rep 10:12318. |
| 1392 | Hu J et.al. (2020). TRPS1 Confers Multidrug Resistance of Breast Cancer Cells by Regulating BCRP Expression. Front Oncol 10:934. |
| 1391 | Prazeres PHDM et.al. (2020). Ablation of sensory nerves favours melanoma progression. J Cell Mol Med 24:9574-9589. |
| 1390 | Simon Serrano S et.al. (2020). Inhibition of mitotic kinase Mps1 promotes cell death in neuroblastoma. Sci Rep 10:11997. |
| 1389 | Zhang H et.al. (2020). Bone marrow mesenchymal stem cell-derived exosomal miR-206 inhibits osteosarcoma progression by targeting TRA2B. Cancer Lett 490:54-65. |
| 1388 | Gassenmaier M et.al. (2020). Expression of DNA Methyltransferase 1 Is a Hallmark of Melanoma, Correlating with Proliferation and Response to B-Raf and Mitogen-Activated Protein Kinase Inhibition in Melanocytic Tumors. Am J Pathol 190:2155-2164. |
| 1387 | Shen Z et.al. (2020). Transcription Factor EBF1 Over-Expression Suppresses Tumor Growth in vivo and in vitro via Modulation of the PNO1/p53 Pathway in Colorectal Cancer. Front Oncol 10:1035. |
| 1386 | He X et.al. (2020). A novel LncRNA transcript, RBAT1, accelerates tumorigenesis through interacting with HNRNPL and cis-activating E2F3. Mol Cancer 19:115. |
| 1385 | Wang C et.al. (2020). Long Noncoding RNA LINC01134 Promotes Hepatocellular Carcinoma Metastasis via Activating AKT1S1 and NF-kappaB Signaling. Front Cell Dev Biol 8:429. |
| 1384 | Zhao Q et.al. (2020). Acylglycerol kinase promotes the stemness of nasopharyngeal carcinoma cells by promoting beta-catenin translocation to the nucleus through activating PI3K/Akt pathway. Environ Toxicol 35:1299-1307. |
| 1383 | Gao J et.al. (2020). Suppression of ABCE1-Mediated mRNA Translation Limits N-MYC-Driven Cancer Progression. Cancer Res 80:3706-3718. |
| 1382 | Qi C et.al. (2020). Serine Incorporator 2 (SERINC2) Expression Predicts an Unfavorable Prognosis of Low-Grade Glioma (LGG): Evidence from Bioinformatics Analysis. J Mol Neurosci 70:1521-1532. |
| 1381 | Toledano-Fonseca M et.al. (2020). Circulating Cell-Free DNA-Based Liquid Biopsy Markers for the Non-Invasive Prognosis and Monitoring of Metastatic Pancreatic Cancer. Cancers (Basel) 12:. |
| 1380 | Yang L et.al. (2020). SETD1A Promotes Proliferation of Castration-Resistant Prostate Cancer Cells via FOXM1 Transcription. Cancers (Basel) 12:. |
| 1379 | Tiburcio PDB et.al. (2020). The neural stem-cell marker CD24 is specifically upregulated in IDH-mutant glioma. Transl Oncol 13:100819. |
| 1378 | Lukosiute-Urboniene A et.al. (2020). Epigenetic Regulation of APAF-1 Through DNA Methylation in Pancreatic Cancer. Anticancer Res 40:3765-3779. |
| 1377 | Schober SJ et.al. (2020). MHC Class I-Restricted TCR-Transgenic CD4(+) T Cells Against STEAP1 Mediate Local Tumor Control of Ewing Sarcoma In Vivo. Cells 9:. |
| 1376 | Tang W et.al. (2020). beta1,4-Galactosyltransferase V Modulates Breast Cancer Stem Cells through Wnt/beta-catenin Signaling Pathway. Cancer Res Treat 52:1084-1102. |
| 1375 | Park SR et.al. (2020). Tryptophanyl-tRNA Synthetase, a Novel Damage-Induced Cytokine, Significantly Increases the Therapeutic Effects of Endometrial Stem Cells. Mol Ther 28:2458-2472. |
| 1374 | Kesherwani V et.al. (2020). Long non-coding RNA profiling of pediatric Medulloblastoma. BMC Med Genomics 13:87. |
| 1373 | Abdelrasoul H et.al. (2020). Synergism between IL7R and CXCR4 drives BCR-ABL induced transformation in Philadelphia chromosome-positive acute lymphoblastic leukemia. Nat Commun 11:3194. |
| 1372 | Zhang H et.al. (2020). Survival Association and Cell Cycle Effects of B7H3 in Neuroblastoma. J Korean Neurosurg Soc 63:707-716. |
| 1371 | Suenaga Y et.al. (2020). De novo evolved gene product NCYM in the pathogenesis and clinical outcome of human neuroblastomas and other cancers. Jpn J Clin Oncol 50:839-846. |
| 1370 | Sobral LM et.al. (2020). KDM3A/Ets1/MCAM axis promotes growth and metastatic properties in Rhabdomyosarcoma. Genes Cancer 11:53-65. |
| 1369 | Wijaya J et.al. (2020). Using Pharmacology to Squeeze the Life Out of Childhood Leukemia, and Potential Strategies to Achieve Breakthroughs in Medulloblastoma Treatment. Pharmacol Rev 72:668-691. |
| 1368 | Xu Y et.al. (2020). Deletion of Glutathione S-Transferase Omega 1 Activates Type I Interferon Genes and Downregulates Tissue Factor. Cancer Res 80:3692-3705. |
| 1367 | Zhang J et.al. (2020). LAIR-1 overexpression inhibits epithelial-mesenchymal transition in osteosarcoma via GLUT1-related energy metabolism. World J Surg Oncol 18:136. |
| 1366 | Zhou H et.al. (2020). Chaperone-mediated Autophagy Governs Progression of Papillary Thyroid Carcinoma via PPARgamma-SDF1/CXCR4 Signaling. J Clin Endocrinol Metab 105:. |
| 1365 | Zeng H et.al. (2020). ZNF367-induced transcriptional activation of KIF15 accelerates the progression of breast cancer. Int J Biol Sci 16:2084-2093. |
| 1364 | Zhou M et.al. (2020). KLF10 inhibits cell growth by regulating PTTG1 in multiple myeloma under the regulation of microRNA-106b-5p. Int J Biol Sci 16:2063-2071. |
| 1363 | Dang TT et.al. (2020). Involvement of POLA2 in Double Strand Break Repair and Genotoxic Stress. Int J Mol Sci 21:. |
| 1362 | Blijlevens M et.al. (2020). Silencing Core Spliceosome Sm Gene Expression Induces a Cytotoxic Splicing Switch in the Proteasome Subunit Beta 3 mRNA in Non-Small Cell Lung Cancer Cells. Int J Mol Sci 21:. |
| 1361 | Perkail S et.al. (2020). BAP1 is a haploinsufficient tumor suppressor linking chronic pancreatitis to pancreatic cancer in mice. Nat Commun 11:3018. |
| 1360 | Mao R et.al. (2020). Ubiquitin C-terminal hydrolase L1 promotes expression of programmed cell death-ligand 1 in non-small-cell lung cancer cells. Cancer Sci 111:3174-3183. |
| 1359 | Bellamy J et.al. (2020). Increased Efficacy of Histone Methyltransferase G9a Inhibitors Against MYCN-Amplified Neuroblastoma. Front Oncol 10:818. |
| 1358 | Jian M et.al. (2020). A novel patient-derived organoids-based xenografts model for preclinical drug response testing in patients with colorectal liver metastases. J Transl Med 18:234. |
| 1357 | Laneve P et.al. (2020). The Non-coding Side of Medulloblastoma. Front Cell Dev Biol 8:275. |
| 1356 | Gao F et.al. (2020). The Membrane Protein Sortilin Can Be Targeted to Inhibit Pancreatic Cancer Cell Invasion. Am J Pathol 190:1931-1942. |
| 1355 | Chen B et.al. (2020). Downregulation of PIF1, a potential new target of MYCN, induces apoptosis and inhibits cell migration in neuroblastoma cells. Life Sci 256:117820. |
| 1354 | Bastiaenen VP et.al. (2020). A mouse model for peritoneal metastases of colorectal origin recapitulates patient heterogeneity. Lab Invest 100:1465-1474. |
| 1353 | Wang Y et.al. (2020). Hepatocyte nuclear factor-1beta suppresses the stemness and migration of colorectal cancer cells through promoting miR-200b activity. Mol Carcinog 59:989-999. |
| 1352 | Long L et.al. (2020). High expression of PKM2 synergizes with PD-L1 in tumor cells and immune cells to predict worse survival in human lung adenocarcinoma. J Cancer 11:4442-4452. |
| 1351 | Auzmendi-Iriarte J et.al. (2020). Characterization of a new small-molecule inhibitor of HDAC6 in glioblastoma. Cell Death Dis 11:417. |
| 1350 | Ding X et.al. (2020). The deubiquitinating enzyme UCHL1 promotes resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase. Theranostics 10:6048-6060. |
| 1349 | Shen L et.al. (2020). Skipping of exon 10 in Axl pre-mRNA regulated by PTBP1 mediates invasion and metastasis process of liver cancer cells. Theranostics 10:5719-5735. |
| 1348 | Xue S et.al. (2020). USP5 Promotes Metastasis in Non-Small Cell Lung Cancer by Inducing Epithelial-Mesenchymal Transition via Wnt/beta-Catenin Pathway. Front Pharmacol 11:668. |
| 1347 | Li X et.al. (2020). PLAP -CAR T cells mediate high specific cytotoxicity against colon cancer cells. Front Biosci (Landmark Ed) 25:1765-1786. |
| 1346 | Lee IN et.al. (2020). Knockdown of Amphiregulin Triggers Doxorubicin-Induced Autophagic and Apoptotic Death by Regulating Endoplasmic Reticulum Stress in Glioblastoma Cells. J Mol Neurosci 70:1461-1470. |
| 1345 | Guo M et.al. (2020). MUC1 plays an essential role in tumor immunity of colorectal cancer stem cell vaccine. Int Immunopharmacol 85:106631. |
| 1344 | Wu S et.al. (2020). UCP2 silencing in glioblastoma reduces cell proliferation and invasiveness by inhibiting p38 MAPK pathway. Exp Cell Res 394:112110. |
| 1343 | Vriend J et.al. (2020). Ubiquitin ligases and medulloblastoma: genetic markers of the four consensus subgroups identified through transcriptome datasets. Biochim Biophys Acta Mol Basis Dis 1866:165839. |
| 1342 | Cai Q et.al. (2020). IGFBP-3/IGFBP-3 Receptor System as an Anti-Tumor and Anti-Metastatic Signaling in Cancer. Cells 9:. |
| 1341 | Parodi S et.al. (2020). The Over-Expression of E2F3 Might Serve as Prognostic Marker for Neuroblastoma Patients with Stage 4S Disease. Diagnostics (Basel) 10:. |
| 1340 | Yu H et.al. (2020). LOXL1 confers antiapoptosis and promotes gliomagenesis through stabilizing BAG2. Cell Death Differ 27:3021-3036. |
| 1339 | Orlandella FM et.al. (2020). miR-622 is a novel potential biomarker of breast carcinoma and impairs motility of breast cancer cells through targeting NUAK1 kinase. Br J Cancer 123:426-437. |
| 1338 | Dorn A et.al. (2020). LINC00261 Is Differentially Expressed in Pancreatic Cancer Subtypes and Regulates a Pro-Epithelial Cell Identity. Cancers (Basel) 12:. |
| 1337 | Kang JY et.al. (2020). Neuropilin1 Expression Acts as a Prognostic Marker in Stomach Adenocarcinoma by Predicting the Infiltration of Treg Cells and M2 Macrophages. J Clin Med 9:. |
| 1336 | Gil M et.al. (2020). Systematic Multiomic Analysis of Ly75 Gene Expression and Its Prognostic Value Through the Infiltration of Natural Killer (NK) Cells in Skin Cutaneous Melanoma. J Clin Med 9:. |
| 1335 | Adam K et.al. (2020). The Potential Functional Roles of NME1 Histidine Kinase Activity in Neuroblastoma Pathogenesis. Int J Mol Sci 21:. |
| 1334 | Candido MF et.al. (2020). NF-small ka, CyrillicB inhibition by DHMEQ: in vitro antiproliferative effects on pilocytic astrocytoma and concise review of the current literature. Childs Nerv Syst 36:2675-2684. |
| 1333 | Bremer J et.al. (2020). A single supratentorial high-grade neuroepithelial tumor with two distinct BCOR mutations, exceptionally long complete remission and survival. Pediatr Blood Cancer 67:e28384. |
| 1332 | Bobyn A et.al. (2020). Ancestry and frequency of genetic variants in the general population are confounders in the characterization of germline variants linked to cancer. BMC Med Genet 21:92. |
| 1331 | Liu X et.al. (2020). HDAC10 Is Positively Associated With PD-L1 Expression and Poor Prognosis in Patients With NSCLC. Front Oncol 10:485. |
| 1330 | Chaturvedi NK et.al. (2020). A Novel Combination Approach Targeting an Enhanced Protein Synthesis Pathway in MYC-driven (Group 3) Medulloblastoma. Mol Cancer Ther 19:1351-1362. |
| 1329 | Hu Z et.al. (2020). Downregulation of GLYR1 contributes to microsatellite instability colorectal cancer by targeting p21 via the p38MAPK and PI3K/AKT pathways. J Exp Clin Cancer Res 39:76. |
| 1328 | Lin Z et.al. (2020). RNA m(6) A methylation regulates sorafenib resistance in liver cancer through FOXO3-mediated autophagy. EMBO J 39:e103181. |
| 1327 | Liu Y et.al. (2020). KIF23 activated Wnt/beta-catenin signaling pathway through direct interaction with Amer1 in gastric cancer. Aging (Albany NY) 12:8372-8396. |
| 1326 | Kim KK et.al. (2020). Role of trypsin and protease-activated receptor-2 in ovarian cancer. PLoS One 15:e0232253. |
| 1325 | Yu X et.al. (2020). Ubiquitination of the DNA-damage checkpoint kinase CHK1 by TRAF4 is required for CHK1 activation. J Hematol Oncol 13:40. |
| 1324 | Wang TX et.al. (2020). Identification of aberrantly methylated differentially expressed genes targeted by differentially expressed miRNA in osteosarcoma. Ann Transl Med 8:373. |
| 1323 | Chen X et.al. (2020). Bcl-3 promotes Wnt signaling by maintaining the acetylation of beta-catenin at lysine 49 in colorectal cancer. Signal Transduct Target Ther 5:52. |
| 1322 | Munoz-Galvan S et.al. (2020). PAI1 is a Marker of Bad Prognosis in Rectal Cancer but Predicts a Better Response to Treatment with PIM Inhibitor AZD1208. Cells 9:. |
| 1321 | Chen D et.al. (2020). LIN28B promotes neuroblastoma metastasis and regulates PDZ binding kinase. Neoplasia 22:231-241. |
| 1320 | Andolfo I et.al. (2020). Kinome multigenic panel identified novel druggable EPHB4-V871I somatic variant in high-risk neuroblastoma. J Cell Mol Med 24:6459-6471. |
| 1319 | Topi G et.al. (2020). Tumour-suppressive effect of oestrogen receptor beta in colorectal cancer patients, colon cancer cells, and a zebrafish model. J Pathol 251:297-309. |
| 1318 | Shen Y et.al. (2020). LncRNA KCNQ1OT1 sponges miR-34c-5p to promote osteosarcoma growth via ALDOA enhanced aerobic glycolysis. Cell Death Dis 11:278. |
| 1317 | Kovar H et.al. (2020). The YAP/TAZ Pathway in Osteogenesis and Bone Sarcoma Pathogenesis. Cells 9:. |
| 1316 | Li TF et.al. (2020). Overexpression of kinesin superfamily members as prognostic biomarkers of breast cancer. Cancer Cell Int 20:123. |
| 1315 | Dos Santos Klinger PH et.al. (2020). Arsenic Trioxide exerts cytotoxic and radiosensitizing effects in pediatric Medulloblastoma cell lines of SHH Subgroup. Sci Rep 10:6836. |
| 1314 | Zhao Y et.al. (2020). NUSAP1 potentiates chemoresistance in glioblastoma through its SAP domain to stabilize ATR. Signal Transduct Target Ther 5:44. |
| 1313 | Aldaregia J et.al. (2020). Erbb4 Is Required for Cerebellar Developmentand Malignant Phenotype of Medulloblastoma. Cancers (Basel) 12:. |
| 1312 | Cassandri M et.al. (2020). ZNF750 represses breast cancer invasion via epigenetic control of prometastatic genes. Oncogene 39:4331-4343. |
| 1311 | Keane S et.al. (2020). Low DLG2 gene expression, a link between 11q-deleted and MYCN-amplified neuroblastoma, causes forced cell cycle progression, and predicts poor patient survival. Cell Commun Signal 18:65. |
| 1310 | Martin SB et.al. (2020). Leucine and branched-chain amino acid metabolism contribute to the growth of bone sarcomas by regulating AMPK and mTORC1 signaling. Biochem J 477:1579-1599. |
| 1309 | Lan Z et.al. (2020). The Interaction Between lncRNA SNHG6 and hnRNPA1 Contributes to the Growth of Colorectal Cancer by Enhancing Aerobic Glycolysis Through the Regulation of Alternative Splicing of PKM. Front Oncol 10:363. |
| 1308 | Zhang D et.al. (2020). The Agpat4/LPA axis in colorectal cancer cells regulates antitumor responses via p38/p65 signaling in macrophages. Signal Transduct Target Ther 5:24. |
| 1307 | Koneru B et.al. (2020). Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma. Cancer Res 80:2663-2675. |
| 1306 | Li C et.al. (2020). Long non-coding RNA DLX6-AS1 regulates neuroblastoma progression by targeting YAP1 via miR-497-5p. Life Sci 252:117657. |
| 1305 | Chung PED et.al. (2020). Modeling germline mutations in pineoblastoma uncovers lysosome disruption-based therapy. Nat Commun 11:1825. |
| 1304 | Jiang S et.al. (2020). Identification of tumorigenicity-associated genes in osteosarcoma cell lines based on bioinformatic analysis and experimental validation. J Cancer 11:3623-3633. |
| 1303 | Berning P et.al. (2020). The Receptor Tyrosine Kinase RON and Its Isoforms as Therapeutic Targets in Ewing Sarcoma. Cancers (Basel) 12:. |
| 1302 | Deng Y et.al. (2020). High SPRR1A expression is associated with poor survival in patients with colon cancer. Oncol Lett 19:3417-3424. |
| 1301 | Parrilla A et.al. (2020). Aurora Borealis (Bora), Which Promotes Plk1 Activation by Aurora A, Has an Oncogenic Role in Ovarian Cancer. Cancers (Basel) 12:. |
| 1300 | Thiruvalluvan A et.al. (2020). DNAJB6, a Key Factor in Neuronal Sensitivity to Amyloidogenesis. Mol Cell 78:346-358.e9. |
| 1299 | Jane EP et.al. (2020). Targeting NAD(+) Biosynthesis Overcomes Panobinostat and Bortezomib-Induced Malignant Glioma Resistance. Mol Cancer Res 18:1004-1017. |
| 1298 | Tran HM et.al. (2020). Upregulation of Protein Synthesis and Proteasome Degradation Confers Sensitivity to Proteasome Inhibitor Bortezomib in Myc-Atypical Teratoid/Rhabdoid Tumors. Cancers (Basel) 12:. |
| 1297 | Li Z et.al. (2020). The dual role of BI 2536, a small-molecule inhibitor that targets PLK1, in induction of apoptosis and attenuation of autophagy in neuroblastoma cells. J Cancer 11:3274-3287. |
| 1296 | Schubert NA et.al. (2020). Systematic target actionability reviews of preclinical proof-of-concept papers to match targeted drugs to paediatric cancers. Eur J Cancer 130:168-181. |
| 1295 | Rotman J et.al. (2020). Adenocarcinoma of the Uterine Cervix Shows Impaired Recruitment of cDC1 and CD8(+) T Cells and Elevated beta-Catenin Activation Compared with Squamous Cell Carcinoma. Clin Cancer Res 26:3791-3802. |
| 1294 | Lu F et.al. (2020). Downregulation of TMOD1 promotes cell motility and cell proliferation in cervical cancer cells. Oncol Lett 19:3339-3348. |
| 1293 | Zhang Y et.al. (2020). FBXW4 Acts as a Protector of FOLFOX-Based Chemotherapy in Metastatic Colorectal Cancer Identified by Co-Expression Network Analysis. Front Genet 11:113. |
| 1292 | Szemes M et.al. (2020). A Wnt-BMP4 Signaling Axis Induces MSX and NOTCH Proteins and Promotes Growth Suppression and Differentiation in Neuroblastoma. Cells 9:. |
| 1291 | Reaman G et.al. (2020). Crossing Oceans: Preclinical Collaboration to Improve Pediatric Drug Development. Am Soc Clin Oncol Educ Book 40:1-8. |
| 1290 | Du W et.al. (2020). MiR-195-5p is a Potential Factor Responsible for CPNE1 Differential Expression between Subtypes of Non-Small Cell Lung Cancer. J Cancer 11:2610-2620. |
| 1289 | Galenkamp KMO et.al. (2020). Golgi Acidification by NHE7 Regulates Cytosolic pH Homeostasis in Pancreatic Cancer Cells. Cancer Discov 10:822-835. |
| 1288 | Louis-Brennetot C et.al. (2020). High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma. EBioMedicine 53:102702. |
| 1287 | Camero S et.al. (2020). BET inhibition therapy counteracts cancer cell survival, clonogenic potential and radioresistance mechanisms in rhabdomyosarcoma cells. Cancer Lett 479:71-88. |
| 1286 | Kavazovic I et.al. (2020). Eomes broadens the scope of CD8 T-cell memory by inhibiting apoptosis in cells of low affinity. PLoS Biol 18:e3000648. |
| 1285 | Vega FM et.al. (2020). Response to High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma. EBioMedicine 53:102703. |
| 1284 | Steins A et.al. (2020). High-grade mesenchymal pancreatic ductal adenocarcinoma drives stromal deactivation through CSF-1. EMBO Rep 21:e48780. |
| 1283 | Meel MH et.al. (2020). Combined Therapy of AXL and HDAC Inhibition Reverses Mesenchymal Transition in Diffuse Intrinsic Pontine Glioma. Clin Cancer Res 26:3319-3332. |
| 1282 | Wu PK et.al. (2020). Mortalin (HSPA9) facilitates BRAF-mutant tumor cell survival by suppressing ANT3-mediated mitochondrial membrane permeability. Sci Signal 13:. |
| 1281 | Belisario DC et.al. (2020). ABCA1/ABCB1 Ratio Determines Chemo Cells 9:. |
| 1280 | Banerjee S et.al. (2020). Pyridoxine enhances chemo-responsiveness of breast cancer stem cells via redox reconditioning. Free Radic Biol Med 152:152-165. |
| 1279 | Gunnarsdottir FB et.al. (2020). Inflammatory macrophage derived TNFalpha downregulates estrogen receptor alpha via FOXO3a inactivation in human breast cancer cells. Exp Cell Res 390:111932. |
| 1278 | Kanchan RK et.al. (2020). MiR-1253 exerts tumor-suppressive effects in medulloblastoma via inhibition of CDK6 and CD276 (B7-H3). Brain Pathol 30:732-745. |
| 1277 | Brack E et.al. (2020). Fenretinide induces a new form of dynamin-dependent cell death in pediatric sarcoma. Cell Death Differ 27:2500-2516. |
| 1276 | Yang J et.al. (2020). Antibiotic tigecycline inhibits cell proliferation, migration and invasion via down-regulating CCNE2 in pancreatic ductal adenocarcinoma. J Cell Mol Med 24:4245-4260. |
| 1275 | Prieto-Garcia C et.al. (2020). Maintaining protein stability of Np63 via USP28 is required by squamous cancer cells. EMBO Mol Med 12:e11101. |
| 1274 | Dong Z et.al. (2020). FOXO3aSIRT6 axis suppresses aerobic glycolysis in melanoma. Int J Oncol 56:728-742. |
| 1273 | Salerno D et.al. (2020). Hepatitis B protein HBx binds the DLEU2 lncRNA to sustain cccDNA and host cancer-related gene transcription. Gut 69:2016-2024. |
| 1272 | Quintanal-Villalonga A et.al. (2020). FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacy. EBioMedicine 53:102683. |
| 1271 | Niesen J et.al. (2020). Pik3ca mutations significantly enhance the growth of SHH medulloblastoma and lead to metastatic tumour growth in a novel mouse model. Cancer Lett 477:10-18. |
| 1270 | Yang X et.al. (2020). METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST. Mol Cancer 19:46. |
| 1269 | Schnetz M et.al. (2020). The Disturbed Iron Phenotype of Tumor Cells and Macrophages in Renal Cell Carcinoma Influences Tumor Growth. Cancers (Basel) 12:. |
| 1268 | Zhou L et.al. (2020). NOTCH4 maintains quiescent mesenchymal-like breast cancer stem cells via transcriptionally activating SLUG and GAS1 in triple-negative breast cancer. Theranostics 10:2405-2421. |
| 1267 | Avitabile M et.al. (2020). Association of PARP1 polymorphisms with response to chemotherapy in patients with high-risk neuroblastoma. J Cell Mol Med 24:4072-4081. |
| 1266 | Wagner M et.al. (2020). Tumor-Derived Lactic Acid Contributes to the Paucity of Intratumoral ILC2s. Cell Rep 30:2743-2757.e5. |
| 1265 | Kim KK et.al. (2020). Development of Potent Forchlorfenuron Analogs and Their Cytotoxic Effect in Cancer Cell Lines. Sci Rep 10:3241. |
| 1264 | Jafarzadeh M et.al. (2020). Epigenetically silenced LINC02381 functions as a tumor suppressor by regulating PI3K-Akt signaling pathway. Biochimie 171-172:63-71. |
| 1263 | Jiang Y et.al. (2020). BICD1 functions as a prognostic biomarker and promotes hepatocellular carcinoma progression. Pathol Res Pract 216:152858. |
| 1262 | Zhao Z et.al. (2020). The PLAGL2/MYCN/miR-506-3p interplay regulates neuroblastoma cell fate and associates with neuroblastoma progression. J Exp Clin Cancer Res 39:41. |
| 1261 | Khanna A et.al. (2020). Constitutive CHK1 Expression Drives a pSTAT3-CIP2A Circuit that Promotes Glioblastoma Cell Survival and Growth. Mol Cancer Res 18:709-722. |
| 1260 | Guo YF et.al. (2020). Inhibition of the ALDH18A1-MYCN positive feedback loop attenuates MYCN-amplified neuroblastoma growth. Sci Transl Med 12:. |
| 1259 | Mekhloufi A et.al. (2020). Bone Marrow Stromal Cell-Derived IL-8 Upregulates PVR Expression on Multiple Myeloma Cells via NF-kB Transcription Factor. Cancers (Basel) 12:. |
| 1258 | Goroshchuk O et.al. (2020). Targeting Plk1 with siRNNs in primary cells from pediatric B-cell acute lymphoblastic leukemia patients. Sci Rep 10:2688. |
| 1257 | Liu Z et.al. (2020). CASZ1 induces skeletal muscle and rhabdomyosarcoma differentiation through a feed-forward loop with MYOD and MYOG. Nat Commun 11:911. |
| 1256 | Yamashita D et.al. (2020). Targeting glioma-initiating cells via the tyrosine metabolic pathway. J Neurosurg 134:721-732. |
| 1255 | da Cunha Jaeger M et.al. (2020). HDAC and MAPK/ERK Inhibitors Cooperate To Reduce Viability and Stemness in Medulloblastoma. J Mol Neurosci 70:981-992. |
| 1254 | Aichmuller CF et.al. (2020). Pilocytic astrocytoma demethylation and transcriptional landscapes link bZIP transcription factors to immune response. Neuro Oncol 22:1327-1338. |
| 1253 | Di Magno L et.al. (2020). Phenformin Inhibits Hedgehog-Dependent Tumor Growth through a Complex I-Independent Redox/Corepressor Module. Cell Rep 30:1735-1752.e7. |
| 1252 | Cimmino F et.al. (2020). Functional characterization of full-length BARD1 strengthens its role as a tumor suppressor in neuroblastoma. J Cancer 11:1495-1504. |
| 1251 | Richter AM et.al. (2020). RASSF10 is frequently epigenetically inactivated in kidney cancer and its knockout promotes neoplasia in cancer prone mice. Oncogene 39:3114-3127. |
| 1250 | Tang K et.al. (2020). Shear stress stimulates integrin beta1 trafficking and increases directional migration of cancer cells via promoting deacetylation of microtubules. Biochim Biophys Acta Mol Cell Res 1867:118676. |
| 1249 | Chen XS et.al. (2020). UCH-L1-mediated Down-regulation of Estrogen Receptor alpha Contributes to Insensitivity to Endocrine Therapy for Breast Cancer. Theranostics 10:1833-1848. |
| 1248 | Mohapatra P et.al. (2020). WNT5A-Induced Activation of the Protein Kinase C Substrate MARCKS Is Required for Melanoma Cell Invasion. Cancers (Basel) 12:. |
| 1247 | Li Y et.al. (2020). Acetate supplementation restores chromatin accessibility and promotes tumor cell differentiation under hypoxia. Cell Death Dis 11:102. |
| 1246 | Sun L et.al. (2020). LncRNA RUNX1-IT1 which is downregulated by hypoxia-driven histone deacetylase 3 represses proliferation and cancer stem-like properties in hepatocellular carcinoma cells. Cell Death Dis 11:95. |
| 1245 | Palombo R et.al. (2020). Poison-Exon Inclusion in DHX9 Reduces Its Expression and Sensitizes Ewing Sarcoma Cells to Chemotherapeutic Treatment. Cells 9:. |
| 1244 | Li YH et.al. (2020). PRMT5-TRIM21 interaction regulates the senescence of osteosarcoma cells by targeting the TXNIP/p21 axis. Aging (Albany NY) 12:2507-2529. |
| 1243 | Song X et.al. (2020). Role of SSH1 in colorectal cancer prognosis and tumor progression. J Gastroenterol Hepatol 35:1180-1188. |
| 1242 | Bufalieri F et.al. (2020). The RNA-Binding Ubiquitin Ligase MEX3A Affects Glioblastoma Tumorigenesis by Inducing Ubiquitylation and Degradation of RIG-I. Cancers (Basel) 12:. |
| 1241 | Richter GHS et.al. (2020). Combined Inhibition of Epigenetic Readers and Transcription Initiation Targets the EWS-ETS Transcriptional Program in Ewing Sarcoma. Cancers (Basel) 12:. |
| 1240 | Andersson MK et.al. (2020). ATR is a MYB regulated gene and potential therapeutic target in adenoid cystic carcinoma. Oncogenesis 9:5. |
| 1239 | Ballabio C et.al. (2020). Modeling medulloblastoma in vivo and with human cerebellar organoids. Nat Commun 11:583. |
| 1238 | Lu Y et.al. (2020). TRIB3 confers glioma cell stemness via interacting with beta-catenin. Environ Toxicol 35:697-706. |
| 1237 | Li X et.al. (2020). Critical Role of Matrix Metalloproteinase 14 in Adipose Tissue Remodeling during Obesity. Mol Cell Biol 40:. |
| 1236 | Zhang Y et.al. (2020). Overexpressed CES2 has prognostic value in CRC and knockdown CES2 reverses L-OHP-resistance in CRC cells by inhibition of the PI3K signaling pathway. Exp Cell Res 389:111856. |
| 1235 | Yu M et.al. (2020). CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated feedforward circuit enforces an immune checkpoint. Nat Commun 11:515. |
| 1234 | Karim MA et.al. (2020). A Multi-Omics Analysis of Bone Morphogenetic Protein 5 (BMP5) mRNA Expression and Clinical Prognostic Outcomes in Different Cancers Using Bioinformatics Approaches. Biomedicines 8:. |
| 1233 | Sommer J et.al. (2020). Four-And-A-Half LIM-Domain Protein 2 (FHL2) Deficiency Aggravates Cholestatic Liver Injury. Cells 9:. |
| 1232 | Ognibene M et.al. (2020). Identification of a minimal region of loss on chromosome 6q27 associated with poor survival of high-risk neuroblastoma patients. Cancer Biol Ther 21:391-399. |
| 1231 | Meijer BJ et.al. (2020). ATF2 and ATF7 Are Critical Mediators of Intestinal Epithelial Repair. Cell Mol Gastroenterol Hepatol 10:23-42. |
| 1230 | Wijaya J et.al. (2020). An ABC Transporter Drives Medulloblastoma Pathogenesis by Regulating Sonic Hedgehog Signaling. Cancer Res 80:1524-1537. |
| 1229 | Wang F et.al. (2020). WDR5-Myc axis promotes the progression of glioblastoma and neuroblastoma by transcriptional activating CARM1. Biochem Biophys Res Commun 523:699-706. |
| 1228 | Persson CU et.al. (2020). ARNT-dependent HIF-2 transcriptional activity is not sufficient to regulate downstream target genes in neuroblastoma. Exp Cell Res 388:111845. |
| 1227 | Aldaz P et.al. (2020). SOX9 promotes tumor progression through the axis BMI1-p21(CIP). Sci Rep 10:357. |
| 1226 | Mus LM et.al. (2020). The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness. Sci Rep 10:218. |
| 1225 | Chen X et.al. (2020). alpha5-nAChR contributes to epithelial-mesenchymal transition and metastasis by regulating Jab1/Csn5 signalling in lung cancer. J Cell Mol Med 24:2497-2506. |
| 1224 | Munoz-Galvan S et.al. (2020). Downregulation of MYPT1 increases tumor resistance in ovarian cancer by targeting the Hippo pathway and increasing the stemness. Mol Cancer 19:7. |
| 1223 | Saric N et.al. (2020). The AHR pathway represses TGFbeta-SMAD3 signalling and has a potent tumour suppressive role in SHH medulloblastoma. Sci Rep 10:148. |
| 1222 | Wang G et.al. (2020). Arf1-mediated lipid metabolism sustains cancer cells and its ablation induces anti-tumor immune responses in mice. Nat Commun 11:220. |
| 1221 | Hsieh MJ et.al. (2020). Basic fibroblast growth factor promotes doxorubicin resistance in chondrosarcoma cells by affecting XRCC5 expression. Mol Carcinog 59:293-303. |
| 1220 | Gritsenko PG et.al. (2020). p120-catenin-dependent collective brain infiltration by glioma cell networks. Nat Cell Biol 22:97-107. |
| 1219 | Huang M et.al. (2020). Epigenetic Targeting of TERT-Associated Gene Expression Signature in Human Neuroblastoma with TERT Overexpression. Cancer Res 80:1024-1035. |
| 1218 | Hnit SST et.al. (2020). Transcriptional regulation of G2/M regulatory proteins and perturbation of G2/M Cell cycle transition by a traditional Chinese medicine recipe. J Ethnopharmacol 251:112526. |
| 1217 | Ommer J et.al. (2020). Aurora A Kinase Inhibition Destabilizes PAX3-FOXO1 and MYCN and Synergizes with Navitoclax to Induce Rhabdomyosarcoma Cell Death. Cancer Res 80:832-842. |
| 1216 | Shen Z et.al. (2020). SNX16 activates c-Myc signaling by inhibiting ubiquitin-mediated proteasomal degradation of eEF1A2 in colorectal cancer development. Mol Oncol 14:387-406. |
| 1215 | Zhao PF et.al. (2020). LPA receptor1 antagonists as anticancer agents suppress human lung tumours. Eur J Pharmacol 868:172886. |
| 1214 | Park SR et.al. (2020). Sonic Hedgehog, a Novel Endogenous Damage Signal, Activates Multiple Beneficial Functions of Human Endometrial Stem Cells. Mol Ther 28:452-465. |
| 1213 | Vrenken KS et.al. (2020). The transcriptional repressor SNAI2 impairs neuroblastoma differentiation and inhibits response to retinoic acid therapy. Biochim Biophys Acta Mol Basis Dis 1866:165644. |
| 1212 | Zhang G et.al. (2020). Elevated GALNT10 expression identifies immunosuppressive microenvironment and dismal prognosis of patients with high grade serous ovarian cancer. Cancer Immunol Immunother 69:175-187. |
| 1211 | Koche RP et.al. (2020). Extrachromosomal circular DNA drives oncogenic genome remodeling in neuroblastoma. Nat Genet 52:29-34. |
| 1210 | Green AL et.al. (2020). BPTF regulates growth of adult and pediatric high-grade glioma through the MYC pathway. Oncogene 39:2305-2327. |
| 1209 | Gagliardi F et.al. (2020). Enhanced SPARCL1 expression in cancer stem cells improves preclinical modeling of glioblastoma by promoting both tumor infiltration and angiogenesis. Neurobiol Dis 134:104705. |
| 1208 | Gao J et.al. (2020). Up-regulated LINC00261 predicts a poor prognosis and promotes a metastasis by EMT process in cholangiocarcinoma. Pathol Res Pract 216:152733. |
| 1207 | Qin X et.al. (2020). Matrix stiffness modulates ILK-mediated YAP activation to control the drug resistance of breast cancer cells. Biochim Biophys Acta Mol Basis Dis 1866:165625. |
| 1206 | Capasso M et.al. (2020). Transcription Factors Involved in Tumorigenesis Are Over-Represented in Mutated Active DNA-Binding Sites in Neuroblastoma. Cancer Res 80:382-393. |
| 1205 | Rehwald C et.al. (2020). The iron load of lipocalin-2 (LCN-2) defines its pro-tumour function in clear-cell renal cell carcinoma. Br J Cancer 122:421-433. |
| 1204 | Zhang W et.al. (2020). miR-1225-5p Functions as a Tumor Suppressor in Osteosarcoma by Targeting Sox9. DNA Cell Biol 39:78-91. |
| 1203 | Chen KS et.al. (2020). Transcription factors NFIA and NFIB induce cellular differentiation in high-grade astrocytoma. J Neurooncol 146:41-53. |
| 1202 | Amoroso L et.al. (2020). Genomic coamplification of CDK4/MDM2/FRS2 is associated with very poor prognosis and atypical clinical features in neuroblastoma patients. Genes Chromosomes Cancer 59:277-285. |
| 1201 | Liu Q et.al. (2020). ATAD2 predicts poor outcomes in patients with ovarian cancer and is a marker of proliferation. Int J Oncol 56:219-231. |
| 1200 | Andolfo I et.al. (2020). Gain-of-function mutations in PIEZO1 directly impair hepatic iron metabolism via the inhibition of the BMP/SMADs pathway. Am J Hematol 95:188-197. |
| 1199 | Tas ML et.al. (2020). Neuroblastoma stage 4S: Tumor regression rate and risk factors of progressive disease. Pediatr Blood Cancer 67:e28061. |
| 1198 | Steins A et.al. (2020). Rapid stromal remodeling by short-term VEGFR2 inhibition increases chemotherapy delivery in esophagogastric adenocarcinoma. Mol Oncol 14:704-720. |
| 1197 | Wang J et.al. (2020). BRD4 promotes glioma cell stemness via enhancing miR-142-5p-mediated activation of Wnt/beta-catenin signaling. Environ Toxicol 35:368-376. |
| 1196 | Meyer LK et.al. (2020). Glucocorticoids paradoxically facilitate steroid resistance in T cell acute lymphoblastic leukemias and thymocytes. J Clin Invest 130:863-876. |
| 1195 | Qian M et.al. (2020). BCL11B regulates MICA/B-mediated immune response by acting as a competitive endogenous RNA. Oncogene 39:1514-1526. |
| 1194 | Bong AHL et.al. (2020). NCS-1 expression is higher in basal breast cancers and regulates calcium influx and cytotoxic responses to doxorubicin. Mol Oncol 14:87-104. |
| 1193 | Li J et.al. (2020). CDGSH Iron Sulfur Domain 2 Deficiency Inhibits Cell Proliferation and Induces Cell Differentiation of Neuroblastoma. Pathol Oncol Res 26:1725-1733. |
| 1192 | Mercatelli N et.al. (2020). Small molecule inhibition of Ewing sarcoma cell growth via targeting the long non coding RNA HULC. Cancer Lett 469:111-123. |
| 1191 | Chava S et.al. (2020). miR-15a-5p, miR-15b-5p, and miR-16-5p inhibit tumor progression by directly targeting MYCN in neuroblastoma. Mol Oncol 14:180-196. |
| 1190 | Kosti A et.al. (2020). ELF4 Is a Target of miR-124 and Promotes Neuroblastoma Proliferation and Undifferentiated State. Mol Cancer Res 18:68-78. |
| 1189 | Cai L et.al. (2020). The let-7c/HoxB7 axis regulates the cell proliferation, migration and apoptosis in hepatocellular carcinoma. Anticancer Drugs 31:6-18. |
| 1188 | Hwang JH et.al. (2020). A mutant KRAS-induced factor REG4 promotes cancer stem cell properties via Wnt/beta-catenin signaling. Int J Cancer 146:2877-2890. |
| 1187 | Veschi V et.al. (2020). Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant. Oncogene 39:987-1003. |
| 1186 | Tong L et.al. (2020). CLEC5A expressed on myeloid cells as a M2 biomarker relates to immunosuppression and decreased survival in patients with glioma. Cancer Gene Ther 27:669-679. |
| 1185 | Record J et.al. (2020). An intronic deletion in megakaryoblastic leukemia 1 is associated with hyperproliferation of B cells in triplets with Hodgkin lymphoma. Haematologica 105:1339-1350. |
| 1184 | Mason B et.al. (2020). Fbxl17 is rearranged in breast cancer and loss of its activity leads to increased global O-GlcNAcylation. Cell Mol Life Sci 77:2605-2620. |
| 1183 | Chi J et.al. (2020). AGR3 promotes the stemness of colorectal cancer via modulating Wnt/beta-catenin signalling. Cell Signal 65:109419. |
| 1182 | Meel MH et.al. (2020). MEK/MELK inhibition and blood-brain barrier deficiencies in atypical teratoid/rhabdoid tumors. Neuro Oncol 22:58-69. |
| 1181 | Adamus A et.al. (2020). SGPL1(321) mutation: one main trigger for invasiveness of pediatric alveolar rhabdomyosarcoma. Cancer Gene Ther 27:571-584. |
| 1180 | Javanmardi N et.al. (2020). Analysis of ALK, MYCN, and the ALK ligand ALKAL2 (FAM150B/AUGalpha) in neuroblastoma patient samples with chromosome arm 2p rearrangements. Genes Chromosomes Cancer 59:50-57. |
| 1179 | Somers K et.al. (2020). Potent antileukemic activity of curaxin CBL0137 against MLL-rearranged leukemia. Int J Cancer 146:1902-1916. |
| 1178 | Grasso S et.al. (2020). The SRCIN1/p140Cap adaptor protein negatively regulates the aggressiveness of neuroblastoma. Cell Death Differ 27:790-807. |
| 1177 | Wang L et.al. (2020). ATF3 promotes erastin-induced ferroptosis by suppressing system Xc(). Cell Death Differ 27:662-675. |
| 1176 | Tsvankin V et.al. (2020). ABC Transporter Inhibition Plus Dexamethasone Enhances the Efficacy of Convection Enhanced Delivery in H3.3K27M Mutant Diffuse Intrinsic Pontine Glioma. Neurosurgery 86:742-751. |
| 1175 | Saha SK et.al. (2020). PROM1 and PROM2 expression differentially modulates clinical prognosis of cancer: a multiomics analysis. Cancer Gene Ther 27:147-167. |
| 1174 | Fan Y et.al. (2020). Expression profile and bioinformatics analysis of COMMD10 in BALB/C mice and human. Cancer Gene Ther 27:216-225. |
| 2019 (n=313) |
| 1173 | van Wezel EM et.al. (2019). Mesenchymal Neuroblastoma Cells Are Undetected by Current mRNA Marker Panels: The Development of a Specific Neuroblastoma Mesenchymal Minimal Residual Disease Panel. JCO Precis Oncol 3:. |
| 1172 | Chaib I et.al. (2019). Osimertinib and dihydroartemisinin: a novel drug combination targeting head and neck squamous cell carcinoma. Ann Transl Med 7:651. |
| 1171 | Guo S et.al. (2019). Novel Breast-Specific Long Non-coding RNA LINC00993 Acts as a Tumor Suppressor in Triple-Negative Breast Cancer. Front Oncol 9:1325. |
| 1170 | Prajapati B et.al. (2019). Identification of lncRNAs Associated With Neuroblastoma in Cross-Sectional Databases: Potential Biomarkers. Front Mol Neurosci 12:293. |
| 1169 | Wang K et.al. (2019). Long Non-Coding RNA LINC00511 Mediates the Effects of ESR1 on Proliferation and Invasion of Ovarian Cancer Through miR-424-5p and miR-370-5p. Cancer Manag Res 11:10807-10819. |
| 1168 | Xu Z et.al. (2019). Demethylation and Overexpression of CSF2 are Involved in Immune Response, Chemotherapy Resistance, and Poor Prognosis in Colorectal Cancer. Onco Targets Ther 12:11255-11269. |
| 1167 | Yang L et.al. (2019). Silencing or inhibition of H3K79 methyltransferase DOT1L induces cell cycle arrest by epigenetically modulating c-Myc expression in colorectal cancer. Clin Epigenetics 11:199. |
| 1166 | Wang X et.al. (2019). Downregulated SPINK4 is associated with poor survival in colorectal cancer. BMC Cancer 19:1258. |
| 1165 | Dyberg C et.al. (2019). Inhibition of Rho-Associated Kinase Suppresses Medulloblastoma Growth. Cancers (Basel) 12:. |
| 1164 | Salcher S et.al. (2019). Repaglinide Silences the FOXO3/Lumican Axis and Represses the Associated Metastatic Potential of Neuronal Cancer Cells. Cells 9:. |
| 1163 | Pai S et.al. (2019). CD47-SIRPalpha Signaling Induces Epithelial-Mesenchymal Transition and Cancer Stemness and Links to a Poor Prognosis in Patients with Oral Squamous Cell Carcinoma. Cells 8:. |
| 1162 | Ding Y et.al. (2019). MYCN and PRC1 cooperatively repress docosahexaenoic acid synthesis in neuroblastoma via ELOVL2. J Exp Clin Cancer Res 38:498. |
| 1161 | Tranchevent LC et.al. (2019). A deep neural network approach to predicting clinical outcomes of neuroblastoma patients. BMC Med Genomics 12:178. |
| 1160 | Slomp A et.al. (2019). Multiple myeloma with 1q21 amplification is highly sensitive to MCL-1 targeting. Blood Adv 3:4202-4214. |
| 1159 | Zhong X et.al. (2019). Cellular components in tumor microenvironment of neuroblastoma and the prognostic value. PeerJ 7:e8017. |
| 1158 | Nguyen HD et.al. (2019). The alpha9 Nicotinic Acetylcholine Receptor Mediates Nicotine-Induced PD-L1 Expression and Regulates Melanoma Cell Proliferation and Migration. Cancers (Basel) 11:. |
| 1157 | Neve A et.al. (2019). Crosstalk between SHH and FGFR Signaling Pathways Controls Tissue Invasion in Medulloblastoma. Cancers (Basel) 11:. |
| 1156 | Almutairi B et.al. (2019). Epigenetic deregulation of GATA3 in neuroblastoma is associated with increased GATA3 protein expression and with poor outcomes. Sci Rep 9:18934. |
| 1155 | Zhang S et.al. (2019). N-myc downstream-regulated gene 1 inhibits the proliferation of colorectal cancer through emulative antagonizing NEDD4-mediated ubiquitylation of p21. J Exp Clin Cancer Res 38:490. |
| 1154 | Luo Y et.al. (2019). miR-624-5p promoted tumorigenesis and metastasis by suppressing hippo signaling through targeting PTPRB in osteosarcoma cells. J Exp Clin Cancer Res 38:488. |
| 1153 | Dudzik P et.al. (2019). Aberrant promoter methylation may be responsible for the control of CD146 (MCAM) gene expression during breast cancer progression. Acta Biochim Pol 66:619-625. |
| 1152 | Xu Y et.al. (2019). TRIM proteins in neuroblastoma. Biosci Rep 39:. |
| 1151 | Wang L et.al. (2019). ASCL1 is a MYCN Nat Commun 10:5622. |
| 1150 | Richter AM et.al. (2019). RASSF10 Is a TGFbeta-Target That Regulates ASPP2 and E-Cadherin Expression and Acts as Tumor Suppressor That Is Epigenetically Downregulated in Advanced Cancer. Cancers (Basel) 11:. |
| 1149 | Dong W et.al. (2019). CARF, As An Oncogene, Promotes Colorectal Cancer Stemness By Activating ERBB Signaling Pathway. Onco Targets Ther 12:9041-9051. |
| 1148 | Lambo S et.al. (2019). The molecular landscape of ETMR at diagnosis and relapse. Nature 576:274-280. |
| 1147 | Deutschmeyer V et.al. (2019). Epigenetic therapy of novel tumour suppressor ZAR1 and its cancer biomarker function. Clin Epigenetics 11:182. |
| 1146 | He Y et.al. (2019). Clinical and transcriptional signatures of human CD204 reveal an applicable marker for the protumor phenotype of tumor-associated macrophages in breast cancer. Aging (Albany NY) 11:10883-10901. |
| 1145 | Wu S et.al. (2019). Silencing expression of PHF14 in glioblastoma promotes apoptosis, mitigates proliferation and invasiveness via Wnt signal pathway. Cancer Cell Int 19:314. |
| 1144 | Boloix A et.al. (2019). Long Non-coding RNA PVT1 as a Prognostic and Therapeutic Target in Pediatric Cancer. Front Oncol 9:1173. |
| 1143 | Trigg RM et.al. (2019). The targetable kinase PIM1 drives ALK inhibitor resistance in high-risk neuroblastoma independent of MYCN status. Nat Commun 10:5428. |
| 1142 | Yuan F et.al. (2019). Identification of Key Pathways and Genes in the Orai2 Mediated Classical and Mesenchymal Subtype of Glioblastoma by Bioinformatic Analyses. Dis Markers 2019:7049294. |
| 1141 | Yari H et.al. (2019). LncRNA REG1CP promotes tumorigenesis through an enhancer complex to recruit FANCJ helicase for REG3A transcription. Nat Commun 10:5334. |
| 1140 | Treisman DM et.al. (2019). Sox2(+) cells in Sonic Hedgehog-subtype medulloblastoma resist p53-mediated cell-cycle arrest response and drive therapy-induced recurrence. Neurooncol Adv 1:vdz027. |
| 1139 | Trojan SE et.al. (2019). The influence of PFK-II overexpression on neuroblastoma patients survival may be dependent on the particular isoenzyme expressed, PFKFB3 or PFKFB4. Cancer Cell Int 19:292. |
| 1138 | Cancer M et.al. (2019). BET and Aurora Kinase A inhibitors synergize against MYCN-positive human glioblastoma cells. Cell Death Dis 10:881. |
| 1137 | Zhang G et.al. (2019). TRIP13 promotes the cell proliferation, migration and invasion of glioblastoma through the FBXW7/c-MYC axis. Br J Cancer 121:1069-1078. |
| 1136 | Li C et.al. (2019). Low Expression of 14-3-3beta Is Associated With Adverse Survival of Diffuse Large B-Cell Lymphoma Patients. Front Med (Lausanne) 6:237. |
| 1135 | Metselaar DS et.al. (2019). Celastrol-induced degradation of FANCD2 sensitizes pediatric high-grade gliomas to the DNA-crosslinking agent carboplatin. EBioMedicine 50:81-92. |
| 1134 | Gil M et.al. (2019). Interleukin-18 Is a Prognostic Biomarker Correlated with CD8(+) T Cell and Natural Killer Cell Infiltration in Skin Cutaneous Melanoma. J Clin Med 8:. |
| 1133 | Song H et.al. (2019). LHX2 promotes malignancy and inhibits autophagy via mTOR in osteosarcoma and is negatively regulated by miR-129-5p. Aging (Albany NY) 11:9794-9810. |
| 1132 | Wang Q et.al. (2019). The Histone Demethylase NO66 Induces Glioma Cell Proliferation. Anticancer Res 39:6007-6014. |
| 1131 | Chaturvedi NK et.al. (2019). Role of protein arginine methyltransferase 5 in group 3 (MYC-driven) Medulloblastoma. BMC Cancer 19:1056. |
| 1130 | Dong Z et.al. (2019). MYST1/KAT8 contributes to tumor progression by activating EGFR signaling in glioblastoma cells. Cancer Med 8:7793-7808. |
| 1129 | Liu PY et.al. (2019). The long noncoding RNA lncNB1 promotes tumorigenesis by interacting with ribosomal protein RPL35. Nat Commun 10:5026. |
| 1128 | Vega FM et.al. (2019). CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours. EBioMedicine 49:82-95. |
| 1127 | Su J et.al. (2019). LCTL Is a Prognostic Biomarker and Correlates With Stromal and Immune Infiltration in Gliomas. Front Oncol 9:1083. |
| 1126 | Lebedev TD et.al. (2019). Two Receptors, Two Isoforms, Two Cancers: Comprehensive Analysis of KIT and TrkA Expression in Neuroblastoma and Acute Myeloid Leukemia. Front Oncol 9:1046. |
| 1125 | Shangguan W et.al. (2019). FoxD2-AS1 is a prognostic factor in glioma and promotes temozolomide resistance in a O(6)-methylguanine-DNA methyltransferase-dependent manner. Korean J Physiol Pharmacol 23:475-482. |
| 1124 | Oliynyk G et.al. (2019). MYCN-enhanced Oxidative and Glycolytic Metabolism Reveals Vulnerabilities for Targeting Neuroblastoma. iScience 21:188-204. |
| 1123 | El-Naggar AM et.al. (2019). Class I HDAC inhibitors enhance YB-1 acetylation and oxidative stress to block sarcoma metastasis. EMBO Rep 20:e48375. |
| 1122 | Fang Y et.al. (2019). Spica Prunellae Extract Enhances Fluorouracil Sensitivity of 5-Fluorouracil-Resistant Human Colon Carcinoma HCT-8/5-FU Cells via TOP2alpha and miR-494. Biomed Res Int 2019:5953619. |
| 1121 | Wang Y et.al. (2019). Integrated analysis of transcriptome-wide m(6)A methylome of osteosarcoma stem cells enriched by chemotherapy. Epigenomics 11:1693-1715. |
| 1120 | Yin C et.al. (2019). G9a promotes cell proliferation and suppresses autophagy in gastric cancer by directly activating mTOR. FASEB J 33:14036-14050. |
| 1119 | Smirnov A et.al. (2019). Transglutaminase 3 is expressed in basal cell carcinoma of the skin. Eur J Dermatol 29:477-483. |
| 1118 | Kostopoulou ON et.al. (2019). Analyses of FGFR3 and PIK3CA mutations in neuroblastomas and the effects of the corresponding inhibitors on neuroblastoma cell lines. Int J Oncol 55:1372-1384. |
| 1117 | Wang R et.al. (2019). Histone methyltransferase SUV39H2 regulates cell growth and chemosensitivity in glioma via regulation of hedgehog signaling. Cancer Cell Int 19:269. |
| 1116 | Xu Y et.al. (2019). Overexpression of Rad51 predicts poor prognosis and silencing of Rad51 increases chemo-sensitivity to doxorubicin in neuroblastoma. Am J Transl Res 11:5788-5799. |
| 1115 | Gu J et.al. (2019). PTPRU, As A Tumor Suppressor, Inhibits Cancer Stemness By Attenuating Hippo/YAP Signaling Pathway. Onco Targets Ther 12:8095-8104. |
| 1114 | Cheung CHY et.al. (2019). Combinatorial targeting of MTHFD2 and PAICS in purine synthesis as a novel therapeutic strategy. Cell Death Dis 10:786. |
| 1113 | Frisira E et.al. (2019). NPI-0052 and gamma-radiation induce a synergistic apoptotic effect in medulloblastoma. Cell Death Dis 10:785. |
| 1112 | Passariello A et.al. (2019). PATZ1 Is Overexpressed in Pediatric Glial Tumors and Correlates with Worse Event-Free Survival in High-grade Gliomas. Cancers (Basel) 11:. |
| 1111 | Li J et.al. (2019). AGR2 is controlled by DNMT3a-centered signaling module and mediates tumor resistance to 5-Aza in colorectal cancer. Exp Cell Res 385:111644. |
| 1110 | Kaesler S et.al. (2019). Targeting tumor-resident mast cells for effective anti-melanoma immune responses. JCI Insight 4:. |
| 1109 | Zhu J et.al. (2019). Engrailed 1 overexpression as a potential prognostic marker in Lower Grade Glioma. PeerJ 7:e7414. |
| 1108 | Fekry B et.al. (2019). HNF4alpha-Deficient Fatty Liver Provides a Permissive Environment for Sex-Independent Hepatocellular Carcinoma. Cancer Res 79:5860-5873. |
| 1107 | Mazzocchi M et.al. (2019). Gene Co-expression Analysis Identifies Histone Deacetylase 5 and 9 Expression in Midbrain Dopamine Neurons and as Regulators of Neurite Growth via Bone Morphogenetic Protein Signaling. Front Cell Dev Biol 7:191. |
| 1106 | Lin DD et.al. (2019). Upregulation of OTUD7B (Cezanne) Promotes Tumor Progression via AKT/VEGF Pathway in Lung Squamous Carcinoma and Adenocarcinoma. Front Oncol 9:862. |
| 1105 | Zhang X et.al. (2019). TRIB3 promotes lung cancer progression by activating beta-catenin signaling. Eur J Pharmacol 863:172697. |
| 1104 | Hsieh CH et.al. (2019). Quantitative Proteomics of Th-MYCN Transgenic Mice Reveals Aurora Kinase Inhibitor Altered Metabolic Pathways and Enhanced ACADM To Suppress Neuroblastoma Progression. J Proteome Res 18:3850-3866. |
| 1103 | Scicchitano S et.al. (2019). The stem cell-associated transcription co-factor, ZNF521, interacts with GLI1 and GLI2 and enhances the activity of the Sonic hedgehog pathway. Cell Death Dis 10:715. |
| 1102 | Ognibene M et.al. (2019). Role of GOLPH3 and TPX2 in Neuroblastoma DNA Damage Response and Cell Resistance to Chemotherapy. Int J Mol Sci 20:. |
| 1101 | Pathania AS et.al. (2019). GRK2 promotes growth of medulloblastoma cells and protects them from chemotherapy-induced apoptosis. Sci Rep 9:13902. |
| 1100 | Wang J et.al. (2019). NT5E/CD73 as Correlative Factor of Patient Survival and Natural Killer Cell Infiltration in Glioblastoma. J Clin Med 8:. |
| 1099 | Robinson MH et.al. (2019). Upregulation of the chromatin remodeler HELLS is mediated by YAP1 in Sonic Hedgehog Medulloblastoma. Sci Rep 9:13611. |
| 1098 | Senfter D et.al. (2019). High impact of miRNA-4521 on FOXM1 expression in medulloblastoma. Cell Death Dis 10:696. |
| 1097 | Wang J et.al. (2019). The association between lncRNA LINC01296 and the clinical characteristics in neuroblastoma. J Pediatr Surg 54:2589-2594. |
| 1096 | Cui J et.al. (2019). Inorganic Selenium Induces Nonapoptotic Programmed Cell Death in PC-3 Prostate Cancer Cells Associated with Inhibition of Glycolysis. J Agric Food Chem 67:10637-10645. |
| 1095 | Liu N et.al. (2019). SNRPB promotes the tumorigenic potential of NSCLC in part by regulating RAB26. Cell Death Dis 10:667. |
| 1094 | Park SY et.al. (2019). The JAK2/STAT3/CCND2 Axis promotes colorectal Cancer stem cell persistence and radioresistance. J Exp Clin Cancer Res 38:399. |
| 1093 | Horn S et.al. (2019). De novo variants in PAK1 lead to intellectual disability with macrocephaly and seizures. Brain 142:3351-3359. |
| 1092 | Koach J et.al. (2019). Drugging MYCN Oncogenic Signaling through the MYCN-PA2G4 Binding Interface. Cancer Res 79:5652-5667. |
| 1091 | Feng S et.al. (2019). LncRNA-CTS promotes metastasis and epithelial-to-mesenchymal transition through regulating miR-505/ZEB2 axis in cervical cancer. Cancer Lett 465:105-117. |
| 1090 | Qiao J et.al. (2019). Identification of alpha-N-catenin as a novel tumor suppressor in neuroblastoma. Oncotarget 10:5028-5040. |
| 1089 | Hua Q et.al. (2019). LINC01123, a c-Myc-activated long non-coding RNA, promotes proliferation and aerobic glycolysis of non-small cell lung cancer through miR-199a-5p/c-Myc axis. J Hematol Oncol 12:91. |
| 1088 | Schonkeren SL et.al. (2019). Nervous NDRGs: the N-myc downstream-regulated gene family in the central and peripheral nervous system. Neurogenetics 20:173-186. |
| 1087 | Hu C et.al. (2019). ROCK1 promotes migration and invasion of nonsmallcell lung cancer cells through the PTEN/PI3K/FAK pathway. Int J Oncol 55:833-844. |
| 1086 | Zhang L et.al. (2019). Single-Cell Transcriptomics in Medulloblastoma Reveals Tumor-Initiating Progenitors and Oncogenic Cascades during Tumorigenesis and Relapse. Cancer Cell 36:302-318.e7. |
| 1085 | Matsumoto S et.al. (2019). GREB1 induced by Wnt signaling promotes development of hepatoblastoma by suppressing TGFbeta signaling. Nat Commun 10:3882. |
| 1084 | Guo P et.al. (2019). Therapeutic genome editing of triple-negative breast tumors using a noncationic and deformable nanolipogel. Proc Natl Acad Sci U S A 116:18295-18303. |
| 1083 | Alptekin A et.al. (2019). Glycine decarboxylase is a transcriptional target of MYCN required for neuroblastoma cell proliferation and tumorigenicity. Oncogene 38:7504-7520. |
| 1082 | Li J et.al. (2019). Down-Regulation of Phosphoribosyl Pyrophosphate Synthetase 1 Inhibits Neuroblastoma Cell Proliferation. Cells 8:. |
| 1081 | Wu PY et.al. (2019). Activation of Aryl Hydrocarbon Receptor by Kynurenine Impairs Progression and Metastasis of Neuroblastoma. Cancer Res 79:5550-5562. |
| 1080 | Suenaga Y et.al. (2019). TAp63 represses transcription of MYCN/NCYM gene and its high levels of expression are associated with favorable outcome in neuroblastoma. Biochem Biophys Res Commun 518:311-318. |
| 1079 | Cheng N et.al. (2019). Transcription factor Six2 induces a stem cell-like phenotype in renal cell carcinoma cells. FEBS Open Bio 9:1808-1816. |
| 1078 | Sun M et.al. (2019). Targeting the Chromosomal Passenger Complex Subunit INCENP Induces Polyploidization, Apoptosis, and Senescence in Neuroblastoma. Cancer Res 79:4937-4950. |
| 1077 | Chen JJ et.al. (2019). MRP4 sustains Wnt/beta-catenin signaling for pregnancy, endometriosis and endometrial cancer. Theranostics 9:5049-5064. |
| 1076 | Somasundaram DB et.al. (2019). De novo regulation of RD3 synthesis in residual neuroblastoma cells after intensive multi-modal clinical therapy harmonizes disease evolution. Sci Rep 9:11766. |
| 1075 | Nitta RT et.al. (2019). Casein kinase 2 inhibition sensitizes medulloblastoma to temozolomide. Oncogene 38:6867-6879. |
| 1074 | Yogev O et.al. (2019). In Vivo Modeling of Chemoresistant Neuroblastoma Provides New Insights into Chemorefractory Disease and Metastasis. Cancer Res 79:5382-5393. |
| 1073 | Ravi A et.al. (2019). Rhinovirus-16 induced temporal interferon responses in nasal epithelium links with viral clearance and symptoms. Clin Exp Allergy 49:1587-1597. |
| 1072 | Debruyne DN et.al. (2019). BORIS promotes chromatin regulatory interactions in treatment-resistant cancer cells. Nature 572:676-680. |
| 1071 | Purvis IJ et.al. (2019). Role of MYC-miR-29-B7-H3 in Medulloblastoma Growth and Angiogenesis. J Clin Med 8:. |
| 1070 | Zong Z et.al. (2019). M1 Macrophages Induce PD-L1 Expression in Hepatocellular Carcinoma Cells Through IL-1beta Signaling. Front Immunol 10:1643. |
| 1069 | Wagner M et.al. (2019). Blockade of Lymphangiogenesis Shapes Tumor-Promoting Adipose Tissue Inflammation. Am J Pathol 189:2102-2114. |
| 1068 | Aravindan S et.al. (2019). Targeting acquired oncogenic burden in resilient pancreatic cancer: a novel benefit from marine polyphenols. Mol Cell Biochem 460:175-193. |
| 1067 | Wellenstein MD et.al. (2019). Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis. Nature 572:538-542. |
| 1066 | Bui CB et.al. (2019). ARID1A-SIN3A drives retinoic acid-induced neuroblastoma differentiation by transcriptional repression of TERT. Mol Carcinog 58:1998-2007. |
| 1065 | Lu J et.al. (2019). Transcription factor CEBPB inhibits the proliferation of osteosarcoma by regulating downstream target gene CLEC5A. J Clin Lab Anal 33:e22985. |
| 1064 | Mu X et.al. (2019). Linc00961 inhibits the proliferation and invasion of skin melanoma by targeting the miR367/PTEN axis. Int J Oncol 55:708-720. |
| 1063 | Ando K et.al. (2019). Co-Inhibition of the DNA Damage Response and CHK1 Enhances Apoptosis of Neuroblastoma Cells. Int J Mol Sci 20:. |
| 1062 | Yi GZ et.al. (2019). Acquired temozolomide resistance in MGMT-deficient glioblastoma cells is associated with regulation of DNA repair by DHC2. Brain 142:2352-2366. |
| 1061 | Wong M et.al. (2019). JMJD6 is a tumorigenic factor and therapeutic target in neuroblastoma. Nat Commun 10:3319. |
| 1060 | Kanemaru Y et.al. (2019). Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacy. Acta Neuropathol Commun 7:119. |
| 1059 | Huang C et.al. (2019). FoxM1 Induced Paclitaxel Resistance via Activation of the FoxM1/PHB1/RAF-MEK-ERK Pathway and Enhancement of the ABCA2 Transporter. Mol Ther Oncolytics 14:196-212. |
| 1058 | Morabito M et.al. (2019). An autocrine ActivinB mechanism drives TGFbeta/Activin signaling in Group 3 medulloblastoma. EMBO Mol Med 11:e9830. |
| 1057 | Guo Q et.al. (2019). NAMPT: A potential prognostic and therapeutic biomarker in patients with glioblastoma. Oncol Rep 42:963-972. |
| 1056 | Bishayee K et.al. (2019). Targeting the Difficult-to-Drug CD71 and MYCN with Gambogic Acid and Vorinostat in a Class of Neuroblastomas. Cell Physiol Biochem 53:258-280. |
| 1055 | Mohlin S et.al. (2019). Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma. EMBO Mol Med 11:e10058. |
| 1054 | Lange I et.al. (2019). Calcium signaling regulates fundamental processes involved in Neuroblastoma progression. Cell Calcium 82:102052. |
| 1053 | Rusu P et.al. (2019). GPD1 Specifically Marks Dormant Glioma Stem Cells with a Distinct Metabolic Profile. Cell Stem Cell 25:241-257.e8. |
| 1052 | Gana CC et.al. (2019). MRP1 modulators synergize with buthionine sulfoximine to exploit collateral sensitivity and selectively kill MRP1-expressing cancer cells. Biochem Pharmacol 168:237-248. |
| 1051 | Jones DTW et.al. (2019). Molecular characteristics and therapeutic vulnerabilities across paediatric solid tumours. Nat Rev Cancer 19:420-438. |
| 1050 | Chen Q et.al. (2019). Screening and identification of hub genes in pancreatic cancer by integrated bioinformatics analysis. J Cell Biochem 120:19496-19508. |
| 1049 | Raman P et.al. (2019). A comparison of survival analysis methods for cancer gene expression RNA-Sequencing data. Cancer Genet 235-236:1-12. |
| 1048 | Cao M et.al. (2019). Identification of age Neurobiol Aging 81:116-126. |
| 1047 | Gambale A et.al. (2019). Germline mutations and new copy number variants among 40 pediatric cancer patients suspected for genetic predisposition. Clin Genet 96:359-365. |
| 1046 | Czystowska-Kuzmicz M et.al. (2019). Small extracellular vesicles containing arginase-1 suppress T-cell responses and promote tumor growth in ovarian carcinoma. Nat Commun 10:3000. |
| 1045 | Berney E et.al. (2019). The SR-B1 Receptor as a Potential Target for Treating Glioblastoma. J Oncol 2019:1805841. |
| 1044 | Bernink JH et.al. (2019). c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologies. Nat Immunol 20:992-1003. |
| 1043 | El Hassouni B et.al. (2019). Uridine Cytidine Kinase 2 as a Potential Biomarker for Treatment with RX-3117 in Pancreatic Cancer. Anticancer Res 39:3609-3614. |
| 1042 | Roca MS et.al. (2019). Implication for Cancer Stem Cells in Solid Cancer Chemo-Resistance: Promising Therapeutic Strategies Based on the Use of HDAC Inhibitors. J Clin Med 8:. |
| 1041 | Romani M et.al. (2019). Targeting of Histone Demethylases KDM5A and KDM6B Inhibits the Proliferation of Temozolomide-Resistant Glioblastoma Cells. Cancers (Basel) 11:. |
| 1040 | Chai Y et.al. (2019). MPC1 deletion is associated with poor prognosis and temozolomide resistance in glioblastoma. J Neurooncol 144:293-301. |
| 1039 | Civita P et.al. (2019). Laser Capture Microdissection and RNA-Seq Analysis: High Sensitivity Approaches to Explain Histopathological Heterogeneity in Human Glioblastoma FFPE Archived Tissues. Front Oncol 9:482. |
| 1038 | Tarone L et.al. (2019). Naturally occurring cancers in pet dogs as pre-clinical models for cancer immunotherapy. Cancer Immunol Immunother 68:1839-1853. |
| 1037 | Riccardo F et.al. (2019). Identification of CSPG4 as a promising target for translational combinatorial approaches in osteosarcoma. Ther Adv Med Oncol 11:1758835919855491. |
| 1036 | Koncar RF et.al. (2019). Identification of Novel RAS Signaling Therapeutic Vulnerabilities in Diffuse Intrinsic Pontine Gliomas. Cancer Res 79:4026-4041. |
| 1035 | Li K et.al. (2019). TROAP Promotes Breast Cancer Proliferation and Metastasis. Biomed Res Int 2019:6140951. |
| 1034 | Mather RL et.al. (2019). Human Sialic acid O-acetyl esterase (SIAE) Sci Rep 9:8609. |
| 1033 | Lin J et.al. (2019). eIF6 Promotes Colorectal Cancer Proliferation and Invasion by Regulating AKT-Related Signaling Pathways. J Biomed Nanotechnol 15:1556-1567. |
| 1032 | Russo R et.al. (2019). Characterization of Two Cases of Congenital Dyserythropoietic Anemia Type I Shed Light on the Uncharacterized C15orf41 Protein. Front Physiol 10:621. |
| 1031 | Piro G et.al. (2019). Vorinostat Potentiates 5-Fluorouracil/Cisplatin Combination by Inhibiting Chemotherapy-Induced EGFR Nuclear Translocation and Increasing Cisplatin Uptake. Mol Cancer Ther 18:1405-1417. |
| 1030 | Pang Y et.al. (2019). TP53BP2 decreases cell proliferation and induces autophagy in neuroblastoma cell lines. Oncol Lett 17:4976-4984. |
| 1029 | Xie R et.al. (2019). ANXA2 Silencing Inhibits Proliferation, Invasion, and Migration in Gastric Cancer Cells. J Oncol 2019:4035460. |
| 1028 | Kampen KR et.al. (2019). Translatome analysis reveals altered serine and glycine metabolism in T-cell acute lymphoblastic leukemia cells. Nat Commun 10:2542. |
| 1027 | Hirano T et.al. (2019). Forced expression of NR4A3 induced the differentiation of human neuroblastoma-derived NB1 cells. Med Oncol 36:66. |
| 1026 | Ye C et.al. (2019). Overexpression of FZD7 is associated with poor survival in patients with colon cancer. Pathol Res Pract 215:152478. |
| 1025 | Maximov V et.al. (2019). Tumour-associated macrophages exhibit anti-tumoural properties in Sonic Hedgehog medulloblastoma. Nat Commun 10:2410. |
| 1024 | Munoz-Galvan S et.al. (2019). New markers for human ovarian cancer that link platinum resistance to the cancer stem cell phenotype and define new therapeutic combinations and diagnostic tools. J Exp Clin Cancer Res 38:234. |
| 1023 | Gong D et.al. (2019). The m(6)A-suppressed P2RX6 activation promotes renal cancer cells migration and invasion through ATP-induced Ca(2+) influx modulating ERK1/2 phosphorylation and MMP9 signaling pathway. J Exp Clin Cancer Res 38:233. |
| 1022 | Folkerts H et.al. (2019). Elevated VMP1 expression in acute myeloid leukemia amplifies autophagy and is protective against venetoclax-induced apoptosis. Cell Death Dis 10:421. |
| 1021 | Nam J et.al. (2019). Disruption of the Myc-PDE4B regulatory circuitry impairs B-cell lymphoma survival. Leukemia 33:2912-2923. |
| 1020 | Kim KS et.al. (2019). miR551b Regulates Colorectal Cancer Progression by Targeting the ZEB1 Signaling Axis. Cancers (Basel) 11:. |
| 1019 | Zheng BN et.al. (2019). Targeting PRMT5 Activity Inhibits the Malignancy of Hepatocellular Carcinoma by Promoting the Transcription of HNF4alpha. Theranostics 9:2606-2617. |
| 1018 | Lee YK et.al. (2019). Promotion of Cell Death in Cisplatin-Resistant Ovarian Cancer Cells through KDM1B-DCLRE1B Modulation. Int J Mol Sci 20:. |
| 1017 | Zhao GS et.al. (2019). High expression of ID1 facilitates metastasis in human osteosarcoma by regulating the sensitivity of anoikis via PI3K/AKT depended suppression of the intrinsic apoptotic signaling pathway. Am J Transl Res 11:2117-2139. |
| 1016 | Li H et.al. (2019). Small molecule inhibitor agerafenib effectively suppresses neuroblastoma tumor growth in mouse models via inhibiting ERK MAPK signaling. Cancer Lett 457:129-141. |
| 1015 | Zhu R et.al. (2019). miR-23b-3p suppressing PGC1alpha promotes proliferation through reprogramming metabolism in osteosarcoma. Cell Death Dis 10:381. |
| 1014 | Xia Y et.al. (2019). Metabolic Reprogramming by MYCN Confers Dependence on the Serine-Glycine-One-Carbon Biosynthetic Pathway. Cancer Res 79:3837-3850. |
| 1013 | Varon M et.al. (2019). The long noncoding RNA TP73-AS1 promotes tumorigenicity of medulloblastoma cells. Int J Cancer 145:3402-3413. |
| 1012 | Cho A et.al. (2019). An Endogenous Anti-aging Factor, Sonic Hedgehog, Suppresses Endometrial Stem Cell Aging through SERPINB2. Mol Ther 27:1286-1298. |
| 1011 | Palombo R et.al. (2019). The Promoter-Associated Noncoding RNA pncCCND1_B Assembles a Protein-RNA Complex to Regulate Cyclin D1 Transcription in Ewing Sarcoma. Cancer Res 79:3570-3582. |
| 1010 | Firuzi O et.al. (2019). Role of c-MET Inhibitors in Overcoming Drug Resistance in Spheroid Models of Primary Human Pancreatic Cancer and Stellate Cells. Cancers (Basel) 11:. |
| 1009 | Huang Z et.al. (2019). miR-340-FHL2 axis inhibits cell growth and metastasis in ovarian cancer. Cell Death Dis 10:372. |
| 1008 | Caggiano C et.al. (2019). c-MYC empowers transcription and productive splicing of the oncogenic splicing factor Sam68 in cancer. Nucleic Acids Res 47:6160-6171. |
| 1007 | Felipe-Abrio B et.al. (2019). c-MYB Mol Oncol 13:1519-1533. |
| 1006 | Lehrer S et.al. (2019). von Willebrand Factor Gene Expression in Primary Lower Grade Glioma: Mutually Co-Occurring Mutations in von Willebrand Factor, ATRX, and TP53. Brain Tumor Res Treat 7:33-38. |
| 1005 | Georgescu C et.al. (2019). A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer. BMC Cancer 19:423. |
| 1004 | Cao H et.al. (2019). High FOXK1 expression correlates with poor outcomes in hepatocellular carcinoma and regulates stemness of hepatocellular carcinoma cells. Life Sci 228:128-134. |
| 1003 | Szemes M et.al. (2019). Wnt Signaling Is a Major Determinant of Neuroblastoma Cell Lineages. Front Mol Neurosci 12:90. |
| 1002 | Koster J et.al. (2019). A library of Neo Open Reading Frame peptides (NOPs) as a sustainable resource of common neoantigens in up to 50% of cancer patients. Sci Rep 9:6577. |
| 1001 | Li X et.al. (2019). Prognostic significance of LAPTM4B and p27kip1 expression in triple-negative breast cancer. Cancer Biomark 25:19-27. |
| 1000 | Zhang Q et.al. (2019). ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway. J Exp Clin Cancer Res 38:173. |
| 999 | Pfaff E et.al. (2019). Brainstem biopsy in pediatric diffuse intrinsic pontine glioma in the era of precision medicine: the INFORM study experience. Eur J Cancer 114:27-35. |
| 998 | Kim JH et.al. (2019). SON haploinsufficiency causes impaired pre-mRNA splicing of CAKUT genes and heterogeneous renal phenotypes. Kidney Int 95:1494-1504. |
| 997 | Dong Z et.al. (2019). Transcriptional activation of SIRT6 via FKHRL1/FOXO3a inhibits the Warburg effect in glioblastoma cells. Cell Signal 60:100-113. |
| 996 | Lim JKM et.al. (2019). Cystine/glutamate antiporter xCT (SLC7A11) facilitates oncogenic RAS transformation by preserving intracellular redox balance. Proc Natl Acad Sci U S A 116:9433-9442. |
| 995 | Goulding SR et.al. (2019). Gene co-expression analysis of the human substantia nigra identifies BMP2 as a neurotrophic factor that can promote neurite growth in cells overexpressing wild-type or A53T alpha-synuclein. Parkinsonism Relat Disord 64:194-201. |
| 994 | Sun L et.al. (2019). Resolvin D1 prevents epithelial-mesenchymal transition and reduces the stemness features of hepatocellular carcinoma by inhibiting paracrine of cancer-associated fibroblast-derived COMP. J Exp Clin Cancer Res 38:170. |
| 993 | MacArthur IC et.al. (2019). Prohibitin promotes de-differentiation and is a potential therapeutic target in neuroblastoma. JCI Insight 5:. |
| 992 | Hu W et.al. (2019). NAV2 facilitates invasion of cutaneous melanoma cells by targeting SNAI2 through the GSK-3beta/beta-catenin pathway. Arch Dermatol Res 311:399-410. |
| 991 | Guo P et.al. (2019). ITGA2 as a potential nanotherapeutic target for glioblastoma. Sci Rep 9:6195. |
| 990 | Saha SK et.al. (2019). Systematic Multiomics Analysis of Alterations in C1QBP mRNA Expression and Relevance for Clinical Outcomes in Cancers. J Clin Med 8:. |
| 989 | Abruzzese MP et.al. (2019). The homeobox transcription factor MEIS2 is a regulator of cancer cell survival and IMiDs activity in Multiple Myeloma: modulation by Bromodomain and Extra-Terminal (BET) protein inhibitors. Cell Death Dis 10:324. |
| 988 | Lee NH et.al. (2019). SERPINB2 Is a Novel Indicator of Cancer Stem Cell Tumorigenicity in Multiple Cancer Types. Cancers (Basel) 11:. |
| 987 | Diviney A et.al. (2019). An age-based, RNA expression paradigm for survival biomarker identification for pediatric neuroblastoma and acute lymphoblastic leukemia. Cancer Cell Int 19:73. |
| 986 | Yu Y et.al. (2019). Inhibition of Ubiquitin-Specific Protease 14 Suppresses Cell Proliferation and Synergizes with Chemotherapeutic Agents in Neuroblastoma. Mol Cancer Ther 18:1045-1056. |
| 985 | Park SR et.al. (2019). A Novel Endogenous Damage Signal, CSF-2, Activates Multiple Beneficial Functions of Adipose Tissue-Derived Mesenchymal Stem Cells. Mol Ther 27:1087-1100. |
| 984 | Savci-Heijink CD et.al. (2019). A specific gene expression signature for visceral organ metastasis in breast cancer. BMC Cancer 19:333. |
| 983 | Yeh YC et.al. (2019). Dichotomy of the function of DDR1 in cells and disease progression. Biochim Biophys Acta Mol Cell Res 1866:118473. |
| 982 | van Groningen T et.al. (2019). A NOTCH feed-forward loop drives reprogramming from adrenergic to mesenchymal state in neuroblastoma. Nat Commun 10:1530. |
| 981 | Cowman S et.al. (2019). Decrease of Nibrin expression in chronic hypoxia is associated with hypoxia-induced chemoresistance in some brain tumour cells. BMC Cancer 19:300. |
| 980 | Zhang YX et.al. (2019). Nanoenabled Modulation of Acidic Tumor Microenvironment Reverses Anergy of Infiltrating T Cells and Potentiates Anti-PD-1 Therapy. Nano Lett 19:2774-2783. |
| 979 | Huang K et.al. (2019). Bioinformatics analysis of the prognostic value of CCT6A and associated signalling pathways in breast cancer. Mol Med Rep 19:4344-4352. |
| 978 | Sahin I et.al. (2019). Citron Rho-interacting kinase silencing causes cytokinesis failure and reduces tumor growth in multiple myeloma. Blood Adv 3:995-1002. |
| 977 | Zhang K et.al. (2019). High KCNQ1OT1 expression might independently predict shorter survival of colon adenocarcinoma. Future Oncol 15:1085-1095. |
| 976 | Sun T et.al. (2019). Anoikis resistant mediated by FASN promoted growth and metastasis of osteosarcoma. Cell Death Dis 10:298. |
| 975 | Chai Y et.al. (2019). Prognostic Role of Chicken Ovalbumin Upstream Promoter Transcription Factor II in Isocitrate Dehydrogenase-Mutant Glioma with 1p19q Co-Deletion. J Mol Neurosci 68:234-242. |
| 974 | Lu L et.al. (2019). Inhibition of the STAT3 target SGK1 sensitizes diffuse large B cell lymphoma cells to AKT inhibitors. Blood Cancer J 9:43. |
| 973 | Hubner JM et.al. (2019). EZHIP/CXorf67 mimics K27M mutated oncohistones and functions as an intrinsic inhibitor of PRC2 function in aggressive posterior fossa ependymoma. Neuro Oncol 21:878-889. |
| 972 | Maggio V et.al. (2019). A novel DNA-binding motif in prostate tumor overexpressed-1 (PTOV1) required for the expression of ALDH1A1 and CCNG2 in cancer cells. Cancer Lett 452:158-167. |
| 971 | Niu Y et.al. (2019). RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3. Mol Cancer 18:46. |
| 970 | Karpus ON et.al. (2019). Colonic CD90+ Crypt Fibroblasts Secrete Semaphorins to Support Epithelial Growth. Cell Rep 26:3698-3708.e5. |
| 969 | Luo H et.al. (2019). WP1130 reveals USP24 as a novel target in T-cell acute lymphoblastic leukemia. Cancer Cell Int 19:56. |
| 968 | Guo P et.al. (2019). Dual complementary liposomes inhibit triple-negative breast tumor progression and metastasis. Sci Adv 5:eaav5010. |
| 967 | Otsuka K et.al. (2019). Combining peptide TNIIIA2 with all-trans retinoic acid accelerates N-Myc protein degradation and neuronal differentiation in MYCN-amplified neuroblastoma cells. Am J Cancer Res 9:434-448. |
| 966 | Herold S et.al. (2019). Recruitment of BRCA1 limits MYCN-driven accumulation of stalled RNA polymerase. Nature 567:545-549. |
| 965 | Zhang R et.al. (2019). Cancer-associated fibroblasts enhance tumor-associated macrophages enrichment and suppress NK cells function in colorectal cancer. Cell Death Dis 10:273. |
| 964 | Bhatia S et.al. (2019). Inhibition of EphB4-Ephrin-B2 Signaling Reprograms the Tumor Immune Microenvironment in Head and Neck Cancers. Cancer Res 79:2722-2735. |
| 963 | Wu Y et.al. (2019). ITGA6 and RPSA synergistically promote pancreatic cancer invasion and metastasis via PI3K and MAPK signaling pathways. Exp Cell Res 379:30-47. |
| 962 | Hoffman M et.al. (2019). Intratumoral Genetic and Functional Heterogeneity in Pediatric Glioblastoma. Cancer Res 79:2111-2123. |
| 961 | Saha SK et.al. (2019). Multiomics Analysis Reveals that GLS and GLS2 Differentially Modulate the Clinical Outcomes of Cancer. J Clin Med 8:. |
| 960 | Rodrigo MAM et.al. (2019). Transcriptomic Landscape of Cisplatin-Resistant Neuroblastoma Cells. Cells 8:. |
| 959 | Chen J et.al. (2019). SLC34A2 promotes neuroblastoma cell stemness via enhancement of miR-25/Gsk3beta-mediated activation of Wnt/beta-catenin signaling. FEBS Open Bio 9:527-537. |
| 958 | Mazor G et.al. (2019). The lncRNA TP73-AS1 is linked to aggressiveness in glioblastoma and promotes temozolomide resistance in glioblastoma cancer stem cells. Cell Death Dis 10:246. |
| 957 | Khalid M et.al. (2019). Gene Regulation by Antitumor miR-204-5p in Pancreatic Ductal Adenocarcinoma: The Clinical Significance of Direct RACGAP1 Regulation. Cancers (Basel) 11:. |
| 956 | Shen A et.al. (2019). EBF1-Mediated Upregulation of Ribosome Assembly Factor PNO1 Contributes to Cancer Progression by Negatively Regulating the p53 Signaling Pathway. Cancer Res 79:2257-2270. |
| 955 | Jolly MK et.al. (2019). E-Cadherin Represses Anchorage-Independent Growth in Sarcomas through Both Signaling and Mechanical Mechanisms. Mol Cancer Res 17:1391-1402. |
| 954 | Wang X et.al. (2019). Hypermethylated and downregulated MEIS2 are involved in stemness properties and oxaliplatin-based chemotherapy resistance of colorectal cancer. J Cell Physiol 234:18180-18191. |
| 953 | Han X et.al. (2019). Tripartite motif-containing 15 overexpression in non-small cell lung cancer is associated with poor patient prognoses. J Cancer 10:843-852. |
| 952 | Yan W et.al. (2019). Identification of B-cell translocation gene 1-controlled gene networks in diffuse large B-cell lymphoma: A study based on bioinformatics analysis. Oncol Lett 17:2825-2835. |
| 951 | Machado RAC et.al. (2019). CHD7 promotes glioblastoma cell motility and invasiveness through transcriptional modulation of an invasion signature. Sci Rep 9:3952. |
| 950 | He X et.al. (2019). Increased LGALS3 expression independently predicts shorter overall survival in patients with the proneural subtype of glioblastoma. Cancer Med 8:2031-2040. |
| 949 | Liu YJ et.al. (2019). Glycine promotes longevity in Caenorhabditis elegans in a methionine cycle-dependent fashion. PLoS Genet 15:e1007633. |
| 948 | Li L et.al. (2019). p53 regulation of ammonia metabolism through urea cycle controls polyamine biosynthesis. Nature 567:253-256. |
| 947 | Zheng L et.al. (2019). Transcriptional factor six2 promotes the competitive endogenous RNA network between CYP4Z1 and pseudogene CYP4Z2P responsible for maintaining the stemness of breast cancer cells. J Hematol Oncol 12:23. |
| 946 | Jiang SH et.al. (2019). GABRP regulates chemokine signalling, macrophage recruitment and tumour progression in pancreatic cancer through tuning KCNN4-mediated Ca(2+) signalling in a GABA-independent manner. Gut 68:1994-2006. |
| 945 | Maurer GD et.al. (2019). Knockdown of the TP53-Induced Glycolysis and Apoptosis Regulator (TIGAR) Sensitizes Glioma Cells to Hypoxia, Irradiation and Temozolomide. Int J Mol Sci 20:. |
| 944 | Yang W et.al. (2019). Sortilin promotes glioblastoma invasion and mesenchymal transition through GSK-3beta/beta-catenin/twist pathway. Cell Death Dis 10:208. |
| 943 | Vriend J et.al. (2019). Differential Expression of Genes for Ubiquitin Ligases in Medulloblastoma Subtypes. Cerebellum 18:469-488. |
| 942 | Shen A et.al. (2019). Cell division cycle associated 5 promotes colorectal cancer progression by activating the ERK signaling pathway. Oncogenesis 8:19. |
| 941 | Issaq SH et.al. (2019). Glutamine synthetase is necessary for sarcoma adaptation to glutamine deprivation and tumor growth. Oncogenesis 8:20. |
| 940 | Pham-Danis C et.al. (2019). Urea Cycle Sustains Cellular Energetics upon EGFR Inhibition in EGFR-Mutant NSCLC. Mol Cancer Res 17:1351-1364. |
| 939 | Cimmino F et.al. (2019). HIF-1 transcription activity: HIF1A driven response in normoxia and in hypoxia. BMC Med Genet 20:37. |
| 938 | Gao L et.al. (2019). MiR-873/PD-L1 axis regulates the stemness of breast cancer cells. EBioMedicine 41:395-407. |
| 937 | Yu X et.al. (2019). KIF15 plays a role in promoting the tumorigenicity of melanoma. Exp Eye Res 185:107598. |
| 936 | Zhou Z et.al. (2019). A C-X-C Chemokine Receptor Type 2-Dominated Cross-talk between Tumor Cells and Macrophages Drives Gastric Cancer Metastasis. Clin Cancer Res 25:3317-3328. |
| 935 | Wei C et.al. (2019). LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway. J Exp Clin Cancer Res 38:95. |
| 934 | Wang Y et.al. (2019). A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis. Mol Cancer 18:28. |
| 933 | Wang Y et.al. (2019). Pancreatic cancer biomarker detection by two support vector strategies for recursive feature elimination. Biomark Med 13:105-121. |
| 932 | Kant R et.al. (2019). Induction of GNMT by 1,2,3,4,6-penta-O-galloyl-beta-D-glucopyranoside through proteasome-independent MYC downregulation in hepatocellular carcinoma. Sci Rep 9:1968. |
| 931 | Dou C et.al. (2019). SHMT1 inhibits the metastasis of HCC by repressing NOX1-mediated ROS production. J Exp Clin Cancer Res 38:70. |
| 930 | Azimi I et.al. (2019). ORAI1 and ORAI3 in Breast Cancer Molecular Subtypes and the Identification of ORAI3 as a Hypoxia Sensitive Gene and a Regulator of Hypoxia Responses. Cancers (Basel) 11:. |
| 929 | Tummler C et.al. (2019). SYK Inhibition Potentiates the Effect of Chemotherapeutic Drugs on Neuroblastoma Cells in Vitro. Cancers (Basel) 11:. |
| 928 | Lee YJ et.al. (2019). Downregulation of PRMT1 promotes the senescence and migration of a non-MYCN amplified neuroblastoma SK-N-SH cells. Sci Rep 9:1771. |
| 927 | Xu S et.al. (2019). An Integrative Systems Biology and Experimental Approach Identifies Convergence of Epithelial Plasticity, Metabolism, and Autophagy to Promote Chemoresistance. J Clin Med 8:. |
| 926 | Li X et.al. (2019). Computational Modeling of the Crosstalk Between Macrophage Polarization and Tumor Cell Plasticity in the Tumor Microenvironment. Front Oncol 9:10. |
| 925 | Spek CA et.al. (2019). Is idiopathic pulmonary fibrosis a cancer-like disease? Transcriptome analysis to fuel the debate. ERJ Open Res 5:. |
| 924 | Blijlevens M et.al. (2019). High-throughput RNAi screening reveals cancer-selective lethal targets in the RNA spliceosome. Oncogene 38:4142-4153. |
| 923 | Gamble LD et.al. (2019). Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastoma. Sci Transl Med 11:. |
| 922 | Satriyo PB et.al. (2019). Cadherin 11 Inhibition Downregulates beta-catenin, Deactivates the Canonical WNT Signalling Pathway and Suppresses the Cancer Stem Cell-Like Phenotype of Triple Negative Breast Cancer. J Clin Med 8:. |
| 921 | Wang F et.al. (2019). Nucleolin Is a Functional Binding Protein for Salinomycin in Neuroblastoma Stem Cells. J Am Chem Soc 141:3613-3622. |
| 920 | Lee YS et.al. (2019). A Computational Framework for Genome-wide Characterization of the Human Disease Landscape. Cell Syst 8:152-162.e6. |
| 919 | Abaev-Schneiderman E et.al. (2019). SETD3 is a positive regulator of DNA-damage-induced apoptosis. Cell Death Dis 10:74. |
| 918 | Zhao Y et.al. (2019). MicroRNA-29a activates a multi-component growth and invasion program in glioblastoma. J Exp Clin Cancer Res 38:36. |
| 917 | Hill BS et.al. (2019). Therapeutic Potential of a Novel alpha(v)beta(3) Antagonist to Hamper the Aggressiveness of Mesenchymal Triple Negative Breast Cancer Sub-Type. Cancers (Basel) 11:. |
| 916 | Jeanquartier F et.al. (2019). Use case driven evaluation of open databases for pediatric cancer research. BioData Min 12:2. |
| 915 | Chlenski A et.al. (2019). Maternal Embryonic Leucine Zipper Kinase (MELK), a Potential Therapeutic Target for Neuroblastoma. Mol Cancer Ther 18:507-516. |
| 914 | Somers K et.al. (2019). A novel small molecule that kills a subset of MLL-rearranged leukemia cells by inducing mitochondrial dysfunction. Oncogene 38:3824-3842. |
| 913 | Dorstyn L et.al. (2019). Transcriptome profiling of caspase-2 deficient EmuMyc and Th-MYCN mouse tumors identifies distinct putative roles for caspase-2 in neuronal differentiation and immune signaling. Cell Death Dis 10:56. |
| 912 | De Vries LCS et.al. (2019). A JAK1 Selective Kinase Inhibitor and Tofacitinib Affect Macrophage Activation and Function. Inflamm Bowel Dis 25:647-660. |
| 911 | Jin F et.al. (2019). Impairment of hypoxia-induced angiogenesis by LDL involves a HIF-centered signaling network linking inflammatory TNFalpha and angiogenic VEGF. Aging (Albany NY) 11:328-349. |
| 910 | Robson JP et.al. (2019). Identification of CD24 as a marker of Patched1 deleted medulloblastoma-initiating neural progenitor cells. PLoS One 14:e0210665. |
| 909 | Cheng X et.al. (2019). ETS variant 5 promotes colorectal cancer angiogenesis by targeting platelet-derived growth factor BB. Int J Cancer 145:179-191. |
| 908 | Harada T et.al. (2019). Chemically Modified Antisense Oligonucleotide Against ARL4C Inhibits Primary and Metastatic Liver Tumor Growth. Mol Cancer Ther 18:602-612. |
| 907 | Mooney MR et.al. (2019). Anti-tumor effect of sulfasalazine in neuroblastoma. Biochem Pharmacol 162:237-249. |
| 906 | Yang L et.al. (2019). Histone demethylase KDM6B has an anti-tumorigenic function in neuroblastoma by promoting differentiation. Oncogenesis 8:3. |
| 905 | Domizi P et.al. (2019). KDM2B regulates choline kinase expression and neuronal differentiation of neuroblastoma cells. PLoS One 14:e0210207. |
| 904 | Xu M et.al. (2019). lncRNA SNHG6 regulates EZH2 expression by sponging miR-26a/b and miR-214 in colorectal cancer. J Hematol Oncol 12:3. |
| 903 | Seitz C et.al. (2019). Multi-faceted inhibition of dendritic cell function by CD4(+)Foxp3(+) regulatory T cells. J Autoimmun 98:86-94. |
| 902 | Shelake S et.al. (2019). Clotam enhances anti-proliferative effect of vincristine in Ewing sarcoma cells. Apoptosis 24:21-32. |
| 901 | Savci-Heijink CD et.al. (2019). Epithelial-to-mesenchymal transition status of primary breast carcinomas and its correlation with metastatic behavior. Breast Cancer Res Treat 174:649-659. |
| 900 | Kim W et.al. (2019). CCAR2/DBC1 and Hsp60 Positively Regulate Expression of Survivin in Neuroblastoma Cells. Int J Mol Sci 20:. |
| 899 | Shen Y et.al. (2019). S1P/S1PR3 axis promotes aerobic glycolysis by YAP/c-MYC/PGAM1 axis in osteosarcoma. EBioMedicine 40:210-223. |
| 898 | Bruns I et.al. (2019). Disruption of peroxisome proliferator-activated receptor gamma coactivator (PGC)-1alpha reverts key features of the neoplastic phenotype of glioma cells. J Biol Chem 294:3037-3050. |
| 897 | Wang X et.al. (2019). Coexpression network analysis linked H2AFJ to chemoradiation resistance in colorectal cancer. J Cell Biochem 120:10351-10362. |
| 896 | Westerlund I et.al. (2019). EPAS1/HIF2alpha correlates with features of low-risk neuroblastoma and with adrenal chromaffin cell differentiation during sympathoadrenal development. Biochem Biophys Res Commun 508:1233-1239. |
| 895 | Nowak-Sliwinska P et.al. (2019). Oncofoetal insulin receptor isoform A marks the tumour endothelium; an underestimated pathway during tumour angiogenesis and angiostatic treatment. Br J Cancer 120:218-228. |
| 894 | Bai J et.al. (2019). lncRNA A1BG-AS1 suppresses proliferation and invasion of hepatocellular carcinoma cells by targeting miR-216a-5p. J Cell Biochem 120:10310-10322. |
| 893 | Zhang L et.al. (2019). LncRNA KTN1-AS1 promotes tumor growth of hepatocellular carcinoma by targeting miR-23c/ERBB2IP axis. Biomed Pharmacother 109:1140-1147. |
| 892 | Le Rhun E et.al. (2019). Profound, durable and MGMT-independent sensitivity of glioblastoma cells to cyclin-dependent kinase inhibition. Int J Cancer 145:242-253. |
| 891 | Fultang L et.al. (2019). Macrophage-Derived IL1beta and TNFalpha Regulate Arginine Metabolism in Neuroblastoma. Cancer Res 79:611-624. |
| 890 | Hald OH et.al. (2019). Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma. Oncogene 38:2800-2813. |
| 889 | Neviani P et.al. (2019). Natural Killer-Derived Exosomal miR-186 Inhibits Neuroblastoma Growth and Immune Escape Mechanisms. Cancer Res 79:1151-1164. |
| 888 | Narayanan A et.al. (2019). The proneural gene ASCL1 governs the transcriptional subgroup affiliation in glioblastoma stem cells by directly repressing the mesenchymal gene NDRG1. Cell Death Differ 26:1813-1831. |
| 887 | Buhl JL et.al. (2019). The Senescence-associated Secretory Phenotype Mediates Oncogene-induced Senescence in Pediatric Pilocytic Astrocytoma. Clin Cancer Res 25:1851-1866. |
| 886 | Navis M et.al. (2019). Mouse fetal intestinal organoids: new model to study epithelial maturation from suckling to weaning. EMBO Rep 20:. |
| 885 | Haruta M et.al. (2019). Combined Genetic and Chromosomal Characterization of Wilms Tumors Identifies Chromosome 12 Gain as a Potential New Marker Predicting a Favorable Outcome. Neoplasia 21:117-131. |
| 884 | Hu X et.al. (2019). Depletion of Ars2 inhibits cell proliferation and leukemogenesis in acute myeloid leukemia by modulating the miR-6734-3p/p27 axis. Leukemia 33:1090-1101. |
| 883 | Qi Y et.al. (2019). Long noncoding RNA HOXD-AS2 regulates cell cycle to promote glioma progression. J Cell Biochem 120:8343-8351. |
| 882 | Karachaliou N et.al. (2019). Integrin-linked kinase (ILK) and src homology 2 domain-containing phosphatase 2 (SHP2): Novel targets in EGFR-mutation positive non-small cell lung cancer (NSCLC). EBioMedicine 39:207-214. |
| 881 | Shi Z et.al. (2019). Distinct roles of histamine H1 Am J Physiol Gastrointest Liver Physiol 316:G205-G216. |
| 880 | Atkinson A et.al. (2019). Collagen Prolyl Hydroxylases Are Bifunctional Growth Regulators in Melanoma. J Invest Dermatol 139:1118-1126. |
| 879 | Tegeder I et.al. (2019). Functional relevance of genes predicted to be affected by epigenetic alterations in atypical teratoid/rhabdoid tumors. J Neurooncol 141:43-55. |
| 878 | Arai T et.al. (2019). Pirin: a potential novel therapeutic target for castration-resistant prostate cancer regulated by miR-455-5p. Mol Oncol 13:322-337. |
| 877 | Hou J et.al. (2019). TROP2 promotes the proliferation and metastasis of glioblastoma cells by activating the JAK2/STAT3 signaling pathway. Oncol Rep 41:753-764. |
| 876 | Sun C et.al. (2019). Gene expression profiles analysis identifies a novel two-gene signature to predict overall survival in diffuse large B-cell lymphoma. Biosci Rep 39:. |
| 875 | Cruz-Bermudez A et.al. (2019). Cancer-associated fibroblasts modify lung cancer metabolism involving ROS and TGF-beta signaling. Free Radic Biol Med 130:163-173. |
| 874 | Chiu CS et.al. (2019). Exploiting Honokiol-induced ER stress CHOP activation inhibits the growth and metastasis of melanoma by suppressing the MITF and beta-catenin pathways. Cancer Lett 442:113-125. |
| 873 | Muller S et.al. (2019). IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A Nucleic Acids Res 47:375-390. |
| 872 | Milone MR et.al. (2019). Novel pathways involved in cisplatin resistance identified by a proteomics approach in non-small-cell lung cancer cells. J Cell Physiol 234:9077-9092. |
| 871 | Laetsch TW et.al. (2019). Larotrectinib for the treatment of TRK fusion solid tumors. Expert Rev Anticancer Ther 19:1-10. |
| 870 | Ramaswamy V et.al. (2019). Bioinformatic Strategies for the Genomic and Epigenomic Characterization of Brain Tumors. Methods Mol Biol 1869:37-56. |
| 869 | Li N et.al. (2019). LncRNA and mRNA signatures associated with neoadjuvant chemoradiotherapy downstaging effects in rectal cancer. J Cell Biochem 120:5207-5217. |
| 868 | Munoz-Galvan S et.al. (2019). Tumor cell-secreted PLD increases tumor stemness by senescence-mediated communication with microenvironment. Oncogene 38:1309-1323. |
| 867 | Ravi A et.al. (2019). Interferon-induced epithelial response to rhinovirus 16 in asthma relates to inflammation and FEV1. J Allergy Clin Immunol 143:442-447.e10. |
| 866 | Dou C et.al. (2019). Hypoxia-induced TUFT1 promotes the growth and metastasis of hepatocellular carcinoma by activating the Ca(2+)/PI3K/AKT pathway. Oncogene 38:1239-1255. |
| 865 | Wei Y et.al. (2019). p53 Function Is Compromised by Inhibitor 2 of Phosphatase 2A in Sonic Hedgehog Medulloblastoma. Mol Cancer Res 17:186-198. |
| 864 | Kato M et.al. (2019). Heterogeneous cancer-associated fibroblast population potentiates neuroendocrine differentiation and castrate resistance in a CD105-dependent manner. Oncogene 38:716-730. |
| 863 | Li S et.al. (2019). Shear stress promotes anoikis resistance of cancer cells via caveolin-1-dependent extrinsic and intrinsic apoptotic pathways. J Cell Physiol 234:3730-3743. |
| 862 | Lieberman NAP et.al. (2019). Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy. Neuro Oncol 21:83-94. |
| 861 | Subbarayan K et.al. (2019). Tumor-dependent Effects of Proteoglycans and Various Glycosaminoglycan Synthesizing Enzymes and Sulfotransferases on Patients Outcome. Curr Cancer Drug Targets 19:210-221. |
| 2018 (n=230) |
| 860 | Wang D et.al. (2018). The correlation of PTPN4 expression with prognosis in breast cancer. Int J Clin Exp Pathol 11:4845-4853. |
| 859 | Jolly MK et.al. (2018). Interconnected feedback loops among ESRP1, HAS2, and CD44 regulate epithelial-mesenchymal plasticity in cancer. APL Bioeng 2:031908. |
| 858 | Baali I et.al. (2018). Predicting clinical outcomes in neuroblastoma with genomic data integration. Biol Direct 13:20. |
| 857 | Hai L et.al. (2018). Jagged1 is Clinically Prognostic and Promotes Invasion of Glioma-Initiating Cells by Activating NF-kappaB(p65) Signaling. Cell Physiol Biochem 51:2925-2937. |
| 856 | Barros-Silva JD et.al. (2018). Single-Cell Analysis Identifies LY6D as a Marker Linking Castration-Resistant Prostate Luminal Cells to Prostate Progenitors and Cancer. Cell Rep 25:3504-3518.e6. |
| 855 | Ogorodnikov A et.al. (2018). Transcriptome 3end organization by PCF11 links alternative polyadenylation to formation and neuronal differentiation of neuroblastoma. Nat Commun 9:5331. |
| 854 | Zhao Z et.al. (2018). microRNA-2110 functions as an onco-suppressor in neuroblastoma by directly targeting Tsukushi. PLoS One 13:e0208777. |
| 853 | Verhagen HJMP et.al. (2018). IGFBP7 Induces Differentiation and Loss of Survival of Human Acute Myeloid Leukemia Stem Cells without Affecting Normal Hematopoiesis. Cell Rep 25:3021-3035.e5. |
| 852 | Adam I et.al. (2018). Upregulation of tryptophanyl-tRNA synthethase adapts human cancer cells to nutritional stress caused by tryptophan degradation. Oncoimmunology 7:e1486353. |
| 851 | Tian J et.al. (2018). Dasatinib sensitises triple negative breast cancer cells to chemotherapy by targeting breast cancer stem cells. Br J Cancer 119:1495-1507. |
| 850 | Li Y et.al. (2018). Zinc finger protein 32 promotes breast cancer stem cell-like properties through directly promoting GPER transcription. Cell Death Dis 9:1162. |
| 849 | Malgulwar PB et.al. (2018). Transcriptional co-expression regulatory network analysis for Snail and Slug identifies IL1R1, an inflammatory cytokine receptor, to be preferentially expressed in ST-EPN-RELA and PF-EPN-A molecular subgroups of intracranial ependymomas. Oncotarget 9:35480-35492. |
| 848 | Van den Eynden J et.al. (2018). Phosphoproteome and gene expression profiling of ALK inhibition in neuroblastoma cell lines reveals conserved oncogenic pathways. Sci Signal 11:. |
| 847 | Wang D et.al. (2018). Clinical Significance of Elevated S100A8 Expression in Breast Cancer Patients. Front Oncol 8:496. |
| 846 | Decaesteker B et.al. (2018). TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets. Nat Commun 9:4866. |
| 845 | Smirnov A et.al. (2018). ZNF185 is a p53 target gene following DNA damage. Aging (Albany NY) 10:3308-3326. |
| 844 | Abballe L et.al. (2018). Numb Isoforms Deregulation in Medulloblastoma and Role of p66 Isoform in Cancer and Neural Stem Cells. Front Pediatr 6:315. |
| 843 | Veenstra VL et.al. (2018). ADAM12 is a circulating marker for stromal activation in pancreatic cancer and predicts response to chemotherapy. Oncogenesis 7:87. |
| 842 | Camorani S et.al. (2018). Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRbeta aptamer. Theranostics 8:5178-5199. |
| 841 | Bachmann AS et.al. (2018). Polyamine synthesis as a target of MYC oncogenes. J Biol Chem 293:18757-18769. |
| 840 | Zaman S et.al. (2018). MAPT (Tau) expression is a biomarker for an increased rate of survival in pediatric neuroblastoma. Cell Cycle 17:2474-2483. |
| 839 | Hu D et.al. (2018). KDM5A Regulates a Translational Program that Controls p53 Protein Expression. iScience 9:84-100. |
| 838 | Schipp C et.al. (2018). EBV Negative Lymphoma and Autoimmune Lymphoproliferative Syndrome Like Phenotype Extend the Clinical Spectrum of Primary Immunodeficiency Caused by STK4 Deficiency. Front Immunol 9:2400. |
| 837 | Depuydt P et.al. (2018). Meta-mining of copy number profiles of high-risk neuroblastoma tumors. Sci Data 5:180240. |
| 836 | Gu Y et.al. (2018). The deubiquitinating enzyme UCHL1 is a favorable prognostic marker in neuroblastoma as it promotes neuronal differentiation. J Exp Clin Cancer Res 37:258. |
| 835 | Abarrategi A et.al. (2018). c-Fos induces chondrogenic tumor formation in immortalized human mesenchymal progenitor cells. Sci Rep 8:15615. |
| 834 | Su C et.al. (2018). TRIM28 is overexpressed in glioma and associated with tumor progression. Onco Targets Ther 11:6447-6458. |
| 833 | Brabetz S et.al. (2018). A biobank of patient-derived pediatric brain tumor models. Nat Med 24:1752-1761. |
| 832 | Fekry B et.al. (2018). Incompatibility of the circadian protein BMAL1 and HNF4alpha in hepatocellular carcinoma. Nat Commun 9:4349. |
| 831 | Wang F et.al. (2018). Identification of a panel of genes as a prognostic biomarker for glioblastoma. EBioMedicine 37:68-77. |
| 830 | Clark CR et.al. (2018). Transposon mutagenesis screen in mice identifies TM9SF2 as a novel colorectal cancer oncogene. Sci Rep 8:15327. |
| 829 | Deng Q et.al. (2018). PHF19 promotes the proliferation, migration, and chemosensitivity of glioblastoma to doxorubicin through modulation of the SIAH1/beta-catenin axis. Cell Death Dis 9:1049. |
| 828 | van der Waals LM et.al. (2018). ALDH1A1 expression is associated with poor differentiation, right-sidedness and poor survival in human colorectal cancer. PLoS One 13:e0205536. |
| 827 | La T et.al. (2018). A p53-Responsive miRNA Network Promotes Cancer Cell Quiescence. Cancer Res 78:6666-6679. |
| 826 | Gao AW et.al. (2018). Identification of key pathways and metabolic fingerprints of longevity in C. elegans. Exp Gerontol 113:128-140. |
| 825 | Saha SK et.al. (2018). Systematic expression alteration analysis of master reprogramming factor OCT4 and its three pseudogenes in human cancer and their prognostic outcomes. Sci Rep 8:14806. |
| 824 | Brassesco MS et.al. (2018). TLE1 as an indicator of adverse prognosis in pediatric acute lymphoblastic leukemia. Leuk Res 74:42-46. |
| 823 | Liu Z et.al. (2018). Hypoxia-induced up-regulation of VASP promotes invasiveness and metastasis of hepatocellular carcinoma. Theranostics 8:4649-4663. |
| 822 | Fan J et.al. (2018). miR124 inhibits cell growth through targeting IQGAP1 in colorectal cancer. Mol Med Rep 18:5270-5278. |
| 821 | Lehrer S et.al. (2018). Increased expression of von Willebrand factor gene is associated with poorer survival in primary lower grade glioma. Glioma 1:132-135. |
| 820 | Gachet S et.al. (2018). Deletion 6q Drives T-cell Leukemia Progression by Ribosome Modulation. Cancer Discov 8:1614-1631. |
| 819 | Hussain S et.al. (2018). UCH-L1 bypasses mTOR to promote protein biosynthesis and is required for MYC-driven lymphomagenesis in mice. Blood 132:2564-2574. |
| 818 | Zhang Y et.al. (2018). Down-regulation of Skp2 expression inhibits invasion and lung metastasis in osteosarcoma. Sci Rep 8:14294. |
| 817 | Das S et.al. (2018). beta7 integrins contribute to intestinal tumor growth in mice. PLoS One 13:e0204181. |
| 816 | Li Z et.al. (2018). EYA4 Promotes Cell Proliferation Through Downregulation of p27Kip1 in Glioma. Cell Physiol Biochem 49:1856-1869. |
| 815 | Al-Zoughbi W et.al. (2018). Early Loss of Forkhead Transcription Factor, O Subgroup, Member 1 Protein in the Development of Pancreatic Ductal Adenocarcinoma. Pathobiology 85:342-347. |
| 814 | Wu D et.al. (2018). Hepatitis B virus-X protein regulates high mobility group box 1 to promote the formation of hepatocellular carcinoma. Oncol Lett 16:4418-4426. |
| 813 | Haro M et.al. (2018). A Paradoxical Correlation of Cancer-Associated Fibroblasts With Survival Outcomes in B-Cell Lymphomas and Carcinomas. Front Cell Dev Biol 6:98. |
| 812 | Forget A et.al. (2018). Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic Profiling. Cancer Cell 34:379-395.e7. |
| 811 | Lehrer S et.al. (2018). Expression of the Vesicular Monoamine Transporter Gene Solute Carrier Family 18 Member 1 (SLC18A1) in Lung Cancer. Cancer Genomics Proteomics 15:387-393. |
| 810 | Tekin C et.al. (2018). PAR1 signaling on tumor cells limits tumor growth by maintaining a mesenchymal phenotype in pancreatic cancer. Oncotarget 9:32010-32023. |
| 809 | Han B et.al. (2018). Identification and Interaction Analysis of Molecular Markers in Colorectal Cancer by Integrated Bioinformatics Analysis. Med Sci Monit 24:6059-6069. |
| 808 | Petroni M et.al. (2018). MRE11 inhibition highlights a replication stress-dependent vulnerability of MYCN-driven tumors. Cell Death Dis 9:895. |
| 807 | Li Z et.al. (2018). SNHG6 Promotes Tumor Growth via Repression of P21 in Colorectal Cancer. Cell Physiol Biochem 49:463-478. |
| 806 | Braekeveldt N et.al. (2018). Patient-Derived Xenograft Models Reveal Intratumor Heterogeneity and Temporal Stability in Neuroblastoma. Cancer Res 78:5958-5969. |
| 805 | Yamada Y et.al. (2018). Molecular pathogenesis of renal cell carcinoma: Impact of the anti-tumor miR-29 family on gene regulation. Int J Urol 25:953-965. |
| 804 | Greenhough A et.al. (2018). Cancer cell adaptation to hypoxia involves a HIF-GPRC5A-YAP axis. EMBO Mol Med 10:. |
| 803 | Cimmino F et.al. (2018). Fine mapping of 2q35 high-risk neuroblastoma locus reveals independent functional risk variants and suggests full-length BARD1 as tumor-suppressor. Int J Cancer 143:2828-2837. |
| 802 | Morgan MJ et.al. (2018). Metastatic cells are preferentially vulnerable to lysosomal inhibition. Proc Natl Acad Sci U S A 115:E8479-E8488. |
| 801 | Weicht RR et.al. (2018). Polyamine Biosynthetic Pathway as a Drug Target for Osteosarcoma Therapy. Med Sci (Basel) 6:. |
| 800 | Eleveld TF et.al. (2018). RAS-MAPK Pathway-Driven Tumor Progression Is Associated with Loss of CIC and Other Genomic Aberrations in Neuroblastoma. Cancer Res 78:6297-6307. |
| 799 | Li C et.al. (2018). PINK1 and PARK2 Suppress Pancreatic Tumorigenesis through Control of Mitochondrial Iron-Mediated Immunometabolism. Dev Cell 46:441-455.e8. |
| 798 | Po A et.al. (2018). Sonic Hedgehog Medulloblastoma Cancer Stem Cells Mirnome and Transcriptome Highlight Novel Functional Networks. Int J Mol Sci 19:. |
| 797 | Weng Y et.al. (2018). The miR-15b-5p/PDK4 axis regulates osteosarcoma proliferation through modulation of the Warburg effect. Biochem Biophys Res Commun 503:2749-2757. |
| 796 | Hu R et.al. (2018). RNA-binding protein PUM2 suppresses osteosarcoma progression via partly and competitively binding to STARD13 3UTR with miRNAs. Cell Prolif 51:e12508. |
| 795 | Kim HJ et.al. (2018). DBC1 regulates Wnt/beta-catenin-mediated expression of MACC1, a key regulator of cancer progression, in colon cancer. Cell Death Dis 9:831. |
| 794 | Malgulwar PB et.al. (2018). Epithelial-to-mesenchymal transition-related transcription factors are up-regulated in ependymomas and correlate with a poor prognosis. Hum Pathol 82:149-157. |
| 793 | Liu J et.al. (2018). CLEC3B is downregulated and inhibits proliferation in clear cell renal cell carcinoma. Oncol Rep 40:2023-2035. |
| 792 | Dudvarski Stankovic N et.al. (2018). EGFL7 enhances surface expression of integrin alpha5beta1 to promote angiogenesis in malignant brain tumors. EMBO Mol Med 10:. |
| 791 | Meel MH et.al. (2018). MELK Inhibition in Diffuse Intrinsic Pontine Glioma. Clin Cancer Res 24:5645-5657. |
| 790 | Shen J et.al. (2018). Hippo component YAP promotes focal adhesion and tumour aggressiveness via transcriptionally activating THBS1/FAK signalling in breast cancer. J Exp Clin Cancer Res 37:175. |
| 789 | Heller S et.al. (2018). Gene Suppression of Transketolase-Like Protein 1 (TKTL1) Sensitizes Glioma Cells to Hypoxia and Ionizing Radiation. Int J Mol Sci 19:. |
| 788 | van der Waals LM et.al. (2018). Increased Levels of Oxidative Damage in Liver Metastases Compared with Corresponding Primary Colorectal Tumors: Association with Molecular Subtype and Prior Treatment. Am J Pathol 188:2369-2377. |
| 787 | Gao W et.al. (2018). Ketohexokinase is involved in fructose utilization and promotes tumor progression in glioma. Biochem Biophys Res Commun 503:1298-1306. |
| 786 | Yao Y et.al. (2018). Blockade of deubiquitinase USP7 overcomes bortezomib resistance by suppressing NF-kappaB signaling pathway in multiple myeloma. J Leukoc Biol 104:1105-1115. |
| 785 | Kerosuo L et.al. (2018). Enhanced expression of MycN/CIP2A drives neural crest toward a neural stem cell-like fate: Implications for priming of neuroblastoma. Proc Natl Acad Sci U S A 115:E7351-E7360. |
| 784 | Cavalli FMG et.al. (2018). Heterogeneity within the PF-EPN-B ependymoma subgroup. Acta Neuropathol 136:227-237. |
| 783 | Li T et.al. (2018). Brutons tyrosine kinase potentiates ALK signaling and serves as a potential therapeutic target of neuroblastoma. Oncogene 37:6180-6194. |
| 782 | Bielli P et.al. (2018). The Splicing Factor PTBP1 Promotes Expression of Oncogenic Splice Variants and Predicts Poor Prognosis in Patients with Non-muscle-Invasive Bladder Cancer. Clin Cancer Res 24:5422-5432. |
| 781 | Breunig C et.al. (2018). TGFbeta1 regulates HGF-induced cell migration and hepatocyte growth factor receptor MET expression via C-ets-1 and miR-128-3p in basal-like breast cancer. Mol Oncol 12:1447-1463. |
| 780 | Gambera S et.al. (2018). Role of Activator Protein-1 Complex on the Phenotype of Human Osteosarcomas Generated from Mesenchymal Stem Cells. Stem Cells 36:1487-1500. |
| 779 | Akgul S et.al. (2018). Opposing Tumor-Promoting and -Suppressive Functions of Rictor/mTORC2 Signaling in Adult Glioma and Pediatric SHH Medulloblastoma. Cell Rep 24:463-478.e5. |
| 778 | Idichi T et.al. (2018). Involvement of anti-tumor miR-124-3p and its targets in the pathogenesis of pancreatic ductal adenocarcinoma: direct regulation of ITGA3 and ITGB1 by miR-124-3p. Oncotarget 9:28849-28865. |
| 777 | Lehrer S et.al. (2018). Loss of MycBP may be associated with the improved survival in 1P co-deletion of lower grade glioma patients. Clin Neurol Neurosurg 172:112-115. |
| 776 | Liang KH et.al. (2018). Extracellular domain of EpCAM enhances tumor progression through EGFR signaling in colon cancer cells. Cancer Lett 433:165-175. |
| 775 | Uhl KL et.al. (2018). Harmine, a dual-specificity tyrosine phosphorylation-regulated kinase (DYRK) inhibitor induces caspase-mediated apoptosis in neuroblastoma. Cancer Cell Int 18:82. |
| 774 | Lehrer S et.al. (2018). Glioblastoma Multiforme: Fewer Tumor Copy Number Segments of the SGK1 Gene Are Associated with Poorer Survival. Cancer Genomics Proteomics 15:273-278. |
| 773 | Tao Y et.al. (2018). Alternative NF-kappaB signaling promotes colorectal tumorigenesis through transcriptionally upregulating Bcl-3. Oncogene 37:5887-5900. |
| 772 | Yamada Y et.al. (2018). Regulation of antitumor miR-144-5p targets oncogenes: Direct regulation of syndecan-3 and its clinical significance. Cancer Sci 109:2919-2936. |
| 771 | Santhana Kumar K et.al. (2018). TGF-beta Determines the Pro-migratory Potential of bFGF Signaling in Medulloblastoma. Cell Rep 23:3798-3812.e8. |
| 770 | Pieraccioli M et.al. (2018). ZNF281 inhibits neuronal differentiation and is a prognostic marker for neuroblastoma. Proc Natl Acad Sci U S A 115:7356-7361. |
| 769 | Mansour MR et.al. (2018). JDP2: An oncogenic bZIP transcription factor in T cell acute lymphoblastic leukemia. J Exp Med 215:1929-1945. |
| 768 | Bettinsoli P et.al. (2018). Favorable prognostic role of tropomodulins in neuroblastoma. Oncotarget 9:27092-27103. |
| 767 | Liang L et.al. (2018). CD271(+) Cells Are Diagnostic and Prognostic and Exhibit Elevated MAPK Activity in SHH Medulloblastoma. Cancer Res 78:4745-4759. |
| 766 | Duan K et.al. (2018). Lactic acid induces lactate transport and glycolysis/OXPHOS interconversion in glioblastoma. Biochem Biophys Res Commun 503:888-894. |
| 765 | Ou-Yang Q et.al. (2018). TRPV4 promotes the migration and invasion of glioma cells via AKT/Rac1 signaling. Biochem Biophys Res Commun 503:876-881. |
| 764 | Yamada Y et.al. (2018). Anti-tumor roles of both strands of the miR-455 duplex: their targets SKA1 and SKA3 are involved in the pathogenesis of renal cell carcinoma. Oncotarget 9:26638-26658. |
| 763 | Lee NH et.al. (2018). SERPINB2 is a novel indicator of stem cell toxicity. Cell Death Dis 9:724. |
| 762 | Bruggeman JW et.al. (2018). Massive expression of germ cell-specific genes is a hallmark of cancer and a potential target for novel treatment development. Oncogene 37:5694-5700. |
| 761 | Hua T et.al. (2018). Estrogenrelated receptor gamma promotes the migration and metastasis of endometrial cancer cells by targeting S100A4. Oncol Rep 40:823-832. |
| 760 | Ognibene M et.al. (2018). CHL1 gene acts as a tumor suppressor in human neuroblastoma. Oncotarget 9:25903-25921. |
| 759 | Chen C et.al. (2018). Downregulation of histone demethylase JMJD1C inhibits colorectal cancer metastasis through targeting ATF2. Am J Cancer Res 8:852-865. |
| 758 | Mari L et.al. (2018). microRNA 125a Regulates MHC-I Expression on Esophageal Adenocarcinoma Cells, Associated With Suppression of Antitumor Immune Response and Poor Outcomes of Patients. Gastroenterology 155:784-798. |
| 757 | Tranchevent LC et.al. (2018). Predicting clinical outcome of neuroblastoma patients using an integrative network-based approach. Biol Direct 13:12. |
| 756 | Li Y et.al. (2018). miR-1268a regulates ABCC1 expression to mediate temozolomide resistance in glioblastoma. J Neurooncol 138:499-508. |
| 755 | Bader S et.al. (2018). Effect of the actin Biochem J 475:2057-2071. |
| 754 | Han T et.al. (2018). Forkhead box D1 promotes proliferation and suppresses apoptosis via regulating polo-like kinase 2 in colorectal cancer. Biomed Pharmacother 103:1369-1375. |
| 753 | Zheng L et.al. (2018). STARD13-correlated ceRNA network-directed inhibition on YAP/TAZ activity suppresses stemness of breast cancer via co-regulating Hippo and Rho-GTPase/F-actin signaling. J Hematol Oncol 11:72. |
| 752 | Gu C et.al. (2018). FSTL1 interacts with VIM and promotes colorectal cancer metastasis via activating the focal adhesion signalling pathway. Cell Death Dis 9:654. |
| 751 | Tripolitsioti D et.al. (2018). MAP4K4 controlled integrin beta1 activation and c-Met endocytosis are associated with invasive behavior of medulloblastoma cells. Oncotarget 9:23220-23236. |
| 750 | Liu XL et.al. (2018). [Effect of 1q21 amplification on bortezomib therapeutic response and prognosis of newly diagnosed multiple myeloma patients]. Zhonghua Xue Ye Xue Za Zhi 39:408-413. |
| 749 | De Santo C et.al. (2018). Metabolic therapy with PEG-arginase induces a sustained complete remission in immunotherapy-resistant melanoma. J Hematol Oncol 11:68. |
| 748 | Lochmann TL et.al. (2018). Targeted inhibition of histone H3K27 demethylation is effective in high-risk neuroblastoma. Sci Transl Med 10:. |
| 747 | Yi L et.al. (2018). Bioinformatic analyses reveal the key pathways and genes in the CXCR4 mediated mesenchymal subtype of glioblastoma. Mol Med Rep 18:741-748. |
| 746 | Taye N et.al. (2018). SMAR1 inhibits Wnt/beta-catenin signaling and prevents colorectal cancer progression. Oncotarget 9:21322-21336. |
| 745 | Miyazaki M et.al. (2018). The p53 activator overcomes resistance to ALK inhibitors by regulating p53-target selectivity in ALK-driven neuroblastomas. Cell Death Discov 4:56. |
| 744 | Liu C et.al. (2018). PRDM1 silences stem cell-related genes and inhibits proliferation of human colon tumor organoids. Proc Natl Acad Sci U S A 115:E5066-E5075. |
| 743 | Agarwal S et.al. (2018). MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma. Oncotarget 9:20323-20338. |
| 742 | Lehrer S et.al. (2018). In primary glioblastoma fewer tumor copy number segments of the F13A1 gene are associated with poorer survival. Thromb Res 167:12-14. |
| 741 | Menard M et.al. (2018). Hey1 PLoS Biol 16:e2002912. |
| 740 | Ishizuka Y et.al. (2018). NRP1 knockdown promotes the migration and invasion of human neuroblastoma-derived SKNAS cells via the activation of beta1 integrin expression. Int J Oncol 53:159-166. |
| 739 | Tong L et.al. (2018). Tumour cell dormancy as a contributor to the reduced survival of GBM patients who received standard therapy. Oncol Rep 40:463-471. |
| 738 | Parry AJ et.al. (2018). NOTCH-mediated non-cell autonomous regulation of chromatin structure during senescence. Nat Commun 9:1840. |
| 737 | Chai P et.al. (2018). Dynamic chromosomal tuning of a novel GAU1 lncing driver at chr12p13.32 accelerates tumorigenesis. Nucleic Acids Res 46:6041-6056. |
| 736 | Zhang T et.al. (2018). Angiopoietin-like 4 promotes osteosarcoma cell proliferation and migration and stimulates osteoclastogenesis. BMC Cancer 18:536. |
| 735 | Wang Y et.al. (2018). Neutrophils infiltrating pancreatic ductal adenocarcinoma indicate higher malignancy and worse prognosis. Biochem Biophys Res Commun 501:313-319. |
| 734 | Liu Q et.al. (2018). SPOCD1 promotes the proliferation and metastasis of glioma cells by up-regulating PTX3. Am J Cancer Res 8:624-635. |
| 733 | Zheng L et.al. (2018). RNA Binding Protein RNPC1 Inhibits Breast Cancer Cell Metastasis via Activating STARD13-Correlated ceRNA Network. Mol Pharm 15:2123-2132. |
| 732 | Trumpi K et.al. (2018). Macrophages induce budding in aggressive human colon cancer subtypes by protease-mediated disruption of tight junctions. Oncotarget 9:19490-19507. |
| 731 | Padua MB et.al. (2018). Dependence receptor UNC5A restricts luminal to basal breast cancer plasticity and metastasis. Breast Cancer Res 20:35. |
| 730 | Engel N et.al. (2018). First evidence of SGPL1 expression in the cell membrane silencing the extracellular S1P siren in mammary epithelial cells. PLoS One 13:e0196854. |
| 729 | Madhav A et.al. (2018). Antagonizing CD105 enhances radiation sensitivity in prostate cancer. Oncogene 37:4385-4397. |
| 728 | Sanghez V et.al. (2018). Efficacy of Asparaginase Erwinia chrysanthemi With and Without Temozolomide Against Glioma Cells and Intracranial Mouse Medulloblastoma. Anticancer Res 38:2627-2634. |
| 727 | Berenguer J et.al. (2018). Glycosylated extracellular vesicles released by glioblastoma cells are decorated by CCL18 allowing for cellular uptake via chemokine receptor CCR8. J Extracell Vesicles 7:1446660. |
| 726 | Chen J et.al. (2018). Promotion of Tumor Growth by ADAMTS4 in Colorectal Cancer: Focused on Macrophages. Cell Physiol Biochem 46:1693-1703. |
| 725 | E Hermosilla V et.al. (2018). SALL2 represses cyclins D1 and E1 expression and restrains G1/S cell cycle transition and cancer-related phenotypes. Mol Oncol 12:1026-1046. |
| 724 | Yi GZ et.al. (2018). Identification of Key Candidate Proteins and Pathways Associated with Temozolomide Resistance in Glioblastoma Based on Subcellular Proteomics and Bioinformatical Analysis. Biomed Res Int 2018:5238760. |
| 723 | Sime W et.al. (2018). BAP1 induces cell death via interaction with 14-3-3 in neuroblastoma. Cell Death Dis 9:458. |
| 722 | Kuipers AJ et.al. (2018). TRPM7 controls mesenchymal features of breast cancer cells by tensional regulation of SOX4. Biochim Biophys Acta Mol Basis Dis 1864:2409-2419. |
| 721 | Xu Q et.al. (2018). MicroRNA-876-5p inhibits epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by targeting BCL6 corepressor like 1. Biomed Pharmacother 103:645-652. |
| 720 | Muller S et.al. (2018). IGF2BP1 enhances an aggressive tumor cell phenotype by impairing miRNA-directed downregulation of oncogenic factors. Nucleic Acids Res 46:6285-6303. |
| 719 | Chen D et.al. (2018). Super enhancer inhibitors suppress MYC driven transcriptional amplification and tumor progression in osteosarcoma. Bone Res 6:11. |
| 718 | Park JW et.al. (2018). Sprouty2 enhances the tumorigenic potential of glioblastoma cells. Neuro Oncol 20:1044-1054. |
| 717 | Subbarayan K et.al. (2018). Biglycan-mediated upregulation of MHC class I expression in HER-2/neu-transformed cells. Oncoimmunology 7:e1373233. |
| 716 | Joly AL et.al. (2018). Alternative Splicing of FOXP3 Controls Regulatory T Cell Effector Functions and Is Associated With Human Atherosclerotic Plaque Stability. Circ Res 122:1385-1394. |
| 715 | Stephenson L et.al. (2018). Building online genomics applications using BioPyramid. Bioinformatics 34:3055-3057. |
| 714 | Wu Y et.al. (2018). Suv4-20h1 promotes G1 to S phase transition by downregulating p21(WAF1/CIP1) expression in chronic myeloid leukemia K562 cells. Oncol Lett 15:6123-6130. |
| 713 | Mettang M et.al. (2018). Blocking distinct interactions between Glioblastoma cells and their tissue microenvironment: A novel multi-targeted therapeutic approach. Sci Rep 8:5527. |
| 712 | Orlando D et.al. (2018). Adoptive Immunotherapy Using PRAME-Specific T Cells in Medulloblastoma. Cancer Res 78:3337-3349. |
| 711 | Khanna S et.al. (2018). Tumor-Derived GM-CSF Promotes Granulocyte Immunosuppression in Mesothelioma Patients. Clin Cancer Res 24:2859-2872. |
| 710 | Valvona CJ et.al. (2018). Oxamate, but Not Selective Targeting of LDH-A, Inhibits Medulloblastoma Cell Glycolysis, Growth and Motility. Brain Sci 8:. |
| 709 | Xu W et.al. (2018). Knockdown of HuR represses osteosarcoma cells migration, invasion and stemness through inhibition of YAP activation and increases susceptibility to chemotherapeutic agents. Biomed Pharmacother 102:587-593. |
| 708 | Hamidian A et.al. (2018). Promoter-associated proteins of EPAS1 identified by enChIP-MS Biochem Biophys Res Commun 499:291-298. |
| 707 | Nikitovic D et.al. (2018). Proteoglycans-Biomarkers and Targets in Cancer Therapy. Front Endocrinol (Lausanne) 9:69. |
| 706 | Kawano Y et.al. (2018). Blocking IFNAR1 inhibits multiple myeloma-driven Treg expansion and immunosuppression. J Clin Invest 128:2487-2499. |
| 705 | Neidert MC et.al. (2018). The natural HLA ligandome of glioblastoma stem-like cells: antigen discovery for T cell-based immunotherapy. Acta Neuropathol 135:923-938. |
| 704 | He J et.al. (2018). Cancer-testis specific gene OIP5: a downstream gene of E2F1 that promotes tumorigenesis and metastasis in glioblastoma by stabilizing E2F1 signaling. Neuro Oncol 20:1173-1184. |
| 703 | Hossain MM et.al. (2018). Hyperactivation of nuclear receptor coactivators induces PERK-dependent cell death. Oncotarget 9:11707-11721. |
| 702 | Revert F et.al. (2018). Selective targeting of collagen IV in the cancer cell microenvironment reduces tumor burden. Oncotarget 9:11020-11045. |
| 701 | Li C et.al. (2018). Long non-coding RNA KCNQ1OT1 mediates the growth of hepatocellular carcinoma by functioning as a competing endogenous RNA of miR-504. Int J Oncol 52:1603-1612. |
| 700 | Tan IL et.al. (2018). Lateral cerebellum is preferentially sensitive to high sonic hedgehog signaling and medulloblastoma formation. Proc Natl Acad Sci U S A 115:3392-3397. |
| 699 | Wang H et.al. (2018). HER4 promotes cell survival and chemoresistance in osteosarcoma via interaction with NDRG1. Biochim Biophys Acta Mol Basis Dis 1864:1839-1849. |
| 698 | Zhao SJ et.al. (2018). SLIT2/ROBO1 axis contributes to the Warburg effect in osteosarcoma through activation of SRC/ERK/c-MYC/PFKFB2 pathway. Cell Death Dis 9:390. |
| 697 | Ma Y et.al. (2018). The tumor suppressive miR-26a regulation of FBXO11 inhibits proliferation, migration and invasion of hepatocellular carcinoma cells. Biomed Pharmacother 101:648-655. |
| 696 | Shen J et.al. (2018). A kinome-wide RNAi screen identifies ALK as a target to sensitize neuroblastoma cells for HDAC8-inhibitor treatment. Cell Death Differ 25:2053-2070. |
| 695 | Depuydt P et.al. (2018). Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients. J Natl Cancer Inst 110:1084-1093. |
| 694 | Paquet-Fifield S et.al. (2018). Tight Junction Protein Claudin-2 Promotes Self-Renewal of Human Colorectal Cancer Stem-like Cells. Cancer Res 78:2925-2938. |
| 693 | Garcia-Heredia JM et.al. (2018). NUMB and NUMBL differences in gene regulation. Oncotarget 9:9219-9234. |
| 692 | Boulagnon-Rombi C et.al. (2018). LRP1 expression in colon cancer predicts clinical outcome. Oncotarget 9:8849-8869. |
| 691 | Li Z et.al. (2018). EZH2 regulates neuroblastoma cell differentiation via NTRK1 promoter epigenetic modifications. Oncogene 37:2714-2727. |
| 690 | Szemes M et.al. (2018). Wnt Signalling Drives Context-Dependent Differentiation or Proliferation in Neuroblastoma. Neoplasia 20:335-350. |
| 689 | Fregni G et.al. (2018). Reciprocal modulation of mesenchymal stem cells and tumor cells promotes lung cancer metastasis. EBioMedicine 29:128-145. |
| 688 | Michaelsen SR et.al. (2018). DNA Methylation Levels of the ELMO Gene Promoter CpG Islands in Human Glioblastomas. Int J Mol Sci 19:. |
| 687 | Ferrucci V et.al. (2018). Metastatic group 3 medulloblastoma is driven by PRUNE1 targeting NME1-TGF-beta-OTX2-SNAIL via PTEN inhibition. Brain 141:1300-1319. |
| 686 | Grobner SN et.al. (2018). The landscape of genomic alterations across childhood cancers. Nature 555:321-327. |
| 685 | Floros KV et.al. (2018). Coamplification of miR-4728 protects HER2-amplified breast cancers from targeted therapy. Proc Natl Acad Sci U S A 115:E2594-E2603. |
| 684 | OBrien EM et.al. (2018). The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells. BMC Cancer 18:217. |
| 683 | Long W et.al. (2018). PHF20 collaborates with PARP1 to promote stemness and aggressiveness of neuroblastoma cells through activation of SOX2 and OCT4. J Mol Cell Biol 10:147-160. |
| 682 | Jin F et.al. (2018). High-density lipoprotein (HDL) promotes angiogenesis via S1P3-dependent VEGFR2 activation. Angiogenesis 21:381-394. |
| 681 | Sun H et.al. (2018). CFTR mutation enhances Dishevelled degradation and results in impairment of Wnt-dependent hematopoiesis. Cell Death Dis 9:275. |
| 680 | Brunen D et.al. (2018). PIM Kinases Are a Potential Prognostic Biomarker and Therapeutic Target in Neuroblastoma. Mol Cancer Ther 17:849-857. |
| 679 | Li W et.al. (2018). Sirtuin7 has an oncogenic potential via promoting the growth of cholangiocarcinoma cells. Biomed Pharmacother 100:257-266. |
| 678 | Karachaliou N et.al. (2018). Common Co-activation of AXL and CDCP1 in EGFR-mutation-positive Non-smallcell Lung Cancer Associated With Poor Prognosis. EBioMedicine 29:112-127. |
| 677 | Yu Y et.al. (2018). Tumor suppressive ZBTB4 inhibits cell growth by regulating cell cycle progression and apoptosis in Ewing sarcoma. Biomed Pharmacother 100:108-115. |
| 676 | Guan S et.al. (2018). MELK is a novel therapeutic target in high-risk neuroblastoma. Oncotarget 9:2591-2602. |
| 675 | Arnhold V et.al. (2018). Reactivating TP53 signaling by the novel MDM2 inhibitor DS-3032b as a therapeutic option for high-risk neuroblastoma. Oncotarget 9:2304-2319. |
| 674 | Tian T et.al. (2018). SNHG1 promotes cell proliferation by acting as a sponge of miR-145 in colorectal cancer. Oncotarget 9:2128-2139. |
| 673 | Yanru W et.al. (2018). Transcriptomic analyses of chemokines reveal that down-regulation of XCR1 is associated with advanced hepatocellular carcinoma. Biochem Biophys Res Commun 496:1314-1321. |
| 672 | Ferrucci F et.al. (2018). MAX to MYCN intracellular ratio drives the aggressive phenotype and clinical outcome of high risk neuroblastoma. Biochim Biophys Acta Gene Regul Mech 1861:235-245. |
| 671 | Zhang H et.al. (2018). Expression profile and clinical significance of Wnt signaling in human gliomas. Oncol Lett 15:610-617. |
| 670 | Gross A et.al. (2018). Tumorigenic and Antiproliferative Properties of the TALE-Transcription Factors MEIS2D and MEIS2A in Neuroblastoma. Cancer Res 78:1935-1947. |
| 669 | Xiang S et.al. (2018). LncRNA IDH1-AS1 links the functions of c-Myc and HIF1alpha via IDH1 to regulate the Warburg effect. Proc Natl Acad Sci U S A 115:E1465-E1474. |
| 668 | Dzieran J et.al. (2018). MYCN-amplified neuroblastoma maintains an aggressive and undifferentiated phenotype by deregulation of estrogen and NGF signaling. Proc Natl Acad Sci U S A 115:E1229-E1238. |
| 667 | Folgiero V et.al. (2018). Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia. EMBO Rep 19:. |
| 666 | Yuan R et.al. (2018). Chk1 and 14-3-3 proteins inhibit atypical E2Fs to prevent a permanent cell cycle arrest. EMBO J 37:. |
| 665 | Wu Q et.al. (2018). miR-375 inhibits IFN-gamma-induced programmed death 1 ligand 1 surface expression in head and neck squamous cell carcinoma cells by blocking JAK2/STAT1 signaling. Oncol Rep 39:1461-1468. |
| 664 | Li X et.al. (2018). Retinoic acid promotes stem cell differentiation and embryonic development by transcriptionally activating CFTR. Biochim Biophys Acta Mol Cell Res 1865:605-615. |
| 663 | Hasna J et.al. (2018). Orai3 calcium channel and resistance to chemotherapy in breast cancer cells: the p53 connection. Cell Death Differ 25:693-707. |
| 662 | Chen S et.al. (2018). EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axis. J Exp Clin Cancer Res 37:3. |
| 661 | Zhang Y et.al. (2018). YAP Promotes Migration and Invasion of Human Glioma Cells. J Mol Neurosci 64:262-272. |
| 660 | Schultz CR et.al. (2018). Synergistic drug combination GC7/DFMO suppresses hypusine/spermidine-dependent eIF5A activation and induces apoptotic cell death in neuroblastoma. Biochem J 475:531-545. |
| 659 | Sun C et.al. (2018). F-box protein 11 promotes the growth and metastasis of gastric cancer via PI3K/AKT pathway-mediated EMT. Biomed Pharmacother 98:416-423. |
| 658 | Han B et.al. (2018). FOXC1-induced non-canonical WNT5A-MMP7 signaling regulates invasiveness in triple-negative breast cancer. Oncogene 37:1399-1408. |
| 657 | Khodaparast S et.al. (2018). Dewetting of Thin Liquid Films Surrounding Air Bubbles in Microchannels. Langmuir 34:1363-1370. |
| 656 | Zhang T et.al. (2018). The atypical protein kinase RIOK3 contributes to glioma cell proliferation/survival, migration/invasion and the AKT/mTOR signaling pathway. Cancer Lett 415:151-163. |
| 655 | Agrawal R et.al. (2018). p53 and miR-210 regulated NeuroD2, a neuronal basic helix-loop-helix transcription factor, is downregulated in glioblastoma patients and functions as a tumor suppressor under hypoxic microenvironment. Int J Cancer 142:1817-1828. |
| 654 | Koster R et.al. (2018). Genome-wide association study identifies the GLDC/IL33 locus associated with survival of osteosarcoma patients. Int J Cancer 142:1594-1601. |
| 653 | Zhang B et.al. (2018). Neuroglobin promotes the proliferation and suppresses the apoptosis of glioma cells by activating the PI3K/AKT pathway. Mol Med Rep 17:2757-2763. |
| 652 | Flannery PC et.al. (2018). Preclinical analysis of MTOR complex 1/2 inhibition in diffuse intrinsic pontine glioma. Oncol Rep 39:455-464. |
| 651 | Wang Z et.al. (2018). RNA binding protein Lin28A promotes osteocarcinoma cells progression by associating with the long noncoding RNA MALAT1. Biotechnol Lett 40:493-500. |
| 650 | Lucena-Cacace A et.al. (2018). NAMPT Is a Potent Oncogene in Colon Cancer Progression that Modulates Cancer Stem Cell Properties and Resistance to Therapy through Sirt1 and PARP. Clin Cancer Res 24:1202-1215. |
| 649 | Liu SM et.al. (2018). miR-596 Modulates Melanoma Growth by Regulating Cell Survival and Death. J Invest Dermatol 138:911-921. |
| 648 | Hwang I et.al. (2018). FOXO protects against age-progressive axonal degeneration. Aging Cell 17:. |
| 647 | Meel MH et.al. (2018). Signaling pathways and mesenchymal transition in pediatric high-grade glioma. Cell Mol Life Sci 75:871-887. |
| 646 | Bogeas A et.al. (2018). Changes in chromatin state reveal ARNT2 at a node of a tumorigenic transcription factor signature driving glioblastoma cell aggressiveness. Acta Neuropathol 135:267-283. |
| 645 | Panchoo M et.al. (2018). Scavenger receptor class B type 1 regulates neuroblastoma cell proliferation, migration and invasion. Biochem Biophys Res Commun 495:614-620. |
| 644 | Lochmann TL et.al. (2018). Venetoclax Is Effective in Small-Cell Lung Cancers with High BCL-2 Expression. Clin Cancer Res 24:360-369. |
| 643 | Huang Y et.al. (2018). Three-dimensional hydrogel is suitable for targeted investigation of amoeboid migration of glioma cells. Mol Med Rep 17:250-256. |
| 642 | Zhao SJ et.al. (2018). SPARCL1 suppresses osteosarcoma metastasis and recruits macrophages by activation of canonical WNT/beta-catenin signaling through stabilization of the WNT-receptor complex. Oncogene 37:1049-1061. |
| 641 | Deng S et.al. (2018). Overexpression of COX7A2 is associated with a good prognosis in patients with glioma. J Neurooncol 136:41-50. |
| 640 | Song KA et.al. (2018). Epithelial-to-Mesenchymal Transition Antagonizes Response to Targeted Therapies in Lung Cancer by Suppressing BIM. Clin Cancer Res 24:197-208. |
| 639 | Marturano-Kruik A et.al. (2018). Biomechanical regulation of drug sensitivity in an engineered model of human tumor. Biomaterials 150:150-161. |
| 638 | Pahlman S et.al. (2018). Hypoxia and hypoxia-inducible factors in neuroblastoma. Cell Tissue Res 372:269-275. |
| 637 | Ge Z et.al. (2018). Plant homeodomain finger protein 2 as a novel IKAROS target in acute lymphoblastic leukemia. Epigenomics 10:59-69. |
| 636 | Wang CH et.al. (2018). Resistin facilitates breast cancer progression via TLR4-mediated induction of mesenchymal phenotypes and stemness properties. Oncogene 37:589-600. |
| 635 | Narayan RS et.al. (2018). Identification of MEK162 as a Radiosensitizer for the Treatment of Glioblastoma. Mol Cancer Ther 17:347-354. |
| 634 | Xie Z et.al. (2018). miR-149 promotes human osteocarcinoma progression via targeting bone morphogenetic protein 9 (BMP9). Biotechnol Lett 40:47-55. |
| 633 | Rifatbegovic F et.al. (2018). Neuroblastoma cells undergo transcriptomic alterations upon dissemination into the bone marrow and subsequent tumor progression. Int J Cancer 142:297-307. |
| 632 | Hasenoehrl C et.al. (2018). G protein-coupled receptor GPR55 promotes colorectal cancer and has opposing effects to cannabinoid receptor 1. Int J Cancer 142:121-132. |
| 631 | Choo S et.al. (2018). Reactivation of TWIST1 contributes to Ewing sarcoma metastasis. Pediatr Blood Cancer 65:. |
| 2017 (n=171) |
| 630 | Leong WZ et.al. (2017). ARID5B as a critical downstream target of the TAL1 complex that activates the oncogenic transcriptional program and promotes T-cell leukemogenesis. Genes Dev 31:2343-2360. |
| 629 | Lange I et.al. (2017). FTY-720 induces apoptosis in neuroblastoma via multiple signaling pathways. Oncotarget 8:109985-109999. |
| 628 | Mu L et.al. (2017). Small-sized colorectal cancer cells harbor metastatic tumor-initiating cells. Oncotarget 8:107907-107919. |
| 627 | Su Z et.al. (2017). Neurocan, an extracellular chondroitin sulfate proteoglycan, stimulates neuroblastoma cells to promote malignant phenotypes. Oncotarget 8:106296-106310. |
| 626 | Verdugo-Sivianes EM et.al. (2017). Coordinated downregulation of Spinophilin and the catalytic subunits of PP1, PPP1CA/B/C, contributes to a worse prognosis in lung cancer. Oncotarget 8:105196-105210. |
| 625 | Arrizabalaga O et.al. (2017). High expression of MKP1/DUSP1 counteracts glioma stem cell activity and mediates HDAC inhibitor response. Oncogenesis 6:401. |
| 624 | Gong L et.al. (2017). Differential radiation response between normal astrocytes and glioma cells revealed by comparative transcriptome analysis. Onco Targets Ther 10:5755-5764. |
| 623 | Mucignat-Caretta C et.al. (2017). Protein Kinase A Distribution Differentiates Human Glioblastoma from Brain Tissue. Cancers (Basel) 10:. |
| 622 | Chen Z et.al. (2017). Small molecule inhibitor regorafenib inhibits RET signaling in neuroblastoma cells and effectively suppresses tumor growth in vivo. Oncotarget 8:104090-104103. |
| 621 | Astrologo L et.al. (2017). ALK1Fc Suppresses the Human Prostate Cancer Growth in in Vitro and in Vivo Preclinical Models. Front Cell Dev Biol 5:104. |
| 620 | Lucena-Cacace A et.al. (2017). NAMPT overexpression induces cancer stemness and defines a novel tumor signature for glioma prognosis. Oncotarget 8:99514-99530. |
| 619 | Sankar S et.al. (2017). Geminin deficiency enhances survival in a murine medulloblastoma model by inducing apoptosis of preneoplastic granule neuron precursors. Genes Cancer 8:725-744. |
| 618 | Mohlin S et.al. (2017). No reason to reconsider HIF-2 as an oncogene in neuroblastoma and other cancer forms. Proc Natl Acad Sci U S A 114:E10856-E10858. |
| 617 | Garcia-Heredia JM et.al. (2017). The cargo protein MAP17 (PDZK1IP1) regulates the immune microenvironment. Oncotarget 8:98580-98597. |
| 616 | Hou J et.al. (2017). Increased Jab1/COPS5 is associated with therapeutic response and adverse outcome in lung cancer and breast cancer patients. Oncotarget 8:97504-97515. |
| 615 | Yuan ZS et.al. (2017). IGFBP2 induces SPRY1 expression via NF-kappaB signaling pathway in glioblastoma multiforme (GBM). Eur Rev Med Pharmacol Sci 21:5072-5080. |
| 614 | Tummler C et.al. (2017). Inhibition of chemerin/CMKLR1 axis in neuroblastoma cells reduces clonogenicity and cell viability in vitro and impairs tumor growth in vivo. Oncotarget 8:95135-95151. |
| 613 | Sun W et.al. (2017). EWS-FLI1 and RNA helicase A interaction inhibitor YK-4-279 inhibits growth of neuroblastoma. Oncotarget 8:94780-94792. |
| 612 | Linares-Clemente P et.al. (2017). Neural crest derived progenitor cells contribute to tumor stroma and aggressiveness in stage 4/M neuroblastoma. Oncotarget 8:89775-89792. |
| 611 | Villasante A et.al. (2017). Vascularized Tissue-Engineered Model for Studying Drug Resistance in Neuroblastoma. Theranostics 7:4099-4117. |
| 610 | Jongen JMJ et.al. (2017). Downregulation of DNA repair proteins and increased DNA damage in hypoxic colon cancer cells is a therapeutically exploitable vulnerability. Oncotarget 8:86296-86311. |
| 609 | Bustos V et.al. (2017). GPER mediates differential effects of estrogen on colon cancer cell proliferation and migration under normoxic and hypoxic conditions. Oncotarget 8:84258-84275. |
| 608 | Paul P et.al. (2017). Elevated TIMP-1 expression is associated with a prometastatic phenotype, disease relapse, and poor survival in neuroblastoma. Oncotarget 8:82609-82620. |
| 607 | Hurst CD et.al. (2017). Genomic Subtypes of Non-invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency. Cancer Cell 32:701-715.e7. |
| 606 | Savci-Heijink CD et.al. (2017). Association between gene expression profile of the primary tumor and chemotherapy response of metastatic breast cancer. BMC Cancer 17:755. |
| 605 | Chang W et.al. (2017). Immature colon carcinoma transcript-1 promotes cell growth of hepatocellular carcinoma via facilitating cell cycle progression and apoptosis resistance. Oncol Rep 38:3489-3496. |
| 604 | Zhang D et.al. (2017). Down-regulation of CHERP inhibits neuroblastoma cell proliferation and induces apoptosis through ER stress induction. Oncotarget 8:80956-80970. |
| 603 | Mir SE et.al. (2017). Trimethylation of H3K27 during human cerebellar development in relation to medulloblastoma. Oncotarget 8:78978-78988. |
| 602 | Zhou G et.al. (2017). Homeobox B4 inhibits breast cancer cell migration by directly binding to StAR-related lipid transfer domain protein 13. Oncol Lett 14:4625-4632. |
| 601 | Hong L et.al. (2017). Downregulation of miR-16 via URGCP pathway contributes to glioma growth. Sci Rep 7:13470. |
| 600 | Yang Z et.al. (2017). Reprogramming of stromal fibroblasts by SNAI2 contributes to tumor desmoplasia and ovarian cancer progression. Mol Cancer 16:163. |
| 599 | Xu L et.al. (2017). YBX1 promotes tumor growth by elevating glycolysis in human bladder cancer. Oncotarget 8:65946-65956. |
| 598 | Delloye-Bourgeois C et.al. (2017). Microenvironment-Driven Shift of Cohesion/Detachment Balance within Tumors Induces a Switch toward Metastasis in Neuroblastoma. Cancer Cell 32:427-443.e8. |
| 597 | Tao Y et.al. (2017). miR-205 regulation of ICT1 has an oncogenic potential via promoting the migration and invasion of gastric cancer cells. Biomed Pharmacother 96:191-197. |
| 596 | Mahmud H et.al. (2017). Peptide microarray profiling identifies phospholipase C gamma 1 (PLC-gamma1) as a potential target for t(8;21) AML. Oncotarget 8:67344-67354. |
| 595 | Lobbardi R et.al. (2017). TOX Regulates Growth, DNA Repair, and Genomic Instability in T-cell Acute Lymphoblastic Leukemia. Cancer Discov 7:1336-1353. |
| 594 | van Attekum MHA et.al. (2017). CD40 signaling instructs chronic lymphocytic leukemia cells to attract monocytes via the CCR2 axis. Haematologica 102:2069-2076. |
| 593 | Vardon A et.al. (2017). Arginine auxotrophic gene signature in paediatric sarcomas and brain tumours provides a viable target for arginine depletion therapies. Oncotarget 8:63506-63517. |
| 592 | Kumar SS et.al. (2017). BMI-1 is a potential therapeutic target in diffuse intrinsic pontine glioma. Oncotarget 8:62962-62975. |
| 591 | Russo R et.al. (2017). Kinome expression profiling of human neuroblastoma tumors identifies potential drug targets for ultra high-risk patients. Carcinogenesis 38:1011-1020. |
| 590 | Kumar SA et.al. (2017). Pathological and prognostic role of mdig in pancreatic cancer. Genes Cancer 8:650-658. |
| 589 | Meel MH et.al. (2017). Culture methods of diffuse intrinsic pontine glioma cells determine response to targeted therapies. Exp Cell Res 360:397-403. |
| 588 | Yue C et.al. (2017). High expression of Brutons tyrosine kinase (BTK) is required for EGFR-induced NF-kappaB activation and predicts poor prognosis in human glioma. J Exp Clin Cancer Res 36:132. |
| 587 | Wu X et.al. (2017). Extra-mitochondrial prosurvival BCL-2 proteins regulate gene transcription by inhibiting the SUFU tumour suppressor. Nat Cell Biol 19:1226-1236. |
| 586 | Guadagno E et.al. (2017). PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype. Oncotarget 8:59282-59300. |
| 585 | Canovas V et.al. (2017). Prostate Tumor Overexpressed-1 (PTOV1) promotes docetaxel-resistance and survival of castration resistant prostate cancer cells. Oncotarget 8:59165-59180. |
| 584 | Jimenez-Garcia MP et.al. (2017). Inflammation and stem markers association to PIM1/PIM2 kinase-induced tumors in breast and uterus. Oncotarget 8:58872-58886. |
| 583 | Wang S et.al. (2017). BMPR2 promotes invasion and metastasis via the RhoA-ROCK-LIMK2 pathway in human osteosarcoma cells. Oncotarget 8:58625-58641. |
| 582 | Villa E et.al. (2017). Parkin-Independent Mitophagy Controls Chemotherapeutic Response in Cancer Cells. Cell Rep 20:2846-2859. |
| 581 | Li Y et.al. (2017). Genomic analysis-integrated whole-exome sequencing of neuroblastomas identifies genetic mutations in axon guidance pathway. Oncotarget 8:56684-56697. |
| 580 | Bosse KR et.al. (2017). Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk Neuroblastoma. Cancer Cell 32:295-309.e12. |
| 579 | Erdreich-Epstein A et.al. (2017). Association of high microvessel alphavbeta3 and low PTEN with poor outcome in stage 3 neuroblastoma: rationale for using first in class dual PI3K/BRD4 inhibitor, SF1126. Oncotarget 8:52193-52210. |
| 578 | Strobel T et.al. (2017). Ape1 guides DNA repair pathway choice that is associated with drug tolerance in glioblastoma. Sci Rep 7:9674. |
| 577 | Ryl T et.al. (2017). Cell-Cycle Position of Single MYC-Driven Cancer Cells Dictates Their Susceptibility to a Chemotherapeutic Drug. Cell Syst 5:237-250.e8. |
| 576 | Bingel C et.al. (2017). Three-dimensional tumor cell growth stimulates autophagic flux and recapitulates chemotherapy resistance. Cell Death Dis 8:e3013. |
| 575 | Jeanne A et.al. (2017). Lumican delays melanoma growth in mice and drives tumor molecular assembly as well as response to matrix-targeted TAX2 therapeutic peptide. Sci Rep 7:7700. |
| 574 | Li Y et.al. (2017). CircHIPK3 sponges miR-558 to suppress heparanase expression in bladder cancer cells. EMBO Rep 18:1646-1659. |
| 573 | Watanabe Y et.al. (2017). ZAR1 knockdown promotes the differentiation of human neuroblastoma cells by suppression of MYCN expression. Med Oncol 34:158. |
| 572 | Ambrosio S et.al. (2017). Lysine-specific demethylase LSD1 regulates autophagy in neuroblastoma through SESN2-dependent pathway. Oncogene 36:6701-6711. |
| 571 | Calero R et.al. (2017). Synergistic anti-tumor effect of 17AAG with the PI3K/mTOR inhibitor NVP-BEZ235 on human melanoma. Cancer Lett 406:1-11. |
| 570 | Roy R et.al. (2017). ADAM12 Is a Novel Regulator of Tumor Angiogenesis via STAT3 Signaling. Mol Cancer Res 15:1608-1622. |
| 569 | Xie Y et.al. (2017). Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma. Gastroenterology 153:1429-1443.e5. |
| 568 | Bloemendaal FM et.al. (2017). Anti-Tumor Necrosis Factor With a Glyco-Engineered Fc-Region Has Increased Efficacy in Mice With Colitis. Gastroenterology 153:1351-1362.e4. |
| 567 | Satterfield L et.al. (2017). miR-130b directly targets ARHGAP1 to drive activation of a metastatic CDC42-PAK1-AP1 positive feedback loop in Ewing sarcoma. Int J Cancer 141:2062-2075. |
| 566 | Vellinga TT et.al. (2017). Lymphangiogenic Gene Expression Is Associated With Lymph Node Recurrence and Poor Prognosis After Partial Hepatectomy for Colorectal Liver Metastasis. Ann Surg 266:765-771. |
| 565 | Li N et.al. (2017). Therapeutically targeting glypican-2 via single-domain antibody-based chimeric antigen receptors and immunotoxins in neuroblastoma. Proc Natl Acad Sci U S A 114:E6623-E6631. |
| 564 | Dyberg C et.al. (2017). Rho-associated kinase is a therapeutic target in neuroblastoma. Proc Natl Acad Sci U S A 114:E6603-E6612. |
| 563 | Brauss TF et.al. (2017). The RNA-binding protein HuR inhibits expression of CCL5 and limits recruitment of macrophages into tumors. Mol Carcinog 56:2620-2629. |
| 562 | Northcott PA et.al. (2017). The whole-genome landscape of medulloblastoma subtypes. Nature 547:311-317. |
| 561 | Wang Y et.al. (2017). Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis. Mol Cancer 16:123. |
| 560 | Park NI et.al. (2017). ASCL1 Reorganizes Chromatin to Direct Neuronal Fate and Suppress Tumorigenicity of Glioblastoma Stem Cells. Cell Stem Cell 21:209-224.e7. |
| 559 | Westerlund I et.al. (2017). Combined epigenetic and differentiation-based treatment inhibits neuroblastoma tumor growth and links HIF2alpha to tumor suppression. Proc Natl Acad Sci U S A 114:E6137-E6146. |
| 558 | Friedrich C et.al. (2017). Tropomyosin receptor kinase C (TrkC) expression in medulloblastoma: relation to the molecular subgroups and impact on treatment response. Childs Nerv Syst 33:1463-1471. |
| 557 | Trumpi K et.al. (2017). Neoadjuvant chemotherapy affects molecular classification of colorectal tumors. Oncogenesis 6:e357. |
| 556 | Neto M et.al. (2017). Nuclear receptors connect progenitor transcription factors to cell cycle control. Sci Rep 7:4845. |
| 555 | Sun Y et.al. (2017). Upregulation of LYAR induces neuroblastoma cell proliferation and survival. Cell Death Differ 24:1645-1654. |
| 554 | Ma X et.al. (2017). CXCR4 expression varies significantly among different subtypes of glioblastoma multiforme (GBM) and its low expression or hypermethylation might predict favorable overall survival. Expert Rev Neurother 17:941-946. |
| 553 | Yang J et.al. (2017). Targeting Histone Demethylases in MYC-Driven Neuroblastomas with Ciclopirox. Cancer Res 77:4626-4638. |
| 552 | Layer JP et.al. (2017). Amplification of N-Myc is associated with a T-cell-poor microenvironment in metastatic neuroblastoma restraining interferon pathway activity and chemokine expression. Oncoimmunology 6:e1320626. |
| 551 | Lennicke C et.al. (2017). Modulation of MHC class I surface expression in B16F10 melanoma cells by methylseleninic acid. Oncoimmunology 6:e1259049. |
| 550 | Capasso M et.al. (2017). The functional variant rs34330 of CDKN1B is associated with risk of neuroblastoma. J Cell Mol Med 21:3224-3230. |
| 549 | van Groningen T et.al. (2017). Neuroblastoma is composed of two super-enhancer-associated differentiation states. Nat Genet 49:1261-1266. |
| 548 | Conduit SE et.al. (2017). A compartmentalized phosphoinositide signaling axis at cilia is regulated by INPP5E to maintain cilia and promote Sonic Hedgehog medulloblastoma. Oncogene 36:5969-5984. |
| 547 | Fell SM et.al. (2017). Neuroblast differentiation during development and in neuroblastoma requires KIF1Bbeta-mediated transport of TRKA. Genes Dev 31:1036-1053. |
| 546 | Rodriguez-Hernandez G et.al. (2017). Infection Exposure Promotes ETV6-RUNX1 Precursor B-cell Leukemia via Impaired H3K4 Demethylases. Cancer Res 77:4365-4377. |
| 545 | Chikaraishi K et.al. (2017). CFC1 is a cancer stemness-regulating factor in neuroblastoma. Oncotarget 8:45046-45059. |
| 544 | de Rooij B et.al. (2017). Acute lymphoblastic leukemia cells create a leukemic niche without affecting the CXCR4/CXCL12 axis. Haematologica 102:e389-e393. |
| 543 | Mu P et.al. (2017). A novel nuclear complex of DRR1, F-actin and COMMD1 involved in NF-kappaB degradation and cell growth suppression in neuroblastoma. Oncogene 36:5745-5756. |
| 542 | Su YK et.al. (2017). Antrodia cinnamomea sensitizes radio-/chemo-therapy of cancer stem-like cells by modulating microRNA expression. J Ethnopharmacol 207:47-56. |
| 541 | Gao S et.al. (2017). Overexpression of RASD1 inhibits glioma cell migration/invasion and inactivates the AKT/mTOR signaling pathway. Sci Rep 7:3202. |
| 540 | Dong X et.al. (2017). RSPO2 suppresses colorectal cancer metastasis by counteracting the Wnt5a/Fzd7-driven noncanonical Wnt pathway. Cancer Lett 402:153-165. |
| 539 | Seifert A et.al. (2017). Tightly controlled MRTF-A activity regulates epithelial differentiation during formation of mammary acini. Breast Cancer Res 19:68. |
| 538 | Delaidelli A et.al. (2017). MYCN amplified neuroblastoma requires the mRNA translation regulator eEF2 kinase to adapt to nutrient deprivation. Cell Death Differ 24:1564-1576. |
| 537 | Maciaczyk D et.al. (2017). CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells. Br J Cancer 117:102-112. |
| 536 | Liu H et.al. (2017). MELK and EZH2 Cooperate to Regulate Medulloblastoma Cancer Stem-like Cell Proliferation and Differentiation. Mol Cancer Res 15:1275-1286. |
| 535 | Stiegelbauer V et.al. (2017). miR-196b-5p Regulates Colorectal Cancer Cell Migration and Metastases through Interaction with HOXB7 and GALNT5. Clin Cancer Res 23:5255-5266. |
| 534 | Kawauchi D et.al. (2017). Novel MYC-driven medulloblastoma models from multiple embryonic cerebellar cells. Oncogene 36:5231-5242. |
| 533 | Henssen AG et.al. (2017). PGBD5 promotes site-specific oncogenic mutations in human tumors. Nat Genet 49:1005-1014. |
| 532 | Veenstra VL et.al. (2017). Stromal SPOCK1 supports invasive pancreatic cancer growth. Mol Oncol 11:1050-1064. |
| 531 | Schmidt C et.al. (2017). Preclinical drug screen reveals topotecan, actinomycin D, and volasertib as potential new therapeutic candidates for ETMR brain tumor patients. Neuro Oncol 19:1607-1617. |
| 530 | Silginer M et.al. (2017). Autocrine activation of the IFN signaling pathway may promote immune escape in glioblastoma. Neuro Oncol 19:1338-1349. |
| 529 | Chen NP et.al. (2017). Human phosphatase CDC14A regulates actin organization through dephosphorylation of epithelial protein lost in neoplasm. Proc Natl Acad Sci U S A 114:5201-5206. |
| 528 | Roy A et.al. (2017). Serglycin as a potential biomarker for glioma: association of serglycin expression, extent of mast cell recruitment and glioblastoma progression. Oncotarget 8:24815-24827. |
| 527 | Duong C et.al. (2017). Novel targeted therapy for neuroblastoma: silencing the MXD3 gene using siRNA. Pediatr Res 82:527-535. |
| 526 | Sanden E et.al. (2017). Establishment and characterization of an orthotopic patient-derived Group 3 medulloblastoma model for preclinical drug evaluation. Sci Rep 7:46366. |
| 525 | Yurugi H et.al. (2017). Targeting prohibitins with chemical ligands inhibits KRAS-mediated lung tumours. Oncogene 36:4778-4789. |
| 524 | Kanska J et.al. (2017). Glucose deprivation elicits phenotypic plasticity via ZEB1-mediated expression of NNMT. Oncotarget 8:26200-26220. |
| 523 | Pezzolo A et.al. (2017). Constitutional 3p26.3 terminal microdeletion in an adolescent with neuroblastoma. Cancer Biol Ther 18:285-289. |
| 522 | Xu J et.al. (2017). PID1 increases chemotherapy-induced apoptosis in medulloblastoma and glioblastoma cells in a manner that involves NFkappaB. Sci Rep 7:835. |
| 521 | Colicchia V et.al. (2017). PARP inhibitors enhance replication stress and cause mitotic catastrophe in MYCN-dependent neuroblastoma. Oncogene 36:4682-4691. |
| 520 | Deivendran S et.al. (2017). Metastasis-associated protein 1 is an upstream regulator of DNMT3a and stimulator of insulin-growth factor binding protein-3 in breast cancer. Sci Rep 7:44225. |
| 519 | Thompson EM et.al. (2017). The role of angiogenesis in Group 3 medulloblastoma pathogenesis and survival. Neuro Oncol 19:1217-1227. |
| 518 | Seystahl K et.al. (2017). Biological Role and Therapeutic Targeting of TGF-beta3 in Glioblastoma. Mol Cancer Ther 16:1177-1186. |
| 517 | Rapetti-Mauss R et.al. (2017). Bidirectional KCNQ1:beta-catenin interaction drives colorectal cancer cell differentiation. Proc Natl Acad Sci U S A 114:4159-4164. |
| 516 | Pang Z et.al. (2017). Expressions of insulin-like growth factor receptor-1 and cezanne-1 in lung adenocarcinoma. Med Oncol 34:78. |
| 515 | Bhatia S et.al. (2017). Combined EphB2 receptor knockdown with radiation decreases cell viability and invasion in medulloblastoma. Cancer Cell Int 17:41. |
| 514 | Kaluski S et.al. (2017). Neuroprotective Functions for the Histone Deacetylase SIRT6. Cell Rep 18:3052-3062. |
| 513 | Dewi DL et.al. (2017). Suppression of indoleamine-2,3-dioxygenase 1 expression by promoter hypermethylation in ER-positive breast cancer. Oncoimmunology 6:e1274477. |
| 512 | Zhang S et.al. (2017). m(6)A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program. Cancer Cell 31:591-606.e6. |
| 511 | Wang K et.al. (2017). The noncoding RNA linc-ADAMTS5 cooperates with RREB1 to protect from intervertebral disc degeneration through inhibiting ADAMTS5 expression. Clin Sci (Lond) 131:965-979. |
| 510 | Guo P et.al. (2017). A quantitative method for screening and identifying molecular targets for nanomedicine. J Control Release 263:57-67. |
| 509 | Zhang X et.al. (2017). Critical Role for GAB2 in Neuroblastoma Pathogenesis through the Promotion of SHP2/MYCN Cooperation. Cell Rep 18:2932-2942. |
| 508 | Thewes V et.al. (2017). The branched-chain amino acid transaminase 1 sustains growth of antiestrogen-resistant and ERalpha-negative breast cancer. Oncogene 36:4124-4134. |
| 507 | Raats DA et.al. (2017). CD95 ligand induces senescence in mismatch repair-deficient human colon cancer via chronic caspase-mediated induction of DNA damage. Cell Death Dis 8:e2669. |
| 506 | Zhang D et.al. (2017). ALG2 regulates glioblastoma cell proliferation, migration and tumorigenicity. Biochem Biophys Res Commun 486:300-306. |
| 505 | Gholamin S et.al. (2017). Disrupting the CD47-SIRPalpha anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors. Sci Transl Med 9:. |
| 504 | Sewing ACP et.al. (2017). Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma. J Neurosurg Pediatr 19:518-530. |
| 503 | Zhou F et.al. (2017). Jab1/Csn5-Thioredoxin Signaling in Relapsed Acute Monocytic Leukemia under Oxidative Stress. Clin Cancer Res 23:4450-4461. |
| 502 | Tao T et.al. (2017). The pre-rRNA processing factor DEF is rate limiting for the pathogenesis of MYCN-driven neuroblastoma. Oncogene 36:3852-3867. |
| 501 | Abbasi MR et.al. (2017). Impact of Disseminated Neuroblastoma Cells on the Identification of the Relapse-Seeding Clone. Clin Cancer Res 23:4224-4232. |
| 500 | An T et.al. (2017). USP7 inhibitor P5091 inhibits Wnt signaling and colorectal tumor growth. Biochem Pharmacol 131:29-39. |
| 499 | Bate-Eya LT et.al. (2017). Enhancer of zeste homologue 2 plays an important role in neuroblastoma cell survival independent of its histone methyltransferase activity. Eur J Cancer 75:63-72. |
| 498 | Wong M et.al. (2017). The Histone Methyltransferase DOT1L Promotes Neuroblastoma by Regulating Gene Transcription. Cancer Res 77:2522-2533. |
| 497 | Tu Y et.al. (2017). Smoothened is a poor prognosis factor and a potential therapeutic target in glioma. Sci Rep 7:42630. |
| 496 | Bi G et.al. (2017). PRRT2 inhibits the proliferation of glioma cells by modulating unfolded protein response pathway. Biochem Biophys Res Commun 485:454-460. |
| 495 | Cheng F et.al. (2017). RNA-Binding Protein Dnd1 Promotes Breast Cancer Apoptosis by Stabilizing the Bim mRNA in a miR-221 Binding Site. Biomed Res Int 2017:9596152. |
| 494 | Duffy DJ et.al. (2017). Retinoic acid and TGF-beta signalling cooperate to overcome MYCN-induced retinoid resistance. Genome Med 9:15. |
| 493 | Gaviglio AL et.al. (2017). Heparin-binding epidermal growth factor-like growth factor promotes neuroblastoma differentiation. FASEB J 31:1903-1915. |
| 492 | Lin C et.al. (2017). Potential importance of protease activated receptor (PAR)-1 expression in the tumor stroma of non-small-cell lung cancer. BMC Cancer 17:113. |
| 491 | Kakumu T et.al. (2017). Identification of proteasomal catalytic subunit PSMA6 as a therapeutic target for lung cancer. Cancer Sci 108:732-743. |
| 490 | Garcia-Heredia JM et.al. (2017). The Cargo Protein MAP17 (PDZK1IP1) Regulates the Cancer Stem Cell Pool Activating the Notch Pathway by Abducting NUMB. Clin Cancer Res 23:3871-3883. |
| 489 | Chanakira A et.al. (2017). Tissue factor-factor VIIa complex triggers protease activated receptor 2-dependent growth factor release and migration in ovarian cancer. Gynecol Oncol 145:167-175. |
| 488 | Wang D et.al. (2017). Aberrant activation of hedgehog signaling promotes cell proliferation via the transcriptional activation of forkhead Box M1 in colorectal cancer cells. J Exp Clin Cancer Res 36:23. |
| 487 | Fancello L et.al. (2017). The ribosomal protein gene RPL5 is a haploinsufficient tumor suppressor in multiple cancer types. Oncotarget 8:14462-14478. |
| 486 | Chung ST et.al. (2017). Osteoprotegerin mediates tumor-promoting effects of Interleukin-1beta in breast cancer cells. Mol Cancer 16:27. |
| 485 | Carpi S et.al. (2017). Tumor-promoting effects of cannabinoid receptor type 1 in human melanoma cells. Toxicol In Vitro 40:272-279. |
| 484 | Xu M et.al. (2017). Interactions between interleukin-6 and myeloid-derived suppressor cells drive the chemoresistant phenotype of hepatocellular cancer. Exp Cell Res 351:142-149. |
| 483 | Jeibmann A et.al. (2017). SMAD dependent signaling plays a detrimental role in a fly model of SMARCB1-deficiency and the biology of atypical teratoid/rhabdoid tumors. J Neurooncol 131:477-484. |
| 482 | Veschi V et.al. (2017). Epigenetic siRNA and Chemical Screens Identify SETD8 Inhibition as a Therapeutic Strategy for p53 Activation in High-Risk Neuroblastoma. Cancer Cell 31:50-63. |
| 481 | Baglio SR et.al. (2017). Blocking Tumor-Educated MSC Paracrine Activity Halts Osteosarcoma Progression. Clin Cancer Res 23:3721-3733. |
| 480 | Busiello T et.al. (2017). Role of ZNF224 in cell growth and chemoresistance of chronic lymphocitic leukemia. Hum Mol Genet 26:344-353. |
| 479 | Villanueva AA et.al. (2017). The Netrin-4/ Neogenin-1 axis promotes neuroblastoma cell survival and migration. Oncotarget 8:9767-9782. |
| 478 | El-Habr EA et.al. (2017). A driver role for GABA metabolism in controlling stem and proliferative cell state through GHB production in glioma. Acta Neuropathol 133:645-660. |
| 477 | Jung M et.al. (2017). A Myc Activity Signature Predicts Poor Clinical Outcomes in Myc-Associated Cancers. Cancer Res 77:971-981. |
| 476 | Hofman IJF et.al. (2017). RPL5 on 1p22.1 is recurrently deleted in multiple myeloma and its expression is linked to bortezomib response. Leukemia 31:1706-1714. |
| 475 | van Keimpema M et.al. (2017). The small FOXP1 isoform predominantly expressed in activated B cell-like diffuse large B-cell lymphoma and full-length FOXP1 exert similar oncogenic and transcriptional activity in human B cells. Haematologica 102:573-583. |
| 474 | Bieerkehazhi S et.al. (2017). Novel Src/Abl tyrosine kinase inhibitor bosutinib suppresses neuroblastoma growth via inhibiting Src/Abl signaling. Oncotarget 8:1469-1480. |
| 473 | Mao X et.al. (2017). Novel multi-targeted ErbB family inhibitor afatinib blocks EGF-induced signaling and induces apoptosis in neuroblastoma. Oncotarget 8:1555-1568. |
| 472 | Seong BK et.al. (2017). A Metastatic Mouse Model Identifies Genes That Regulate Neuroblastoma Metastasis. Cancer Res 77:696-706. |
| 471 | Ambrosio S et.al. (2017). LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene. Oncotarget 8:3854-3869. |
| 470 | Charlet J et.al. (2017). Genome-wide DNA methylation analysis identifies MEGF10 as a novel epigenetically repressed candidate tumor suppressor gene in neuroblastoma. Mol Carcinog 56:1290-1301. |
| 469 | Zhang H et.al. (2017). STARD13 promotes hepatocellular carcinoma apoptosis by acting as a ceRNA for Fas. Biotechnol Lett 39:207-217. |
| 468 | Jeanne A et.al. (2017). Thrombospondin-targeting TAX2 peptide impairs tumor growth in preclinical mouse models of childhood neuroblastoma. Pediatr Res 81:480-488. |
| 467 | McManus M et.al. (2017). Hes4: A potential prognostic biomarker for newly diagnosed patients with high-grade osteosarcoma. Pediatr Blood Cancer 64:. |
| 466 | Xiong N et.al. (2017). Involvement of caveolin-1 in low shear stress-induced breast cancer cell motility and adhesion: Roles of FAK/Src and ROCK/p-MLC pathways. Biochim Biophys Acta Mol Cell Res 1864:12-22. |
| 465 | Jan A et.al. (2017). eEF2K inhibition blocks Abeta42 neurotoxicity by promoting an NRF2 antioxidant response. Acta Neuropathol 133:101-119. |
| 464 | Borovski T et.al. (2017). Inhibition of RAF1 kinase activity restores apicobasal polarity and impairs tumour growth in human colorectal cancer. Gut 66:1106-1115. |
| 463 | Hou J et.al. (2017). CSN6 controls the proliferation and metastasis of glioblastoma by CHIP-mediated degradation of EGFR. Oncogene 36:1134-1144. |
| 462 | Pan Y et.al. (2017). Stat3 contributes to cancer progression by regulating Jab1/Csn5 expression. Oncogene 36:1069-1079. |
| 461 | Huang MY et.al. (2017). MINA controls proliferation and tumorigenesis of glioblastoma by epigenetically regulating cyclins and CDKs via H3K9me3 demethylation. Oncogene 36:387-396. |
| 460 | Li C et.al. (2017). Elevated AQP1 Expression Is Associated With Unfavorable Oncologic Outcome in Patients With Hilar Cholangiocarcinoma. Technol Cancer Res Treat 16:421-427. |
| 2016 (n=142) |
| 459 | Hansen JN et.al. (2016). EYA1 expression and subcellular localization in neuroblastoma and its association with prognostic markers. J Cancer Res Ther (Manch) 4:11-18. |
| 458 | Cangelosi D et.al. (2016). Artificial neural network classifier predicts neuroblastoma patients outcome. BMC Bioinformatics 17:347. |
| 457 | Eissler N et.al. (2016). Regulation of myeloid cells by activated T cells determines the efficacy of PD-1 blockade. Oncoimmunology 5:e1232222. |
| 456 | Kasim M et.al. (2016). Achaete-Scute Homolog 1 Expression Controls Cellular Differentiation of Neuroblastoma. Front Mol Neurosci 9:156. |
| 455 | Salazar BM et.al. (2016). Neuroblastoma, a Paradigm for Big Data Science in Pediatric Oncology. Int J Mol Sci 18:. |
| 454 | Mooberry LK et.al. (2016). Targeting the SR-B1 Receptor as a Gateway for Cancer Therapy and Imaging. Front Pharmacol 7:466. |
| 453 | Chen Z et.al. (2016). Wip1 inhibitor GSK2830371 inhibits neuroblastoma growth by inducing Chk2/p53-mediated apoptosis. Sci Rep 6:38011. |
| 452 | Ma W et.al. (2016). Human Papillomavirus Downregulates the Expression of IFITM1 and RIPK3 to Escape from IFNgamma Front Immunol 7:496. |
| 451 | Jimenez-Garcia MP et.al. (2016). The role of PIM1/PIM2 kinases in tumors of the male reproductive system. Sci Rep 6:38079. |
| 450 | Vella S et.al. (2016). Targeting CDKs with Roscovitine Increases Sensitivity to DNA Damaging Drugs of Human Osteosarcoma Cells. PLoS One 11:e0166233. |
| 449 | Gao S et.al. (2016). Low Expression of CAPON in Glioma Contributes to Cell Proliferation via the Akt Signaling Pathway. Int J Mol Sci 17:. |
| 448 | den Uil SH et.al. (2016). Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence. Br J Cancer 115:1565-1574. |
| 447 | Qiu X et.al. (2016). Overexpression of FZD7 promotes glioma cell proliferation by upregulating TAZ. Oncotarget 7:85987-85999. |
| 446 | Augustin I et.al. (2016). Immune cell recruitment in teratomas is impaired by increased Wnt secretion. Stem Cell Res 17:607-615. |
| 445 | Stankovic ND et.al. (2016). No role of IFITM3 in brain tumor formation in vivo. Oncotarget 7:86388-86405. |
| 444 | Maugeri M et.al. (2016). Altered expression of miRNAs and methylation of their promoters are correlated in neuroblastoma. Oncotarget 7:83330-83341. |
| 443 | Sulzmaier FJ et.al. (2016). RSK2 activity mediates glioblastoma invasiveness and is a potential target for new therapeutics. Oncotarget 7:79869-79884. |
| 442 | Bassett EA et.al. (2016). Norrin/Frizzled4 signalling in the preneoplastic niche blocks medulloblastoma initiation. Elife 5:. |
| 441 | Techavichit P et.al. (2016). Secreted Frizzled-Related Protein 2 (sFRP2) promotes osteosarcoma invasion and metastatic potential. BMC Cancer 16:869. |
| 440 | Trypsteen W et.al. (2016). Differential expression of lncRNAs during the HIV replication cycle: an underestimated layer in the HIV-host interplay. Sci Rep 6:36111. |
| 439 | Xiao D et.al. (2016). Polo-like Kinase-1 Regulates Myc Stabilization and Activates a Feedforward Circuit Promoting Tumor Cell Survival. Mol Cell 64:493-506. |
| 438 | Zhao Z et.al. (2016). A combined gene expression and functional study reveals the crosstalk between N-Myc and differentiation-inducing microRNAs in neuroblastoma cells. Oncotarget 7:79372-79387. |
| 437 | Liu PY et.al. (2016). NCYM is upregulated by lncUSMycN and modulates N-Myc expression. Int J Oncol 49:2464-2470. |
| 436 | Liu X et.al. (2016). CRM1/XPO1 is associated with clinical outcome in glioma and represents a therapeutic target by perturbing multiple core pathways. J Hematol Oncol 9:108. |
| 435 | Flahaut M et.al. (2016). Aldehyde dehydrogenase activity plays a Key role in the aggressive phenotype of neuroblastoma. BMC Cancer 16:781. |
| 434 | Zhang H et.al. (2016). Expression and significance of Hippo/YAP signaling in glioma progression. Tumour Biol :. |
| 433 | Liu M et.al. (2016). Transcriptional Profiling Reveals a Common Metabolic Program in High-Risk Human Neuroblastoma and Mouse Neuroblastoma Sphere-Forming Cells. Cell Rep 17:609-623. |
| 432 | Matas-Rico E et.al. (2016). Glycerophosphodiesterase GDE2 Promotes Neuroblastoma Differentiation through Glypican Release and Is a Marker of Clinical Outcome. Cancer Cell 30:548-562. |
| 431 | Catena V et.al. (2016). Deptor transcriptionally regulates endoplasmic reticulum homeostasis in multiple myeloma cells. Oncotarget 7:70546-70558. |
| 430 | Brand A et.al. (2016). LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells. Cell Metab 24:657-671. |
| 429 | Henrich KO et.al. (2016). Integrative Genome-Scale Analysis Identifies Epigenetic Mechanisms of Transcriptional Deregulation in Unfavorable Neuroblastomas. Cancer Res 76:5523-37. |
| 428 | Wang LY et.al. (2016). KDM4A Coactivates E2F1 to Regulate the PDK-Dependent Metabolic Switch between Mitochondrial Oxidation and Glycolysis. Cell Rep 16:3016-3027. |
| 427 | Suryo Rahmanto A et.al. (2016). FBW7 suppression leads to SOX9 stabilization and increased malignancy in medulloblastoma. EMBO J 35:2192-2212. |
| 426 | Tavana O et.al. (2016). HAUSP deubiquitinates and stabilizes N-Myc in neuroblastoma. Nat Med 22:1180-1186. |
| 425 | Garcia-Heredia JM et.al. (2016). Numb-like (NumbL) downregulation increases tumorigenicity, cancer stem cell-like properties and resistance to chemotherapy. Oncotarget 7:63611-63628. |
| 424 | Ubink I et.al. (2016). A potential role for CCN2/CTGF in aggressive colorectal cancer. J Cell Commun Signal 10:223-227. |
| 423 | Jia D et.al. (2016). A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets. Cancer Lett 382:203-214. |
| 422 | Cimmino F et.al. (2016). Proteomic Alterations in Response to Hypoxia Inducible Factor 2alpha in Normoxic Neuroblastoma Cells. J Proteome Res 15:3643-3655. |
| 421 | Qu H et.al. (2016). Smad4 suppresses the tumorigenesis and aggressiveness of neuroblastoma through repressing the expression of heparanase. Sci Rep 6:32628. |
| 420 | Chakrabarti A et.al. (2016). Targeting histone deacetylase 8 as a therapeutic approach to cancer and neurodegenerative diseases. Future Med Chem 8:1609-34. |
| 419 | Fabian J et.al. (2016). MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma. Oncotarget 7:66344-66359. |
| 418 | Eberhardt A et.al. (2016). Protein arginine methyltransferase 1 is a novel regulator of MYCN in neuroblastoma. Oncotarget 7:63629-63639. |
| 417 | Wang Z et.al. (2016). CD151-mediated adhesion is crucial to osteosarcoma pulmonary metastasis. Oncotarget 7:60623-60638. |
| 416 | Murakami-Tonami Y et.al. (2016). SGO1 is involved in the DNA damage response in MYCN-amplified neuroblastoma cells. Sci Rep 6:31615. |
| 415 | Montalban Del Barrio I et.al. (2016). Adenosine-generating ovarian cancer cells attract myeloid cells which differentiate into adenosine-generating tumor associated macrophages J Immunother Cancer 4:49. |
| 414 | Duffy DJ et.al. (2016). Wnt signalling is a bi-directional vulnerability of cancer cells. Oncotarget 7:60310-60331. |
| 413 | Buren S et.al. (2016). Regulation of OGT by URI in Response to Glucose Confers c-MYC-Dependent Survival Mechanisms. Cancer Cell 30:290-307. |
| 412 | Franco R et.al. (2016). PATZ1 expression correlates positively with BAX and negatively with BCL6 and survival in human diffuse large B cell lymphomas. Oncotarget 7:59158-59172. |
| 411 | Worst BC et.al. (2016). Next-generation personalised medicine for high-risk paediatric cancer patients Eur J Cancer 65:91-101. |
| 410 | Kritikou JS et.al. (2016). IL-2 in the tumor microenvironment is necessary for Wiskott-Aldrich syndrome protein deficient NK cells to respond to tumors in vivo. Sci Rep 6:30636. |
| 409 | Lu F et.al. (2016). Downregulation of CREB Promotes Cell Proliferation by Mediating G1/S Phase Transition in Hodgkin Lymphoma. Oncol Res 24:171-9. |
| 408 | Prince EW et.al. (2016). Checkpoint kinase 1 expression is an adverse prognostic marker and therapeutic target in MYC-driven medulloblastoma. Oncotarget 7:53881-53894. |
| 407 | Snapkov I et.al. (2016). The role of formyl peptide receptor 1 (FPR1) in neuroblastoma tumorigenesis. BMC Cancer 16:490. |
| 406 | Thimsen V et.al. (2016). EpCAM (CD326) is differentially expressed in craniopharyngioma subtypes and Rathkes cleft cysts. Sci Rep 6:29731. |
| 405 | Madan M et.al. (2016). ATP13A3 and caveolin-1 as potential biomarkers for difluoromethylornithine-based therapies in pancreatic cancers. Am J Cancer Res 6:1231-52. |
| 404 | van Engen CE et.al. (2016). CYP4F2 affects phenotypic outcome in adrenoleukodystrophy by modulating the clearance of very long-chain fatty acids. Biochim Biophys Acta 1862:1861-70. |
| 403 | Somarelli JA et.al. (2016). Mesenchymal-Epithelial Transition in Sarcomas Is Controlled by the Combinatorial Expression of MicroRNA 200s and GRHL2. Mol Cell Biol 36:2503-13. |
| 402 | Middelbeek J et.al. (2016). The TRPM7 interactome defines a cytoskeletal complex linked to neuroblastoma progression. Eur J Cell Biol 95:465-474. |
| 401 | Powers JT et.al. (2016). Multiple mechanisms disrupt the let-7 microRNA family in neuroblastoma. Nature 535:246-51. |
| 400 | Taminiau A et.al. (2016). HOXA1 binds RBCK1/HOIL-1 and TRAF2 and modulates the TNF/NF-kappaB pathway in a transcription-independent manner. Nucleic Acids Res 44:7331-49. |
| 399 | Chen Z et.al. (2016). Multiple CDK inhibitor dinaciclib suppresses neuroblastoma growth via inhibiting CDK2 and CDK9 activity. Sci Rep 6:29090. |
| 398 | Sheikh A et.al. (2016). Unfavorable neuroblastoma prognostic factor NLRR2 inhibits cell differentiation by transcriptional induction through JNK pathway. Cancer Sci 107:1223-32. |
| 397 | Gramatzki D et.al. (2016). Interleukin-33 in human gliomas: Expression and prognostic significance. Oncol Lett 12:445-452. |
| 396 | Wang Y et.al. (2016). TP53INP1 3-UTR functions as a ceRNA in repressing the metastasis of glioma cells by regulating miRNA activity. Biotechnol Lett 38:1699-707. |
| 395 | Jansen MH et.al. (2016). Bevacizumab Targeting Diffuse Intrinsic Pontine Glioma: Results of 89Zr-Bevacizumab PET Imaging in Brain Tumor Models. Mol Cancer Ther 15:2166-74. |
| 394 | Agnihotri S et.al. (2016). PINK1 Is a Negative Regulator of Growth and the Warburg Effect in Glioblastoma. Cancer Res 76:4708-19. |
| 393 | Joosten M et.al. (2016). A novel approach to detect resistance mechanisms reveals FGR as a factor mediating HDAC inhibitor SAHA resistance in B-cell lymphoma. Mol Oncol 10:1232-44. |
| 392 | Shackleford GM et.al. (2016). BarTeL, a Genetically Versatile, Bioluminescent and Granule Neuron Precursor-Targeted Mouse Model for Medulloblastoma. PLoS One 11:e0156907. |
| 391 | Phillips E et.al. (2016). Targeting atypical protein kinase C iota reduces viability in glioblastoma stem-like cells via a notch signaling mechanism. Int J Cancer 139:1776-87. |
| 390 | Blaeschke F et.al. (2016). Human HLA-A*02:01/CHM1+ allo-restricted T cell receptor transgenic CD8+ T cells specifically inhibit Ewing sarcoma growth in vitro and in vivo. Oncotarget 7:43267-43280. |
| 389 | Villasante A et.al. (2016). Recapitulating the Size and Cargo of Tumor Exosomes in a Tissue-Engineered Model. Theranostics 6:1119-30. |
| 388 | Qu H et.al. (2016). microRNA-558 facilitates the expression of hypoxia-inducible factor 2 alpha through binding to 5-untranslated region in neuroblastoma. Oncotarget 7:40657-40673. |
| 387 | Garcia-Ramirez I et.al. (2016). Could Vitamin D Analogues Be Used to Target Leukemia Stem Cells? Int J Mol Sci 17:. |
| 386 | Han X et.al. (2016). Microfluidic Cell Deformability Assay for Rapid and Efficient Kinase Screening with the CRISPR-Cas9 System. Angew Chem Int Ed Engl 55:8561-5. |
| 385 | Yogev O et.al. (2016). p53 Loss in MYC-Driven Neuroblastoma Leads to Metabolic Adaptations Supporting Radioresistance. Cancer Res 76:3025-35. |
| 384 | Formicola D et.al. (2016). An 18 gene expression-based score classifier predicts the clinical outcome in stage 4 neuroblastoma. J Transl Med 14:142. |
| 383 | Faouzi M et.al. (2016). Functional cooperation between KCa3.1 and TRPC1 channels in human breast cancer: Role in cell proliferation and patient prognosis. Oncotarget 7:36419-36435. |
| 382 | Fletcher JI et.al. (2016). ABC transporters as mediators of drug resistance and contributors to cancer cell biology. Drug Resist Updat 26:1-9. |
| 381 | Folgiero V et.al. (2016). IDO1 involvement in mTOR pathway: a molecular mechanism of resistance to mTOR targeting in medulloblastoma. Oncotarget 7:52900-52911. |
| 380 | Hsu CL et.al. (2016). Unveiling MYCN regulatory networks in neuroblastoma via integrative analysis of heterogeneous genomics data. Oncotarget 7:36293-36310. |
| 379 | Yang R et.al. (2016). The Hippo transducer TAZ promotes cell proliferation and tumor formation of glioblastoma cells through EGFR pathway. Oncotarget 7:36255-36265. |
| 378 | Berlanga P et.al. (2016). miR-200c and phospho-AKT as prognostic factors and mediators of osteosarcoma progression and lung metastasis. Mol Oncol 10:1043-53. |
| 377 | Weeks A et.al. (2016). Epithelial Cell Transforming 2 and Aurora Kinase B Modulate Formation of Stress Granule-Containing Transcripts from Diverse Cellular Pathways in Astrocytoma Cells. Am J Pathol 186:1674-87. |
| 376 | Fuady JH et.al. (2016). Estrogen-dependent downregulation of hypoxia-inducible factor (HIF)-2alpha in invasive breast cancer cells. Oncotarget 7:31153-65. |
| 375 | Bate-Eya LT et.al. (2016). High efficacy of the BCL-2 inhibitor ABT199 (venetoclax) in BCL-2 high-expressing neuroblastoma cell lines and xenografts and rational for combination with MCL-1 inhibition. Oncotarget 7:27946-58. |
| 374 | Kloepper J et.al. (2016). Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival. Proc Natl Acad Sci U S A 113:4476-81. |
| 373 | Cimmino F et.al. (2016). CD55 is a HIF-2alpha marker with anti-adhesive and pro-invading properties in neuroblastoma. Oncogenesis 5:e212. |
| 372 | Dyberg C et.al. (2016). Planar cell polarity gene expression correlates with tumor cell viability and prognostic outcome in neuroblastoma. BMC Cancer 16:259. |
| 371 | Woodfield SE et.al. (2016). Neuroblastoma patient outcomes, tumor differentiation, and ERK activation are correlated with expression levels of the ubiquitin ligase UBE4B. Genes Cancer 7:13-26. |
| 370 | Lasorsa VA et.al. (2016). Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression. Oncotarget 7:21840-52. |
| 369 | Szabo E et.al. (2016). Autocrine VEGFR1 and VEGFR2 signaling promotes survival in human glioblastoma models in vitro and in vivo. Neuro Oncol 18:1242-52. |
| 368 | Vellinga TT et.al. (2016). Collagen-rich stroma in aggressive colon tumors induces mesenchymal gene expression and tumor cell invasion. Oncogene 35:5263-5271. |
| 367 | Agarwal S et.al. (2016). Transmembrane adaptor protein PAG1 is a novel tumor suppressor in neuroblastoma. Oncotarget 7:24018-26. |
| 366 | Casey SC et.al. (2016). MYC regulates the antitumor immune response through CD47 and PD-L1. Science 352:227-31. |
| 365 | Savci-Heijink CD et.al. (2016). A novel gene expression signature for bone metastasis in breast carcinomas. Breast Cancer Res Treat 156:249-59. |
| 364 | Aykul S et.al. (2016). Transforming Growth Factor-beta Family Ligands Can Function as Antagonists by Competing for Type II Receptor Binding. J Biol Chem 291:10792-804. |
| 363 | Mao Y et.al. (2016). Targeting Suppressive Myeloid Cells Potentiates Checkpoint Inhibitors to Control Spontaneous Neuroblastoma. Clin Cancer Res 22:3849-59. |
| 362 | Dondero A et.al. (2016). PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance. Oncoimmunology 5:e1064578. |
| 361 | Lee D et.al. (2016). Endogenous transmembrane protein UT2 inhibits pSTAT3 and suppresses hematological malignancy. J Clin Invest 126:1300-10. |
| 360 | Holsken A et.al. (2016). Adamantinomatous and papillary craniopharyngiomas are characterized by distinct epigenomic as well as mutational and transcriptomic profiles. Acta Neuropathol Commun 4:20. |
| 359 | Woodfield SE et.al. (2016). Binimetinib inhibits MEK and is effective against neuroblastoma tumor cells with low NF1 expression. BMC Cancer 16:172. |
| 358 | Johann PD et.al. (2016). Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes. Cancer Cell 29:379-393. |
| 357 | Panosyan EH et.al. (2016). Clinical aggressiveness of malignant gliomas is linked to augmented metabolism of amino acids. J Neurooncol 128:57-66. |
| 356 | Sturm D et.al. (2016). New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs. Cell 164:1060-1072. |
| 355 | Bijnsdorp IV et.al. (2016). miR-129-3p controls centrosome number in metastatic prostate cancer cells by repressing CP110. Oncotarget 7:16676-87. |
| 354 | Busch B et.al. (2016). The oncogenic triangle of HMGA2, LIN28B and IGF2BP1 antagonizes tumor-suppressive actions of the let-7 family. Nucleic Acids Res 44:3845-64. |
| 353 | Yang L et.al. (2016). PHOX2B Is Associated with Neuroblastoma Cell Differentiation. Cancer Biother Radiopharm 31:44-51. |
| 352 | Huang S et.al. (2016). Impact of S100A4 Expression on Clinicopathological Characteristics and Prognosis in Pancreatic Cancer: A Meta-Analysis. Dis Markers 2016:8137378. |
| 351 | Kim PY et.al. (2016). High TDP43 expression is required for TRIM16-induced inhibition of cancer cell growth and correlated with good prognosis of neuroblastoma and breast cancer patients. Cancer Lett 374:315-23. |
| 350 | Stojcheva N et.al. (2016). MicroRNA-138 promotes acquired alkylator resistance in glioblastoma by targeting the Bcl-2-interacting mediator BIM. Oncotarget 7:12937-50. |
| 349 | Abbou S et.al. (2016). Polo-like Kinase Inhibitor Volasertib Exhibits Antitumor Activity and Synergy with Vincristine in Pediatric Malignancies. Anticancer Res 36:599-609. |
| 348 | Tetteh PW et.al. (2016). Replacement of Lost Lgr5-Positive Stem Cells through Plasticity of Their Enterocyte-Lineage Daughters. Cell Stem Cell 18:203-13. |
| 347 | Soriano A et.al. (2016). MicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeting cell cycle, survival and vascular permeability genes. Oncotarget 7:9271-87. |
| 346 | Li S et.al. (2016). The 1p36 Tumor Suppressor KIF 1Bbeta Is Required for Calcineurin Activation, Controlling Mitochondrial Fission and Apoptosis. Dev Cell 36:164-78. |
| 345 | Olsson M et.al. (2016). Genome-wide methylation profiling identifies novel methylated genes in neuroblastoma tumors. Epigenetics 11:74-84. |
| 344 | Morrissy AS et.al. (2016). Divergent clonal selection dominates medulloblastoma at recurrence. Nature 529:351-7. |
| 343 | Sanchez-Osuna M et.al. (2016). An intrinsic DFF40/CAD endonuclease deficiency impairs oligonucleosomal DNA hydrolysis during caspase-dependent cell death: a common trait in human glioblastoma cells. Neuro Oncol 18:950-61. |
| 342 | Than BL et.al. (2016). CFTR is a tumor suppressor gene in murine and human intestinal cancer. Oncogene 35:4179-87. |
| 341 | Chen NP et.al. (2016). Human phosphatase CDC14A is recruited to the cell leading edge to regulate cell migration and adhesion. Proc Natl Acad Sci U S A 113:990-5. |
| 340 | Codo P et.al. (2016). Control of glioma cell migration and invasiveness by GDF-15. Oncotarget 7:7732-46. |
| 339 | Flori M et.al. (2016). The hematopoietic oncoprotein FOXP1 promotes tumor cell survival in diffuse large B-cell lymphoma by repressing S1PR2 signaling. Blood 127:1438-48. |
| 338 | Dey A et.al. (2016). YB-1 is elevated in medulloblastoma and drives proliferation in Sonic hedgehog-dependent cerebellar granule neuron progenitor cells and medulloblastoma cells. Oncogene 35:4256-68. |
| 337 | Beach JA et.al. (2016). Sphingosine kinase 1 is required for TGF-beta mediated fibroblastto Oncotarget 7:4167-82. |
| 336 | Roth SA et.al. (2016). Next generation sequencing of microRNAs from isogenic neuroblastoma cell lines isolated before and after treatment. Cancer Lett 372:128-36. |
| 335 | Ochs K et.al. (2016). Tryptophan-2,3-dioxygenase is regulated by prostaglandin E2 in malignant glioma via a positive signaling loop involving prostaglandin E receptor-4. J Neurochem 136:1142-1154. |
| 334 | Bedekovics T et.al. (2016). UCH-L1 is induced in germinal center B cells and identifies patients with aggressive germinal center diffuse large B-cell lymphoma. Blood 127:1564-74. |
| 333 | DAsti E et.al. (2016). Tissue Factor Regulation by miR-520g in Primitive Neuronal Brain Tumor Cells: A Possible Link between Oncomirs and the Vascular Tumor Microenvironment. Am J Pathol 186:446-59. |
| 332 | Shen B et.al. (2016). Upregulated SMYD3 promotes bladder cancer progression by targeting BCLAF1 and activating autophagy. Tumour Biol 37:7371-81. |
| 331 | Henssen A et.al. (2016). Targeting MYCN-Driven Transcription By BET-Bromodomain Inhibition. Clin Cancer Res 22:2470-81. |
| 330 | Fest S et.al. (2016). Targeting of heme oxygenase-1 as a novel immune regulator of neuroblastoma. Int J Cancer 138:2030-42. |
| 329 | Xuan F et.al. (2016). Homeobox C9 suppresses Beclin1-mediated autophagy in glioblastoma by directly inhibiting the transcription of death-associated protein kinase 1. Neuro Oncol 18:819-29. |
| 328 | Martins-Neves SR et.al. (2016). Chemotherapy induces stemness in osteosarcoma cells through activation of Wnt/beta-catenin signaling. Cancer Lett 370:286-95. |
| 327 | Zhao X et.al. (2016). CTCF cooperates with noncoding RNA MYCNOS to promote neuroblastoma progression through facilitating MYCN expression. Oncogene 35:3565-76. |
| 326 | Silginer M et.al. (2016). The aryl hydrocarbon receptor links integrin signaling to the TGF-beta pathway. Oncogene 35:3260-71. |
| 325 | Masserot C et.al. (2016). WT1 expression is inversely correlated with MYCN amplification or expression and associated with poor survival in non-MYCN-amplified neuroblastoma. Mol Oncol 10:240-52. |
| 324 | Jin Y et.al. (2016). Single nucleotide polymorphism rs11669203 in TGFBR3L is associated with the risk of neuroblastoma in a Chinese population. Tumour Biol 37:3739-47. |
| 323 | Godin-Heymann N et.al. (2016). Tumour-suppression function of KLF12 through regulation of anoikis. Oncogene 35:3324-34. |
| 322 | Guo ST et.al. (2016). INPP4B is an oncogenic regulator in human colon cancer. Oncogene 35:3049-61. |
| 321 | Martins-Neves SR et.al. (2016). Osteosarcoma Stem Cells Have Active Wnt/beta-catenin and Overexpress SOX2 and KLF4. J Cell Physiol 231:876-86. |
| 320 | Rad A et.al. (2016). Predicting the molecular role of MEIS1 in esophageal squamous cell carcinoma. Tumour Biol 37:1715-25. |
| 319 | Rogers MA et.al. (2016). CITED4 gene silencing in colorectal cancer cells modulates adherens/tight junction gene expression and reduces cell proliferation. J Cancer Res Clin Oncol 142:225-37. |
| 318 | Heim S et.al. (2016). Papillary Tumor of the Pineal Region: A Distinct Molecular Entity. Brain Pathol 26:199-205. |
| 2015 (n=124) |
| 317 | Dolman ME et.al. (2015). DNA-Dependent Protein Kinase As Molecular Target for Radiosensitization of Neuroblastoma Cells. PLoS One 10:e0145744. |
| 316 | Forgham H et.al. (2015). Stem Cell Markers in Neuroblastoma-An Emerging Role for LGR5. Front Cell Dev Biol 3:77. |
| 315 | Ordonez-Moran P et.al. (2015). HOXA5 Counteracts Stem Cell Traits by Inhibiting Wnt Signaling in Colorectal Cancer. Cancer Cell 28:815-829. |
| 314 | Giachino C et.al. (2015). A Tumor Suppressor Function for Notch Signaling in Forebrain Tumor Subtypes. Cancer Cell 28:730-742. |
| 313 | Wickstrom M et.al. (2015). Wnt/beta-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance. Nat Commun 6:8904. |
| 312 | Carter DR et.al. (2015). Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastoma. Sci Transl Med 7:312ra176. |
| 311 | Xiao D et.al. (2015). Myc promotes glutaminolysis in human neuroblastoma through direct activation of glutaminase 2. Oncotarget 6:40655-66. |
| 310 | Best MG et.al. (2015). RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics. Cancer Cell 28:666-676. |
| 309 | Valentijn LJ et.al. (2015). TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors. Nat Genet 47:1411-4. |
| 308 | Vieira GC et.al. (2015). LGR5 regulates pro-survival MEK/ERK and proliferative Wnt/beta-catenin signalling in neuroblastoma. Oncotarget 6:40053-67. |
| 307 | Trumpi K et.al. (2015). ABC-Transporter Expression Does Not Correlate with Response to Irinotecan in Patients with Metastatic Colorectal Cancer. J Cancer 6:1079-86. |
| 306 | Hussain S et.al. (2015). UCHL1 is a biomarker of aggressive multiple myeloma required for disease progression. Oncotarget 6:40704-18. |
| 305 | Bogen D et.al. (2015). Aurora B kinase is a potent and selective target in MYCN-driven neuroblastoma. Oncotarget 6:35247-62. |
| 304 | Raman P et.al. (2015). FXYD5 is a Marker for Poor Prognosis and a Potential Driver for Metastasis in Ovarian Carcinomas. Cancer Inform 14:113-9. |
| 303 | Sun Y et.al. (2015). WDR5 Supports an N-Myc Transcriptional Complex That Drives a Protumorigenic Gene Expression Signature in Neuroblastoma. Cancer Res 75:5143-54. |
| 302 | Park SY et.al. (2015). Combinatorial TGF-beta attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cells. Oncotarget 6:37526-43. |
| 301 | Wielenga MCB et.al. (2015). ER-Stress-Induced Differentiation Sensitizes Colon Cancer Stem Cells to Chemotherapy. Cell Rep 13:489-494. |
| 300 | Bergenfelz C et.al. (2015). S100A9 expressed in ER(-)PgR(-) breast cancers induces inflammatory cytokines and is associated with an impaired overall survival. Br J Cancer 113:1234-43. |
| 299 | Mohlin S et.al. (2015). PI3K-mTORC2 but not PI3K-mTORC1 regulates transcription of HIF2A/EPAS1 and vascularization in neuroblastoma. Cancer Res 75:4617-28. |
| 298 | Baranski Z et.al. (2015). Pharmacological inhibition of Bcl-xL sensitizes osteosarcoma to doxorubicin. Oncotarget 6:36113-25. |
| 297 | Shchors K et.al. (2015). Dual Targeting of the Autophagic Regulatory Circuitry in Gliomas with Repurposed Drugs Elicits Cell-Lethal Autophagy and Therapeutic Benefit. Cancer Cell 28:456-471. |
| 296 | Dassi E et.al. (2015). Translational compensation of genomic instability in neuroblastoma. Sci Rep 5:14364. |
| 295 | Mehmeti M et.al. (2015). Expression of functional toll like receptor 4 in estrogen receptor/progesterone receptor-negative breast cancer. Breast Cancer Res 17:130. |
| 294 | Fontebasso AM et.al. (2015). Non-random aneuploidy specifies subgroups of pilocytic astrocytoma and correlates with older age. Oncotarget 6:31844-56. |
| 293 | Khan FH et.al. (2015). RD3 loss dictates high-risk aggressive neuroblastoma and poor clinical outcomes. Oncotarget 6:36522-34. |
| 292 | Ge X et.al. (2015). Phosphodiesterase 4D acts downstream of Neuropilin to control Hedgehog signal transduction and the growth of medulloblastoma. Elife 4:. |
| 291 | Liu Z et.al. (2015). Suboptimal cytoreduction in ovarian carcinoma is associated with molecular pathways characteristic of increased stromal activation. Gynecol Oncol 139:394-400. |
| 290 | Li C et.al. (2015). Identification and characterization of ANO9 in stage II and III colorectal carcinoma. Oncotarget 6:29324-34. |
| 289 | De Mariano M et.al. (2015). Identification of GALNT14 as a novel neuroblastoma predisposition gene. Oncotarget 6:26335-46. |
| 288 | Bartolini A et.al. (2015). The Neuronal Pentraxin-2 Pathway Is an Unrecognized Target in Human Neuroblastoma, Which Also Offers Prognostic Value in Patients. Cancer Res 75:4265-71. |
| 287 | Zheng Y et.al. (2015). FoxM1 transactivates PTTG1 and promotes colorectal cancer cell migration and invasion. BMC Med Genomics 8:49. |
| 286 | Choe SC et.al. (2015). Autophagy capacity and sub-mitochondrial heterogeneity shape Bnip3-induced mitophagy regulation of apoptosis. Cell Commun Signal 13:37. |
| 285 | Lee EJ et.al. (2015). Identification of Global DNA Methylation Signatures in Glioblastoma-Derived Cancer Stem Cells. J Genet Genomics 42:355-71. |
| 284 | Ramani P et.al. (2015). High proliferation index, as determined by immunohistochemical expression of Aurora kinase B and geminin, indicates poor prognosis in neuroblastomas. Virchows Arch 467:319-27. |
| 283 | Stigliani S et.al. (2015). Expression of FOXP3, CD14, and ARG1 in Neuroblastoma Tumor Tissue from High-Risk Patients Predicts Event-Free and Overall Survival. Biomed Res Int 2015:347867. |
| 282 | Khan FH et.al. (2015). Acquired genetic alterations in tumor cells dictate the development of high-risk neuroblastoma and clinical outcomes. BMC Cancer 15:514. |
| 281 | Ochodnicka-Mackovicova K et.al. (2015). NF-kappaB and AKT signaling prevent DNA damage in transformed pre-B cells by suppressing RAG1/2 expression and activity. Blood 126:1324-35. |
| 280 | Khan FH et.al. (2015). Reorganization of metastamiRs in the evolution of metastatic aggressive neuroblastoma cells. BMC Genomics 16:501. |
| 279 | Eleveld TF et.al. (2015). Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations. Nat Genet 47:864-71. |
| 278 | Sahay D et.al. (2015). The LPA1/ZEB1/miR-21-activation pathway regulates metastasis in basal breast cancer. Oncotarget 6:20604-20. |
| 277 | Eling N et.al. (2015). Identification of artesunate as a specific activator of ferroptosis in pancreatic cancer cells. Oncoscience 2:517-32. |
| 276 | Yco LP et.al. (2015). Effect of sulfasalazine on human neuroblastoma: analysis of sepiapterin reductase (SPR) as a new therapeutic target. BMC Cancer 15:477. |
| 275 | Larsson K et.al. (2015). COX/mPGES-1/PGE2 pathway depicts an inflammatory-dependent high-risk neuroblastoma subset. Proc Natl Acad Sci U S A 112:8070-5. |
| 274 | Stermann A et.al. (2015). Targeting of MYCN by means of DNA vaccination is effective against neuroblastoma in mice. Cancer Immunol Immunother 64:1215-27. |
| 273 | Cimmino F et.al. (2015). Inhibition of hypoxia inducible factors combined with all-trans retinoic acid treatment enhances glial transdifferentiation of neuroblastoma cells. Sci Rep 5:11158. |
| 272 | Tummers B et.al. (2015). The interferon-related developmental regulator 1 is used by human papillomavirus to suppress NFkappaB activation. Nat Commun 6:6537. |
| 271 | Mussai F et.al. (2015). Neuroblastoma Arginase Activity Creates an Immunosuppressive Microenvironment That Impairs Autologous and Engineered Immunity. Cancer Res 75:3043-53. |
| 270 | Mandriota SJ et.al. (2015). Ataxia-telangiectasia mutated (ATM) silencing promotes neuroblastoma progression through a MYCN independent mechanism. Oncotarget 6:18558-76. |
| 269 | Xiang X et.al. (2015). miRNA-584-5p exerts tumor suppressive functions in human neuroblastoma through repressing transcription of matrix metalloproteinase 14. Biochim Biophys Acta 1852:1743-54. |
| 268 | Boer JM et.al. (2015). BCR-ABL1-like cases in pediatric acute lymphoblastic leukemia: a comparison between DCOG/Erasmus MC and COG/St. Jude signatures. Haematologica 100:e354-7. |
| 267 | Tian T et.al. (2015). TAZ promotes temozolomide resistance by upregulating MCL-1 in human glioma cells. Biochem Biophys Res Commun 463:638-43. |
| 266 | Schwermer M et.al. (2015). Sensitivity to cdk1-inhibition is modulated by p53 status in preclinical models of embryonal tumors. Oncotarget 6:15425-35. |
| 265 | Bunt J et.al. (2015). PAX6 does not regulate Nfia and Nfib expression during neocortical development. Sci Rep 5:10668. |
| 264 | Young SA et.al. (2015). Integrin alpha4 Enhances Metastasis and May Be Associated with Poor Prognosis in MYCN-low Neuroblastoma. PLoS One 10:e0120815. |
| 263 | Challagundla KB et.al. (2015). Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy. J Natl Cancer Inst 107:. |
| 262 | Liu CY et.al. (2015). Vimentin contributes to epithelial-mesenchymal transition cancer cell mechanics by mediating cytoskeletal organization and focal adhesion maturation. Oncotarget 6:15966-83. |
| 261 | Pajtler KW et.al. (2015). Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups. Cancer Cell 27:728-43. |
| 260 | Cheung BB et.al. (2015). Thymosin-beta4 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastoma. Mol Oncol 9:1484-500. |
| 259 | Fatrai S et.al. (2015). Maintenance of Clonogenic KIT(+) Human Colon Tumor Cells Requires Secretion of Stem Cell Factor by Differentiated Tumor Cells. Gastroenterology 149:692-704. |
| 258 | van de Wetering M et.al. (2015). Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell 161:933-45. |
| 257 | Kuo YT et.al. (2015). JARID1B Expression Plays a Critical Role in Chemoresistance and Stem Cell-Like Phenotype of Neuroblastoma Cells. PLoS One 10:e0125343. |
| 256 | Wang M et.al. (2015). Transcriptional co-activator TAZ sustains proliferation and tumorigenicity of neuroblastoma by targeting CTGF and PDGF-beta. Oncotarget 6:9517-30. |
| 255 | Delic S et.al. (2015). Systematic investigation of CMTM family genes suggests relevance to glioblastoma pathogenesis and CMTM1 and CMTM3 as priority targets. Genes Chromosomes Cancer 54:433-43. |
| 254 | Cheon DJ et.al. (2015). ADAM12 is a prognostic factor associated with an aggressive molecular subtype of high-grade serous ovarian carcinoma. Carcinogenesis 36:739-47. |
| 253 | Yang J et.al. (2015). The role of histone demethylase KDM4B in Myc signaling in neuroblastoma. J Natl Cancer Inst 107:djv080. |
| 252 | Cheng P et.al. (2015). Kinome-wide shRNA screen identifies the receptor tyrosine kinase AXL as a key regulator for mesenchymal glioblastoma stem-like cells. Stem Cell Reports 4:899-913. |
| 251 | Salm F et.al. (2015). The Phosphoinositide 3-Kinase p110alpha Isoform Regulates Leukemia Inhibitory Factor Receptor Expression via c-Myc and miR-125b to Promote Cell Proliferation in Medulloblastoma. PLoS One 10:e0123958. |
| 250 | Hamidian A et.al. (2015). Differential regulation of HIF-1alpha and HIF-2alpha in neuroblastoma: Estrogen-related receptor alpha (ERRalpha) regulates HIF2A transcription and correlates to poor outcome. Biochem Biophys Res Commun 461:560-7. |
| 249 | Vaillant C et.al. (2015). Serpine2/PN-1 Is Required for Proliferative Expansion of Pre-Neoplastic Lesions and Malignant Progression to Medulloblastoma. PLoS One 10:e0124870. |
| 248 | Li D et.al. (2015). Intelectin 1 suppresses the growth, invasion and metastasis of neuroblastoma cells through up-regulation of N-myc downstream regulated gene 2. Mol Cancer 14:47. |
| 247 | Bui TT et.al. (2015). gamma-Glutamyl transferase 7 is a novel regulator of glioblastoma growth. BMC Cancer 15:225. |
| 246 | Chakrabarti G et.al. (2015). Expanding antitumor therapeutic windows by targeting cancer-specific nicotinamide adenine dinucleotide phosphate-biogenesis pathways. Clin Pharmacol 7:57-68. |
| 245 | Sousa SF et.al. (2015). Defects of the Carney complex gene (PRKAR1A) in odontogenic tumors. Endocr Relat Cancer 22:399-408. |
| 244 | Perez-Gomez E et.al. (2015). Role of cannabinoid receptor CB2 in HER2 pro-oncogenic signaling in breast cancer. 107:djv077. |
| 243 | Ecker J et.al. (2015). Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastoma. Acta Neuropathol Commun 3:22. |
| 242 | Frei K et.al. (2015). Transforming growth factor-beta pathway activity in glioblastoma. Oncotarget 6:5963-77. |
| 241 | Schmid CA et.al. (2015). DUSP4 deficiency caused by promoter hypermethylation drives JNK signaling and tumor cell survival in diffuse large B cell lymphoma. J Exp Med 212:775-92. |
| 240 | Evans L et.al. (2015). SKP2 is a direct transcriptional target of MYCN and a potential therapeutic target in neuroblastoma. Cancer Lett 363:37-45. |
| 239 | Sanden E et.al. (2015). Aberrant immunostaining pattern of the CD24 glycoprotein in clinical samples and experimental models of pediatric medulloblastomas. J Neurooncol 123:1-13. |
| 238 | Pahl JH et.al. (2015). Expression of the immune regulation antigen CD70 in osteosarcoma. Cancer Cell Int 15:31. |
| 237 | Wylie LA et.al. (2015). Ascl1 phospho-status regulates neuronal differentiation in a Xenopus developmental model of neuroblastoma. Dis Model Mech 8:429-41. |
| 236 | Vellinga TT et.al. (2015). SIRT1/PGC1alpha-Dependent Increase in Oxidative Phosphorylation Supports Chemotherapy Resistance of Colon Cancer. Clin Cancer Res 21:2870-9. |
| 235 | Yanez Y et.al. (2015). Two independent epigenetic biomarkers predict survival in neuroblastoma. Clin Epigenetics 7:16. |
| 234 | Zhao Z et.al. (2015). microRNA-449a functions as a tumor suppressor in neuroblastoma through inducing cell differentiation and cell cycle arrest. RNA Biol 12:538-54. |
| 233 | Yang R et.al. (2015). HDAC9 promotes glioblastoma growth via TAZ-mediated EGFR pathway activation. Oncotarget 6:7644-56. |
| 232 | Baranski Z et.al. (2015). Aven-mediated checkpoint kinase control regulates proliferation and resistance to chemotherapy in conventional osteosarcoma. J Pathol 236:348-59. |
| 231 | Bell JL et.al. (2015). IGF2BP1 harbors prognostic significance by gene gain and diverse expression in neuroblastoma. J Clin Oncol 33:1285-93. |
| 230 | Zhang Y et.al. (2015). miR-182 promotes cell growth and invasion by targeting forkhead box F2 transcription factor in colorectal cancer. Oncol Rep 33:2592-8. |
| 229 | Mussai F et.al. (2015). Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target. Blood 125:2386-96. |
| 228 | Song R et.al. (2015). Connecting rules from paired miRNA and mRNA expression data sets of HCV patients to detect both inverse and positive regulatory relationships. BMC Genomics 16 Suppl 2:S11. |
| 227 | Rettig I et.al. (2015). Selective inhibition of HDAC8 decreases neuroblastoma growth in vitro and in vivo and enhances retinoic acid-mediated differentiation. Cell Death Dis 6:e1657. |
| 226 | Wegert J et.al. (2015). Mutations in the SIX1/2 pathway and the DROSHA/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumors. Cancer Cell 27:298-311. |
| 225 | Richter M et.al. (2015). WIP1 phosphatase as a potential therapeutic target in neuroblastoma. PLoS One 10:e0115635. |
| 224 | von Stedingk K et.al. (2015). Individual patient risk stratification of high-risk neuroblastomas using a two-gene score suited for clinical use. Int J Cancer 137:868-77. |
| 223 | Ouyang Q et.al. (2015). Neurotensin promotes the progression of malignant glioma through NTSR1 and impacts the prognosis of glioma patients. Mol Cancer 14:21. |
| 222 | Chen J et.al. (2015). The genetics of splicing in neuroblastoma. Cancer Discov 5:380-95. |
| 221 | Santhana Kumar K et.al. (2015). The Ser/Thr kinase MAP4K4 drives c-Met-induced motility and invasiveness in a cell-based model of SHH medulloblastoma. Springerplus 4:19. |
| 220 | Amoroso F et.al. (2015). The P2X7 receptor is a key modulator of the PI3K/GSK3beta/VEGF signaling network: evidence in experimental neuroblastoma. Oncogene 34:5240-51. |
| 219 | Qu H et.al. (2015). miRNA-558 promotes tumorigenesis and aggressiveness of neuroblastoma cells through activating the transcription of heparanase. Hum Mol Genet 24:2539-51. |
| 218 | Xiang X et.al. (2015). Hepatocyte nuclear factor 4 alpha promotes the invasion, metastasis and angiogenesis of neuroblastoma cells via targeting matrix metalloproteinase 14. Cancer Lett 359:187-97. |
| 217 | Zhao S et.al. (2015). NKD2, a negative regulator of Wnt signaling, suppresses tumor growth and metastasis in osteosarcoma. Oncogene 34:5069-79. |
| 216 | Wang F et.al. (2015). A microRNA-1280/JAG2 network comprises a novel biological target in high-risk medulloblastoma. Oncotarget 6:2709-24. |
| 215 | Nasser MW et.al. (2015). RAGE mediates S100A7-induced breast cancer growth and metastasis by modulating the tumor microenvironment. Cancer Res 75:974-85. |
| 214 | Newman EA et.al. (2015). Alternative NHEJ Pathway Components Are Therapeutic Targets in High-Risk Neuroblastoma. Mol Cancer Res 13:470-82. |
| 213 | Nakaguro M et.al. (2015). Nucleolar protein PES1 is a marker of neuroblastoma outcome and is associated with neuroblastoma differentiation. Cancer Sci 106:237-43. |
| 212 | Hartomo TB et.al. (2015). Involvement of aldehyde dehydrogenase 1A2 in the regulation of cancer stem cell properties in neuroblastoma. Int J Oncol 46:1089-98. |
| 211 | Ren X et.al. (2015). Quantitative nuclear proteomics identifies that miR-137-mediated EZH2 reduction regulates resveratrol-induced apoptosis of neuroblastoma cells. Mol Cell Proteomics 14:316-28. |
| 210 | Park JH et.al. (2015). Protein arginine methyltransferase 5 is a key regulator of the MYCN oncoprotein in neuroblastoma cells. Mol Oncol 9:617-27. |
| 209 | Yang HW et.al. (2015). A small subunit processome protein promotes cancer by altering translation. Oncogene 34:4471-81. |
| 208 | Ryland KE et.al. (2015). Polycomb-dependent repression of the potassium channel-encoding gene KCNA5 promotes cancer cell survival under conditions of stress. Oncogene 34:4591-600. |
| 207 | Krause S et.al. (2015). Mer tyrosine kinase promotes the survival of t(1;19)-positive acute lymphoblastic leukemia (ALL) in the central nervous system (CNS). Blood 125:820-30. |
| 206 | Unland R et.al. (2015). Analysis of the antiproliferative effects of 3-deazaneoplanocin A in combination with standard anticancer agents in rhabdoid tumor cell lines. Anticancer Drugs 26:301-11. |
| 205 | Cwiek P et.al. (2015). RNA interference screening identifies a novel role for PCTK1/CDK16 in medulloblastoma with c-Myc amplification. Oncotarget 6:116-29. |
| 204 | Bartfeld S et.al. (2015). In vitro expansion of human gastric epithelial stem cells and their responses to bacterial infection. Gastroenterology 148:126-136.e6. |
| 203 | Beckers A et.al. (2015). MYCN-targeting miRNAs are predominantly downregulated during MYCNdriven neuroblastoma tumor formation. Oncotarget 6:5204-16. |
| 202 | Harter PN et.al. (2015). Paired box gene 8 (PAX8) expression is associated with sonic hedgehog (SHH)/wingless int (WNT) subtypes, desmoplastic histology and patient survival in human medulloblastomas. Neuropathol Appl Neurobiol 41:165-79. |
| 201 | Nitta RT et.al. (2015). Casein kinase 2alpha regulates glioblastoma brain tumor-initiating cell growth through the beta-catenin pathway. Oncogene 34:3688-99. |
| 200 | Zeiner PS et.al. (2015). MIF Receptor CD74 is Restricted to Microglia/Macrophages, Associated with a M1-Polarized Immune Milieu and Prolonged Patient Survival in Gliomas. Brain Pathol 25:491-504. |
| 199 | Fernandez S et.al. (2015). miR-340 inhibits tumor cell proliferation and induces apoptosis by targeting multiple negative regulators of p27 in non-small cell lung cancer. Oncogene 34:3240-50. |
| 198 | Harvey H et.al. (2015). Modulation of chemotherapeutic drug resistance in neuroblastoma SK-N-AS cells by the neural apoptosis inhibitory protein and miR-520f. Int J Cancer 136:1579-88. |
| 197 | Ott M et.al. (2015). Suppression of TDO-mediated tryptophan catabolism in glioblastoma cells by a steroid-responsive FKBP52-dependent pathway. Glia 63:78-90. |
| 196 | Kobayashi T et.al. (2015). Deubiquitinating activity of CYLD is impaired by SUMOylation in neuroblastoma cells. Oncogene 34:2251-60. |
| 195 | Shimozato O et.al. (2015). Receptor-type protein tyrosine phosphatase kappa directly dephosphorylates CD133 and regulates downstream AKT activation. Oncogene 34:1949-60. |
| 194 | Buss MC et.al. (2015). The WIP1 oncogene promotes progression and invasion of aggressive medulloblastoma variants. Oncogene 34:1126-40. |
| 2014 (n=63) |
| 193 | Pandey GK et.al. (2014). The risk-associated long noncoding RNA NBAT-1 controls neuroblastoma progression by regulating cell proliferation and neuronal differentiation. Cancer Cell 26:722-37. |
| 192 | Simmini S et.al. (2014). Transformation of intestinal stem cells into gastric stem cells on loss of transcription factor Cdx2. Nat Commun 5:5728. |
| 191 | Saini RK et.al. (2014). Proteomics of dedifferentiation of SK-N-BE2 neuroblastoma cells. Biochem Biophys Res Commun 454:202-9. |
| 190 | Yamaguchi S et.al. (2014). Eribulin mesylate targets human telomerase reverse transcriptase in ovarian cancer cells. PLoS One 9:e112438. |
| 189 | Pajtler KW et.al. (2014). Neuroblastoma in dialog with its stroma: NTRK1 is a regulator of cellular cross-talk with Schwann cells. Oncotarget 5:11180-92. |
| 188 | Chavali PL et.al. (2014). TLX activates MMP-2, promotes self-renewal of tumor spheres in neuroblastoma and correlates with poor patient survival. Cell Death Dis 5:e1502. |
| 187 | Bandino A et.al. (2014). Deoxyhypusine synthase (DHPS) inhibitor GC7 induces p21/Rb-mediated inhibition of tumor cell growth and DHPS expression correlates with poor prognosis in neuroblastoma patients. Cell Oncol (Dordr) 37:387-98. |
| 186 | Lee S et.al. (2014). Robust selection of cancer survival signatures from high-throughput genomic data using two-fold subsampling. PLoS One 9:e108818. |
| 185 | Zhang Z et.al. (2014). N-Myc-induced up-regulation of TRPM6/TRPM7 channels promotes neuroblastoma cell proliferation. Oncotarget 5:7625-34. |
| 184 | van Keimpema M et.al. (2014). FOXP1 directly represses transcription of proapoptotic genes and cooperates with NF-kappaB to promote survival of human B cells. Blood 124:3431-40. |
| 183 | Emmink BL et.al. (2014). GPx2 suppression of H2O2 stress links the formation of differentiated tumor mass to metastatic capacity in colorectal cancer. Cancer Res 74:6717-30. |
| 182 | Jasinski-Bergner S et.al. (2014). Identification of 14-3-3beta gene as a novel miR-152 target using a proteome-based approach. J Biol Chem 289:31121-35. |
| 181 | Ke XX et.al. (2014). Inhibition of H3K9 methyltransferase G9a repressed cell proliferation and induced autophagy in neuroblastoma cells. PLoS One 9:e106962. |
| 180 | Sero V et.al. (2014). Targeting polo-like kinase 1 by NMS-P937 in osteosarcoma cell lines inhibits tumor cell growth and partially overcomes drug resistance. Invest New Drugs 32:1167-80. |
| 179 | DAsti E et.al. (2014). Coagulation and angiogenic gene expression profiles are defined by molecular subgroups of medulloblastoma: evidence for growth factor-thrombin cross-talk. J Thromb Haemost 12:1838-49. |
| 178 | Izumi H et.al. (2014). Trim32 facilitates degradation of MYCN on spindle poles and induces asymmetric cell division in human neuroblastoma cells. Cancer Res 74:5620-30. |
| 177 | Basak O et.al. (2014). Mapping early fate determination in Lgr5+ crypt stem cells using a novel Ki67-RFP allele. EMBO J 33:2057-68. |
| 176 | Cangelosi D et.al. (2014). Use of Attribute Driven Incremental Discretization and Logic Learning Machine to build a prognostic classifier for neuroblastoma patients. BMC Bioinformatics 15 Suppl 5:S4. |
| 175 | Rack PG et.al. (2014). Arhgap36-dependent activation of Gli transcription factors. Proc Natl Acad Sci U S A 111:11061-6. |
| 174 | Rutten MJ et.al. (2014). HLA-G expression is an independent predictor for improved survival in high grade ovarian carcinomas. J Immunol Res 2014:274584. |
| 173 | Weichhaus M et.al. (2014). Osteoprotegerin expression in triple-negative breast cancer cells promotes metastasis. Cancer Med 3:1112-25. |
| 172 | Forget A et.al. (2014). Shh signaling protects Atoh1 from degradation mediated by the E3 ubiquitin ligase Huwe1 in neural precursors. Dev Cell 29:649-61. |
| 171 | Shahbazi J et.al. (2014). Histone deacetylase 2 and N-Myc reduce p53 protein phosphorylation at serine 46 by repressing gene transcription of tumor protein 53-induced nuclear protein 1. Oncotarget 5:4257-68. |
| 170 | Tummers B et.al. (2014). CD40-mediated amplification of local immunity by epithelial cells is impaired by HPV. J Invest Dermatol 134:2918-2927. |
| 169 | Hiddingh L et.al. (2014). Identification of temozolomide resistance factors in glioblastoma via integrative miRNA/mRNA regulatory network analysis. Sci Rep 4:5260. |
| 168 | De Antonellis P et.al. (2014). Early targets of miR-34a in neuroblastoma. Mol Cell Proteomics 13:2114-31. |
| 167 | Liu PY et.al. (2014). Effects of a novel long noncoding RNA, lncUSMycN, on N-Myc expression and neuroblastoma progression. J Natl Cancer Inst 106:. |
| 166 | Jeibmann A et.al. (2014). Identification of genes involved in the biology of atypical teratoid/rhabdoid tumours using Drosophila melanogaster. Nat Commun 5:4005. |
| 165 | Quandt D et.al. (2014). Synergistic effects of IL-4 and TNFalpha on the induction of B7-H1 in renal cell carcinoma cells inhibiting allogeneic T cell proliferation. J Transl Med 12:151. |
| 164 | Wille C et.al. (2014). Protein Kinase D family kinases: roads start to segregate. Bioarchitecture 4:111-5. |
| 163 | Hovestadt V et.al. (2014). Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing. Nature 510:537-41. |
| 162 | Zhu Z et.al. (2014). Targeting self-renewal in high-grade brain tumors leads to loss of brain tumor stem cells and prolonged survival. Cell Stem Cell 15:185-98. |
| 161 | Tomiyama A et.al. (2014). Flotillin-1 regulates oncogenic signaling in neuroblastoma cells by regulating ALK membrane association. Cancer Res 74:3790-801. |
| 160 | David M et.al. (2014). Identification of heparin-binding EGF-like growth factor (HB-EGF) as a biomarker for lysophosphatidic acid receptor type 1 (LPA1) activation in human breast and prostate cancers. PLoS One 9:e97771. |
| 159 | Venkataraman S et.al. (2014). Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma. Oncotarget 5:2355-71. |
| 158 | Fiaschetti G et.al. (2014). NOTCH ligands JAG1 and JAG2 as critical pro-survival factors in childhood medulloblastoma. Acta Neuropathol Commun 2:39. |
| 157 | Litzenburger UM et.al. (2014). Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR. Oncotarget 5:1038-51. |
| 156 | Kool M et.al. (2014). Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition. Cancer Cell 25:393-405. |
| 155 | Kerami Z et.al. (2014). Effect of interleukin-17 on gene expression profile of fibroblasts from Crohns disease patients. J Crohns Colitis 8:1208-16. |
| 154 | van Buul JD et.al. (2014). Rho GAPs and GEFs: controling switches in endothelial cell adhesion. Cell Adh Migr 8:108-24. |
| 153 | Koso H et.al. (2014). Identification of FoxR2 as an oncogene in medulloblastoma. Cancer Res 74:2351-61. |
| 152 | Yamaguchi Y et.al. (2014). Novel 1p tumour suppressor Dnmt1-associated protein 1 regulates MYCN/ataxia telangiectasia mutated/p53 pathway. Eur J Cancer 50:1555-65. |
| 151 | Laetsch TW et.al. (2014). Multiple components of the spliceosome regulate Mcl1 activity in neuroblastoma. Cell Death Dis 5:e1072. |
| 150 | Murakami-Tonami Y et.al. (2014). Inactivation of SMC2 shows a synergistic lethal response in MYCN-amplified neuroblastoma cells. Cell Cycle 13:1115-31. |
| 149 | Xu B et.al. (2014). Regulation of endometrial receptivity by the highly expressed HOXA9, HOXA11 and HOXD10 HOX-class homeobox genes. Hum Reprod 29:781-90. |
| 148 | Bageritz J et.al. (2014). Stem cell characteristics in glioblastoma are maintained by the ecto-nucleotidase E-NPP1. Cell Death Differ 21:929-40. |
| 147 | Hiddingh L et.al. (2014). EFEMP1 induces gamma-secretase/Notch-mediated temozolomide resistance in glioblastoma. Oncotarget 5:363-74. |
| 146 | van Vuurden DG et.al. (2014). Pre-B-cell leukemia homeobox interacting protein 1 is overexpressed in astrocytoma and promotes tumor cell growth and migration. Neuro Oncol 16:946-59. |
| 145 | Chen ZX et.al. (2014). RNA helicase A is a downstream mediator of KIF1Bbeta tumor-suppressor function in neuroblastoma. Cancer Discov 4:434-51. |
| 144 | Kerl K et.al. (2014). Arsenic trioxide inhibits tumor cell growth in malignant rhabdoid tumors in vitro and in vivo by targeting overexpressed Gli1. Int J Cancer 135:989-95. |
| 143 | Fabian J et.al. (2014). GRHL1 acts as tumor suppressor in neuroblastoma and is negatively regulated by MYCN and HDAC3. Cancer Res 74:2604-16. |
| 142 | Wolter JK et.al. (2014). Anti-tumor activity of the beta-adrenergic receptor antagonist propranolol in neuroblastoma. Oncotarget 5:161-72. |
| 141 | Wirsching HG et.al. (2014). Thymosin beta 4 gene silencing decreases stemness and invasiveness in glioblastoma. Brain 137:433-48. |
| 140 | Fiaschetti G et.al. (2014). Epigenetic silencing of miRNA-9 is associated with HES1 oncogenic activity and poor prognosis of medulloblastoma. Br J Cancer 110:636-47. |
| 139 | Fryer LG et.al. (2014). The endoplasmic reticulum coat protein II transport machinery coordinates cellular lipid secretion and cholesterol biosynthesis. J Biol Chem 289:4244-61. |
| 138 | Wille C et.al. (2014). Protein kinase D2 induces invasion of pancreatic cancer cells by regulating matrix metalloproteinases. Mol Biol Cell 25:324-36. |
| 137 | Barbieri E et.al. (2014). Histone chaperone CHAF1A inhibits differentiation and promotes aggressive neuroblastoma. Cancer Res 74:765-74. |
| 136 | Bate-Eya LT et.al. (2014). Newly-derived neuroblastoma cell lines propagated in serum-free media recapitulate the genotype and phenotype of primary neuroblastoma tumours. Eur J Cancer 50:628-37. |
| 135 | Erdreich-Epstein A et.al. (2014). PID1 (NYGGF4), a new growth-inhibitory gene in embryonal brain tumors and gliomas. Clin Cancer Res 20:827-36. |
| 134 | Ciarapica R et.al. (2014). The Polycomb group (PcG) protein EZH2 supports the survival of PAX3-FOXO1 alveolar rhabdomyosarcoma by repressing FBXO32 (Atrogin1/MAFbx). Oncogene 33:4173-84. |
| 133 | Sengupta S et.al. (2014). alpha5-GABAA receptors negatively regulate MYC-amplified medulloblastoma growth. Acta Neuropathol 127:593-603. |
| 132 | Lange I et.al. (2014). Novel interaction of ornithine decarboxylase with sepiapterin reductase regulates neuroblastoma cell proliferation. J Mol Biol 426:332-46. |
| 131 | Milla LA et.al. (2014). Neogenin1 is a Sonic Hedgehog target in medulloblastoma and is necessary for cell cycle progression. Int J Cancer 134:21-31. |
| 2013 (n=56) |
| 130 | Ecker J et.al. (2013). Targeting of histone deacetylases in brain tumors. CNS Oncol 2:359-76. |
| 129 | Barbieri E et.al. (2013). A p53 drug response signature identifies prognostic genes in high-risk neuroblastoma. PLoS One 8:e79843. |
| 128 | Ding J et.al. (2013). The histone H3 methyltransferase G9A epigenetically activates the serine-glycine synthesis pathway to sustain cancer cell survival and proliferation. Cell Metab 18:896-907. |
| 127 | Li D et.al. (2013). FOXD3 is a novel tumor suppressor that affects growth, invasion, metastasis and angiogenesis of neuroblastoma. Oncotarget 4:2021-44. |
| 126 | Pajtler KW et.al. (2013). The KDM1A histone demethylase is a promising new target for the epigenetic therapy of medulloblastoma. Acta Neuropathol Commun 1:19. |
| 125 | Whittier KL et.al. (2013). G-protein coupled receptor expression patterns delineate medulloblastoma subgroups. Acta Neuropathol Commun 1:66. |
| 124 | Bergiers I et.al. (2013). The homeodomain transcription factor Hoxa2 interacts with and promotes the proteasomal degradation of the E3 ubiquitin protein ligase RCHY1. PLoS One 8:e80387. |
| 123 | Henssen A et.al. (2013). BET bromodomain protein inhibition is a therapeutic option for medulloblastoma. Oncotarget 4:2080-95. |
| 122 | Ingram WJ et.al. (2013). ABC transporter activity linked to radiation resistance and molecular subtype in pediatric medulloblastoma. Exp Hematol Oncol 2:26. |
| 121 | Totaro F et.al. (2013). Impact of interleukin-6 -174 G>C gene promoter polymorphism on neuroblastoma. PLoS One 8:e76810. |
| 120 | Remke M et.al. (2013). TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma. Acta Neuropathol 126:917-29. |
| 119 | Jager N et.al. (2013). Hypermutation of the inactive X chromosome is a frequent event in cancer. Cell 155:567-81. |
| 118 | Fan YH et.al. (2013). USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis. Cell Death Dis 4:e867. |
| 117 | Tavanti E et.al. (2013). Preclinical validation of Aurora kinases-targeting drugs in osteosarcoma. Br J Cancer 109:2607-18. |
| 116 | Stange DE et.al. (2013). Differentiated Troy+ chief cells act as reserve stem cells to generate all lineages of the stomach epithelium. Cell 155:357-68. |
| 115 | Djos A et.al. (2013). Aneuploidy in neuroblastoma tumors is not associated with inactivating point mutations in the STAG2 gene. BMC Med Genet 14:102. |
| 114 | Pascutti MF et.al. (2013). IL-21 and CD40L signals from autologous T cells can induce antigen-independent proliferation of CLL cells. Blood 122:3010-9. |
| 113 | Tan F et.al. (2013). Dihydropyrimidinase-like protein 3 expression is negatively regulated by MYCN and associated with clinical outcome in neuroblastoma. Cancer Sci 104:1586-92. |
| 112 | Zeilstra J et.al. (2013). CD44 expression in intestinal epithelium and colorectal cancer is independent of p53 status. PLoS One 8:e72849. |
| 111 | Snoeren N et.al. (2013). Maspin is a marker for early recurrence in primary stage III and IV colorectal cancer. Br J Cancer 109:1636-47. |
| 110 | Tannous BA et.al. (2013). Effects of the selective MPS1 inhibitor MPS1-IN-3 on glioblastoma sensitivity to antimitotic drugs. J Natl Cancer Inst 105:1322-31. |
| 109 | Spina R et.al. (2013). Critical role of zinc finger protein 521 in the control of growth, clonogenicity and tumorigenic potential of medulloblastoma cells. Oncotarget 4:1280-92. |
| 108 | Shi K et.al. (2013). Protease-activated receptor-2 induces migration of pancreatic cancer cells in an extracellular ATP-dependent manner. J Thromb Haemost 11:1892-902. |
| 107 | Wilzen A et.al. (2013). ERBB3 is a marker of a ganglioneuroblastoma/ganglioneuroma-like expression profile in neuroblastic tumours. Mol Cancer 12:70. |
| 106 | Feng W et.al. (2013). The chromatin remodeler CHD7 regulates adult neurogenesis via activation of SoxC transcription factors. Cell Stem Cell 13:62-72. |
| 105 | Jones DT et.al. (2013). Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. Nat Genet 45:927-32. |
| 104 | Cangelosi D et.al. (2013). Logic Learning Machine creates explicit and stable rules stratifying neuroblastoma patients. BMC Bioinformatics 14 Suppl 7:S12. |
| 103 | Oehme I et.al. (2013). Histone deacetylase 10 promotes autophagy-mediated cell survival. Proc Natl Acad Sci U S A 110:E2592-601. |
| 102 | Abba M et.al. (2013). Unraveling the role of FOXQ1 in colorectal cancer metastasis. Mol Cancer Res 11:1017-28. |
| 101 | Kaaij LT et.al. (2013). DNA methylation dynamics during intestinal stem cell differentiation reveals enhancers driving gene expression in the villus. Genome Biol 14:R50. |
| 100 | Leprivier G et.al. (2013). The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation. Cell 153:1064-79. |
| 99 | Tomaselli S et.al. (2013). ADAR2 editing activity in newly diagnosed versus relapsed pediatric high-grade astrocytomas. BMC Cancer 13:255. |
| 98 | Remke M et.al. (2013). Somatostatin receptor subtype 2 (sst(2)) is a potential prognostic marker and a therapeutic target in medulloblastoma. Childs Nerv Syst 29:1253-62. |
| 97 | Gramatzki D et.al. (2013). Glioma cell death induced by irradiation or alkylating agent chemotherapy is independent of the intrinsic ceramide pathway. PLoS One 8:e63527. |
| 96 | van Nes J et.al. (2013). A NOTCH3 transcriptional module induces cell motility in neuroblastoma. Clin Cancer Res 19:3485-94. |
| 95 | Veringa SJ et.al. (2013). In vitro drug response and efflux transporters associated with drug resistance in pediatric high grade glioma and diffuse intrinsic pontine glioma. PLoS One 8:e61512. |
| 94 | Fransson S et.al. (2013). Aggressive neuroblastomas have high p110alpha but low p110delta and p55alpha/p50alpha protein levels compared to low stage neuroblastomas. J Mol Signal 8:4. |
| 93 | Valdora F et.al. (2013). Epigenetic Silencing of DKK3 in medulloblastoma. Int J Mol Sci 14:7492-505. |
| 92 | Lundberg G et.al. (2013). Intratumour diversity of chromosome copy numbers in neuroblastoma mediated by on-going chromosome loss from a polyploid state. PLoS One 8:e59268. |
| 91 | Sahm F et.al. (2013). The endogenous tryptophan metabolite and NAD+ precursor quinolinic acid confers resistance of gliomas to oxidative stress. Cancer Res 73:3225-34. |
| 90 | Creevey L et.al. (2013). MicroRNA-497 increases apoptosis in MYCN amplified neuroblastoma cells by targeting the key cell cycle regulator WEE1. Mol Cancer 12:23. |
| 89 | Damon M et.al. (2013). Associations between muscle gene expression pattern and technological and sensory meat traits highlight new biomarkers for pork quality assessment. Meat Sci 95:744-54. |
| 88 | Mohlin S et.al. (2013). HIF2A and IGF2 expression correlates in human neuroblastoma cells and normal immature sympathetic neuroblasts. Neoplasia 15:328-34. |
| 87 | Carotenuto M et.al. (2013). Neuroblastoma tumorigenesis is regulated through the Nm23-H1/h-Prune C-terminal interaction. Sci Rep 3:1351. |
| 86 | Pettersen I et.al. (2013). Expression of TWEAK/Fn14 in neuroblastoma: implications in tumorigenesis. Int J Oncol 42:1239-48. |
| 85 | Steller EJ et.al. (2013). PDGFRB promotes liver metastasis formation of mesenchymal-like colorectal tumor cells. Neoplasia 15:204-17. |
| 84 | Yco LP et.al. (2013). PRAF2 stimulates cell proliferation and migration and predicts poor prognosis in neuroblastoma. Int J Oncol 42:1408-16. |
| 83 | Koomoa DL et.al. (2013). DFMO/eflornithine inhibits migration and invasion downstream of MYCN and involves p27Kip1 activity in neuroblastoma. Int J Oncol 42:1219-28. |
| 82 | Pajtler KW et.al. (2013). Expression of NTRK1/TrkA affects immunogenicity of neuroblastoma cells. Int J Cancer 133:908-19. |
| 81 | Santo EE et.al. (2013). FOXO3a is a major target of inactivation by PI3K/AKT signaling in aggressive neuroblastoma. Cancer Res 73:2189-98. |
| 80 | Caretti V et.al. (2013). WEE1 kinase inhibition enhances the radiation response of diffuse intrinsic pontine gliomas. Mol Cancer Ther 12:141-50. |
| 79 | Zhu Y et.al. (2013). Modulation of serines 17 and 24 in the LC3-interacting region of Bnip3 determines pro-survival mitophagy versus apoptosis. J Biol Chem 288:1099-113. |
| 78 | Wickstrom M et.al. (2013). Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in vitro and in vivo. Int J Cancer 132:1516-24. |
| 77 | Sung PJ et.al. (2013). Identification and characterisation of STMN4 and ROBO2 gene involvement in neuroblastoma cell differentiation. Cancer Lett 328:168-75. |
| 76 | Nakata S et.al. (2013). LGR5 is a marker of poor prognosis in glioblastoma and is required for survival of brain cancer stem-like cells. Brain Pathol 23:60-72. |
| 75 | Das S et.al. (2013). Modulation of neuroblastoma disease pathogenesis by an extensive network of epigenetically regulated microRNAs. Oncogene 32:2927-36. |
| 2012 (n=39) |
| 74 | Salih DA et.al. (2012). FoxO6 regulates memory consolidation and synaptic function. Genes Dev 26:2780-801. |
| 73 | Le DT et.al. (2012). Differential gene expression in soybean leaf tissues at late developmental stages under drought stress revealed by genome-wide transcriptome analysis. PLoS One 7:e49522. |
| 72 | Korshunov A et.al. (2012). LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR). Acta Neuropathol 124:875-81. |
| 71 | Valentijn LJ et.al. (2012). Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplification. Proc Natl Acad Sci U S A 109:19190-5. |
| 70 | Sturm D et.al. (2012). Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 22:425-37. |
| 69 | Schramm A et.al. (2012). Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcome. Br J Cancer 107:1409-17. |
| 68 | Molenaar JJ et.al. (2012). LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression. Nat Genet 44:1199-206. |
| 67 | von Bueren AO et.al. (2012). Mismatch repair deficiency: a temozolomide resistance factor in medulloblastoma cell lines that is uncommon in primary medulloblastoma tumours. Br J Cancer 107:1399-408. |
| 66 | Diskin SJ et.al. (2012). Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma. Nat Genet 44:1126-30. |
| 65 | Liu XY et.al. (2012). Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations. Acta Neuropathol 124:615-25. |
| 64 | Jones DT et.al. (2012). Dissecting the genomic complexity underlying medulloblastoma. Nature 488:100-5. |
| 63 | Grunewald TG et.al. (2012). The STEAP protein family: versatile oxidoreductases and targets for cancer immunotherapy with overlapping and distinct cellular functions. Biol Cell 104:641-57. |
| 62 | Lamers F et.al. (2012). Identification of BIRC6 as a novel intervention target for neuroblastoma therapy. BMC Cancer 12:285. |
| 61 | Wernicke CM et.al. (2012). MondoA is highly overexpressed in acute lymphoblastic leukemia cells and modulates their metabolism, differentiation and survival. Leuk Res 36:1185-92. |
| 60 | Smits M et.al. (2012). EZH2-regulated DAB2IP is a medulloblastoma tumor suppressor and a positive marker for survival. Clin Cancer Res 18:4048-58. |
| 59 | Geurts van Kessel A et.al. (2012). New insights and clinical advancements in cellular oncology. Cell Oncol (Dordr) 35:139-47. |
| 58 | Munoz J et.al. (2012). The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent +4 cell markers. EMBO J 31:3079-91. |
| 57 | Kunkele A et.al. (2012). Pharmacological activation of the p53 pathway by nutlin-3 exerts anti-tumoral effects in medulloblastomas. Neuro Oncol 14:859-69. |
| 56 | Lawlor ER et.al. (2012). Epigenetic changes in pediatric solid tumors: promising new targets. Clin Cancer Res 18:2768-79. |
| 55 | Milde T et.al. (2012). Nestin expression identifies ependymoma patients with poor outcome. Brain Pathol 22:848-60. |
| 54 | Lee MJ et.al. (2012). Hedgehog pathway inhibitor saridegib (IPI-926) increases lifespan in a mouse medulloblastoma model. Proc Natl Acad Sci U S A 109:7859-64. |
| 53 | Cornero A et.al. (2012). Design of a multi-signature ensemble classifier predicting neuroblastoma patients outcome. BMC Bioinformatics 13 Suppl 4:S13. |
| 52 | Kemper K et.al. (2012). Mutations in the Ras-Raf Axis underlie the prognostic value of CD133 in colorectal cancer. Clin Cancer Res 18:3132-41. |
| 51 | Lynch J et.al. (2012). MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-beta signalling pathway. Carcinogenesis 33:976-85. |
| 50 | Molenaar JJ et.al. (2012). Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes. Nature 483:589-93. |
| 49 | Lamers F et.al. (2012). Targeted BCL2 inhibition effectively inhibits neuroblastoma tumour growth. Eur J Cancer 48:3093-103. |
| 48 | Kool M et.al. (2012). Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. Acta Neuropathol 123:473-84. |
| 47 | Grammel D et.al. (2012). Sonic hedgehog-associated medulloblastoma arising from the cochlear nuclei of the brainstem. Acta Neuropathol 123:601-14. |
| 46 | Meehan M et.al. (2012). Protein tyrosine phosphatase receptor delta acts as a neuroblastoma tumor suppressor by destabilizing the aurora kinase A oncogene. Mol Cancer 11:6. |
| 45 | Rasmuson A et.al. (2012). Autocrine prostaglandin E2 signaling promotes tumor cell survival and proliferation in childhood neuroblastoma. PLoS One 7:e29331. |
| 44 | Gawecka JE et.al. (2012). PEA15 impairs cell migration and correlates with clinical features predicting good prognosis in neuroblastoma. Int J Cancer 131:1556-68. |
| 43 | Dittmann LM et.al. (2012). Downregulation of PRDX1 by promoter hypermethylation is frequent in 1p/19q-deleted oligodendroglial tumours and increases radio Oncogene 31:3409-18. |
| 42 | Hoogewijs D et.al. (2012). Androglobin: a chimeric globin in metazoans that is preferentially expressed in Mammalian testes. Mol Biol Evol 29:1105-14. |
| 41 | Sulzmaier FJ et.al. (2012). PEA-15 potentiates H-Ras-mediated epithelial cell transformation through phospholipase D. Oncogene 31:3547-60. |
| 40 | Lamers F et.al. (2012). Targeted BIRC5 silencing using YM155 causes cell death in neuroblastoma cells with low ABCB1 expression. Eur J Cancer 48:763-71. |
| 39 | Wang C et.al. (2012). EZH2 Mediates epigenetic silencing of neuroblastoma suppressor genes CASZ1, CLU, RUNX3, and NGFR. Cancer Res 72:315-24. |
| 38 | Molenaar JJ et.al. (2012). Copy number defects of G1-cell cycle genes in neuroblastoma are frequent and correlate with high expression of E2F target genes and a poor prognosis. Genes Chromosomes Cancer 51:10-9. |
| 37 | Bunt J et.al. (2012). OTX2 directly activates cell cycle genes and inhibits differentiation in medulloblastoma cells. Int J Cancer 131:E21-32. |
| 36 | Santo EE et.al. (2012). Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastoma. Oncogene 31:1571-81. |
| 2011 (n=10) |
| 35 | Thomas DM et.al. (2011). Workshop Report on the European Bone Sarcoma Networking Meeting: Integration of Clinical Trials with Tumor Biology. J Adolesc Young Adult Oncol 1:118-23. |
| 34 | van Vuurden DG et.al. (2011). PARP inhibition sensitizes childhood high grade glioma, medulloblastoma and ependymoma to radiation. Oncotarget 2:984-96. |
| 33 | de Sousa E Melo F et.al. (2011). Methylation of cancer-stem-cell-associated Wnt target genes predicts poor prognosis in colorectal cancer patients. Cell Stem Cell 9:476-85. |
| 32 | Bunt J et.al. (2011). Joint binding of OTX2 and MYC in promotor regions is associated with high gene expression in medulloblastoma. PLoS One 6:e26058. |
| 31 | Lamers F et.al. (2011). Knockdown of survivin (BIRC5) causes apoptosis in neuroblastoma via mitotic catastrophe. Endocr Relat Cancer 18:657-68. |
| 30 | Haug BH et.al. (2011). MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma. Carcinogenesis 32:1005-12. |
| 29 | Murphy DM et.al. (2011). Dissection of the oncogenic MYCN transcriptional network reveals a large set of clinically relevant cell cycle genes as drivers of neuroblastoma tumorigenesis. Mol Carcinog 50:403-11. |
| 28 | PosthumaDeBoer J et.al. (2011). WEE1 inhibition sensitizes osteosarcoma to radiotherapy. BMC Cancer 11:156. |
| 27 | Liu Z et.al. (2011). CASZ1, a candidate tumor-suppressor gene, suppresses neuroblastoma tumor growth through reprogramming gene expression. Cell Death Differ 18:1174-83. |
| 26 | Buckley PG et.al. (2011). Genome-wide DNA methylation analysis of neuroblastic tumors reveals clinically relevant epigenetic events and large-scale epigenomic alterations localized to telomeric regions. Int J Cancer 128:2296-305. |
| 2010 (n=8) |
| 25 | Bunt J et.al. (2010). Regulation of cell cycle genes and induction of senescence by overexpression of OTX2 in medulloblastoma cell lines. Mol Cancer Res 8:1344-57. |
| 24 | Mergui X et.al. (2010). p21Waf1 expression is regulated by nuclear intermediate filament vimentin in neuroblastoma. BMC Cancer 10:473. |
| 23 | Holzel M et.al. (2010). NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome. Cell 142:218-29. |
| 22 | Borsics T et.al. (2010). Subcellular distribution and expression of prenylated Rab acceptor 1 domain family, member 2 (PRAF2) in malignant glioma: Influence on cell survival and migration. Cancer Sci 101:1624-31. |
| 21 | Verissimo CS et.al. (2010). Silencing of the microtubule-associated proteins doublecortin-like and doublecortin-like kinase-long induces apoptosis in neuroblastoma cells. Endocr Relat Cancer 17:399-414. |
| 20 | Molenaar JJ et.al. (2010). Cyclin D1 is a direct transcriptional target of GATA3 in neuroblastoma tumor cells. Oncogene 29:2739-45. |
| 19 | Geerts D et.al. (2010). The polyamine metabolism genes ornithine decarboxylase and antizyme 2 predict aggressive behavior in neuroblastomas with and without MYCN amplification. Int J Cancer 126:2012-24. |
| 18 | Revet I et.al. (2010). MSX1 induces the Wnt pathway antagonist genes DKK1, DKK2, DKK3, and SFRP1 in neuroblastoma cells, but does not block Wnt3 and Wnt5A signalling to DVL3. Cancer Lett 289:195-207. |
| 2009 (n=7) |
| 17 | Molenaar JJ et.al. (2009). Inactivation of CDK2 is synthetically lethal to MYCN over-expressing cancer cells. Proc Natl Acad Sci U S A 106:12968-73. |
| 16 | Cimmino F et.al. (2009). Galectin-1 is a major effector of TrkB-mediated neuroblastoma aggressiveness. Oncogene 28:2015-23. |
| 15 | Huang S et.al. (2009). ZNF423 is critically required for retinoic acid-induced differentiation and is a marker of neuroblastoma outcome. Cancer Cell 15:328-40. |
| 14 | van Hooff SR et.al. (2009). The construction of genome-based transcriptional units. OMICS 13:105-14. |
| 13 | Missiaglia E et.al. (2009). Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: an approach to identify candidate genes involved in tumor development. Genes Chromosomes Cancer 48:455-67. |
| 12 | Schulte JH et.al. (2009). Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy. Cancer Res 69:2065-71. |
| 11 | Schulte JH et.al. (2009). The low-affinity neurotrophin receptor, p75, is upregulated in ganglioneuroblastoma/ganglioneuroma and reduces tumorigenicity of neuroblastoma cells in vivo. Int J Cancer 124:2488-94. |
| 2008 (n=5) |
| 10 | Kool M et.al. (2008). Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PLoS One 3:e3088. |
| 9 | Molenaar JJ et.al. (2008). Cyclin D1 and CDK4 activity contribute to the undifferentiated phenotype in neuroblastoma. Cancer Res 68:2599-609. |
| 8 | Revet I et.al. (2008). The MSX1 homeobox transcription factor is a downstream target of PHOX2B and activates the Delta-Notch pathway in neuroblastoma. Exp Cell Res 314:707-19. |
| 7 | Merks JH et.al. (2008). Prevalence and patterns of morphological abnormalities in patients with childhood cancer. JAMA 299:61-9. |
| 6 | Koppen A et.al. (2008). Dickkopf-3 expression is a marker for neuroblastic tumor maturation and is down-regulated by MYCN. Int J Cancer 122:1455-64. |
| 2007 (n=4) |
| 5 | Geerts D et.al. (2007). Expression of prenylated Rab acceptor 1 domain family, member 2 (PRAF2) in neuroblastoma: correlation with clinical features, cellular localization, and cerulenin-mediated apoptosis regulation. Clin Cancer Res 13:6312-9. |
| 4 | Koppen A et.al. (2007). Direct regulation of the minichromosome maintenance complex by MYCN in neuroblastoma. Eur J Cancer 43:2413-22. |
| 3 | Koppen A et.al. (2007). Dickkopf-1 is down-regulated by MYCN and inhibits neuroblastoma cell proliferation. Cancer Lett 256:218-28. |
| 2 | Mainguy G et.al. (2007). Extensive polycistronism and antisense transcription in the mammalian Hox clusters. PLoS One 2:e356. |
| 2006 (n=1) |
| 1 | Valentijn LJ et.al. (2006). Read-through transcript from NM23-H1 into the neighboring NM23-H2 gene encodes a novel protein, NM23-LV. Genomics 87:483-9. |
